id	sid	tid	token	lemma	pos
10_1101-2021_01_07_425675	1	1	Mass	Mass	NNP
10_1101-2021_01_07_425675	1	2	spectrometry	spectrometry	NN
10_1101-2021_01_07_425675	1	3	-	-	HYPH
10_1101-2021_01_07_425675	1	4	based	base	VBN
10_1101-2021_01_07_425675	1	5	sequencing	sequencing	NN
10_1101-2021_01_07_425675	1	6	of	of	IN
10_1101-2021_01_07_425675	1	7	the	the	DT
10_1101-2021_01_07_425675	1	8	anti	anti	JJ
10_1101-2021_01_07_425675	1	9	-	-	JJ
10_1101-2021_01_07_425675	1	10	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	1	11	-	-	HYPH
10_1101-2021_01_07_425675	1	12	M2	M2	NNP
10_1101-2021_01_07_425675	1	13	antibody	antibody	NN
10_1101-2021_01_07_425675	1	14	using	use	VBG
10_1101-2021_01_07_425675	1	15	multiple	multiple	JJ
10_1101-2021_01_07_425675	1	16	proteases	protease	NNS
10_1101-2021_01_07_425675	1	17	and	and	CC
10_1101-2021_01_07_425675	1	18	a	a	DT
10_1101-2021_01_07_425675	1	19	dual	dual	JJ
10_1101-2021_01_07_425675	1	20	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	1	21	scheme	scheme	NN
10_1101-2021_01_07_425675	1	22	1	1	CD
10_1101-2021_01_07_425675	1	23	Mass	Mass	NNP
10_1101-2021_01_07_425675	1	24	spectrometry	spectrometry	NN
10_1101-2021_01_07_425675	1	25	-	-	HYPH
10_1101-2021_01_07_425675	1	26	based	base	VBN
10_1101-2021_01_07_425675	1	27	sequencing	sequencing	NN
10_1101-2021_01_07_425675	1	28	of	of	IN
10_1101-2021_01_07_425675	1	29	the	the	DT
10_1101-2021_01_07_425675	1	30	anti	anti	JJ
10_1101-2021_01_07_425675	1	31	-	-	JJ
10_1101-2021_01_07_425675	1	32	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	1	33	-	-	HYPH
10_1101-2021_01_07_425675	1	34	M2	M2	NNP
10_1101-2021_01_07_425675	1	35	antibody	antibody	NN
10_1101-2021_01_07_425675	1	36	using	use	VBG
10_1101-2021_01_07_425675	1	37	multiple	multiple	JJ
10_1101-2021_01_07_425675	1	38	1	1	CD
10_1101-2021_01_07_425675	1	39	proteases	protease	NNS
10_1101-2021_01_07_425675	1	40	and	and	CC
10_1101-2021_01_07_425675	1	41	a	a	DT
10_1101-2021_01_07_425675	1	42	dual	dual	JJ
10_1101-2021_01_07_425675	1	43	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	1	44	scheme	scheme	NN
10_1101-2021_01_07_425675	1	45	2	2	CD
10_1101-2021_01_07_425675	1	46	3	3	CD
10_1101-2021_01_07_425675	1	47	Authors	author	NNS
10_1101-2021_01_07_425675	1	48	:	:	:
10_1101-2021_01_07_425675	1	49	4	4	CD
10_1101-2021_01_07_425675	1	50	Weiwei	Weiwei	NNP
10_1101-2021_01_07_425675	1	51	Peng1	peng1	CD
10_1101-2021_01_07_425675	1	52	#	#	$
10_1101-2021_01_07_425675	1	53	,	,	,
10_1101-2021_01_07_425675	1	54	Matti	Matti	NNP
10_1101-2021_01_07_425675	1	55	F.	F.	NNP
10_1101-2021_01_07_425675	1	56	Pronker1	Pronker1	NNP
10_1101-2021_01_07_425675	1	57	#	#	NNP
10_1101-2021_01_07_425675	1	58	,	,	,
10_1101-2021_01_07_425675	1	59	Joost	Joost	NNP
10_1101-2021_01_07_425675	1	60	Snijder1	Snijder1	NNP
10_1101-2021_01_07_425675	1	61	*	*	NFP
10_1101-2021_01_07_425675	1	62	5	5	CD
10_1101-2021_01_07_425675	1	63	6	6	CD
10_1101-2021_01_07_425675	1	64	#	#	$
10_1101-2021_01_07_425675	1	65	equal	equal	JJ
10_1101-2021_01_07_425675	1	66	contribution	contribution	NN
10_1101-2021_01_07_425675	1	67	7	7	CD
10_1101-2021_01_07_425675	1	68	*	*	SYM
10_1101-2021_01_07_425675	1	69	corresponding	correspond	VBG
10_1101-2021_01_07_425675	1	70	author	author	NN
10_1101-2021_01_07_425675	1	71	:	:	:
10_1101-2021_01_07_425675	1	72	j.snijder@uu.nl	j.snijder@uu.nl	NNP
10_1101-2021_01_07_425675	1	73	8	8	CD
10_1101-2021_01_07_425675	1	74	9	9	CD
10_1101-2021_01_07_425675	1	75	Affiliation	affiliation	NN
10_1101-2021_01_07_425675	1	76	:	:	:
10_1101-2021_01_07_425675	1	77	10	10	CD
10_1101-2021_01_07_425675	1	78	1	1	CD
10_1101-2021_01_07_425675	1	79	Biomolecular	Biomolecular	NNP
10_1101-2021_01_07_425675	1	80	Mass	Mass	NNP
10_1101-2021_01_07_425675	1	81	Spectrometry	Spectrometry	NNP
10_1101-2021_01_07_425675	1	82	and	and	CC
10_1101-2021_01_07_425675	1	83	Proteomics	Proteomics	NNP
10_1101-2021_01_07_425675	1	84	,	,	,
10_1101-2021_01_07_425675	1	85	Bijvoet	Bijvoet	NNP
10_1101-2021_01_07_425675	1	86	Center	Center	NNP
10_1101-2021_01_07_425675	1	87	for	for	IN
10_1101-2021_01_07_425675	1	88	Biomolecular	Biomolecular	NNP
10_1101-2021_01_07_425675	1	89	Research	Research	NNP
10_1101-2021_01_07_425675	1	90	11	11	CD
10_1101-2021_01_07_425675	1	91	and	and	CC
10_1101-2021_01_07_425675	1	92	Utrecht	Utrecht	NNP
10_1101-2021_01_07_425675	1	93	Institute	Institute	NNP
10_1101-2021_01_07_425675	1	94	of	of	IN
10_1101-2021_01_07_425675	1	95	Pharmaceutical	Pharmaceutical	NNP
10_1101-2021_01_07_425675	1	96	Sciences	Sciences	NNPS
10_1101-2021_01_07_425675	1	97	,	,	,
10_1101-2021_01_07_425675	1	98	Utrecht	Utrecht	NNP
10_1101-2021_01_07_425675	1	99	University	University	NNP
10_1101-2021_01_07_425675	1	100	,	,	,
10_1101-2021_01_07_425675	1	101	Padualaan	Padualaan	NNP
10_1101-2021_01_07_425675	1	102	8	8	CD
10_1101-2021_01_07_425675	1	103	,	,	,
10_1101-2021_01_07_425675	1	104	3584	3584	CD
10_1101-2021_01_07_425675	1	105	CH	CH	NNP
10_1101-2021_01_07_425675	1	106	12	12	CD
10_1101-2021_01_07_425675	1	107	Utrecht	Utrecht	NNP
10_1101-2021_01_07_425675	1	108	,	,	,
10_1101-2021_01_07_425675	1	109	The	the	DT
10_1101-2021_01_07_425675	1	110	Netherlands	Netherlands	NNP
10_1101-2021_01_07_425675	1	111	13	13	CD
10_1101-2021_01_07_425675	1	112	14	14	CD
10_1101-2021_01_07_425675	1	113	Keywords	keyword	NNS
10_1101-2021_01_07_425675	1	114	:	:	:
10_1101-2021_01_07_425675	1	115	15	15	CD
10_1101-2021_01_07_425675	1	116	mass	mass	NN
10_1101-2021_01_07_425675	1	117	spectrometry	spectrometry	NN
10_1101-2021_01_07_425675	1	118	,	,	,
10_1101-2021_01_07_425675	1	119	antibody	antibody	NN
10_1101-2021_01_07_425675	1	120	,	,	,
10_1101-2021_01_07_425675	1	121	de	de	NNP
10_1101-2021_01_07_425675	1	122	novo	novo	NNP
10_1101-2021_01_07_425675	1	123	sequencing	sequencing	NNP
10_1101-2021_01_07_425675	1	124	,	,	,
10_1101-2021_01_07_425675	1	125	EThcD	EThcD	NNP
10_1101-2021_01_07_425675	1	126	,	,	,
10_1101-2021_01_07_425675	1	127	stepped	step	VBD
10_1101-2021_01_07_425675	1	128	HCD	HCD	NNP
10_1101-2021_01_07_425675	1	129	,	,	,
10_1101-2021_01_07_425675	1	130	Herceptin	Herceptin	NNP
10_1101-2021_01_07_425675	1	131	,	,	,
10_1101-2021_01_07_425675	1	132	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	1	133	tag	tag	NN
10_1101-2021_01_07_425675	1	134	,	,	,
10_1101-2021_01_07_425675	1	135	16	16	CD
10_1101-2021_01_07_425675	1	136	anti	anti	JJ
10_1101-2021_01_07_425675	1	137	-	-	JJ
10_1101-2021_01_07_425675	1	138	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	1	139	-	-	HYPH
10_1101-2021_01_07_425675	1	140	M2	M2	NNP
10_1101-2021_01_07_425675	1	141	.	.	.
10_1101-2021_01_07_425675	2	1	17	17	CD
10_1101-2021_01_07_425675	2	2	.CC	.CC	:
10_1101-2021_01_07_425675	2	3	-	-	:
10_1101-2021_01_07_425675	2	4	BY	by	IN
10_1101-2021_01_07_425675	2	5	4.0	4.0	CD
10_1101-2021_01_07_425675	2	6	International	International	NNP
10_1101-2021_01_07_425675	2	7	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	2	8	under	under	IN
10_1101-2021_01_07_425675	2	9	a	a	DT
10_1101-2021_01_07_425675	2	10	(	(	-LRB-
10_1101-2021_01_07_425675	2	11	which	which	WDT
10_1101-2021_01_07_425675	2	12	was	be	VBD
10_1101-2021_01_07_425675	2	13	not	not	RB
10_1101-2021_01_07_425675	2	14	certified	certify	VBN
10_1101-2021_01_07_425675	2	15	by	by	IN
10_1101-2021_01_07_425675	2	16	peer	peer	NN
10_1101-2021_01_07_425675	2	17	review	review	NN
10_1101-2021_01_07_425675	2	18	)	)	-RRB-
10_1101-2021_01_07_425675	2	19	is	be	VBZ
10_1101-2021_01_07_425675	2	20	the	the	DT
10_1101-2021_01_07_425675	2	21	author	author	NN
10_1101-2021_01_07_425675	2	22	/	/	SYM
10_1101-2021_01_07_425675	2	23	funder	funder	NN
10_1101-2021_01_07_425675	2	24	,	,	,
10_1101-2021_01_07_425675	2	25	who	who	WP
10_1101-2021_01_07_425675	2	26	has	have	VBZ
10_1101-2021_01_07_425675	2	27	granted	grant	VBN
10_1101-2021_01_07_425675	2	28	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	2	29	a	a	DT
10_1101-2021_01_07_425675	2	30	license	license	NN
10_1101-2021_01_07_425675	2	31	to	to	TO
10_1101-2021_01_07_425675	2	32	display	display	VB
10_1101-2021_01_07_425675	2	33	the	the	DT
10_1101-2021_01_07_425675	2	34	preprint	preprint	NN
10_1101-2021_01_07_425675	2	35	in	in	IN
10_1101-2021_01_07_425675	2	36	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	2	37	.	.	.
10_1101-2021_01_07_425675	3	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	3	2	is	be	VBZ
10_1101-2021_01_07_425675	3	3	made	make	VBN
10_1101-2021_01_07_425675	3	4	The	the	DT
10_1101-2021_01_07_425675	3	5	copyright	copyright	NN
10_1101-2021_01_07_425675	3	6	holder	holder	NN
10_1101-2021_01_07_425675	3	7	for	for	IN
10_1101-2021_01_07_425675	3	8	this	this	DT
10_1101-2021_01_07_425675	3	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	3	10	version	version	NN
10_1101-2021_01_07_425675	3	11	posted	post	VBD
10_1101-2021_01_07_425675	3	12	January	January	NNP
10_1101-2021_01_07_425675	3	13	8	8	CD
10_1101-2021_01_07_425675	3	14	,	,	,
10_1101-2021_01_07_425675	3	15	2021	2021	CD
10_1101-2021_01_07_425675	3	16	.	.	.
10_1101-2021_01_07_425675	3	17	;	;	:
10_1101-2021_01_07_425675	3	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	3	19	:	:	:
10_1101-2021_01_07_425675	3	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	3	21	preprint	preprint	NN
10_1101-2021_01_07_425675	3	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NN
10_1101-2021_01_07_425675	3	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	3	24	2	2	CD
10_1101-2021_01_07_425675	3	25	Abstract	Abstract	NNP
10_1101-2021_01_07_425675	3	26	:	:	:
10_1101-2021_01_07_425675	3	27	18	18	CD
10_1101-2021_01_07_425675	3	28	Antibody	antibody	NN
10_1101-2021_01_07_425675	3	29	sequence	sequence	NN
10_1101-2021_01_07_425675	3	30	information	information	NN
10_1101-2021_01_07_425675	3	31	is	be	VBZ
10_1101-2021_01_07_425675	3	32	crucial	crucial	JJ
10_1101-2021_01_07_425675	3	33	to	to	IN
10_1101-2021_01_07_425675	3	34	understanding	understand	VBG
10_1101-2021_01_07_425675	3	35	the	the	DT
10_1101-2021_01_07_425675	3	36	structural	structural	JJ
10_1101-2021_01_07_425675	3	37	basis	basis	NN
10_1101-2021_01_07_425675	3	38	for	for	IN
10_1101-2021_01_07_425675	3	39	antigen	antigen	NNP
10_1101-2021_01_07_425675	3	40	binding	bind	VBG
10_1101-2021_01_07_425675	3	41	19	19	CD
10_1101-2021_01_07_425675	3	42	and	and	CC
10_1101-2021_01_07_425675	3	43	enables	enable	VBZ
10_1101-2021_01_07_425675	3	44	the	the	DT
10_1101-2021_01_07_425675	3	45	use	use	NN
10_1101-2021_01_07_425675	3	46	of	of	IN
10_1101-2021_01_07_425675	3	47	antibodies	antibody	NNS
10_1101-2021_01_07_425675	3	48	as	as	IN
10_1101-2021_01_07_425675	3	49	therapeutics	therapeutic	NNS
10_1101-2021_01_07_425675	3	50	and	and	CC
10_1101-2021_01_07_425675	3	51	research	research	NN
10_1101-2021_01_07_425675	3	52	tools	tool	NNS
10_1101-2021_01_07_425675	3	53	.	.	.
10_1101-2021_01_07_425675	4	1	Here	here	RB
10_1101-2021_01_07_425675	4	2	we	-PRON-	PRP
10_1101-2021_01_07_425675	4	3	demonstrate	demonstrate	VBP
10_1101-2021_01_07_425675	4	4	a	a	DT
10_1101-2021_01_07_425675	4	5	20	20	CD
10_1101-2021_01_07_425675	4	6	method	method	NN
10_1101-2021_01_07_425675	4	7	for	for	IN
10_1101-2021_01_07_425675	4	8	direct	direct	JJ
10_1101-2021_01_07_425675	4	9	de	de	FW
10_1101-2021_01_07_425675	4	10	novo	novo	NNP
10_1101-2021_01_07_425675	4	11	sequencing	sequencing	NN
10_1101-2021_01_07_425675	4	12	of	of	IN
10_1101-2021_01_07_425675	4	13	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	4	14	IgG	IgG	NNP
10_1101-2021_01_07_425675	4	15	from	from	IN
10_1101-2021_01_07_425675	4	16	the	the	DT
10_1101-2021_01_07_425675	4	17	purified	purified	JJ
10_1101-2021_01_07_425675	4	18	antibody	antibody	NN
10_1101-2021_01_07_425675	4	19	products	product	NNS
10_1101-2021_01_07_425675	4	20	.	.	.
10_1101-2021_01_07_425675	5	1	The	the	DT
10_1101-2021_01_07_425675	5	2	21	21	CD
10_1101-2021_01_07_425675	5	3	method	method	NN
10_1101-2021_01_07_425675	5	4	uses	use	VBZ
10_1101-2021_01_07_425675	5	5	a	a	DT
10_1101-2021_01_07_425675	5	6	panel	panel	NN
10_1101-2021_01_07_425675	5	7	of	of	IN
10_1101-2021_01_07_425675	5	8	multiple	multiple	JJ
10_1101-2021_01_07_425675	5	9	complementary	complementary	JJ
10_1101-2021_01_07_425675	5	10	proteases	protease	NNS
10_1101-2021_01_07_425675	5	11	to	to	TO
10_1101-2021_01_07_425675	5	12	generate	generate	VB
10_1101-2021_01_07_425675	5	13	suitable	suitable	JJ
10_1101-2021_01_07_425675	5	14	peptides	peptide	NNS
10_1101-2021_01_07_425675	5	15	for	for	IN
10_1101-2021_01_07_425675	5	16	de	de	NNP
10_1101-2021_01_07_425675	5	17	22	22	CD
10_1101-2021_01_07_425675	5	18	novo	novo	NNP
10_1101-2021_01_07_425675	5	19	sequencing	sequencing	NN
10_1101-2021_01_07_425675	5	20	by	by	IN
10_1101-2021_01_07_425675	5	21	LC	LC	NNP
10_1101-2021_01_07_425675	5	22	-	-	HYPH
10_1101-2021_01_07_425675	5	23	MS	MS	NNP
10_1101-2021_01_07_425675	5	24	/	/	SYM
10_1101-2021_01_07_425675	5	25	MS	MS	NNP
10_1101-2021_01_07_425675	5	26	in	in	IN
10_1101-2021_01_07_425675	5	27	a	a	DT
10_1101-2021_01_07_425675	5	28	bottom	bottom	NN
10_1101-2021_01_07_425675	5	29	-	-	HYPH
10_1101-2021_01_07_425675	5	30	up	up	RP
10_1101-2021_01_07_425675	5	31	fashion	fashion	NN
10_1101-2021_01_07_425675	5	32	.	.	.
10_1101-2021_01_07_425675	6	1	Furthermore	furthermore	RB
10_1101-2021_01_07_425675	6	2	,	,	,
10_1101-2021_01_07_425675	6	3	we	-PRON-	PRP
10_1101-2021_01_07_425675	6	4	apply	apply	VBP
10_1101-2021_01_07_425675	6	5	a	a	DT
10_1101-2021_01_07_425675	6	6	dual	dual	JJ
10_1101-2021_01_07_425675	6	7	23	23	CD
10_1101-2021_01_07_425675	6	8	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	6	9	scheme	scheme	NN
10_1101-2021_01_07_425675	6	10	,	,	,
10_1101-2021_01_07_425675	6	11	using	use	VBG
10_1101-2021_01_07_425675	6	12	both	both	DT
10_1101-2021_01_07_425675	6	13	stepped	step	VBD
10_1101-2021_01_07_425675	6	14	high	high	JJ
10_1101-2021_01_07_425675	6	15	-	-	HYPH
10_1101-2021_01_07_425675	6	16	energy	energy	NN
10_1101-2021_01_07_425675	6	17	collision	collision	NN
10_1101-2021_01_07_425675	6	18	dissociation	dissociation	NN
10_1101-2021_01_07_425675	6	19	(	(	-LRB-
10_1101-2021_01_07_425675	6	20	stepped	step	VBD
10_1101-2021_01_07_425675	6	21	HCD	HCD	NNP
10_1101-2021_01_07_425675	6	22	)	)	-RRB-
10_1101-2021_01_07_425675	6	23	and	and	CC
10_1101-2021_01_07_425675	6	24	24	24	CD
10_1101-2021_01_07_425675	6	25	electron	electron	NN
10_1101-2021_01_07_425675	6	26	transfer	transfer	NN
10_1101-2021_01_07_425675	6	27	high	high	JJ
10_1101-2021_01_07_425675	6	28	-	-	HYPH
10_1101-2021_01_07_425675	6	29	energy	energy	NN
10_1101-2021_01_07_425675	6	30	collision	collision	NN
10_1101-2021_01_07_425675	6	31	dissociation	dissociation	NN
10_1101-2021_01_07_425675	6	32	(	(	-LRB-
10_1101-2021_01_07_425675	6	33	EThcD	EThcD	NNP
10_1101-2021_01_07_425675	6	34	)	)	-RRB-
10_1101-2021_01_07_425675	6	35	on	on	IN
10_1101-2021_01_07_425675	6	36	all	all	DT
10_1101-2021_01_07_425675	6	37	peptide	peptide	JJ
10_1101-2021_01_07_425675	6	38	precursors	precursor	NNS
10_1101-2021_01_07_425675	6	39	.	.	.
10_1101-2021_01_07_425675	7	1	The	the	DT
10_1101-2021_01_07_425675	7	2	method	method	NN
10_1101-2021_01_07_425675	7	3	25	25	CD
10_1101-2021_01_07_425675	7	4	achieves	achieve	VBZ
10_1101-2021_01_07_425675	7	5	full	full	JJ
10_1101-2021_01_07_425675	7	6	sequence	sequence	NN
10_1101-2021_01_07_425675	7	7	coverage	coverage	NN
10_1101-2021_01_07_425675	7	8	of	of	IN
10_1101-2021_01_07_425675	7	9	the	the	DT
10_1101-2021_01_07_425675	7	10	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	7	11	antibody	antibody	NN
10_1101-2021_01_07_425675	7	12	Herceptin	Herceptin	NNP
10_1101-2021_01_07_425675	7	13	,	,	,
10_1101-2021_01_07_425675	7	14	with	with	IN
10_1101-2021_01_07_425675	7	15	an	an	DT
10_1101-2021_01_07_425675	7	16	accuracy	accuracy	NN
10_1101-2021_01_07_425675	7	17	of	of	IN
10_1101-2021_01_07_425675	7	18	99	99	CD
10_1101-2021_01_07_425675	7	19	%	%	NN
10_1101-2021_01_07_425675	7	20	26	26	CD
10_1101-2021_01_07_425675	7	21	in	in	IN
10_1101-2021_01_07_425675	7	22	the	the	DT
10_1101-2021_01_07_425675	7	23	variable	variable	JJ
10_1101-2021_01_07_425675	7	24	regions	region	NNS
10_1101-2021_01_07_425675	7	25	.	.	.
10_1101-2021_01_07_425675	8	1	We	-PRON-	PRP
10_1101-2021_01_07_425675	8	2	applied	apply	VBD
10_1101-2021_01_07_425675	8	3	the	the	DT
10_1101-2021_01_07_425675	8	4	method	method	NN
10_1101-2021_01_07_425675	8	5	to	to	TO
10_1101-2021_01_07_425675	8	6	sequence	sequence	VB
10_1101-2021_01_07_425675	8	7	the	the	DT
10_1101-2021_01_07_425675	8	8	widely	widely	RB
10_1101-2021_01_07_425675	8	9	used	use	VBN
10_1101-2021_01_07_425675	8	10	anti	anti	JJ
10_1101-2021_01_07_425675	8	11	-	-	JJ
10_1101-2021_01_07_425675	8	12	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	8	13	-	-	HYPH
10_1101-2021_01_07_425675	8	14	M2	M2	NNP
10_1101-2021_01_07_425675	8	15	mouse	mouse	NN
10_1101-2021_01_07_425675	8	16	27	27	CD
10_1101-2021_01_07_425675	8	17	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	8	18	antibody	antibody	NN
10_1101-2021_01_07_425675	8	19	,	,	,
10_1101-2021_01_07_425675	8	20	which	which	WDT
10_1101-2021_01_07_425675	8	21	we	-PRON-	PRP
10_1101-2021_01_07_425675	8	22	successfully	successfully	RB
10_1101-2021_01_07_425675	8	23	validated	validate	VBD
10_1101-2021_01_07_425675	8	24	by	by	IN
10_1101-2021_01_07_425675	8	25	remodeling	remodel	VBG
10_1101-2021_01_07_425675	8	26	a	a	DT
10_1101-2021_01_07_425675	8	27	high	high	JJ
10_1101-2021_01_07_425675	8	28	-	-	HYPH
10_1101-2021_01_07_425675	8	29	resolution	resolution	NN
10_1101-2021_01_07_425675	8	30	crystal	crystal	NN
10_1101-2021_01_07_425675	8	31	28	28	CD
10_1101-2021_01_07_425675	8	32	structure	structure	NN
10_1101-2021_01_07_425675	8	33	of	of	IN
10_1101-2021_01_07_425675	8	34	the	the	DT
10_1101-2021_01_07_425675	8	35	Fab	Fab	NNP
10_1101-2021_01_07_425675	8	36	and	and	CC
10_1101-2021_01_07_425675	8	37	demonstrating	demonstrate	VBG
10_1101-2021_01_07_425675	8	38	binding	bind	VBG
10_1101-2021_01_07_425675	8	39	to	to	IN
10_1101-2021_01_07_425675	8	40	a	a	DT
10_1101-2021_01_07_425675	8	41	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	8	42	-	-	HYPH
10_1101-2021_01_07_425675	8	43	tagged	tag	VBN
10_1101-2021_01_07_425675	8	44	target	target	NN
10_1101-2021_01_07_425675	8	45	protein	protein	NN
10_1101-2021_01_07_425675	8	46	in	in	IN
10_1101-2021_01_07_425675	8	47	Western	western	JJ
10_1101-2021_01_07_425675	8	48	blot	blot	NN
10_1101-2021_01_07_425675	8	49	29	29	CD
10_1101-2021_01_07_425675	8	50	analysis	analysis	NN
10_1101-2021_01_07_425675	8	51	.	.	.
10_1101-2021_01_07_425675	9	1	The	the	DT
10_1101-2021_01_07_425675	9	2	method	method	NN
10_1101-2021_01_07_425675	9	3	thus	thus	RB
10_1101-2021_01_07_425675	9	4	offers	offer	VBZ
10_1101-2021_01_07_425675	9	5	robust	robust	JJ
10_1101-2021_01_07_425675	9	6	and	and	CC
10_1101-2021_01_07_425675	9	7	reliable	reliable	JJ
10_1101-2021_01_07_425675	9	8	sequences	sequence	NNS
10_1101-2021_01_07_425675	9	9	of	of	IN
10_1101-2021_01_07_425675	9	10	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	9	11	antibodies	antibody	NNS
10_1101-2021_01_07_425675	9	12	.	.	.
10_1101-2021_01_07_425675	10	1	30	30	CD
10_1101-2021_01_07_425675	10	2	.CC	.CC	:
10_1101-2021_01_07_425675	10	3	-	-	:
10_1101-2021_01_07_425675	10	4	BY	by	IN
10_1101-2021_01_07_425675	10	5	4.0	4.0	CD
10_1101-2021_01_07_425675	10	6	International	International	NNP
10_1101-2021_01_07_425675	10	7	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	10	8	under	under	IN
10_1101-2021_01_07_425675	10	9	a	a	DT
10_1101-2021_01_07_425675	10	10	(	(	-LRB-
10_1101-2021_01_07_425675	10	11	which	which	WDT
10_1101-2021_01_07_425675	10	12	was	be	VBD
10_1101-2021_01_07_425675	10	13	not	not	RB
10_1101-2021_01_07_425675	10	14	certified	certify	VBN
10_1101-2021_01_07_425675	10	15	by	by	IN
10_1101-2021_01_07_425675	10	16	peer	peer	NN
10_1101-2021_01_07_425675	10	17	review	review	NN
10_1101-2021_01_07_425675	10	18	)	)	-RRB-
10_1101-2021_01_07_425675	10	19	is	be	VBZ
10_1101-2021_01_07_425675	10	20	the	the	DT
10_1101-2021_01_07_425675	10	21	author	author	NN
10_1101-2021_01_07_425675	10	22	/	/	SYM
10_1101-2021_01_07_425675	10	23	funder	funder	NN
10_1101-2021_01_07_425675	10	24	,	,	,
10_1101-2021_01_07_425675	10	25	who	who	WP
10_1101-2021_01_07_425675	10	26	has	have	VBZ
10_1101-2021_01_07_425675	10	27	granted	grant	VBN
10_1101-2021_01_07_425675	10	28	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	10	29	a	a	DT
10_1101-2021_01_07_425675	10	30	license	license	NN
10_1101-2021_01_07_425675	10	31	to	to	TO
10_1101-2021_01_07_425675	10	32	display	display	VB
10_1101-2021_01_07_425675	10	33	the	the	DT
10_1101-2021_01_07_425675	10	34	preprint	preprint	NN
10_1101-2021_01_07_425675	10	35	in	in	IN
10_1101-2021_01_07_425675	10	36	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	10	37	.	.	.
10_1101-2021_01_07_425675	11	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	11	2	is	be	VBZ
10_1101-2021_01_07_425675	11	3	made	make	VBN
10_1101-2021_01_07_425675	11	4	The	the	DT
10_1101-2021_01_07_425675	11	5	copyright	copyright	NN
10_1101-2021_01_07_425675	11	6	holder	holder	NN
10_1101-2021_01_07_425675	11	7	for	for	IN
10_1101-2021_01_07_425675	11	8	this	this	DT
10_1101-2021_01_07_425675	11	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	11	10	version	version	NN
10_1101-2021_01_07_425675	11	11	posted	post	VBD
10_1101-2021_01_07_425675	11	12	January	January	NNP
10_1101-2021_01_07_425675	11	13	8	8	CD
10_1101-2021_01_07_425675	11	14	,	,	,
10_1101-2021_01_07_425675	11	15	2021	2021	CD
10_1101-2021_01_07_425675	11	16	.	.	.
10_1101-2021_01_07_425675	11	17	;	;	:
10_1101-2021_01_07_425675	11	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	11	19	:	:	:
10_1101-2021_01_07_425675	11	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	11	21	preprint	preprint	NN
10_1101-2021_01_07_425675	11	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NN
10_1101-2021_01_07_425675	11	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	11	24	3	3	CD
10_1101-2021_01_07_425675	11	25	Introduction	introduction	NN
10_1101-2021_01_07_425675	11	26	31	31	CD
10_1101-2021_01_07_425675	11	27	Antibodies	Antibodies	NNPS
10_1101-2021_01_07_425675	11	28	can	can	MD
10_1101-2021_01_07_425675	11	29	bind	bind	VB
10_1101-2021_01_07_425675	11	30	a	a	DT
10_1101-2021_01_07_425675	11	31	great	great	JJ
10_1101-2021_01_07_425675	11	32	molecular	molecular	JJ
10_1101-2021_01_07_425675	11	33	diversity	diversity	NN
10_1101-2021_01_07_425675	11	34	of	of	IN
10_1101-2021_01_07_425675	11	35	antigens	antigen	NNS
10_1101-2021_01_07_425675	11	36	,	,	,
10_1101-2021_01_07_425675	11	37	owing	owe	VBG
10_1101-2021_01_07_425675	11	38	to	to	IN
10_1101-2021_01_07_425675	11	39	the	the	DT
10_1101-2021_01_07_425675	11	40	high	high	JJ
10_1101-2021_01_07_425675	11	41	degree	degree	NN
10_1101-2021_01_07_425675	11	42	of	of	IN
10_1101-2021_01_07_425675	11	43	sequence	sequence	NN
10_1101-2021_01_07_425675	11	44	32	32	CD
10_1101-2021_01_07_425675	11	45	diversity	diversity	NN
10_1101-2021_01_07_425675	11	46	that	that	WDT
10_1101-2021_01_07_425675	11	47	is	be	VBZ
10_1101-2021_01_07_425675	11	48	available	available	JJ
10_1101-2021_01_07_425675	11	49	through	through	IN
10_1101-2021_01_07_425675	11	50	somatic	somatic	JJ
10_1101-2021_01_07_425675	11	51	recombination	recombination	NN
10_1101-2021_01_07_425675	11	52	,	,	,
10_1101-2021_01_07_425675	11	53	hypermutation	hypermutation	NN
10_1101-2021_01_07_425675	11	54	,	,	,
10_1101-2021_01_07_425675	11	55	and	and	CC
10_1101-2021_01_07_425675	11	56	heavy	heavy	JJ
10_1101-2021_01_07_425675	11	57	-	-	HYPH
10_1101-2021_01_07_425675	11	58	light	light	NN
10_1101-2021_01_07_425675	11	59	chain	chain	NN
10_1101-2021_01_07_425675	11	60	33	33	CD
10_1101-2021_01_07_425675	11	61	pairings	pairing	NNS
10_1101-2021_01_07_425675	11	62	1	1	CD
10_1101-2021_01_07_425675	11	63	-	-	SYM
10_1101-2021_01_07_425675	11	64	2	2	CD
10_1101-2021_01_07_425675	11	65	.	.	.
10_1101-2021_01_07_425675	12	1	Sequence	sequence	NN
10_1101-2021_01_07_425675	12	2	information	information	NN
10_1101-2021_01_07_425675	12	3	on	on	IN
10_1101-2021_01_07_425675	12	4	antibodies	antibody	NNS
10_1101-2021_01_07_425675	12	5	therefore	therefore	RB
10_1101-2021_01_07_425675	12	6	is	be	VBZ
10_1101-2021_01_07_425675	12	7	crucial	crucial	JJ
10_1101-2021_01_07_425675	12	8	to	to	IN
10_1101-2021_01_07_425675	12	9	understanding	understand	VBG
10_1101-2021_01_07_425675	12	10	the	the	DT
10_1101-2021_01_07_425675	12	11	34	34	CD
10_1101-2021_01_07_425675	12	12	structural	structural	JJ
10_1101-2021_01_07_425675	12	13	basis	basis	NN
10_1101-2021_01_07_425675	12	14	of	of	IN
10_1101-2021_01_07_425675	12	15	antigen	antigen	NNP
10_1101-2021_01_07_425675	12	16	binding	bind	VBG
10_1101-2021_01_07_425675	12	17	,	,	,
10_1101-2021_01_07_425675	12	18	how	how	WRB
10_1101-2021_01_07_425675	12	19	somatic	somatic	JJ
10_1101-2021_01_07_425675	12	20	hypermutation	hypermutation	NN
10_1101-2021_01_07_425675	12	21	governs	govern	VBZ
10_1101-2021_01_07_425675	12	22	affinity	affinity	NNP
10_1101-2021_01_07_425675	12	23	maturation	maturation	NNP
10_1101-2021_01_07_425675	12	24	,	,	,
10_1101-2021_01_07_425675	12	25	and	and	CC
10_1101-2021_01_07_425675	12	26	35	35	CD
10_1101-2021_01_07_425675	12	27	an	an	DT
10_1101-2021_01_07_425675	12	28	overall	overall	JJ
10_1101-2021_01_07_425675	12	29	understanding	understanding	NN
10_1101-2021_01_07_425675	12	30	of	of	IN
10_1101-2021_01_07_425675	12	31	the	the	DT
10_1101-2021_01_07_425675	12	32	adaptive	adaptive	JJ
10_1101-2021_01_07_425675	12	33	immune	immune	JJ
10_1101-2021_01_07_425675	12	34	response	response	NN
10_1101-2021_01_07_425675	12	35	in	in	IN
10_1101-2021_01_07_425675	12	36	health	health	NN
10_1101-2021_01_07_425675	12	37	and	and	CC
10_1101-2021_01_07_425675	12	38	disease	disease	NN
10_1101-2021_01_07_425675	12	39	,	,	,
10_1101-2021_01_07_425675	12	40	by	by	IN
10_1101-2021_01_07_425675	12	41	mapping	map	VBG
10_1101-2021_01_07_425675	12	42	36	36	CD
10_1101-2021_01_07_425675	12	43	out	out	IN
10_1101-2021_01_07_425675	12	44	the	the	DT
10_1101-2021_01_07_425675	12	45	antibody	antibody	NN
10_1101-2021_01_07_425675	12	46	repertoire	repertoire	NN
10_1101-2021_01_07_425675	12	47	.	.	.
10_1101-2021_01_07_425675	13	1	Moreover	moreover	RB
10_1101-2021_01_07_425675	13	2	,	,	,
10_1101-2021_01_07_425675	13	3	antibodies	antibody	NNS
10_1101-2021_01_07_425675	13	4	have	have	VBP
10_1101-2021_01_07_425675	13	5	become	become	VBN
10_1101-2021_01_07_425675	13	6	invaluable	invaluable	JJ
10_1101-2021_01_07_425675	13	7	research	research	NN
10_1101-2021_01_07_425675	13	8	tools	tool	NNS
10_1101-2021_01_07_425675	13	9	in	in	IN
10_1101-2021_01_07_425675	13	10	the	the	DT
10_1101-2021_01_07_425675	13	11	37	37	CD
10_1101-2021_01_07_425675	13	12	life	life	NN
10_1101-2021_01_07_425675	13	13	sciences	science	NNS
10_1101-2021_01_07_425675	13	14	and	and	CC
10_1101-2021_01_07_425675	13	15	ever	ever	RB
10_1101-2021_01_07_425675	13	16	more	more	RBR
10_1101-2021_01_07_425675	13	17	widely	widely	RB
10_1101-2021_01_07_425675	13	18	developed	develop	VBN
10_1101-2021_01_07_425675	13	19	as	as	IN
10_1101-2021_01_07_425675	13	20	therapeutic	therapeutic	JJ
10_1101-2021_01_07_425675	13	21	agents	agent	NNS
10_1101-2021_01_07_425675	13	22	3	3	CD
10_1101-2021_01_07_425675	13	23	-	-	SYM
10_1101-2021_01_07_425675	13	24	4	4	CD
10_1101-2021_01_07_425675	13	25	.	.	.
10_1101-2021_01_07_425675	14	1	In	in	IN
10_1101-2021_01_07_425675	14	2	this	this	DT
10_1101-2021_01_07_425675	14	3	context	context	NN
10_1101-2021_01_07_425675	14	4	,	,	,
10_1101-2021_01_07_425675	14	5	sequence	sequence	VB
10_1101-2021_01_07_425675	14	6	38	38	CD
10_1101-2021_01_07_425675	14	7	information	information	NN
10_1101-2021_01_07_425675	14	8	is	be	VBZ
10_1101-2021_01_07_425675	14	9	crucial	crucial	JJ
10_1101-2021_01_07_425675	14	10	for	for	IN
10_1101-2021_01_07_425675	14	11	the	the	DT
10_1101-2021_01_07_425675	14	12	use	use	NN
10_1101-2021_01_07_425675	14	13	,	,	,
10_1101-2021_01_07_425675	14	14	production	production	NN
10_1101-2021_01_07_425675	14	15	and	and	CC
10_1101-2021_01_07_425675	14	16	validation	validation	NN
10_1101-2021_01_07_425675	14	17	of	of	IN
10_1101-2021_01_07_425675	14	18	these	these	DT
10_1101-2021_01_07_425675	14	19	important	important	JJ
10_1101-2021_01_07_425675	14	20	research	research	NN
10_1101-2021_01_07_425675	14	21	tools	tool	NNS
10_1101-2021_01_07_425675	14	22	and	and	CC
10_1101-2021_01_07_425675	14	23	39	39	CD
10_1101-2021_01_07_425675	14	24	biopharmaceutical	biopharmaceutical	JJ
10_1101-2021_01_07_425675	14	25	agents	agent	NNS
10_1101-2021_01_07_425675	14	26	5	5	CD
10_1101-2021_01_07_425675	14	27	-	-	SYM
10_1101-2021_01_07_425675	14	28	6	6	CD
10_1101-2021_01_07_425675	14	29	.	.	.
10_1101-2021_01_07_425675	15	1	40	40	CD
10_1101-2021_01_07_425675	15	2	Antibody	antibody	NN
10_1101-2021_01_07_425675	15	3	sequences	sequence	NNS
10_1101-2021_01_07_425675	15	4	are	be	VBP
10_1101-2021_01_07_425675	15	5	typically	typically	RB
10_1101-2021_01_07_425675	15	6	obtained	obtain	VBN
10_1101-2021_01_07_425675	15	7	through	through	IN
10_1101-2021_01_07_425675	15	8	cloning	clone	VBG
10_1101-2021_01_07_425675	15	9	and	and	CC
10_1101-2021_01_07_425675	15	10	sequencing	sequencing	NN
10_1101-2021_01_07_425675	15	11	of	of	IN
10_1101-2021_01_07_425675	15	12	the	the	DT
10_1101-2021_01_07_425675	15	13	coding	coding	NN
10_1101-2021_01_07_425675	15	14	mRNAs	mrnas	$
10_1101-2021_01_07_425675	15	15	41	41	CD
10_1101-2021_01_07_425675	15	16	of	of	IN
10_1101-2021_01_07_425675	15	17	the	the	DT
10_1101-2021_01_07_425675	15	18	paired	pair	VBN
10_1101-2021_01_07_425675	15	19	heavy	heavy	JJ
10_1101-2021_01_07_425675	15	20	and	and	CC
10_1101-2021_01_07_425675	15	21	light	light	JJ
10_1101-2021_01_07_425675	15	22	chains	chain	NNS
10_1101-2021_01_07_425675	15	23	7	7	CD
10_1101-2021_01_07_425675	15	24	-	-	SYM
10_1101-2021_01_07_425675	15	25	9	9	CD
10_1101-2021_01_07_425675	15	26	.	.	.
10_1101-2021_01_07_425675	16	1	The	the	DT
10_1101-2021_01_07_425675	16	2	sequencing	sequencing	NN
10_1101-2021_01_07_425675	16	3	workflows	workflow	NNS
10_1101-2021_01_07_425675	16	4	thereby	thereby	RB
10_1101-2021_01_07_425675	16	5	rely	rely	VBP
10_1101-2021_01_07_425675	16	6	on	on	IN
10_1101-2021_01_07_425675	16	7	isolation	isolation	NN
10_1101-2021_01_07_425675	16	8	of	of	IN
10_1101-2021_01_07_425675	16	9	the	the	DT
10_1101-2021_01_07_425675	16	10	42	42	CD
10_1101-2021_01_07_425675	16	11	antibody	antibody	NN
10_1101-2021_01_07_425675	16	12	-	-	HYPH
10_1101-2021_01_07_425675	16	13	producing	produce	VBG
10_1101-2021_01_07_425675	16	14	cells	cell	NNS
10_1101-2021_01_07_425675	16	15	from	from	IN
10_1101-2021_01_07_425675	16	16	peripheral	peripheral	JJ
10_1101-2021_01_07_425675	16	17	blood	blood	NN
10_1101-2021_01_07_425675	16	18	monocytes	monocyte	NNS
10_1101-2021_01_07_425675	16	19	,	,	,
10_1101-2021_01_07_425675	16	20	or	or	CC
10_1101-2021_01_07_425675	16	21	spleen	spleen	NN
10_1101-2021_01_07_425675	16	22	and	and	CC
10_1101-2021_01_07_425675	16	23	bone	bone	NN
10_1101-2021_01_07_425675	16	24	marrow	marrow	NN
10_1101-2021_01_07_425675	16	25	tissues	tissue	NNS
10_1101-2021_01_07_425675	16	26	.	.	.
10_1101-2021_01_07_425675	17	1	43	43	CD
10_1101-2021_01_07_425675	17	2	These	these	DT
10_1101-2021_01_07_425675	17	3	antibody	antibody	NN
10_1101-2021_01_07_425675	17	4	-	-	HYPH
10_1101-2021_01_07_425675	17	5	producing	produce	VBG
10_1101-2021_01_07_425675	17	6	cells	cell	NNS
10_1101-2021_01_07_425675	17	7	are	be	VBP
10_1101-2021_01_07_425675	17	8	not	not	RB
10_1101-2021_01_07_425675	17	9	always	always	RB
10_1101-2021_01_07_425675	17	10	readily	readily	RB
10_1101-2021_01_07_425675	17	11	available	available	JJ
10_1101-2021_01_07_425675	17	12	however	however	RB
10_1101-2021_01_07_425675	17	13	,	,	,
10_1101-2021_01_07_425675	17	14	and	and	CC
10_1101-2021_01_07_425675	17	15	cloning	clone	VBG
10_1101-2021_01_07_425675	17	16	/	/	SYM
10_1101-2021_01_07_425675	17	17	sequencing	sequence	VBG
10_1101-2021_01_07_425675	17	18	44	44	CD
10_1101-2021_01_07_425675	17	19	of	of	IN
10_1101-2021_01_07_425675	17	20	the	the	DT
10_1101-2021_01_07_425675	17	21	paired	pair	VBN
10_1101-2021_01_07_425675	17	22	heavy	heavy	JJ
10_1101-2021_01_07_425675	17	23	and	and	CC
10_1101-2021_01_07_425675	17	24	light	light	JJ
10_1101-2021_01_07_425675	17	25	chains	chain	NNS
10_1101-2021_01_07_425675	17	26	is	be	VBZ
10_1101-2021_01_07_425675	17	27	a	a	DT
10_1101-2021_01_07_425675	17	28	non	non	JJ
10_1101-2021_01_07_425675	17	29	-	-	JJ
10_1101-2021_01_07_425675	17	30	trivial	trivial	JJ
10_1101-2021_01_07_425675	17	31	task	task	NN
10_1101-2021_01_07_425675	17	32	with	with	IN
10_1101-2021_01_07_425675	17	33	a	a	DT
10_1101-2021_01_07_425675	17	34	limited	limited	JJ
10_1101-2021_01_07_425675	17	35	success	success	NN
10_1101-2021_01_07_425675	17	36	rate	rate	NN
10_1101-2021_01_07_425675	17	37	7	7	CD
10_1101-2021_01_07_425675	17	38	-	-	SYM
10_1101-2021_01_07_425675	17	39	9	9	CD
10_1101-2021_01_07_425675	17	40	.	.	.
10_1101-2021_01_07_425675	18	1	Moreover	moreover	RB
10_1101-2021_01_07_425675	18	2	,	,	,
10_1101-2021_01_07_425675	18	3	45	45	CD
10_1101-2021_01_07_425675	18	4	antibodies	antibody	NNS
10_1101-2021_01_07_425675	18	5	are	be	VBP
10_1101-2021_01_07_425675	18	6	secreted	secrete	VBN
10_1101-2021_01_07_425675	18	7	in	in	IN
10_1101-2021_01_07_425675	18	8	bodily	bodily	NNP
10_1101-2021_01_07_425675	18	9	fluids	fluid	NNS
10_1101-2021_01_07_425675	18	10	and	and	CC
10_1101-2021_01_07_425675	18	11	mucus	mucus	NNP
10_1101-2021_01_07_425675	18	12	.	.	.
10_1101-2021_01_07_425675	19	1	Antibodies	antibody	NNS
10_1101-2021_01_07_425675	19	2	are	be	VBP
10_1101-2021_01_07_425675	19	3	thereby	thereby	RB
10_1101-2021_01_07_425675	19	4	in	in	IN
10_1101-2021_01_07_425675	19	5	large	large	JJ
10_1101-2021_01_07_425675	19	6	part	part	NN
10_1101-2021_01_07_425675	19	7	46	46	CD
10_1101-2021_01_07_425675	19	8	functionally	functionally	RB
10_1101-2021_01_07_425675	19	9	disconnected	disconnect	VBN
10_1101-2021_01_07_425675	19	10	from	from	IN
10_1101-2021_01_07_425675	19	11	their	-PRON-	PRP$
10_1101-2021_01_07_425675	19	12	producing	produce	VBG
10_1101-2021_01_07_425675	19	13	B	b	NN
10_1101-2021_01_07_425675	19	14	-	-	HYPH
10_1101-2021_01_07_425675	19	15	cell	cell	NN
10_1101-2021_01_07_425675	19	16	,	,	,
10_1101-2021_01_07_425675	19	17	which	which	WDT
10_1101-2021_01_07_425675	19	18	raises	raise	VBZ
10_1101-2021_01_07_425675	19	19	questions	question	NNS
10_1101-2021_01_07_425675	19	20	on	on	IN
10_1101-2021_01_07_425675	19	21	how	how	WRB
10_1101-2021_01_07_425675	19	22	the	the	DT
10_1101-2021_01_07_425675	19	23	secreted	secreted	JJ
10_1101-2021_01_07_425675	19	24	47	47	CD
10_1101-2021_01_07_425675	19	25	antibody	antibody	NN
10_1101-2021_01_07_425675	19	26	pool	pool	NN
10_1101-2021_01_07_425675	19	27	relates	relate	VBZ
10_1101-2021_01_07_425675	19	28	quantitatively	quantitatively	RB
10_1101-2021_01_07_425675	19	29	to	to	IN
10_1101-2021_01_07_425675	19	30	the	the	DT
10_1101-2021_01_07_425675	19	31	underlying	underlie	VBG
10_1101-2021_01_07_425675	19	32	B	b	NN
10_1101-2021_01_07_425675	19	33	-	-	HYPH
10_1101-2021_01_07_425675	19	34	cell	cell	NN
10_1101-2021_01_07_425675	19	35	population	population	NN
10_1101-2021_01_07_425675	19	36	and	and	CC
10_1101-2021_01_07_425675	19	37	whether	whether	IN
10_1101-2021_01_07_425675	19	38	there	there	EX
10_1101-2021_01_07_425675	19	39	are	be	VBP
10_1101-2021_01_07_425675	19	40	48	48	CD
10_1101-2021_01_07_425675	19	41	potential	potential	JJ
10_1101-2021_01_07_425675	19	42	sampling	sample	VBG
10_1101-2021_01_07_425675	19	43	biases	bias	NNS
10_1101-2021_01_07_425675	19	44	in	in	IN
10_1101-2021_01_07_425675	19	45	current	current	JJ
10_1101-2021_01_07_425675	19	46	antibody	antibody	NN
10_1101-2021_01_07_425675	19	47	sequencing	sequencing	NN
10_1101-2021_01_07_425675	19	48	strategies	strategy	NNS
10_1101-2021_01_07_425675	19	49	.	.	.
10_1101-2021_01_07_425675	20	1	49	49	CD
10_1101-2021_01_07_425675	20	2	Direct	direct	JJ
10_1101-2021_01_07_425675	20	3	mass	mass	NN
10_1101-2021_01_07_425675	20	4	spectrometry	spectrometry	NN
10_1101-2021_01_07_425675	20	5	(	(	-LRB-
10_1101-2021_01_07_425675	20	6	MS)-based	ms)-base	VBN
10_1101-2021_01_07_425675	20	7	sequencing	sequencing	NN
10_1101-2021_01_07_425675	20	8	of	of	IN
10_1101-2021_01_07_425675	20	9	the	the	DT
10_1101-2021_01_07_425675	20	10	secreted	secrete	VBN
10_1101-2021_01_07_425675	20	11	antibody	antibody	NN
10_1101-2021_01_07_425675	20	12	products	product	NNS
10_1101-2021_01_07_425675	20	13	is	be	VBZ
10_1101-2021_01_07_425675	20	14	a	a	DT
10_1101-2021_01_07_425675	20	15	useful	useful	JJ
10_1101-2021_01_07_425675	20	16	50	50	CD
10_1101-2021_01_07_425675	20	17	complementary	complementary	JJ
10_1101-2021_01_07_425675	20	18	tool	tool	NN
10_1101-2021_01_07_425675	20	19	that	that	WDT
10_1101-2021_01_07_425675	20	20	can	can	MD
10_1101-2021_01_07_425675	20	21	address	address	VB
10_1101-2021_01_07_425675	20	22	some	some	DT
10_1101-2021_01_07_425675	20	23	of	of	IN
10_1101-2021_01_07_425675	20	24	the	the	DT
10_1101-2021_01_07_425675	20	25	challenges	challenge	NNS
10_1101-2021_01_07_425675	20	26	faced	face	VBN
10_1101-2021_01_07_425675	20	27	by	by	IN
10_1101-2021_01_07_425675	20	28	conventional	conventional	JJ
10_1101-2021_01_07_425675	20	29	sequencing	sequence	VBG
10_1101-2021_01_07_425675	20	30	51	51	CD
10_1101-2021_01_07_425675	20	31	strategies	strategy	NNS
10_1101-2021_01_07_425675	20	32	relying	rely	VBG
10_1101-2021_01_07_425675	20	33	on	on	IN
10_1101-2021_01_07_425675	20	34	cloning	clone	VBG
10_1101-2021_01_07_425675	20	35	/	/	SYM
10_1101-2021_01_07_425675	20	36	sequencing	sequencing	NN
10_1101-2021_01_07_425675	20	37	of	of	IN
10_1101-2021_01_07_425675	20	38	the	the	DT
10_1101-2021_01_07_425675	20	39	coding	coding	JJ
10_1101-2021_01_07_425675	20	40	mRNAs	mrnas	$
10_1101-2021_01_07_425675	20	41	10	10	CD
10_1101-2021_01_07_425675	20	42	-	-	SYM
10_1101-2021_01_07_425675	20	43	17	17	CD
10_1101-2021_01_07_425675	20	44	.	.	.
10_1101-2021_01_07_425675	21	1	MS	MS	NNP
10_1101-2021_01_07_425675	21	2	-	-	HYPH
10_1101-2021_01_07_425675	21	3	based	base	VBN
10_1101-2021_01_07_425675	21	4	methods	method	NNS
10_1101-2021_01_07_425675	21	5	do	do	VBP
10_1101-2021_01_07_425675	21	6	not	not	RB
10_1101-2021_01_07_425675	21	7	52	52	CD
10_1101-2021_01_07_425675	21	8	rely	rely	VB
10_1101-2021_01_07_425675	21	9	on	on	IN
10_1101-2021_01_07_425675	21	10	the	the	DT
10_1101-2021_01_07_425675	21	11	availability	availability	NN
10_1101-2021_01_07_425675	21	12	of	of	IN
10_1101-2021_01_07_425675	21	13	the	the	DT
10_1101-2021_01_07_425675	21	14	antibody	antibody	NN
10_1101-2021_01_07_425675	21	15	-	-	HYPH
10_1101-2021_01_07_425675	21	16	producing	produce	VBG
10_1101-2021_01_07_425675	21	17	cells	cell	NNS
10_1101-2021_01_07_425675	21	18	,	,	,
10_1101-2021_01_07_425675	21	19	but	but	CC
10_1101-2021_01_07_425675	21	20	rather	rather	RB
10_1101-2021_01_07_425675	21	21	target	target	VB
10_1101-2021_01_07_425675	21	22	the	the	DT
10_1101-2021_01_07_425675	21	23	polypeptide	polypeptide	NN
10_1101-2021_01_07_425675	21	24	products	product	NNS
10_1101-2021_01_07_425675	21	25	53	53	CD
10_1101-2021_01_07_425675	21	26	directly	directly	RB
10_1101-2021_01_07_425675	21	27	,	,	,
10_1101-2021_01_07_425675	21	28	offering	offer	VBG
10_1101-2021_01_07_425675	21	29	the	the	DT
10_1101-2021_01_07_425675	21	30	prospect	prospect	NN
10_1101-2021_01_07_425675	21	31	of	of	IN
10_1101-2021_01_07_425675	21	32	a	a	DT
10_1101-2021_01_07_425675	21	33	next	next	JJ
10_1101-2021_01_07_425675	21	34	generation	generation	NN
10_1101-2021_01_07_425675	21	35	of	of	IN
10_1101-2021_01_07_425675	21	36	serology	serology	NN
10_1101-2021_01_07_425675	21	37	,	,	,
10_1101-2021_01_07_425675	21	38	in	in	IN
10_1101-2021_01_07_425675	21	39	which	which	WDT
10_1101-2021_01_07_425675	21	40	secreted	secrete	VBD
10_1101-2021_01_07_425675	21	41	antibody	antibody	NN
10_1101-2021_01_07_425675	21	42	54	54	CD
10_1101-2021_01_07_425675	21	43	sequences	sequence	NNS
10_1101-2021_01_07_425675	21	44	might	may	MD
10_1101-2021_01_07_425675	21	45	be	be	VB
10_1101-2021_01_07_425675	21	46	obtained	obtain	VBN
10_1101-2021_01_07_425675	21	47	from	from	IN
10_1101-2021_01_07_425675	21	48	any	any	DT
10_1101-2021_01_07_425675	21	49	bodily	bodily	JJ
10_1101-2021_01_07_425675	21	50	fluid	fluid	NN
10_1101-2021_01_07_425675	21	51	.	.	.
10_1101-2021_01_07_425675	22	1	Whereas	whereas	IN
10_1101-2021_01_07_425675	22	2	MS	MS	NNP
10_1101-2021_01_07_425675	22	3	-	-	HYPH
10_1101-2021_01_07_425675	22	4	based	base	VBN
10_1101-2021_01_07_425675	22	5	de	de	NNP
10_1101-2021_01_07_425675	22	6	novo	novo	NNP
10_1101-2021_01_07_425675	22	7	sequencing	sequencing	NN
10_1101-2021_01_07_425675	22	8	still	still	RB
10_1101-2021_01_07_425675	22	9	55	55	CD
10_1101-2021_01_07_425675	22	10	has	have	VBZ
10_1101-2021_01_07_425675	22	11	a	a	DT
10_1101-2021_01_07_425675	22	12	long	long	JJ
10_1101-2021_01_07_425675	22	13	way	way	NN
10_1101-2021_01_07_425675	22	14	to	to	TO
10_1101-2021_01_07_425675	22	15	go	go	VB
10_1101-2021_01_07_425675	22	16	towards	towards	IN
10_1101-2021_01_07_425675	22	17	this	this	DT
10_1101-2021_01_07_425675	22	18	goal	goal	NN
10_1101-2021_01_07_425675	22	19	,	,	,
10_1101-2021_01_07_425675	22	20	owing	owe	VBG
10_1101-2021_01_07_425675	22	21	to	to	IN
10_1101-2021_01_07_425675	22	22	limitations	limitation	NNS
10_1101-2021_01_07_425675	22	23	in	in	IN
10_1101-2021_01_07_425675	22	24	sample	sample	NN
10_1101-2021_01_07_425675	22	25	requirements	requirement	NNS
10_1101-2021_01_07_425675	22	26	,	,	,
10_1101-2021_01_07_425675	22	27	sequencing	sequence	VBG
10_1101-2021_01_07_425675	22	28	56	56	CD
10_1101-2021_01_07_425675	22	29	accuracy	accuracy	NN
10_1101-2021_01_07_425675	22	30	,	,	,
10_1101-2021_01_07_425675	22	31	read	read	VB
10_1101-2021_01_07_425675	22	32	length	length	NN
10_1101-2021_01_07_425675	22	33	and	and	CC
10_1101-2021_01_07_425675	22	34	sequence	sequence	NN
10_1101-2021_01_07_425675	22	35	assembly	assembly	NN
10_1101-2021_01_07_425675	22	36	,	,	,
10_1101-2021_01_07_425675	22	37	MS	MS	NNP
10_1101-2021_01_07_425675	22	38	has	have	VBZ
10_1101-2021_01_07_425675	22	39	been	be	VBN
10_1101-2021_01_07_425675	22	40	successfully	successfully	RB
10_1101-2021_01_07_425675	22	41	used	use	VBN
10_1101-2021_01_07_425675	22	42	to	to	TO
10_1101-2021_01_07_425675	22	43	profile	profile	VB
10_1101-2021_01_07_425675	22	44	the	the	DT
10_1101-2021_01_07_425675	22	45	57	57	CD
10_1101-2021_01_07_425675	22	46	antibody	antibody	NN
10_1101-2021_01_07_425675	22	47	repertoire	repertoire	NN
10_1101-2021_01_07_425675	22	48	and	and	CC
10_1101-2021_01_07_425675	22	49	obtain	obtain	VB
10_1101-2021_01_07_425675	22	50	(	(	-LRB-
10_1101-2021_01_07_425675	22	51	partial	partial	JJ
10_1101-2021_01_07_425675	22	52	)	)	-RRB-
10_1101-2021_01_07_425675	22	53	antibody	antibody	NN
10_1101-2021_01_07_425675	22	54	sequences	sequence	NNS
10_1101-2021_01_07_425675	22	55	beyond	beyond	IN
10_1101-2021_01_07_425675	22	56	those	those	DT
10_1101-2021_01_07_425675	22	57	available	available	JJ
10_1101-2021_01_07_425675	22	58	from	from	IN
10_1101-2021_01_07_425675	22	59	58	58	CD
10_1101-2021_01_07_425675	22	60	conventional	conventional	JJ
10_1101-2021_01_07_425675	22	61	sequencing	sequencing	NN
10_1101-2021_01_07_425675	22	62	strategies	strategy	NNS
10_1101-2021_01_07_425675	22	63	based	base	VBN
10_1101-2021_01_07_425675	22	64	on	on	IN
10_1101-2021_01_07_425675	22	65	cloning	clone	VBG
10_1101-2021_01_07_425675	22	66	/	/	SYM
10_1101-2021_01_07_425675	22	67	sequencing	sequencing	NN
10_1101-2021_01_07_425675	22	68	of	of	IN
10_1101-2021_01_07_425675	22	69	the	the	DT
10_1101-2021_01_07_425675	22	70	coding	coding	JJ
10_1101-2021_01_07_425675	22	71	mRNAs	mrnas	$
10_1101-2021_01_07_425675	22	72	10	10	CD
10_1101-2021_01_07_425675	22	73	-	-	SYM
10_1101-2021_01_07_425675	22	74	17	17	CD
10_1101-2021_01_07_425675	22	75	.	.	.
10_1101-2021_01_07_425675	23	1	59	59	CD
10_1101-2021_01_07_425675	23	2	Most	Most	JJS
10_1101-2021_01_07_425675	23	3	MS	MS	NNP
10_1101-2021_01_07_425675	23	4	-	-	HYPH
10_1101-2021_01_07_425675	23	5	based	base	VBN
10_1101-2021_01_07_425675	23	6	strategies	strategy	NNS
10_1101-2021_01_07_425675	23	7	for	for	IN
10_1101-2021_01_07_425675	23	8	antibody	antibody	NN
10_1101-2021_01_07_425675	23	9	sequencing	sequencing	NN
10_1101-2021_01_07_425675	23	10	rely	rely	VB
10_1101-2021_01_07_425675	23	11	on	on	IN
10_1101-2021_01_07_425675	23	12	a	a	DT
10_1101-2021_01_07_425675	23	13	proteomics	proteomic	NNS
10_1101-2021_01_07_425675	23	14	-	-	HYPH
10_1101-2021_01_07_425675	23	15	type	type	NN
10_1101-2021_01_07_425675	23	16	bottom	bottom	NN
10_1101-2021_01_07_425675	23	17	-	-	HYPH
10_1101-2021_01_07_425675	23	18	up	up	RP
10_1101-2021_01_07_425675	23	19	LC-60	LC-60	NNP
10_1101-2021_01_07_425675	23	20	MS	MS	NNP
10_1101-2021_01_07_425675	23	21	/	/	SYM
10_1101-2021_01_07_425675	23	22	MS	MS	NNP
10_1101-2021_01_07_425675	23	23	workflow	workflow	NN
10_1101-2021_01_07_425675	23	24	,	,	,
10_1101-2021_01_07_425675	23	25	in	in	IN
10_1101-2021_01_07_425675	23	26	which	which	WDT
10_1101-2021_01_07_425675	23	27	the	the	DT
10_1101-2021_01_07_425675	23	28	antibody	antibody	NN
10_1101-2021_01_07_425675	23	29	product	product	NN
10_1101-2021_01_07_425675	23	30	is	be	VBZ
10_1101-2021_01_07_425675	23	31	digested	digest	VBN
10_1101-2021_01_07_425675	23	32	into	into	IN
10_1101-2021_01_07_425675	23	33	smaller	small	JJR
10_1101-2021_01_07_425675	23	34	peptides	peptide	NNS
10_1101-2021_01_07_425675	23	35	for	for	IN
10_1101-2021_01_07_425675	23	36	MS	MS	NNP
10_1101-2021_01_07_425675	23	37	analysis	analysis	NN
10_1101-2021_01_07_425675	23	38	61	61	CD
10_1101-2021_01_07_425675	23	39	14	14	CD
10_1101-2021_01_07_425675	23	40	,	,	,
10_1101-2021_01_07_425675	23	41	18	18	CD
10_1101-2021_01_07_425675	23	42	-	-	SYM
10_1101-2021_01_07_425675	23	43	23	23	CD
10_1101-2021_01_07_425675	23	44	.	.	.
10_1101-2021_01_07_425675	24	1	Available	available	JJ
10_1101-2021_01_07_425675	24	2	germline	germline	NN
10_1101-2021_01_07_425675	24	3	antibody	antibody	NN
10_1101-2021_01_07_425675	24	4	sequences	sequence	NNS
10_1101-2021_01_07_425675	24	5	are	be	VBP
10_1101-2021_01_07_425675	24	6	then	then	RB
10_1101-2021_01_07_425675	24	7	often	often	RB
10_1101-2021_01_07_425675	24	8	used	use	VBN
10_1101-2021_01_07_425675	24	9	either	either	CC
10_1101-2021_01_07_425675	24	10	as	as	IN
10_1101-2021_01_07_425675	24	11	a	a	DT
10_1101-2021_01_07_425675	24	12	template	template	NN
10_1101-2021_01_07_425675	24	13	to	to	TO
10_1101-2021_01_07_425675	24	14	guide	guide	VB
10_1101-2021_01_07_425675	24	15	62	62	CD
10_1101-2021_01_07_425675	24	16	.CC	.CC	,
10_1101-2021_01_07_425675	24	17	-	-	:
10_1101-2021_01_07_425675	24	18	BY	by	IN
10_1101-2021_01_07_425675	24	19	4.0	4.0	CD
10_1101-2021_01_07_425675	24	20	International	International	NNP
10_1101-2021_01_07_425675	24	21	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	24	22	under	under	IN
10_1101-2021_01_07_425675	24	23	a	a	DT
10_1101-2021_01_07_425675	24	24	(	(	-LRB-
10_1101-2021_01_07_425675	24	25	which	which	WDT
10_1101-2021_01_07_425675	24	26	was	be	VBD
10_1101-2021_01_07_425675	24	27	not	not	RB
10_1101-2021_01_07_425675	24	28	certified	certify	VBN
10_1101-2021_01_07_425675	24	29	by	by	IN
10_1101-2021_01_07_425675	24	30	peer	peer	NN
10_1101-2021_01_07_425675	24	31	review	review	NN
10_1101-2021_01_07_425675	24	32	)	)	-RRB-
10_1101-2021_01_07_425675	24	33	is	be	VBZ
10_1101-2021_01_07_425675	24	34	the	the	DT
10_1101-2021_01_07_425675	24	35	author	author	NN
10_1101-2021_01_07_425675	24	36	/	/	SYM
10_1101-2021_01_07_425675	24	37	funder	funder	NN
10_1101-2021_01_07_425675	24	38	,	,	,
10_1101-2021_01_07_425675	24	39	who	who	WP
10_1101-2021_01_07_425675	24	40	has	have	VBZ
10_1101-2021_01_07_425675	24	41	granted	grant	VBN
10_1101-2021_01_07_425675	24	42	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	24	43	a	a	DT
10_1101-2021_01_07_425675	24	44	license	license	NN
10_1101-2021_01_07_425675	24	45	to	to	TO
10_1101-2021_01_07_425675	24	46	display	display	VB
10_1101-2021_01_07_425675	24	47	the	the	DT
10_1101-2021_01_07_425675	24	48	preprint	preprint	NN
10_1101-2021_01_07_425675	24	49	in	in	IN
10_1101-2021_01_07_425675	24	50	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	24	51	.	.	.
10_1101-2021_01_07_425675	25	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	25	2	is	be	VBZ
10_1101-2021_01_07_425675	25	3	made	make	VBN
10_1101-2021_01_07_425675	25	4	The	the	DT
10_1101-2021_01_07_425675	25	5	copyright	copyright	NN
10_1101-2021_01_07_425675	25	6	holder	holder	NN
10_1101-2021_01_07_425675	25	7	for	for	IN
10_1101-2021_01_07_425675	25	8	this	this	DT
10_1101-2021_01_07_425675	25	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	25	10	version	version	NN
10_1101-2021_01_07_425675	25	11	posted	post	VBD
10_1101-2021_01_07_425675	25	12	January	January	NNP
10_1101-2021_01_07_425675	25	13	8	8	CD
10_1101-2021_01_07_425675	25	14	,	,	,
10_1101-2021_01_07_425675	25	15	2021	2021	CD
10_1101-2021_01_07_425675	25	16	.	.	.
10_1101-2021_01_07_425675	25	17	;	;	:
10_1101-2021_01_07_425675	25	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	25	19	:	:	:
10_1101-2021_01_07_425675	25	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	25	21	preprint	preprint	NN
10_1101-2021_01_07_425675	25	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NNP
10_1101-2021_01_07_425675	25	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	25	24	4	4	CD
10_1101-2021_01_07_425675	25	25	assembly	assembly	NN
10_1101-2021_01_07_425675	25	26	of	of	IN
10_1101-2021_01_07_425675	25	27	de	de	FW
10_1101-2021_01_07_425675	25	28	novo	novo	NNP
10_1101-2021_01_07_425675	25	29	peptide	peptide	NNP
10_1101-2021_01_07_425675	25	30	reads	read	VBZ
10_1101-2021_01_07_425675	25	31	(	(	-LRB-
10_1101-2021_01_07_425675	25	32	such	such	JJ
10_1101-2021_01_07_425675	25	33	as	as	IN
10_1101-2021_01_07_425675	25	34	in	in	IN
10_1101-2021_01_07_425675	25	35	PEAKS	PEAKS	NNP
10_1101-2021_01_07_425675	25	36	Ab	Ab	NNP
10_1101-2021_01_07_425675	25	37	)	)	-RRB-
10_1101-2021_01_07_425675	25	38	23	23	CD
10_1101-2021_01_07_425675	25	39	,	,	,
10_1101-2021_01_07_425675	25	40	or	or	CC
10_1101-2021_01_07_425675	25	41	used	use	VBN
10_1101-2021_01_07_425675	25	42	as	as	IN
10_1101-2021_01_07_425675	25	43	a	a	DT
10_1101-2021_01_07_425675	25	44	starting	starting	NN
10_1101-2021_01_07_425675	25	45	point	point	NN
10_1101-2021_01_07_425675	25	46	to	to	IN
10_1101-2021_01_07_425675	25	47	63	63	CD
10_1101-2021_01_07_425675	25	48	iteratively	iteratively	RB
10_1101-2021_01_07_425675	25	49	identify	identify	VBP
10_1101-2021_01_07_425675	25	50	somatic	somatic	JJ
10_1101-2021_01_07_425675	25	51	mutations	mutation	NNS
10_1101-2021_01_07_425675	25	52	to	to	TO
10_1101-2021_01_07_425675	25	53	arrive	arrive	VB
10_1101-2021_01_07_425675	25	54	at	at	IN
10_1101-2021_01_07_425675	25	55	the	the	DT
10_1101-2021_01_07_425675	25	56	mature	mature	JJ
10_1101-2021_01_07_425675	25	57	antibody	antibody	NN
10_1101-2021_01_07_425675	25	58	sequence	sequence	NN
10_1101-2021_01_07_425675	25	59	(	(	-LRB-
10_1101-2021_01_07_425675	25	60	such	such	JJ
10_1101-2021_01_07_425675	25	61	as	as	IN
10_1101-2021_01_07_425675	25	62	in	in	IN
10_1101-2021_01_07_425675	25	63	64	64	CD
10_1101-2021_01_07_425675	25	64	Supernovo	Supernovo	NNP
10_1101-2021_01_07_425675	25	65	)	)	-RRB-
10_1101-2021_01_07_425675	25	66	21	21	CD
10_1101-2021_01_07_425675	25	67	.	.	.
10_1101-2021_01_07_425675	26	1	To	to	TO
10_1101-2021_01_07_425675	26	2	maximize	maximize	VB
10_1101-2021_01_07_425675	26	3	sequence	sequence	NN
10_1101-2021_01_07_425675	26	4	coverage	coverage	NN
10_1101-2021_01_07_425675	26	5	and	and	CC
10_1101-2021_01_07_425675	26	6	aid	aid	NN
10_1101-2021_01_07_425675	26	7	read	read	VBD
10_1101-2021_01_07_425675	26	8	assembly	assembly	NNP
10_1101-2021_01_07_425675	26	9	,	,	,
10_1101-2021_01_07_425675	26	10	these	these	DT
10_1101-2021_01_07_425675	26	11	MS	MS	NNP
10_1101-2021_01_07_425675	26	12	-	-	HYPH
10_1101-2021_01_07_425675	26	13	based	base	VBN
10_1101-2021_01_07_425675	26	14	65	65	CD
10_1101-2021_01_07_425675	26	15	workflows	workflow	NNS
10_1101-2021_01_07_425675	26	16	typically	typically	RB
10_1101-2021_01_07_425675	26	17	use	use	VBP
10_1101-2021_01_07_425675	26	18	a	a	DT
10_1101-2021_01_07_425675	26	19	combination	combination	NN
10_1101-2021_01_07_425675	26	20	of	of	IN
10_1101-2021_01_07_425675	26	21	complementary	complementary	JJ
10_1101-2021_01_07_425675	26	22	proteases	protease	NNS
10_1101-2021_01_07_425675	26	23	and	and	CC
10_1101-2021_01_07_425675	26	24	aspecific	aspecific	JJ
10_1101-2021_01_07_425675	26	25	digestion	digestion	NN
10_1101-2021_01_07_425675	26	26	to	to	IN
10_1101-2021_01_07_425675	26	27	66	66	CD
10_1101-2021_01_07_425675	26	28	generate	generate	NN
10_1101-2021_01_07_425675	26	29	overlapping	overlapping	NN
10_1101-2021_01_07_425675	26	30	peptides	peptide	NNS
10_1101-2021_01_07_425675	26	31	.	.	.
10_1101-2021_01_07_425675	27	1	The	the	DT
10_1101-2021_01_07_425675	27	2	most	most	RBS
10_1101-2021_01_07_425675	27	3	straightforward	straightforward	JJ
10_1101-2021_01_07_425675	27	4	application	application	NN
10_1101-2021_01_07_425675	27	5	of	of	IN
10_1101-2021_01_07_425675	27	6	these	these	DT
10_1101-2021_01_07_425675	27	7	MS	MS	NNP
10_1101-2021_01_07_425675	27	8	-	-	HYPH
10_1101-2021_01_07_425675	27	9	based	base	VBN
10_1101-2021_01_07_425675	27	10	67	67	CD
10_1101-2021_01_07_425675	27	11	sequencing	sequence	VBG
10_1101-2021_01_07_425675	27	12	workflows	workflow	NNS
10_1101-2021_01_07_425675	27	13	is	be	VBZ
10_1101-2021_01_07_425675	27	14	the	the	DT
10_1101-2021_01_07_425675	27	15	successful	successful	JJ
10_1101-2021_01_07_425675	27	16	sequencing	sequencing	NN
10_1101-2021_01_07_425675	27	17	of	of	IN
10_1101-2021_01_07_425675	27	18	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	27	19	antibodies	antibody	NNS
10_1101-2021_01_07_425675	27	20	from	from	IN
10_1101-2021_01_07_425675	27	21	(	(	-LRB-
10_1101-2021_01_07_425675	27	22	lost	lose	VBN
10_1101-2021_01_07_425675	27	23	)	)	-RRB-
10_1101-2021_01_07_425675	27	24	68	68	CD
10_1101-2021_01_07_425675	27	25	hybridoma	hybridoma	NN
10_1101-2021_01_07_425675	27	26	cell	cell	NN
10_1101-2021_01_07_425675	27	27	lines	line	NNS
10_1101-2021_01_07_425675	27	28	,	,	,
10_1101-2021_01_07_425675	27	29	but	but	CC
10_1101-2021_01_07_425675	27	30	it	-PRON-	PRP
10_1101-2021_01_07_425675	27	31	also	also	RB
10_1101-2021_01_07_425675	27	32	forms	form	VBZ
10_1101-2021_01_07_425675	27	33	the	the	DT
10_1101-2021_01_07_425675	27	34	basis	basis	NN
10_1101-2021_01_07_425675	27	35	of	of	IN
10_1101-2021_01_07_425675	27	36	more	more	RBR
10_1101-2021_01_07_425675	27	37	advanced	advanced	JJ
10_1101-2021_01_07_425675	27	38	and	and	CC
10_1101-2021_01_07_425675	27	39	challenging	challenging	JJ
10_1101-2021_01_07_425675	27	40	applications	application	NNS
10_1101-2021_01_07_425675	27	41	to	to	IN
10_1101-2021_01_07_425675	27	42	69	69	CD
10_1101-2021_01_07_425675	27	43	characterize	characterize	VB
10_1101-2021_01_07_425675	27	44	polyclonal	polyclonal	JJ
10_1101-2021_01_07_425675	27	45	antibody	antibody	NN
10_1101-2021_01_07_425675	27	46	mixtures	mixture	NNS
10_1101-2021_01_07_425675	27	47	and	and	CC
10_1101-2021_01_07_425675	27	48	profile	profile	VB
10_1101-2021_01_07_425675	27	49	the	the	DT
10_1101-2021_01_07_425675	27	50	full	full	JJ
10_1101-2021_01_07_425675	27	51	antibody	antibody	NN
10_1101-2021_01_07_425675	27	52	repertoire	repertoire	NN
10_1101-2021_01_07_425675	27	53	from	from	IN
10_1101-2021_01_07_425675	27	54	serum	serum	NNP
10_1101-2021_01_07_425675	27	55	.	.	.
10_1101-2021_01_07_425675	28	1	70	70	CD
10_1101-2021_01_07_425675	28	2	Here	here	RB
10_1101-2021_01_07_425675	28	3	we	-PRON-	PRP
10_1101-2021_01_07_425675	28	4	describe	describe	VBP
10_1101-2021_01_07_425675	28	5	an	an	DT
10_1101-2021_01_07_425675	28	6	efficient	efficient	JJ
10_1101-2021_01_07_425675	28	7	protocol	protocol	NN
10_1101-2021_01_07_425675	28	8	for	for	IN
10_1101-2021_01_07_425675	28	9	MS	MS	NNP
10_1101-2021_01_07_425675	28	10	-	-	HYPH
10_1101-2021_01_07_425675	28	11	based	base	VBN
10_1101-2021_01_07_425675	28	12	sequencing	sequencing	NN
10_1101-2021_01_07_425675	28	13	of	of	IN
10_1101-2021_01_07_425675	28	14	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	28	15	antibodies	antibody	NNS
10_1101-2021_01_07_425675	28	16	.	.	.
10_1101-2021_01_07_425675	29	1	The	the	DT
10_1101-2021_01_07_425675	29	2	71	71	CD
10_1101-2021_01_07_425675	29	3	protocol	protocol	NN
10_1101-2021_01_07_425675	29	4	requires	require	VBZ
10_1101-2021_01_07_425675	29	5	approximately	approximately	RB
10_1101-2021_01_07_425675	29	6	200	200	CD
10_1101-2021_01_07_425675	29	7	picomol	picomol	NN
10_1101-2021_01_07_425675	29	8	of	of	IN
10_1101-2021_01_07_425675	29	9	the	the	DT
10_1101-2021_01_07_425675	29	10	antibody	antibody	NN
10_1101-2021_01_07_425675	29	11	product	product	NN
10_1101-2021_01_07_425675	29	12	and	and	CC
10_1101-2021_01_07_425675	29	13	sample	sample	NN
10_1101-2021_01_07_425675	29	14	preparation	preparation	NN
10_1101-2021_01_07_425675	29	15	can	can	MD
10_1101-2021_01_07_425675	29	16	72	72	CD
10_1101-2021_01_07_425675	29	17	be	be	VB
10_1101-2021_01_07_425675	29	18	completed	complete	VBN
10_1101-2021_01_07_425675	29	19	within	within	IN
10_1101-2021_01_07_425675	29	20	one	one	CD
10_1101-2021_01_07_425675	29	21	working	work	VBG
10_1101-2021_01_07_425675	29	22	day	day	NN
10_1101-2021_01_07_425675	29	23	.	.	.
10_1101-2021_01_07_425675	30	1	We	-PRON-	PRP
10_1101-2021_01_07_425675	30	2	selected	select	VBD
10_1101-2021_01_07_425675	30	3	a	a	DT
10_1101-2021_01_07_425675	30	4	panel	panel	NN
10_1101-2021_01_07_425675	30	5	of	of	IN
10_1101-2021_01_07_425675	30	6	9	9	CD
10_1101-2021_01_07_425675	30	7	proteases	protease	NNS
10_1101-2021_01_07_425675	30	8	with	with	IN
10_1101-2021_01_07_425675	30	9	complementary	complementary	JJ
10_1101-2021_01_07_425675	30	10	73	73	CD
10_1101-2021_01_07_425675	30	11	specificities	specificity	NNS
10_1101-2021_01_07_425675	30	12	,	,	,
10_1101-2021_01_07_425675	30	13	which	which	WDT
10_1101-2021_01_07_425675	30	14	are	be	VBP
10_1101-2021_01_07_425675	30	15	active	active	JJ
10_1101-2021_01_07_425675	30	16	in	in	IN
10_1101-2021_01_07_425675	30	17	the	the	DT
10_1101-2021_01_07_425675	30	18	same	same	JJ
10_1101-2021_01_07_425675	30	19	buffer	buffer	NN
10_1101-2021_01_07_425675	30	20	conditions	condition	NNS
10_1101-2021_01_07_425675	30	21	for	for	IN
10_1101-2021_01_07_425675	30	22	parallel	parallel	JJ
10_1101-2021_01_07_425675	30	23	digestion	digestion	NN
10_1101-2021_01_07_425675	30	24	of	of	IN
10_1101-2021_01_07_425675	30	25	the	the	DT
10_1101-2021_01_07_425675	30	26	antibodies	antibody	NNS
10_1101-2021_01_07_425675	30	27	.	.	.
10_1101-2021_01_07_425675	31	1	74	74	CD
10_1101-2021_01_07_425675	31	2	We	-PRON-	PRP
10_1101-2021_01_07_425675	31	3	developed	develop	VBD
10_1101-2021_01_07_425675	31	4	a	a	DT
10_1101-2021_01_07_425675	31	5	dual	dual	JJ
10_1101-2021_01_07_425675	31	6	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	31	7	strategy	strategy	NN
10_1101-2021_01_07_425675	31	8	for	for	IN
10_1101-2021_01_07_425675	31	9	MS	MS	NNP
10_1101-2021_01_07_425675	31	10	/	/	SYM
10_1101-2021_01_07_425675	31	11	MS	MS	NNP
10_1101-2021_01_07_425675	31	12	analysis	analysis	NN
10_1101-2021_01_07_425675	31	13	of	of	IN
10_1101-2021_01_07_425675	31	14	the	the	DT
10_1101-2021_01_07_425675	31	15	resulting	result	VBG
10_1101-2021_01_07_425675	31	16	peptides	peptide	NNS
10_1101-2021_01_07_425675	31	17	to	to	TO
10_1101-2021_01_07_425675	31	18	yield	yield	VB
10_1101-2021_01_07_425675	31	19	75	75	CD
10_1101-2021_01_07_425675	31	20	rich	rich	JJ
10_1101-2021_01_07_425675	31	21	sequence	sequence	NN
10_1101-2021_01_07_425675	31	22	information	information	NN
10_1101-2021_01_07_425675	31	23	from	from	IN
10_1101-2021_01_07_425675	31	24	the	the	DT
10_1101-2021_01_07_425675	31	25	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	31	26	spectra	spectra	NN
10_1101-2021_01_07_425675	31	27	of	of	IN
10_1101-2021_01_07_425675	31	28	the	the	DT
10_1101-2021_01_07_425675	31	29	peptides	peptide	NNS
10_1101-2021_01_07_425675	31	30	.	.	.
10_1101-2021_01_07_425675	32	1	The	the	DT
10_1101-2021_01_07_425675	32	2	protocol	protocol	NN
10_1101-2021_01_07_425675	32	3	yields	yield	VBZ
10_1101-2021_01_07_425675	32	4	full	full	JJ
10_1101-2021_01_07_425675	32	5	76	76	CD
10_1101-2021_01_07_425675	32	6	and	and	CC
10_1101-2021_01_07_425675	32	7	deep	deep	JJ
10_1101-2021_01_07_425675	32	8	sequence	sequence	NN
10_1101-2021_01_07_425675	32	9	coverage	coverage	NN
10_1101-2021_01_07_425675	32	10	of	of	IN
10_1101-2021_01_07_425675	32	11	the	the	DT
10_1101-2021_01_07_425675	32	12	variable	variable	JJ
10_1101-2021_01_07_425675	32	13	domains	domain	NNS
10_1101-2021_01_07_425675	32	14	of	of	IN
10_1101-2021_01_07_425675	32	15	both	both	CC
10_1101-2021_01_07_425675	32	16	heavy	heavy	JJ
10_1101-2021_01_07_425675	32	17	and	and	CC
10_1101-2021_01_07_425675	32	18	light	light	JJ
10_1101-2021_01_07_425675	32	19	chains	chain	NNS
10_1101-2021_01_07_425675	32	20	as	as	IN
10_1101-2021_01_07_425675	32	21	77	77	CD
10_1101-2021_01_07_425675	32	22	demonstrated	demonstrate	VBD
10_1101-2021_01_07_425675	32	23	on	on	IN
10_1101-2021_01_07_425675	32	24	the	the	DT
10_1101-2021_01_07_425675	32	25	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	32	26	antibody	antibody	NN
10_1101-2021_01_07_425675	32	27	Herceptin	Herceptin	NNP
10_1101-2021_01_07_425675	32	28	.	.	.
10_1101-2021_01_07_425675	33	1	As	as	IN
10_1101-2021_01_07_425675	33	2	a	a	DT
10_1101-2021_01_07_425675	33	3	test	test	NN
10_1101-2021_01_07_425675	33	4	case	case	NN
10_1101-2021_01_07_425675	33	5	,	,	,
10_1101-2021_01_07_425675	33	6	we	-PRON-	PRP
10_1101-2021_01_07_425675	33	7	used	use	VBD
10_1101-2021_01_07_425675	33	8	our	-PRON-	PRP$
10_1101-2021_01_07_425675	33	9	protocol	protocol	NN
10_1101-2021_01_07_425675	33	10	to	to	IN
10_1101-2021_01_07_425675	33	11	78	78	CD
10_1101-2021_01_07_425675	33	12	sequence	sequence	NN
10_1101-2021_01_07_425675	33	13	the	the	DT
10_1101-2021_01_07_425675	33	14	widely	widely	RB
10_1101-2021_01_07_425675	33	15	used	use	VBN
10_1101-2021_01_07_425675	33	16	anti	anti	JJ
10_1101-2021_01_07_425675	33	17	-	-	JJ
10_1101-2021_01_07_425675	33	18	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	33	19	-	-	HYPH
10_1101-2021_01_07_425675	33	20	M2	M2	NNP
10_1101-2021_01_07_425675	33	21	mouse	mouse	NNP
10_1101-2021_01_07_425675	33	22	monoclonal	monoclonal	NNP
10_1101-2021_01_07_425675	33	23	antibody	antibody	NN
10_1101-2021_01_07_425675	33	24	,	,	,
10_1101-2021_01_07_425675	33	25	for	for	IN
10_1101-2021_01_07_425675	33	26	which	which	WDT
10_1101-2021_01_07_425675	33	27	no	no	DT
10_1101-2021_01_07_425675	33	28	sequence	sequence	NN
10_1101-2021_01_07_425675	33	29	79	79	CD
10_1101-2021_01_07_425675	33	30	was	be	VBD
10_1101-2021_01_07_425675	33	31	publicly	publicly	RB
10_1101-2021_01_07_425675	33	32	available	available	JJ
10_1101-2021_01_07_425675	33	33	despite	despite	IN
10_1101-2021_01_07_425675	33	34	its	-PRON-	PRP$
10_1101-2021_01_07_425675	33	35	described	described	JJ
10_1101-2021_01_07_425675	33	36	use	use	NN
10_1101-2021_01_07_425675	33	37	in	in	IN
10_1101-2021_01_07_425675	33	38	5000	5000	CD
10_1101-2021_01_07_425675	33	39	+	+	SYM
10_1101-2021_01_07_425675	33	40	peer	peer	NN
10_1101-2021_01_07_425675	33	41	-	-	HYPH
10_1101-2021_01_07_425675	33	42	reviewed	review	VBN
10_1101-2021_01_07_425675	33	43	publications	publication	NNS
10_1101-2021_01_07_425675	33	44	24	24	CD
10_1101-2021_01_07_425675	33	45	-	-	SYM
10_1101-2021_01_07_425675	33	46	25	25	CD
10_1101-2021_01_07_425675	33	47	.	.	.
10_1101-2021_01_07_425675	34	1	The	the	DT
10_1101-2021_01_07_425675	34	2	80	80	CD
10_1101-2021_01_07_425675	34	3	protocol	protocol	NN
10_1101-2021_01_07_425675	34	4	achieved	achieve	VBD
10_1101-2021_01_07_425675	34	5	full	full	JJ
10_1101-2021_01_07_425675	34	6	sequence	sequence	NN
10_1101-2021_01_07_425675	34	7	coverage	coverage	NN
10_1101-2021_01_07_425675	34	8	of	of	IN
10_1101-2021_01_07_425675	34	9	the	the	DT
10_1101-2021_01_07_425675	34	10	variable	variable	JJ
10_1101-2021_01_07_425675	34	11	domains	domain	NNS
10_1101-2021_01_07_425675	34	12	of	of	IN
10_1101-2021_01_07_425675	34	13	both	both	CC
10_1101-2021_01_07_425675	34	14	heavy	heavy	JJ
10_1101-2021_01_07_425675	34	15	and	and	CC
10_1101-2021_01_07_425675	34	16	light	light	JJ
10_1101-2021_01_07_425675	34	17	chains	chain	NNS
10_1101-2021_01_07_425675	34	18	,	,	,
10_1101-2021_01_07_425675	34	19	81	81	CD
10_1101-2021_01_07_425675	34	20	including	include	VBG
10_1101-2021_01_07_425675	34	21	all	all	DT
10_1101-2021_01_07_425675	34	22	complementarity	complementarity	NN
10_1101-2021_01_07_425675	34	23	determining	determine	VBG
10_1101-2021_01_07_425675	34	24	regions	region	NNS
10_1101-2021_01_07_425675	34	25	(	(	-LRB-
10_1101-2021_01_07_425675	34	26	CDRs	CDRs	NNP
10_1101-2021_01_07_425675	34	27	)	)	-RRB-
10_1101-2021_01_07_425675	34	28	.	.	.
10_1101-2021_01_07_425675	35	1	The	the	DT
10_1101-2021_01_07_425675	35	2	obtained	obtain	VBN
10_1101-2021_01_07_425675	35	3	sequence	sequence	NN
10_1101-2021_01_07_425675	35	4	was	be	VBD
10_1101-2021_01_07_425675	35	5	82	82	CD
10_1101-2021_01_07_425675	35	6	successfully	successfully	RB
10_1101-2021_01_07_425675	35	7	validated	validate	VBN
10_1101-2021_01_07_425675	35	8	by	by	IN
10_1101-2021_01_07_425675	35	9	remodeling	remodel	VBG
10_1101-2021_01_07_425675	35	10	the	the	DT
10_1101-2021_01_07_425675	35	11	published	publish	VBN
10_1101-2021_01_07_425675	35	12	crystal	crystal	NN
10_1101-2021_01_07_425675	35	13	structure	structure	NN
10_1101-2021_01_07_425675	35	14	of	of	IN
10_1101-2021_01_07_425675	35	15	the	the	DT
10_1101-2021_01_07_425675	35	16	anti	anti	JJ
10_1101-2021_01_07_425675	35	17	-	-	JJ
10_1101-2021_01_07_425675	35	18	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	35	19	-	-	HYPH
10_1101-2021_01_07_425675	35	20	M2	M2	NNP
10_1101-2021_01_07_425675	35	21	Fab	Fab	NNP
10_1101-2021_01_07_425675	35	22	and	and	CC
10_1101-2021_01_07_425675	35	23	83	83	CD
10_1101-2021_01_07_425675	35	24	demonstrating	demonstrating	NN
10_1101-2021_01_07_425675	35	25	binding	binding	NN
10_1101-2021_01_07_425675	35	26	of	of	IN
10_1101-2021_01_07_425675	35	27	the	the	DT
10_1101-2021_01_07_425675	35	28	synthetic	synthetic	JJ
10_1101-2021_01_07_425675	35	29	recombinant	recombinant	JJ
10_1101-2021_01_07_425675	35	30	antibody	antibody	NN
10_1101-2021_01_07_425675	35	31	following	follow	VBG
10_1101-2021_01_07_425675	35	32	the	the	DT
10_1101-2021_01_07_425675	35	33	experimental	experimental	JJ
10_1101-2021_01_07_425675	35	34	sequence	sequence	NN
10_1101-2021_01_07_425675	35	35	84	84	CD
10_1101-2021_01_07_425675	35	36	to	to	IN
10_1101-2021_01_07_425675	35	37	a	a	DT
10_1101-2021_01_07_425675	35	38	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	35	39	-	-	HYPH
10_1101-2021_01_07_425675	35	40	tagged	tag	VBN
10_1101-2021_01_07_425675	35	41	protein	protein	NN
10_1101-2021_01_07_425675	35	42	in	in	IN
10_1101-2021_01_07_425675	35	43	Western	western	JJ
10_1101-2021_01_07_425675	35	44	blot	blot	NN
10_1101-2021_01_07_425675	35	45	analysis	analysis	NN
10_1101-2021_01_07_425675	35	46	.	.	.
10_1101-2021_01_07_425675	36	1	The	the	DT
10_1101-2021_01_07_425675	36	2	protocol	protocol	NN
10_1101-2021_01_07_425675	36	3	developed	develop	VBN
10_1101-2021_01_07_425675	36	4	here	here	RB
10_1101-2021_01_07_425675	36	5	thus	thus	RB
10_1101-2021_01_07_425675	36	6	offers	offer	VBZ
10_1101-2021_01_07_425675	36	7	robust	robust	JJ
10_1101-2021_01_07_425675	36	8	85	85	CD
10_1101-2021_01_07_425675	36	9	and	and	CC
10_1101-2021_01_07_425675	36	10	reliable	reliable	JJ
10_1101-2021_01_07_425675	36	11	sequencing	sequencing	NN
10_1101-2021_01_07_425675	36	12	of	of	IN
10_1101-2021_01_07_425675	36	13	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	36	14	antibodies	antibody	NNS
10_1101-2021_01_07_425675	36	15	with	with	IN
10_1101-2021_01_07_425675	36	16	prospective	prospective	JJ
10_1101-2021_01_07_425675	36	17	applications	application	NNS
10_1101-2021_01_07_425675	36	18	for	for	IN
10_1101-2021_01_07_425675	36	19	sequencing	sequence	VBG
10_1101-2021_01_07_425675	36	20	86	86	CD
10_1101-2021_01_07_425675	36	21	secreted	secrete	VBN
10_1101-2021_01_07_425675	36	22	antibodies	antibody	NNS
10_1101-2021_01_07_425675	36	23	from	from	IN
10_1101-2021_01_07_425675	36	24	bodily	bodily	NNP
10_1101-2021_01_07_425675	36	25	fluids	fluid	NNS
10_1101-2021_01_07_425675	36	26	.	.	.
10_1101-2021_01_07_425675	37	1	87	87	CD
10_1101-2021_01_07_425675	37	2	88	88	CD
10_1101-2021_01_07_425675	37	3	Results	result	NNS
10_1101-2021_01_07_425675	37	4	89	89	CD
10_1101-2021_01_07_425675	37	5	We	-PRON-	PRP
10_1101-2021_01_07_425675	37	6	used	use	VBD
10_1101-2021_01_07_425675	37	7	an	an	DT
10_1101-2021_01_07_425675	37	8	in	in	IN
10_1101-2021_01_07_425675	37	9	-	-	HYPH
10_1101-2021_01_07_425675	37	10	solution	solution	NN
10_1101-2021_01_07_425675	37	11	digestion	digestion	NN
10_1101-2021_01_07_425675	37	12	protocol	protocol	NN
10_1101-2021_01_07_425675	37	13	,	,	,
10_1101-2021_01_07_425675	37	14	with	with	IN
10_1101-2021_01_07_425675	37	15	sodium	sodium	NN
10_1101-2021_01_07_425675	37	16	-	-	HYPH
10_1101-2021_01_07_425675	37	17	deoxycholate	deoxycholate	NN
10_1101-2021_01_07_425675	37	18	as	as	IN
10_1101-2021_01_07_425675	37	19	the	the	DT
10_1101-2021_01_07_425675	37	20	denaturing	denature	VBG
10_1101-2021_01_07_425675	37	21	agent	agent	NN
10_1101-2021_01_07_425675	37	22	,	,	,
10_1101-2021_01_07_425675	37	23	to	to	IN
10_1101-2021_01_07_425675	37	24	90	90	CD
10_1101-2021_01_07_425675	37	25	generate	generate	NN
10_1101-2021_01_07_425675	37	26	peptides	peptide	NNS
10_1101-2021_01_07_425675	37	27	from	from	IN
10_1101-2021_01_07_425675	37	28	the	the	DT
10_1101-2021_01_07_425675	37	29	antibodies	antibody	NNS
10_1101-2021_01_07_425675	37	30	for	for	IN
10_1101-2021_01_07_425675	37	31	LC	LC	NNP
10_1101-2021_01_07_425675	37	32	-	-	HYPH
10_1101-2021_01_07_425675	37	33	MS	MS	NNP
10_1101-2021_01_07_425675	37	34	/	/	SYM
10_1101-2021_01_07_425675	37	35	MS	MS	NNP
10_1101-2021_01_07_425675	37	36	analysis	analysis	NN
10_1101-2021_01_07_425675	37	37	.	.	.
10_1101-2021_01_07_425675	38	1	Following	follow	VBG
10_1101-2021_01_07_425675	38	2	heat	heat	NN
10_1101-2021_01_07_425675	38	3	denaturation	denaturation	NN
10_1101-2021_01_07_425675	38	4	and	and	CC
10_1101-2021_01_07_425675	38	5	91	91	CD
10_1101-2021_01_07_425675	38	6	disulfide	disulfide	JJ
10_1101-2021_01_07_425675	38	7	bond	bond	NN
10_1101-2021_01_07_425675	38	8	reduction	reduction	NN
10_1101-2021_01_07_425675	38	9	,	,	,
10_1101-2021_01_07_425675	38	10	we	-PRON-	PRP
10_1101-2021_01_07_425675	38	11	used	use	VBD
10_1101-2021_01_07_425675	38	12	iodoacetic	iodoacetic	JJ
10_1101-2021_01_07_425675	38	13	acid	acid	NN
10_1101-2021_01_07_425675	38	14	as	as	IN
10_1101-2021_01_07_425675	38	15	the	the	DT
10_1101-2021_01_07_425675	38	16	alkylating	alkylate	VBG
10_1101-2021_01_07_425675	38	17	agent	agent	NN
10_1101-2021_01_07_425675	38	18	to	to	TO
10_1101-2021_01_07_425675	38	19	cap	cap	VB
10_1101-2021_01_07_425675	38	20	free	free	JJ
10_1101-2021_01_07_425675	38	21	cysteines	cysteine	NNS
10_1101-2021_01_07_425675	38	22	.	.	.
10_1101-2021_01_07_425675	39	1	92	92	CD
10_1101-2021_01_07_425675	39	2	Note	note	NN
10_1101-2021_01_07_425675	39	3	that	that	IN
10_1101-2021_01_07_425675	39	4	conventional	conventional	JJ
10_1101-2021_01_07_425675	39	5	alkylating	alkylating	NN
10_1101-2021_01_07_425675	39	6	agents	agent	NNS
10_1101-2021_01_07_425675	39	7	like	like	IN
10_1101-2021_01_07_425675	39	8	iodo-/chloroacetamide	iodo-/chloroacetamide	JJ
10_1101-2021_01_07_425675	39	9	generate	generate	NN
10_1101-2021_01_07_425675	39	10	+57	+57	CD
10_1101-2021_01_07_425675	39	11	Da	Da	NNP
10_1101-2021_01_07_425675	39	12	mass	mass	NN
10_1101-2021_01_07_425675	39	13	93	93	CD
10_1101-2021_01_07_425675	39	14	differences	difference	NNS
10_1101-2021_01_07_425675	39	15	on	on	IN
10_1101-2021_01_07_425675	39	16	cysteines	cysteine	NNS
10_1101-2021_01_07_425675	39	17	and	and	CC
10_1101-2021_01_07_425675	39	18	primary	primary	JJ
10_1101-2021_01_07_425675	39	19	amines	amine	NNS
10_1101-2021_01_07_425675	39	20	,	,	,
10_1101-2021_01_07_425675	39	21	which	which	WDT
10_1101-2021_01_07_425675	39	22	may	may	MD
10_1101-2021_01_07_425675	39	23	lead	lead	VB
10_1101-2021_01_07_425675	39	24	to	to	IN
10_1101-2021_01_07_425675	39	25	spurious	spurious	JJ
10_1101-2021_01_07_425675	39	26	assignments	assignment	NNS
10_1101-2021_01_07_425675	39	27	as	as	IN
10_1101-2021_01_07_425675	39	28	glycine	glycine	NN
10_1101-2021_01_07_425675	39	29	94	94	CD
10_1101-2021_01_07_425675	39	30	.CC	.CC	,
10_1101-2021_01_07_425675	39	31	-	-	:
10_1101-2021_01_07_425675	39	32	BY	by	IN
10_1101-2021_01_07_425675	39	33	4.0	4.0	CD
10_1101-2021_01_07_425675	39	34	International	International	NNP
10_1101-2021_01_07_425675	39	35	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	39	36	under	under	IN
10_1101-2021_01_07_425675	39	37	a	a	DT
10_1101-2021_01_07_425675	39	38	(	(	-LRB-
10_1101-2021_01_07_425675	39	39	which	which	WDT
10_1101-2021_01_07_425675	39	40	was	be	VBD
10_1101-2021_01_07_425675	39	41	not	not	RB
10_1101-2021_01_07_425675	39	42	certified	certify	VBN
10_1101-2021_01_07_425675	39	43	by	by	IN
10_1101-2021_01_07_425675	39	44	peer	peer	NN
10_1101-2021_01_07_425675	39	45	review	review	NN
10_1101-2021_01_07_425675	39	46	)	)	-RRB-
10_1101-2021_01_07_425675	39	47	is	be	VBZ
10_1101-2021_01_07_425675	39	48	the	the	DT
10_1101-2021_01_07_425675	39	49	author	author	NN
10_1101-2021_01_07_425675	39	50	/	/	SYM
10_1101-2021_01_07_425675	39	51	funder	funder	NN
10_1101-2021_01_07_425675	39	52	,	,	,
10_1101-2021_01_07_425675	39	53	who	who	WP
10_1101-2021_01_07_425675	39	54	has	have	VBZ
10_1101-2021_01_07_425675	39	55	granted	grant	VBN
10_1101-2021_01_07_425675	39	56	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	39	57	a	a	DT
10_1101-2021_01_07_425675	39	58	license	license	NN
10_1101-2021_01_07_425675	39	59	to	to	TO
10_1101-2021_01_07_425675	39	60	display	display	VB
10_1101-2021_01_07_425675	39	61	the	the	DT
10_1101-2021_01_07_425675	39	62	preprint	preprint	NN
10_1101-2021_01_07_425675	39	63	in	in	IN
10_1101-2021_01_07_425675	39	64	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	39	65	.	.	.
10_1101-2021_01_07_425675	40	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	40	2	is	be	VBZ
10_1101-2021_01_07_425675	40	3	made	make	VBN
10_1101-2021_01_07_425675	40	4	The	the	DT
10_1101-2021_01_07_425675	40	5	copyright	copyright	NN
10_1101-2021_01_07_425675	40	6	holder	holder	NN
10_1101-2021_01_07_425675	40	7	for	for	IN
10_1101-2021_01_07_425675	40	8	this	this	DT
10_1101-2021_01_07_425675	40	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	40	10	version	version	NN
10_1101-2021_01_07_425675	40	11	posted	post	VBD
10_1101-2021_01_07_425675	40	12	January	January	NNP
10_1101-2021_01_07_425675	40	13	8	8	CD
10_1101-2021_01_07_425675	40	14	,	,	,
10_1101-2021_01_07_425675	40	15	2021	2021	CD
10_1101-2021_01_07_425675	40	16	.	.	.
10_1101-2021_01_07_425675	40	17	;	;	:
10_1101-2021_01_07_425675	40	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	40	19	:	:	:
10_1101-2021_01_07_425675	40	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	40	21	preprint	preprint	NN
10_1101-2021_01_07_425675	40	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NN
10_1101-2021_01_07_425675	40	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	40	24	5	5	CD
10_1101-2021_01_07_425675	40	25	residues	residue	NNS
10_1101-2021_01_07_425675	40	26	in	in	IN
10_1101-2021_01_07_425675	40	27	de	de	NNP
10_1101-2021_01_07_425675	40	28	novo	novo	NNP
10_1101-2021_01_07_425675	40	29	sequencing	sequencing	NN
10_1101-2021_01_07_425675	40	30	.	.	.
10_1101-2021_01_07_425675	41	1	The	the	DT
10_1101-2021_01_07_425675	41	2	+58	+58	CD
10_1101-2021_01_07_425675	41	3	Da	Da	NNP
10_1101-2021_01_07_425675	41	4	mass	mass	NN
10_1101-2021_01_07_425675	41	5	differences	difference	NNS
10_1101-2021_01_07_425675	41	6	generated	generate	VBN
10_1101-2021_01_07_425675	41	7	by	by	IN
10_1101-2021_01_07_425675	41	8	alkylation	alkylation	NN
10_1101-2021_01_07_425675	41	9	with	with	IN
10_1101-2021_01_07_425675	41	10	95	95	CD
10_1101-2021_01_07_425675	41	11	iodoacetic	iodoacetic	JJ
10_1101-2021_01_07_425675	41	12	acid	acid	NN
10_1101-2021_01_07_425675	41	13	circumvents	circumvent	VBZ
10_1101-2021_01_07_425675	41	14	this	this	DT
10_1101-2021_01_07_425675	41	15	potential	potential	JJ
10_1101-2021_01_07_425675	41	16	pitfall	pitfall	NN
10_1101-2021_01_07_425675	41	17	.	.	.
10_1101-2021_01_07_425675	42	1	96	96	CD
10_1101-2021_01_07_425675	42	2	We	-PRON-	PRP
10_1101-2021_01_07_425675	42	3	chose	choose	VBD
10_1101-2021_01_07_425675	42	4	a	a	DT
10_1101-2021_01_07_425675	42	5	panel	panel	NN
10_1101-2021_01_07_425675	42	6	of	of	IN
10_1101-2021_01_07_425675	42	7	9	9	CD
10_1101-2021_01_07_425675	42	8	proteases	protease	NNS
10_1101-2021_01_07_425675	42	9	with	with	IN
10_1101-2021_01_07_425675	42	10	activity	activity	NN
10_1101-2021_01_07_425675	42	11	at	at	IN
10_1101-2021_01_07_425675	42	12	pH	pH	NNP
10_1101-2021_01_07_425675	42	13	7.5	7.5	CD
10_1101-2021_01_07_425675	42	14	-	-	SYM
10_1101-2021_01_07_425675	42	15	8.5	8.5	CD
10_1101-2021_01_07_425675	42	16	,	,	,
10_1101-2021_01_07_425675	42	17	so	so	IN
10_1101-2021_01_07_425675	42	18	that	that	IN
10_1101-2021_01_07_425675	42	19	the	the	DT
10_1101-2021_01_07_425675	42	20	denatured	denatured	JJ
10_1101-2021_01_07_425675	42	21	,	,	,
10_1101-2021_01_07_425675	42	22	reduced	reduce	VBN
10_1101-2021_01_07_425675	42	23	and	and	CC
10_1101-2021_01_07_425675	42	24	97	97	CD
10_1101-2021_01_07_425675	42	25	alkylated	alkylated	JJ
10_1101-2021_01_07_425675	42	26	antibodies	antibody	NNS
10_1101-2021_01_07_425675	42	27	could	could	MD
10_1101-2021_01_07_425675	42	28	be	be	VB
10_1101-2021_01_07_425675	42	29	easily	easily	RB
10_1101-2021_01_07_425675	42	30	split	split	VBN
10_1101-2021_01_07_425675	42	31	for	for	IN
10_1101-2021_01_07_425675	42	32	parallel	parallel	JJ
10_1101-2021_01_07_425675	42	33	digestion	digestion	NN
10_1101-2021_01_07_425675	42	34	under	under	IN
10_1101-2021_01_07_425675	42	35	the	the	DT
10_1101-2021_01_07_425675	42	36	same	same	JJ
10_1101-2021_01_07_425675	42	37	buffer	buffer	NN
10_1101-2021_01_07_425675	42	38	conditions	condition	NNS
10_1101-2021_01_07_425675	42	39	.	.	.
10_1101-2021_01_07_425675	43	1	98	98	CD
10_1101-2021_01_07_425675	43	2	These	these	DT
10_1101-2021_01_07_425675	43	3	proteases	protease	NNS
10_1101-2021_01_07_425675	43	4	(	(	-LRB-
10_1101-2021_01_07_425675	43	5	with	with	IN
10_1101-2021_01_07_425675	43	6	indicated	indicate	VBN
10_1101-2021_01_07_425675	43	7	cleavage	cleavage	NN
10_1101-2021_01_07_425675	43	8	specificities	specificity	NNS
10_1101-2021_01_07_425675	43	9	)	)	-RRB-
10_1101-2021_01_07_425675	43	10	included	include	VBD
10_1101-2021_01_07_425675	43	11	:	:	:
10_1101-2021_01_07_425675	43	12	trypsin	trypsin	NNP
10_1101-2021_01_07_425675	43	13	(	(	-LRB-
10_1101-2021_01_07_425675	43	14	C	c	NN
10_1101-2021_01_07_425675	43	15	-	-	HYPH
10_1101-2021_01_07_425675	43	16	terminal	terminal	NN
10_1101-2021_01_07_425675	43	17	of	of	IN
10_1101-2021_01_07_425675	43	18	R	R	NNP
10_1101-2021_01_07_425675	43	19	/	/	SYM
10_1101-2021_01_07_425675	43	20	K	K	NNP
10_1101-2021_01_07_425675	43	21	)	)	-RRB-
10_1101-2021_01_07_425675	43	22	,	,	,
10_1101-2021_01_07_425675	43	23	99	99	CD
10_1101-2021_01_07_425675	43	24	chymotrypsin	chymotrypsin	NN
10_1101-2021_01_07_425675	43	25	(	(	-LRB-
10_1101-2021_01_07_425675	43	26	C	c	NN
10_1101-2021_01_07_425675	43	27	-	-	HYPH
10_1101-2021_01_07_425675	43	28	terminal	terminal	NN
10_1101-2021_01_07_425675	43	29	of	of	IN
10_1101-2021_01_07_425675	43	30	F	F	NNP
10_1101-2021_01_07_425675	43	31	/	/	SYM
10_1101-2021_01_07_425675	43	32	Y	Y	NNP
10_1101-2021_01_07_425675	43	33	/	/	SYM
10_1101-2021_01_07_425675	43	34	W	W	NNP
10_1101-2021_01_07_425675	43	35	/	/	SYM
10_1101-2021_01_07_425675	43	36	M	M	NNP
10_1101-2021_01_07_425675	43	37	/	/	SYM
10_1101-2021_01_07_425675	43	38	L	L	NNP
10_1101-2021_01_07_425675	43	39	)	)	-RRB-
10_1101-2021_01_07_425675	43	40	,	,	,
10_1101-2021_01_07_425675	43	41	α	α	NNP
10_1101-2021_01_07_425675	43	42	-	-	HYPH
10_1101-2021_01_07_425675	43	43	lytic	lytic	NN
10_1101-2021_01_07_425675	43	44	protease	protease	NN
10_1101-2021_01_07_425675	43	45	(	(	-LRB-
10_1101-2021_01_07_425675	43	46	C	c	NN
10_1101-2021_01_07_425675	43	47	-	-	HYPH
10_1101-2021_01_07_425675	43	48	terminal	terminal	NN
10_1101-2021_01_07_425675	43	49	of	of	IN
10_1101-2021_01_07_425675	43	50	T	t	NN
10_1101-2021_01_07_425675	43	51	/	/	,
10_1101-2021_01_07_425675	43	52	A	A	NNP
10_1101-2021_01_07_425675	43	53	/	/	SYM
10_1101-2021_01_07_425675	43	54	S	S	NNP
10_1101-2021_01_07_425675	43	55	/	/	SYM
10_1101-2021_01_07_425675	43	56	V	V	NNP
10_1101-2021_01_07_425675	43	57	)	)	-RRB-
10_1101-2021_01_07_425675	43	58	,	,	,
10_1101-2021_01_07_425675	43	59	elastase	elastase	VB
10_1101-2021_01_07_425675	43	60	100	100	CD
10_1101-2021_01_07_425675	43	61	(	(	-LRB-
10_1101-2021_01_07_425675	43	62	unspecific	unspecific	NNP
10_1101-2021_01_07_425675	43	63	)	)	-RRB-
10_1101-2021_01_07_425675	43	64	,	,	,
10_1101-2021_01_07_425675	43	65	thermolysin	thermolysin	NNP
10_1101-2021_01_07_425675	43	66	(	(	-LRB-
10_1101-2021_01_07_425675	43	67	unspecific	unspecific	NNP
10_1101-2021_01_07_425675	43	68	)	)	-RRB-
10_1101-2021_01_07_425675	43	69	,	,	,
10_1101-2021_01_07_425675	43	70	lysN	lysn	JJ
10_1101-2021_01_07_425675	43	71	(	(	-LRB-
10_1101-2021_01_07_425675	43	72	N	n	NN
10_1101-2021_01_07_425675	43	73	-	-	NN
10_1101-2021_01_07_425675	43	74	terminal	terminal	NN
10_1101-2021_01_07_425675	43	75	of	of	IN
10_1101-2021_01_07_425675	43	76	K	K	NNP
10_1101-2021_01_07_425675	43	77	)	)	-RRB-
10_1101-2021_01_07_425675	43	78	,	,	,
10_1101-2021_01_07_425675	43	79	lysC	lysc	ADD
10_1101-2021_01_07_425675	43	80	(	(	-LRB-
10_1101-2021_01_07_425675	43	81	C	c	NN
10_1101-2021_01_07_425675	43	82	-	-	HYPH
10_1101-2021_01_07_425675	43	83	terminal	terminal	NN
10_1101-2021_01_07_425675	43	84	of	of	IN
10_1101-2021_01_07_425675	43	85	K	K	NNP
10_1101-2021_01_07_425675	43	86	)	)	-RRB-
10_1101-2021_01_07_425675	43	87	,	,	,
10_1101-2021_01_07_425675	43	88	aspN	aspn	IN
10_1101-2021_01_07_425675	43	89	(	(	-LRB-
10_1101-2021_01_07_425675	43	90	N-101	n-101	UH
10_1101-2021_01_07_425675	43	91	terminal	terminal	NN
10_1101-2021_01_07_425675	43	92	of	of	IN
10_1101-2021_01_07_425675	43	93	D	d	NN
10_1101-2021_01_07_425675	43	94	/	/	SYM
10_1101-2021_01_07_425675	43	95	E	e	NN
10_1101-2021_01_07_425675	43	96	)	)	-RRB-
10_1101-2021_01_07_425675	43	97	,	,	,
10_1101-2021_01_07_425675	43	98	and	and	CC
10_1101-2021_01_07_425675	43	99	gluC	gluC	NNP
10_1101-2021_01_07_425675	43	100	(	(	-LRB-
10_1101-2021_01_07_425675	43	101	C	c	NN
10_1101-2021_01_07_425675	43	102	-	-	HYPH
10_1101-2021_01_07_425675	43	103	terminal	terminal	NN
10_1101-2021_01_07_425675	43	104	of	of	IN
10_1101-2021_01_07_425675	43	105	D	d	NN
10_1101-2021_01_07_425675	43	106	/	/	SYM
10_1101-2021_01_07_425675	43	107	E	e	NN
10_1101-2021_01_07_425675	43	108	)	)	-RRB-
10_1101-2021_01_07_425675	43	109	.	.	.
10_1101-2021_01_07_425675	44	1	Correct	correct	JJ
10_1101-2021_01_07_425675	44	2	placement	placement	NN
10_1101-2021_01_07_425675	44	3	or	or	CC
10_1101-2021_01_07_425675	44	4	assembly	assembly	NN
10_1101-2021_01_07_425675	44	5	of	of	IN
10_1101-2021_01_07_425675	44	6	peptide	peptide	NN
10_1101-2021_01_07_425675	44	7	reads	read	VBZ
10_1101-2021_01_07_425675	44	8	102	102	CD
10_1101-2021_01_07_425675	44	9	is	be	VBZ
10_1101-2021_01_07_425675	44	10	a	a	DT
10_1101-2021_01_07_425675	44	11	common	common	JJ
10_1101-2021_01_07_425675	44	12	challenge	challenge	NN
10_1101-2021_01_07_425675	44	13	in	in	IN
10_1101-2021_01_07_425675	44	14	de	de	FW
10_1101-2021_01_07_425675	44	15	novo	novo	NNP
10_1101-2021_01_07_425675	44	16	sequencing	sequencing	NN
10_1101-2021_01_07_425675	44	17	,	,	,
10_1101-2021_01_07_425675	44	18	which	which	WDT
10_1101-2021_01_07_425675	44	19	can	can	MD
10_1101-2021_01_07_425675	44	20	be	be	VB
10_1101-2021_01_07_425675	44	21	facilitated	facilitate	VBN
10_1101-2021_01_07_425675	44	22	by	by	IN
10_1101-2021_01_07_425675	44	23	sufficient	sufficient	JJ
10_1101-2021_01_07_425675	44	24	overlap	overlap	NN
10_1101-2021_01_07_425675	44	25	103	103	CD
10_1101-2021_01_07_425675	44	26	between	between	IN
10_1101-2021_01_07_425675	44	27	the	the	DT
10_1101-2021_01_07_425675	44	28	peptide	peptide	NN
10_1101-2021_01_07_425675	44	29	reads	read	VBZ
10_1101-2021_01_07_425675	44	30	.	.	.
10_1101-2021_01_07_425675	45	1	This	this	DT
10_1101-2021_01_07_425675	45	2	favors	favor	VBZ
10_1101-2021_01_07_425675	45	3	the	the	DT
10_1101-2021_01_07_425675	45	4	occurrence	occurrence	NN
10_1101-2021_01_07_425675	45	5	of	of	IN
10_1101-2021_01_07_425675	45	6	missed	miss	VBN
10_1101-2021_01_07_425675	45	7	cleavages	cleavage	NNS
10_1101-2021_01_07_425675	45	8	and	and	CC
10_1101-2021_01_07_425675	45	9	longer	long	JJR
10_1101-2021_01_07_425675	45	10	reads	read	VBZ
10_1101-2021_01_07_425675	45	11	,	,	,
10_1101-2021_01_07_425675	45	12	so	so	RB
10_1101-2021_01_07_425675	45	13	104	104	CD
10_1101-2021_01_07_425675	45	14	we	-PRON-	PRP
10_1101-2021_01_07_425675	45	15	opted	opt	VBD
10_1101-2021_01_07_425675	45	16	to	to	TO
10_1101-2021_01_07_425675	45	17	perform	perform	VB
10_1101-2021_01_07_425675	45	18	a	a	DT
10_1101-2021_01_07_425675	45	19	brief	brief	JJ
10_1101-2021_01_07_425675	45	20	4-hour	4-hour	CD
10_1101-2021_01_07_425675	45	21	digestion	digestion	NN
10_1101-2021_01_07_425675	45	22	.	.	.
10_1101-2021_01_07_425675	46	1	Following	follow	VBG
10_1101-2021_01_07_425675	46	2	digestion	digestion	NN
10_1101-2021_01_07_425675	46	3	,	,	,
10_1101-2021_01_07_425675	46	4	SDC	SDC	NNP
10_1101-2021_01_07_425675	46	5	is	be	VBZ
10_1101-2021_01_07_425675	46	6	removed	remove	VBN
10_1101-2021_01_07_425675	46	7	by	by	IN
10_1101-2021_01_07_425675	46	8	precipitation	precipitation	NN
10_1101-2021_01_07_425675	46	9	105	105	CD
10_1101-2021_01_07_425675	46	10	and	and	CC
10_1101-2021_01_07_425675	46	11	the	the	DT
10_1101-2021_01_07_425675	46	12	peptide	peptide	JJ
10_1101-2021_01_07_425675	46	13	supernatant	supernatant	JJ
10_1101-2021_01_07_425675	46	14	is	be	VBZ
10_1101-2021_01_07_425675	46	15	desalted	desalt	VBN
10_1101-2021_01_07_425675	46	16	,	,	,
10_1101-2021_01_07_425675	46	17	ready	ready	JJ
10_1101-2021_01_07_425675	46	18	for	for	IN
10_1101-2021_01_07_425675	46	19	LC	LC	NNP
10_1101-2021_01_07_425675	46	20	-	-	HYPH
10_1101-2021_01_07_425675	46	21	MS	MS	NNP
10_1101-2021_01_07_425675	46	22	/	/	SYM
10_1101-2021_01_07_425675	46	23	MS	MS	NNP
10_1101-2021_01_07_425675	46	24	analysis	analysis	NN
10_1101-2021_01_07_425675	46	25	.	.	.
10_1101-2021_01_07_425675	47	1	The	the	DT
10_1101-2021_01_07_425675	47	2	resulting	result	VBG
10_1101-2021_01_07_425675	47	3	raw	raw	JJ
10_1101-2021_01_07_425675	47	4	data	datum	NNS
10_1101-2021_01_07_425675	47	5	106	106	CD
10_1101-2021_01_07_425675	47	6	was	be	VBD
10_1101-2021_01_07_425675	47	7	used	use	VBN
10_1101-2021_01_07_425675	47	8	for	for	IN
10_1101-2021_01_07_425675	47	9	automated	automate	VBN
10_1101-2021_01_07_425675	47	10	de	de	NNP
10_1101-2021_01_07_425675	47	11	novo	novo	NNP
10_1101-2021_01_07_425675	47	12	sequencing	sequencing	NN
10_1101-2021_01_07_425675	47	13	with	with	IN
10_1101-2021_01_07_425675	47	14	the	the	DT
10_1101-2021_01_07_425675	47	15	Supernovo	Supernovo	NNP
10_1101-2021_01_07_425675	47	16	software	software	NN
10_1101-2021_01_07_425675	47	17	package	package	NN
10_1101-2021_01_07_425675	47	18	.	.	.
10_1101-2021_01_07_425675	48	1	107	107	CD
10_1101-2021_01_07_425675	48	2	As	as	IN
10_1101-2021_01_07_425675	48	3	peptide	peptide	JJ
10_1101-2021_01_07_425675	48	4	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	48	5	is	be	VBZ
10_1101-2021_01_07_425675	48	6	dependent	dependent	JJ
10_1101-2021_01_07_425675	48	7	on	on	IN
10_1101-2021_01_07_425675	48	8	many	many	JJ
10_1101-2021_01_07_425675	48	9	factors	factor	NNS
10_1101-2021_01_07_425675	48	10	like	like	IN
10_1101-2021_01_07_425675	48	11	length	length	NN
10_1101-2021_01_07_425675	48	12	,	,	,
10_1101-2021_01_07_425675	48	13	charge	charge	NN
10_1101-2021_01_07_425675	48	14	state	state	NN
10_1101-2021_01_07_425675	48	15	,	,	,
10_1101-2021_01_07_425675	48	16	composition	composition	NN
10_1101-2021_01_07_425675	48	17	and	and	CC
10_1101-2021_01_07_425675	48	18	108	108	CD
10_1101-2021_01_07_425675	48	19	sequence	sequence	NN
10_1101-2021_01_07_425675	48	20	26	26	CD
10_1101-2021_01_07_425675	48	21	,	,	,
10_1101-2021_01_07_425675	48	22	we	-PRON-	PRP
10_1101-2021_01_07_425675	48	23	needed	need	VBD
10_1101-2021_01_07_425675	48	24	a	a	DT
10_1101-2021_01_07_425675	48	25	versatile	versatile	JJ
10_1101-2021_01_07_425675	48	26	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	48	27	strategy	strategy	NN
10_1101-2021_01_07_425675	48	28	to	to	TO
10_1101-2021_01_07_425675	48	29	accommodate	accommodate	VB
10_1101-2021_01_07_425675	48	30	the	the	DT
10_1101-2021_01_07_425675	48	31	diversity	diversity	NN
10_1101-2021_01_07_425675	48	32	of	of	IN
10_1101-2021_01_07_425675	48	33	109	109	CD
10_1101-2021_01_07_425675	48	34	antibody	antibody	NN
10_1101-2021_01_07_425675	48	35	-	-	HYPH
10_1101-2021_01_07_425675	48	36	derived	derive	VBN
10_1101-2021_01_07_425675	48	37	peptides	peptide	NNS
10_1101-2021_01_07_425675	48	38	generated	generate	VBN
10_1101-2021_01_07_425675	48	39	by	by	IN
10_1101-2021_01_07_425675	48	40	the	the	DT
10_1101-2021_01_07_425675	48	41	9	9	CD
10_1101-2021_01_07_425675	48	42	proteases	protease	NNS
10_1101-2021_01_07_425675	48	43	.	.	.
10_1101-2021_01_07_425675	49	1	We	-PRON-	PRP
10_1101-2021_01_07_425675	49	2	opted	opt	VBD
10_1101-2021_01_07_425675	49	3	for	for	IN
10_1101-2021_01_07_425675	49	4	a	a	DT
10_1101-2021_01_07_425675	49	5	dual	dual	JJ
10_1101-2021_01_07_425675	49	6	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	49	7	110	110	CD
10_1101-2021_01_07_425675	49	8	scheme	scheme	NN
10_1101-2021_01_07_425675	49	9	that	that	WDT
10_1101-2021_01_07_425675	49	10	applies	apply	VBZ
10_1101-2021_01_07_425675	49	11	both	both	DT
10_1101-2021_01_07_425675	49	12	stepped	step	VBD
10_1101-2021_01_07_425675	49	13	high	high	JJ
10_1101-2021_01_07_425675	49	14	-	-	HYPH
10_1101-2021_01_07_425675	49	15	energy	energy	NN
10_1101-2021_01_07_425675	49	16	collision	collision	NN
10_1101-2021_01_07_425675	49	17	dissociation	dissociation	NN
10_1101-2021_01_07_425675	49	18	(	(	-LRB-
10_1101-2021_01_07_425675	49	19	stepped	step	VBD
10_1101-2021_01_07_425675	49	20	HCD	HCD	NNP
10_1101-2021_01_07_425675	49	21	)	)	-RRB-
10_1101-2021_01_07_425675	49	22	and	and	CC
10_1101-2021_01_07_425675	49	23	electron	electron	NN
10_1101-2021_01_07_425675	49	24	111	111	CD
10_1101-2021_01_07_425675	49	25	transfer	transfer	NN
10_1101-2021_01_07_425675	49	26	high	high	JJ
10_1101-2021_01_07_425675	49	27	-	-	HYPH
10_1101-2021_01_07_425675	49	28	energy	energy	NN
10_1101-2021_01_07_425675	49	29	collision	collision	NN
10_1101-2021_01_07_425675	49	30	dissociation	dissociation	NN
10_1101-2021_01_07_425675	49	31	(	(	-LRB-
10_1101-2021_01_07_425675	49	32	EThcD	EThcD	NNP
10_1101-2021_01_07_425675	49	33	)	)	-RRB-
10_1101-2021_01_07_425675	49	34	on	on	IN
10_1101-2021_01_07_425675	49	35	all	all	DT
10_1101-2021_01_07_425675	49	36	peptide	peptide	JJ
10_1101-2021_01_07_425675	49	37	precursors	precursor	NNS
10_1101-2021_01_07_425675	49	38	27	27	CD
10_1101-2021_01_07_425675	49	39	-	-	SYM
10_1101-2021_01_07_425675	49	40	29	29	CD
10_1101-2021_01_07_425675	49	41	.	.	.
10_1101-2021_01_07_425675	50	1	The	the	DT
10_1101-2021_01_07_425675	50	2	stepped	step	VBN
10_1101-2021_01_07_425675	50	3	112	112	CD
10_1101-2021_01_07_425675	50	4	HCD	HCD	NNP
10_1101-2021_01_07_425675	50	5	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	50	6	includes	include	VBZ
10_1101-2021_01_07_425675	50	7	three	three	CD
10_1101-2021_01_07_425675	50	8	collision	collision	NN
10_1101-2021_01_07_425675	50	9	energies	energy	NNS
10_1101-2021_01_07_425675	50	10	to	to	TO
10_1101-2021_01_07_425675	50	11	cover	cover	VB
10_1101-2021_01_07_425675	50	12	multiple	multiple	JJ
10_1101-2021_01_07_425675	50	13	dissociation	dissociation	NN
10_1101-2021_01_07_425675	50	14	regimes	regime	NNS
10_1101-2021_01_07_425675	50	15	and	and	CC
10_1101-2021_01_07_425675	50	16	113	113	CD
10_1101-2021_01_07_425675	50	17	the	the	DT
10_1101-2021_01_07_425675	50	18	EThcD	EThcD	NNP
10_1101-2021_01_07_425675	50	19	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	50	20	works	work	VBZ
10_1101-2021_01_07_425675	50	21	especially	especially	RB
10_1101-2021_01_07_425675	50	22	well	well	RB
10_1101-2021_01_07_425675	50	23	for	for	IN
10_1101-2021_01_07_425675	50	24	higher	high	JJR
10_1101-2021_01_07_425675	50	25	charge	charge	NN
10_1101-2021_01_07_425675	50	26	states	state	NNS
10_1101-2021_01_07_425675	50	27	,	,	,
10_1101-2021_01_07_425675	50	28	also	also	RB
10_1101-2021_01_07_425675	50	29	adding	add	VBG
10_1101-2021_01_07_425675	50	30	114	114	CD
10_1101-2021_01_07_425675	50	31	complementary	complementary	JJ
10_1101-2021_01_07_425675	50	32	c	c	NN
10_1101-2021_01_07_425675	50	33	/	/	SYM
10_1101-2021_01_07_425675	50	34	z	z	NNP
10_1101-2021_01_07_425675	50	35	ions	ion	NNS
10_1101-2021_01_07_425675	50	36	for	for	IN
10_1101-2021_01_07_425675	50	37	maximum	maximum	JJ
10_1101-2021_01_07_425675	50	38	sequence	sequence	NN
10_1101-2021_01_07_425675	50	39	coverage	coverage	NN
10_1101-2021_01_07_425675	50	40	.	.	.
10_1101-2021_01_07_425675	51	1	115	115	CD
10_1101-2021_01_07_425675	51	2	We	-PRON-	PRP
10_1101-2021_01_07_425675	51	3	used	use	VBD
10_1101-2021_01_07_425675	51	4	the	the	DT
10_1101-2021_01_07_425675	51	5	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	51	6	antibody	antibody	NN
10_1101-2021_01_07_425675	51	7	Herceptin	Herceptin	NNP
10_1101-2021_01_07_425675	51	8	(	(	-LRB-
10_1101-2021_01_07_425675	51	9	also	also	RB
10_1101-2021_01_07_425675	51	10	known	know	VBN
10_1101-2021_01_07_425675	51	11	as	as	IN
10_1101-2021_01_07_425675	51	12	Trastuzumab	Trastuzumab	NNP
10_1101-2021_01_07_425675	51	13	)	)	-RRB-
10_1101-2021_01_07_425675	51	14	as	as	IN
10_1101-2021_01_07_425675	51	15	a	a	DT
10_1101-2021_01_07_425675	51	16	benchmark	benchmark	NN
10_1101-2021_01_07_425675	51	17	to	to	TO
10_1101-2021_01_07_425675	51	18	116	116	CD
10_1101-2021_01_07_425675	51	19	test	test	NN
10_1101-2021_01_07_425675	51	20	our	-PRON-	PRP$
10_1101-2021_01_07_425675	51	21	protocol	protocol	JJ
10_1101-2021_01_07_425675	51	22	30	30	CD
10_1101-2021_01_07_425675	51	23	-	-	SYM
10_1101-2021_01_07_425675	51	24	31	31	CD
10_1101-2021_01_07_425675	51	25	.	.	.
10_1101-2021_01_07_425675	52	1	From	from	IN
10_1101-2021_01_07_425675	52	2	the	the	DT
10_1101-2021_01_07_425675	52	3	total	total	JJ
10_1101-2021_01_07_425675	52	4	dataset	dataset	NN
10_1101-2021_01_07_425675	52	5	of	of	IN
10_1101-2021_01_07_425675	52	6	9	9	CD
10_1101-2021_01_07_425675	52	7	proteases	protease	NNS
10_1101-2021_01_07_425675	52	8	,	,	,
10_1101-2021_01_07_425675	52	9	we	-PRON-	PRP
10_1101-2021_01_07_425675	52	10	collected	collect	VBD
10_1101-2021_01_07_425675	52	11	4408	4408	CD
10_1101-2021_01_07_425675	52	12	peptide	peptide	NN
10_1101-2021_01_07_425675	52	13	reads	read	VBZ
10_1101-2021_01_07_425675	52	14	117	117	CD
10_1101-2021_01_07_425675	52	15	(	(	-LRB-
10_1101-2021_01_07_425675	52	16	defined	define	VBN
10_1101-2021_01_07_425675	52	17	as	as	IN
10_1101-2021_01_07_425675	52	18	peptides	peptide	NNS
10_1101-2021_01_07_425675	52	19	with	with	IN
10_1101-2021_01_07_425675	52	20	score	score	NN
10_1101-2021_01_07_425675	52	21	>	>	XX
10_1101-2021_01_07_425675	52	22	=	=	SYM
10_1101-2021_01_07_425675	52	23	500	500	CD
10_1101-2021_01_07_425675	52	24	,	,	,
10_1101-2021_01_07_425675	52	25	see	see	VB
10_1101-2021_01_07_425675	52	26	methods	method	NNS
10_1101-2021_01_07_425675	52	27	for	for	IN
10_1101-2021_01_07_425675	52	28	details	detail	NNS
10_1101-2021_01_07_425675	52	29	)	)	-RRB-
10_1101-2021_01_07_425675	52	30	,	,	,
10_1101-2021_01_07_425675	52	31	2866	2866	CD
10_1101-2021_01_07_425675	52	32	of	of	IN
10_1101-2021_01_07_425675	52	33	which	which	WDT
10_1101-2021_01_07_425675	52	34	with	with	IN
10_1101-2021_01_07_425675	52	35	superior	superior	JJ
10_1101-2021_01_07_425675	52	36	118	118	CD
10_1101-2021_01_07_425675	52	37	stepped	step	VBD
10_1101-2021_01_07_425675	52	38	HCD	HCD	NNP
10_1101-2021_01_07_425675	52	39	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	52	40	,	,	,
10_1101-2021_01_07_425675	52	41	and	and	CC
10_1101-2021_01_07_425675	52	42	1722	1722	CD
10_1101-2021_01_07_425675	52	43	with	with	IN
10_1101-2021_01_07_425675	52	44	superior	superior	JJ
10_1101-2021_01_07_425675	52	45	EThcD	EThcD	NNP
10_1101-2021_01_07_425675	52	46	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	52	47	(	(	-LRB-
10_1101-2021_01_07_425675	52	48	see	see	VB
10_1101-2021_01_07_425675	52	49	Table	table	NN
10_1101-2021_01_07_425675	52	50	S1	s1	NN
10_1101-2021_01_07_425675	52	51	)	)	-RRB-
10_1101-2021_01_07_425675	52	52	.	.	.
10_1101-2021_01_07_425675	53	1	119	119	CD
10_1101-2021_01_07_425675	53	2	Sequence	sequence	NN
10_1101-2021_01_07_425675	53	3	coverage	coverage	NN
10_1101-2021_01_07_425675	53	4	was	be	VBD
10_1101-2021_01_07_425675	53	5	100	100	CD
10_1101-2021_01_07_425675	53	6	%	%	NN
10_1101-2021_01_07_425675	53	7	in	in	IN
10_1101-2021_01_07_425675	53	8	both	both	CC
10_1101-2021_01_07_425675	53	9	heavy	heavy	JJ
10_1101-2021_01_07_425675	53	10	and	and	CC
10_1101-2021_01_07_425675	53	11	light	light	JJ
10_1101-2021_01_07_425675	53	12	chains	chain	NNS
10_1101-2021_01_07_425675	53	13	across	across	IN
10_1101-2021_01_07_425675	53	14	the	the	DT
10_1101-2021_01_07_425675	53	15	variable	variable	JJ
10_1101-2021_01_07_425675	53	16	and	and	CC
10_1101-2021_01_07_425675	53	17	constant	constant	JJ
10_1101-2021_01_07_425675	53	18	120	120	CD
10_1101-2021_01_07_425675	53	19	domains	domain	NNS
10_1101-2021_01_07_425675	53	20	(	(	-LRB-
10_1101-2021_01_07_425675	53	21	see	see	VB
10_1101-2021_01_07_425675	53	22	Figures	Figures	NNP
10_1101-2021_01_07_425675	53	23	S1	S1	NNS
10_1101-2021_01_07_425675	53	24	and	and	CC
10_1101-2021_01_07_425675	53	25	S2	S2	NNP
10_1101-2021_01_07_425675	53	26	)	)	-RRB-
10_1101-2021_01_07_425675	53	27	.	.	.
10_1101-2021_01_07_425675	54	1	The	the	DT
10_1101-2021_01_07_425675	54	2	median	median	JJ
10_1101-2021_01_07_425675	54	3	depth	depth	NN
10_1101-2021_01_07_425675	54	4	of	of	IN
10_1101-2021_01_07_425675	54	5	coverage	coverage	NN
10_1101-2021_01_07_425675	54	6	was	be	VBD
10_1101-2021_01_07_425675	54	7	148	148	CD
10_1101-2021_01_07_425675	54	8	overall	overall	JJ
10_1101-2021_01_07_425675	54	9	and	and	CC
10_1101-2021_01_07_425675	54	10	slightly	slightly	RB
10_1101-2021_01_07_425675	54	11	121	121	CD
10_1101-2021_01_07_425675	54	12	higher	high	JJR
10_1101-2021_01_07_425675	54	13	in	in	IN
10_1101-2021_01_07_425675	54	14	the	the	DT
10_1101-2021_01_07_425675	54	15	light	light	JJ
10_1101-2021_01_07_425675	54	16	chain	chain	NN
10_1101-2021_01_07_425675	54	17	(	(	-LRB-
10_1101-2021_01_07_425675	54	18	see	see	VB
10_1101-2021_01_07_425675	54	19	Table	table	NN
10_1101-2021_01_07_425675	54	20	S1	S1	NNS
10_1101-2021_01_07_425675	54	21	and	and	CC
10_1101-2021_01_07_425675	54	22	Figure	Figure	NNP
10_1101-2021_01_07_425675	54	23	S1	S1	NNS
10_1101-2021_01_07_425675	54	24	-	-	:
10_1101-2021_01_07_425675	54	25	2	2	CD
10_1101-2021_01_07_425675	54	26	)	)	-RRB-
10_1101-2021_01_07_425675	54	27	.	.	.
10_1101-2021_01_07_425675	55	1	The	the	DT
10_1101-2021_01_07_425675	55	2	median	median	JJ
10_1101-2021_01_07_425675	55	3	depth	depth	NN
10_1101-2021_01_07_425675	55	4	of	of	IN
10_1101-2021_01_07_425675	55	5	coverage	coverage	NN
10_1101-2021_01_07_425675	55	6	in	in	IN
10_1101-2021_01_07_425675	55	7	the	the	DT
10_1101-2021_01_07_425675	55	8	122	122	CD
10_1101-2021_01_07_425675	55	9	CDRs	cdr	NNS
10_1101-2021_01_07_425675	55	10	of	of	IN
10_1101-2021_01_07_425675	55	11	both	both	DT
10_1101-2021_01_07_425675	55	12	chains	chain	NNS
10_1101-2021_01_07_425675	55	13	ranged	range	VBD
10_1101-2021_01_07_425675	55	14	from	from	IN
10_1101-2021_01_07_425675	55	15	42	42	CD
10_1101-2021_01_07_425675	55	16	to	to	IN
10_1101-2021_01_07_425675	55	17	210	210	CD
10_1101-2021_01_07_425675	55	18	.	.	.
10_1101-2021_01_07_425675	56	1	123	123	CD
10_1101-2021_01_07_425675	56	2	.CC	.CC	NFP
10_1101-2021_01_07_425675	56	3	-	-	:
10_1101-2021_01_07_425675	56	4	BY	by	IN
10_1101-2021_01_07_425675	56	5	4.0	4.0	CD
10_1101-2021_01_07_425675	56	6	International	International	NNP
10_1101-2021_01_07_425675	56	7	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	56	8	under	under	IN
10_1101-2021_01_07_425675	56	9	a	a	DT
10_1101-2021_01_07_425675	56	10	(	(	-LRB-
10_1101-2021_01_07_425675	56	11	which	which	WDT
10_1101-2021_01_07_425675	56	12	was	be	VBD
10_1101-2021_01_07_425675	56	13	not	not	RB
10_1101-2021_01_07_425675	56	14	certified	certify	VBN
10_1101-2021_01_07_425675	56	15	by	by	IN
10_1101-2021_01_07_425675	56	16	peer	peer	NN
10_1101-2021_01_07_425675	56	17	review	review	NN
10_1101-2021_01_07_425675	56	18	)	)	-RRB-
10_1101-2021_01_07_425675	56	19	is	be	VBZ
10_1101-2021_01_07_425675	56	20	the	the	DT
10_1101-2021_01_07_425675	56	21	author	author	NN
10_1101-2021_01_07_425675	56	22	/	/	SYM
10_1101-2021_01_07_425675	56	23	funder	funder	NN
10_1101-2021_01_07_425675	56	24	,	,	,
10_1101-2021_01_07_425675	56	25	who	who	WP
10_1101-2021_01_07_425675	56	26	has	have	VBZ
10_1101-2021_01_07_425675	56	27	granted	grant	VBN
10_1101-2021_01_07_425675	56	28	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	56	29	a	a	DT
10_1101-2021_01_07_425675	56	30	license	license	NN
10_1101-2021_01_07_425675	56	31	to	to	TO
10_1101-2021_01_07_425675	56	32	display	display	VB
10_1101-2021_01_07_425675	56	33	the	the	DT
10_1101-2021_01_07_425675	56	34	preprint	preprint	NN
10_1101-2021_01_07_425675	56	35	in	in	IN
10_1101-2021_01_07_425675	56	36	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	56	37	.	.	.
10_1101-2021_01_07_425675	57	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	57	2	is	be	VBZ
10_1101-2021_01_07_425675	57	3	made	make	VBN
10_1101-2021_01_07_425675	57	4	The	the	DT
10_1101-2021_01_07_425675	57	5	copyright	copyright	NN
10_1101-2021_01_07_425675	57	6	holder	holder	NN
10_1101-2021_01_07_425675	57	7	for	for	IN
10_1101-2021_01_07_425675	57	8	this	this	DT
10_1101-2021_01_07_425675	57	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	57	10	version	version	NN
10_1101-2021_01_07_425675	57	11	posted	post	VBD
10_1101-2021_01_07_425675	57	12	January	January	NNP
10_1101-2021_01_07_425675	57	13	8	8	CD
10_1101-2021_01_07_425675	57	14	,	,	,
10_1101-2021_01_07_425675	57	15	2021	2021	CD
10_1101-2021_01_07_425675	57	16	.	.	.
10_1101-2021_01_07_425675	57	17	;	;	:
10_1101-2021_01_07_425675	57	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	57	19	:	:	:
10_1101-2021_01_07_425675	57	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	57	21	preprint	preprint	NN
10_1101-2021_01_07_425675	57	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NNP
10_1101-2021_01_07_425675	57	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	57	24	6	6	CD
10_1101-2021_01_07_425675	57	25	124	124	CD
10_1101-2021_01_07_425675	57	26	Figure	Figure	NNP
10_1101-2021_01_07_425675	57	27	1	1	CD
10_1101-2021_01_07_425675	57	28	.	.	.
10_1101-2021_01_07_425675	57	29	mass	mass	NNP
10_1101-2021_01_07_425675	57	30	spectrometry	spectrometry	NNP
10_1101-2021_01_07_425675	57	31	-	-	HYPH
10_1101-2021_01_07_425675	57	32	based	base	VBN
10_1101-2021_01_07_425675	57	33	de	de	NNP
10_1101-2021_01_07_425675	57	34	novo	novo	NNP
10_1101-2021_01_07_425675	57	35	sequencing	sequencing	NN
10_1101-2021_01_07_425675	57	36	of	of	IN
10_1101-2021_01_07_425675	57	37	the	the	DT
10_1101-2021_01_07_425675	57	38	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	57	39	antibody	antibody	NN
10_1101-2021_01_07_425675	57	40	Herceptin	Herceptin	NNP
10_1101-2021_01_07_425675	57	41	.	.	.
10_1101-2021_01_07_425675	58	1	The	the	DT
10_1101-2021_01_07_425675	58	2	125	125	CD
10_1101-2021_01_07_425675	58	3	variable	variable	JJ
10_1101-2021_01_07_425675	58	4	regions	region	NNS
10_1101-2021_01_07_425675	58	5	of	of	IN
10_1101-2021_01_07_425675	58	6	the	the	DT
10_1101-2021_01_07_425675	58	7	Heavy	heavy	JJ
10_1101-2021_01_07_425675	58	8	(	(	-LRB-
10_1101-2021_01_07_425675	58	9	A	a	NN
10_1101-2021_01_07_425675	58	10	)	)	-RRB-
10_1101-2021_01_07_425675	58	11	and	and	CC
10_1101-2021_01_07_425675	58	12	Light	Light	NNP
10_1101-2021_01_07_425675	58	13	Chains	Chains	NNPS
10_1101-2021_01_07_425675	58	14	(	(	-LRB-
10_1101-2021_01_07_425675	58	15	B	b	NN
10_1101-2021_01_07_425675	58	16	)	)	-RRB-
10_1101-2021_01_07_425675	58	17	are	be	VBP
10_1101-2021_01_07_425675	58	18	shown	show	VBN
10_1101-2021_01_07_425675	58	19	.	.	.
10_1101-2021_01_07_425675	59	1	The	the	DT
10_1101-2021_01_07_425675	59	2	MS	MS	NNP
10_1101-2021_01_07_425675	59	3	-	-	HYPH
10_1101-2021_01_07_425675	59	4	based	base	VBN
10_1101-2021_01_07_425675	59	5	sequence	sequence	NN
10_1101-2021_01_07_425675	59	6	is	be	VBZ
10_1101-2021_01_07_425675	59	7	shown	show	VBN
10_1101-2021_01_07_425675	59	8	126	126	CD
10_1101-2021_01_07_425675	59	9	alongside	alongside	IN
10_1101-2021_01_07_425675	59	10	the	the	DT
10_1101-2021_01_07_425675	59	11	known	known	JJ
10_1101-2021_01_07_425675	59	12	Herceptin	Herceptin	NNP
10_1101-2021_01_07_425675	59	13	sequence	sequence	NN
10_1101-2021_01_07_425675	59	14	,	,	,
10_1101-2021_01_07_425675	59	15	with	with	IN
10_1101-2021_01_07_425675	59	16	differences	difference	NNS
10_1101-2021_01_07_425675	59	17	highlighted	highlight	VBN
10_1101-2021_01_07_425675	59	18	by	by	IN
10_1101-2021_01_07_425675	59	19	asterisks	asterisk	NNS
10_1101-2021_01_07_425675	59	20	(	(	-LRB-
10_1101-2021_01_07_425675	59	21	*	*	NFP
10_1101-2021_01_07_425675	59	22	)	)	-RRB-
10_1101-2021_01_07_425675	59	23	.	.	.
10_1101-2021_01_07_425675	60	1	Exemplary	Exemplary	NNP
10_1101-2021_01_07_425675	60	2	MS	MS	NNP
10_1101-2021_01_07_425675	60	3	/	/	SYM
10_1101-2021_01_07_425675	60	4	MS	MS	NNP
10_1101-2021_01_07_425675	60	5	127	127	CD
10_1101-2021_01_07_425675	60	6	spectra	spectra	NN
10_1101-2021_01_07_425675	60	7	supporting	support	VBG
10_1101-2021_01_07_425675	60	8	the	the	DT
10_1101-2021_01_07_425675	60	9	assigned	assign	VBN
10_1101-2021_01_07_425675	60	10	sequences	sequence	NNS
10_1101-2021_01_07_425675	60	11	of	of	IN
10_1101-2021_01_07_425675	60	12	the	the	DT
10_1101-2021_01_07_425675	60	13	Heavy	Heavy	NNP
10_1101-2021_01_07_425675	60	14	and	and	CC
10_1101-2021_01_07_425675	60	15	Light	Light	NNP
10_1101-2021_01_07_425675	60	16	Chain	Chain	NNP
10_1101-2021_01_07_425675	60	17	CDRs	cdr	NNS
10_1101-2021_01_07_425675	60	18	are	be	VBP
10_1101-2021_01_07_425675	60	19	shown	show	VBN
10_1101-2021_01_07_425675	60	20	below	below	IN
10_1101-2021_01_07_425675	60	21	the	the	DT
10_1101-2021_01_07_425675	60	22	128	128	CD
10_1101-2021_01_07_425675	60	23	alignments	alignment	NNS
10_1101-2021_01_07_425675	60	24	.	.	.
10_1101-2021_01_07_425675	61	1	Peptide	peptide	JJ
10_1101-2021_01_07_425675	61	2	sequence	sequence	NN
10_1101-2021_01_07_425675	61	3	and	and	CC
10_1101-2021_01_07_425675	61	4	fragment	fragment	NN
10_1101-2021_01_07_425675	61	5	coverage	coverage	NN
10_1101-2021_01_07_425675	61	6	are	be	VBP
10_1101-2021_01_07_425675	61	7	indicated	indicate	VBN
10_1101-2021_01_07_425675	61	8	on	on	IN
10_1101-2021_01_07_425675	61	9	top	top	NN
10_1101-2021_01_07_425675	61	10	of	of	IN
10_1101-2021_01_07_425675	61	11	the	the	DT
10_1101-2021_01_07_425675	61	12	spectra	spectra	NNP
10_1101-2021_01_07_425675	61	13	,	,	,
10_1101-2021_01_07_425675	61	14	with	with	IN
10_1101-2021_01_07_425675	61	15	b	b	NN
10_1101-2021_01_07_425675	61	16	/	/	SYM
10_1101-2021_01_07_425675	61	17	c	c	NNP
10_1101-2021_01_07_425675	61	18	ions	ion	NNS
10_1101-2021_01_07_425675	61	19	129	129	CD
10_1101-2021_01_07_425675	61	20	indicated	indicate	VBN
10_1101-2021_01_07_425675	61	21	in	in	IN
10_1101-2021_01_07_425675	61	22	blue	blue	NNP
10_1101-2021_01_07_425675	61	23	and	and	CC
10_1101-2021_01_07_425675	61	24	y	y	NNP
10_1101-2021_01_07_425675	61	25	/	/	SYM
10_1101-2021_01_07_425675	61	26	z	z	NNP
10_1101-2021_01_07_425675	61	27	ions	ion	NNS
10_1101-2021_01_07_425675	61	28	in	in	IN
10_1101-2021_01_07_425675	61	29	red	red	NN
10_1101-2021_01_07_425675	61	30	.	.	.
10_1101-2021_01_07_425675	62	1	The	the	DT
10_1101-2021_01_07_425675	62	2	same	same	JJ
10_1101-2021_01_07_425675	62	3	coloring	coloring	NN
10_1101-2021_01_07_425675	62	4	is	be	VBZ
10_1101-2021_01_07_425675	62	5	used	use	VBN
10_1101-2021_01_07_425675	62	6	to	to	TO
10_1101-2021_01_07_425675	62	7	annotate	annotate	VB
10_1101-2021_01_07_425675	62	8	peaks	peak	NNS
10_1101-2021_01_07_425675	62	9	in	in	IN
10_1101-2021_01_07_425675	62	10	the	the	DT
10_1101-2021_01_07_425675	62	11	spectra	spectra	NNP
10_1101-2021_01_07_425675	62	12	,	,	,
10_1101-2021_01_07_425675	62	13	with	with	IN
10_1101-2021_01_07_425675	62	14	130	130	CD
10_1101-2021_01_07_425675	62	15	additional	additional	JJ
10_1101-2021_01_07_425675	62	16	peaks	peak	NNS
10_1101-2021_01_07_425675	62	17	such	such	JJ
10_1101-2021_01_07_425675	62	18	as	as	IN
10_1101-2021_01_07_425675	62	19	intact	intact	JJ
10_1101-2021_01_07_425675	62	20	/	/	SYM
10_1101-2021_01_07_425675	62	21	charge	charge	VB
10_1101-2021_01_07_425675	62	22	reduced	reduce	VBN
10_1101-2021_01_07_425675	62	23	precursors	precursor	NNS
10_1101-2021_01_07_425675	62	24	,	,	,
10_1101-2021_01_07_425675	62	25	neutral	neutral	JJ
10_1101-2021_01_07_425675	62	26	losses	loss	NNS
10_1101-2021_01_07_425675	62	27	and	and	CC
10_1101-2021_01_07_425675	62	28	immonium	immonium	NN
10_1101-2021_01_07_425675	62	29	ions	ion	NNS
10_1101-2021_01_07_425675	62	30	indicated	indicate	VBN
10_1101-2021_01_07_425675	62	31	in	in	IN
10_1101-2021_01_07_425675	62	32	131	131	CD
10_1101-2021_01_07_425675	62	33	green	green	JJ
10_1101-2021_01_07_425675	62	34	.	.	.
10_1101-2021_01_07_425675	63	1	Note	note	VB
10_1101-2021_01_07_425675	63	2	that	that	DT
10_1101-2021_01_07_425675	63	3	to	to	TO
10_1101-2021_01_07_425675	63	4	prevent	prevent	VB
10_1101-2021_01_07_425675	63	5	overlapping	overlap	VBG
10_1101-2021_01_07_425675	63	6	peak	peak	NN
10_1101-2021_01_07_425675	63	7	labels	label	NNS
10_1101-2021_01_07_425675	63	8	,	,	,
10_1101-2021_01_07_425675	63	9	only	only	RB
10_1101-2021_01_07_425675	63	10	a	a	DT
10_1101-2021_01_07_425675	63	11	subset	subset	NN
10_1101-2021_01_07_425675	63	12	of	of	IN
10_1101-2021_01_07_425675	63	13	successfully	successfully	RB
10_1101-2021_01_07_425675	63	14	matched	match	VBN
10_1101-2021_01_07_425675	63	15	peaks	peak	NNS
10_1101-2021_01_07_425675	63	16	is	be	VBZ
10_1101-2021_01_07_425675	63	17	132	132	CD
10_1101-2021_01_07_425675	63	18	annotated	annotate	VBN
10_1101-2021_01_07_425675	63	19	.	.	.
10_1101-2021_01_07_425675	64	1	133	133	CD
10_1101-2021_01_07_425675	64	2	134	134	CD
10_1101-2021_01_07_425675	64	3	The	the	DT
10_1101-2021_01_07_425675	64	4	experimentally	experimentally	RB
10_1101-2021_01_07_425675	64	5	determined	determine	VBN
10_1101-2021_01_07_425675	64	6	de	de	NNP
10_1101-2021_01_07_425675	64	7	novo	novo	NNP
10_1101-2021_01_07_425675	64	8	sequence	sequence	NN
10_1101-2021_01_07_425675	64	9	is	be	VBZ
10_1101-2021_01_07_425675	64	10	shown	show	VBN
10_1101-2021_01_07_425675	64	11	alongside	alongside	IN
10_1101-2021_01_07_425675	64	12	the	the	DT
10_1101-2021_01_07_425675	64	13	known	known	JJ
10_1101-2021_01_07_425675	64	14	Herceptin	Herceptin	NNP
10_1101-2021_01_07_425675	64	15	135	135	CD
10_1101-2021_01_07_425675	64	16	sequence	sequence	NN
10_1101-2021_01_07_425675	64	17	for	for	IN
10_1101-2021_01_07_425675	64	18	the	the	DT
10_1101-2021_01_07_425675	64	19	variable	variable	JJ
10_1101-2021_01_07_425675	64	20	domains	domain	NNS
10_1101-2021_01_07_425675	64	21	of	of	IN
10_1101-2021_01_07_425675	64	22	both	both	DT
10_1101-2021_01_07_425675	64	23	chains	chain	NNS
10_1101-2021_01_07_425675	64	24	in	in	IN
10_1101-2021_01_07_425675	64	25	Figure	Figure	NNP
10_1101-2021_01_07_425675	64	26	1	1	CD
10_1101-2021_01_07_425675	64	27	,	,	,
10_1101-2021_01_07_425675	64	28	with	with	IN
10_1101-2021_01_07_425675	64	29	exemplary	exemplary	JJ
10_1101-2021_01_07_425675	64	30	MS	MS	NNP
10_1101-2021_01_07_425675	64	31	/	/	SYM
10_1101-2021_01_07_425675	64	32	MS	MS	NNP
10_1101-2021_01_07_425675	64	33	spectra	spectra	NN
10_1101-2021_01_07_425675	64	34	for	for	IN
10_1101-2021_01_07_425675	64	35	136	136	CD
10_1101-2021_01_07_425675	64	36	the	the	DT
10_1101-2021_01_07_425675	64	37	CDRs	cdr	NNS
10_1101-2021_01_07_425675	64	38	.	.	.
10_1101-2021_01_07_425675	65	1	We	-PRON-	PRP
10_1101-2021_01_07_425675	65	2	achieved	achieve	VBD
10_1101-2021_01_07_425675	65	3	an	an	DT
10_1101-2021_01_07_425675	65	4	overall	overall	JJ
10_1101-2021_01_07_425675	65	5	sequence	sequence	NN
10_1101-2021_01_07_425675	65	6	accuracy	accuracy	NN
10_1101-2021_01_07_425675	65	7	of	of	IN
10_1101-2021_01_07_425675	65	8	99	99	CD
10_1101-2021_01_07_425675	65	9	%	%	NN
10_1101-2021_01_07_425675	65	10	with	with	IN
10_1101-2021_01_07_425675	65	11	the	the	DT
10_1101-2021_01_07_425675	65	12	automated	automate	VBN
10_1101-2021_01_07_425675	65	13	sequencing	sequencing	NN
10_1101-2021_01_07_425675	65	14	137	137	CD
10_1101-2021_01_07_425675	65	15	procedure	procedure	NN
10_1101-2021_01_07_425675	65	16	of	of	IN
10_1101-2021_01_07_425675	65	17	Supernovo	Supernovo	NNP
10_1101-2021_01_07_425675	65	18	,	,	,
10_1101-2021_01_07_425675	65	19	with	with	IN
10_1101-2021_01_07_425675	65	20	3	3	CD
10_1101-2021_01_07_425675	65	21	incorrect	incorrect	JJ
10_1101-2021_01_07_425675	65	22	assignments	assignment	NNS
10_1101-2021_01_07_425675	65	23	in	in	IN
10_1101-2021_01_07_425675	65	24	the	the	DT
10_1101-2021_01_07_425675	65	25	light	light	JJ
10_1101-2021_01_07_425675	65	26	chain	chain	NN
10_1101-2021_01_07_425675	65	27	.	.	.
10_1101-2021_01_07_425675	66	1	In	in	IN
10_1101-2021_01_07_425675	66	2	framework	framework	NN
10_1101-2021_01_07_425675	66	3	3	3	CD
10_1101-2021_01_07_425675	66	4	of	of	IN
10_1101-2021_01_07_425675	66	5	the	the	DT
10_1101-2021_01_07_425675	66	6	138	138	CD
10_1101-2021_01_07_425675	66	7	light	light	JJ
10_1101-2021_01_07_425675	66	8	chain	chain	NN
10_1101-2021_01_07_425675	66	9	,	,	,
10_1101-2021_01_07_425675	66	10	I75	I75	NNP
10_1101-2021_01_07_425675	66	11	was	be	VBD
10_1101-2021_01_07_425675	66	12	incorrectly	incorrectly	RB
10_1101-2021_01_07_425675	66	13	assigned	assign	VBN
10_1101-2021_01_07_425675	66	14	as	as	IN
10_1101-2021_01_07_425675	66	15	the	the	DT
10_1101-2021_01_07_425675	66	16	isomer	isomer	NN
10_1101-2021_01_07_425675	66	17	Leucine	Leucine	NNP
10_1101-2021_01_07_425675	66	18	(	(	-LRB-
10_1101-2021_01_07_425675	66	19	L	L	NNP
10_1101-2021_01_07_425675	66	20	)	)	-RRB-
10_1101-2021_01_07_425675	66	21	,	,	,
10_1101-2021_01_07_425675	66	22	a	a	DT
10_1101-2021_01_07_425675	66	23	common	common	JJ
10_1101-2021_01_07_425675	66	24	MS	MS	NNP
10_1101-2021_01_07_425675	66	25	-	-	HYPH
10_1101-2021_01_07_425675	66	26	based	base	VBN
10_1101-2021_01_07_425675	66	27	139	139	CD
10_1101-2021_01_07_425675	66	28	sequencing	sequencing	NN
10_1101-2021_01_07_425675	66	29	error	error	NN
10_1101-2021_01_07_425675	66	30	.	.	.
10_1101-2021_01_07_425675	67	1	In	in	IN
10_1101-2021_01_07_425675	67	2	CDRL3	cdrl3	NN
10_1101-2021_01_07_425675	67	3	of	of	IN
10_1101-2021_01_07_425675	67	4	the	the	DT
10_1101-2021_01_07_425675	67	5	light	light	JJ
10_1101-2021_01_07_425675	67	6	chain	chain	NN
10_1101-2021_01_07_425675	67	7	,	,	,
10_1101-2021_01_07_425675	67	8	an	an	DT
10_1101-2021_01_07_425675	67	9	additional	additional	JJ
10_1101-2021_01_07_425675	67	10	misassignment	misassignment	NN
10_1101-2021_01_07_425675	67	11	was	be	VBD
10_1101-2021_01_07_425675	67	12	made	make	VBN
10_1101-2021_01_07_425675	67	13	for	for	IN
10_1101-2021_01_07_425675	67	14	the	the	DT
10_1101-2021_01_07_425675	67	15	140	140	CD
10_1101-2021_01_07_425675	67	16	dipeptide	dipeptide	NN
10_1101-2021_01_07_425675	67	17	H91	H91	NNP
10_1101-2021_01_07_425675	67	18	/	/	SYM
10_1101-2021_01_07_425675	67	19	Y92	Y92	NNP
10_1101-2021_01_07_425675	67	20	,	,	,
10_1101-2021_01_07_425675	67	21	which	which	WDT
10_1101-2021_01_07_425675	67	22	was	be	VBD
10_1101-2021_01_07_425675	67	23	incorrectly	incorrectly	RB
10_1101-2021_01_07_425675	67	24	assigned	assign	VBN
10_1101-2021_01_07_425675	67	25	as	as	IN
10_1101-2021_01_07_425675	67	26	W91	W91	NNP
10_1101-2021_01_07_425675	67	27	/	/	SYM
10_1101-2021_01_07_425675	67	28	N92	N92	NNP
10_1101-2021_01_07_425675	67	29	.	.	.
10_1101-2021_01_07_425675	68	1	The	the	DT
10_1101-2021_01_07_425675	68	2	dipeptides	dipeptide	NNS
10_1101-2021_01_07_425675	68	3	HY	HY	NNP
10_1101-2021_01_07_425675	68	4	and	and	CC
10_1101-2021_01_07_425675	68	5	WN	WN	NNP
10_1101-2021_01_07_425675	68	6	141	141	CD
10_1101-2021_01_07_425675	68	7	have	have	VBP
10_1101-2021_01_07_425675	68	8	identical	identical	JJ
10_1101-2021_01_07_425675	68	9	masses	masse	NNS
10_1101-2021_01_07_425675	68	10	,	,	,
10_1101-2021_01_07_425675	68	11	and	and	CC
10_1101-2021_01_07_425675	68	12	the	the	DT
10_1101-2021_01_07_425675	68	13	misassignment	misassignment	NN
10_1101-2021_01_07_425675	68	14	of	of	IN
10_1101-2021_01_07_425675	68	15	W91	W91	NNP
10_1101-2021_01_07_425675	68	16	/	/	SYM
10_1101-2021_01_07_425675	68	17	N92	N92	NNP
10_1101-2021_01_07_425675	68	18	(	(	-LRB-
10_1101-2021_01_07_425675	68	19	especially	especially	RB
10_1101-2021_01_07_425675	68	20	W91	W91	NNP
10_1101-2021_01_07_425675	68	21	)	)	-RRB-
10_1101-2021_01_07_425675	68	22	was	be	VBD
10_1101-2021_01_07_425675	68	23	poorly	poorly	RB
10_1101-2021_01_07_425675	68	24	142	142	CD
10_1101-2021_01_07_425675	68	25	.CC	.CC	NFP
10_1101-2021_01_07_425675	68	26	-	-	:
10_1101-2021_01_07_425675	68	27	BY	by	IN
10_1101-2021_01_07_425675	68	28	4.0	4.0	CD
10_1101-2021_01_07_425675	68	29	International	International	NNP
10_1101-2021_01_07_425675	68	30	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	68	31	under	under	IN
10_1101-2021_01_07_425675	68	32	a	a	DT
10_1101-2021_01_07_425675	68	33	(	(	-LRB-
10_1101-2021_01_07_425675	68	34	which	which	WDT
10_1101-2021_01_07_425675	68	35	was	be	VBD
10_1101-2021_01_07_425675	68	36	not	not	RB
10_1101-2021_01_07_425675	68	37	certified	certify	VBN
10_1101-2021_01_07_425675	68	38	by	by	IN
10_1101-2021_01_07_425675	68	39	peer	peer	NN
10_1101-2021_01_07_425675	68	40	review	review	NN
10_1101-2021_01_07_425675	68	41	)	)	-RRB-
10_1101-2021_01_07_425675	68	42	is	be	VBZ
10_1101-2021_01_07_425675	68	43	the	the	DT
10_1101-2021_01_07_425675	68	44	author	author	NN
10_1101-2021_01_07_425675	68	45	/	/	SYM
10_1101-2021_01_07_425675	68	46	funder	funder	NN
10_1101-2021_01_07_425675	68	47	,	,	,
10_1101-2021_01_07_425675	68	48	who	who	WP
10_1101-2021_01_07_425675	68	49	has	have	VBZ
10_1101-2021_01_07_425675	68	50	granted	grant	VBN
10_1101-2021_01_07_425675	68	51	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	68	52	a	a	DT
10_1101-2021_01_07_425675	68	53	license	license	NN
10_1101-2021_01_07_425675	68	54	to	to	TO
10_1101-2021_01_07_425675	68	55	display	display	VB
10_1101-2021_01_07_425675	68	56	the	the	DT
10_1101-2021_01_07_425675	68	57	preprint	preprint	NN
10_1101-2021_01_07_425675	68	58	in	in	IN
10_1101-2021_01_07_425675	68	59	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	68	60	.	.	.
10_1101-2021_01_07_425675	69	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	69	2	is	be	VBZ
10_1101-2021_01_07_425675	69	3	made	make	VBN
10_1101-2021_01_07_425675	69	4	The	the	DT
10_1101-2021_01_07_425675	69	5	copyright	copyright	NN
10_1101-2021_01_07_425675	69	6	holder	holder	NN
10_1101-2021_01_07_425675	69	7	for	for	IN
10_1101-2021_01_07_425675	69	8	this	this	DT
10_1101-2021_01_07_425675	69	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	69	10	version	version	NN
10_1101-2021_01_07_425675	69	11	posted	post	VBD
10_1101-2021_01_07_425675	69	12	January	January	NNP
10_1101-2021_01_07_425675	69	13	8	8	CD
10_1101-2021_01_07_425675	69	14	,	,	,
10_1101-2021_01_07_425675	69	15	2021	2021	CD
10_1101-2021_01_07_425675	69	16	.	.	.
10_1101-2021_01_07_425675	69	17	;	;	:
10_1101-2021_01_07_425675	69	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	69	19	:	:	:
10_1101-2021_01_07_425675	69	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	69	21	preprint	preprint	NN
10_1101-2021_01_07_425675	69	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NN
10_1101-2021_01_07_425675	69	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	69	24	7	7	CD
10_1101-2021_01_07_425675	69	25	supported	support	VBN
10_1101-2021_01_07_425675	69	26	by	by	IN
10_1101-2021_01_07_425675	69	27	the	the	DT
10_1101-2021_01_07_425675	69	28	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	69	29	spectra	spectra	NNP
10_1101-2021_01_07_425675	69	30	,	,	,
10_1101-2021_01_07_425675	69	31	in	in	IN
10_1101-2021_01_07_425675	69	32	contrast	contrast	NN
10_1101-2021_01_07_425675	69	33	to	to	IN
10_1101-2021_01_07_425675	69	34	the	the	DT
10_1101-2021_01_07_425675	69	35	correct	correct	JJ
10_1101-2021_01_07_425675	69	36	H91	H91	NNP
10_1101-2021_01_07_425675	69	37	/	/	SYM
10_1101-2021_01_07_425675	69	38	Y92	Y92	NNP
10_1101-2021_01_07_425675	69	39	assignment	assignment	NN
10_1101-2021_01_07_425675	69	40	(	(	-LRB-
10_1101-2021_01_07_425675	69	41	see	see	VB
10_1101-2021_01_07_425675	69	42	c6	c6	NNP
10_1101-2021_01_07_425675	69	43	/	/	SYM
10_1101-2021_01_07_425675	69	44	c7	c7	NNP
10_1101-2021_01_07_425675	69	45	143	143	CD
10_1101-2021_01_07_425675	69	46	in	in	IN
10_1101-2021_01_07_425675	69	47	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	69	48	spectra	spectra	NN
10_1101-2021_01_07_425675	69	49	,	,	,
10_1101-2021_01_07_425675	69	50	Figure	Figure	NNP
10_1101-2021_01_07_425675	69	51	1	1	CD
10_1101-2021_01_07_425675	69	52	)	)	-RRB-
10_1101-2021_01_07_425675	69	53	.	.	.
10_1101-2021_01_07_425675	70	1	Overall	overall	RB
10_1101-2021_01_07_425675	70	2	,	,	,
10_1101-2021_01_07_425675	70	3	the	the	DT
10_1101-2021_01_07_425675	70	4	protocol	protocol	NN
10_1101-2021_01_07_425675	70	5	yielded	yield	VBD
10_1101-2021_01_07_425675	70	6	highly	highly	RB
10_1101-2021_01_07_425675	70	7	accurate	accurate	JJ
10_1101-2021_01_07_425675	70	8	sequences	sequence	NNS
10_1101-2021_01_07_425675	70	9	at	at	IN
10_1101-2021_01_07_425675	70	10	a	a	DT
10_1101-2021_01_07_425675	70	11	144	144	CD
10_1101-2021_01_07_425675	70	12	combined	combine	VBN
10_1101-2021_01_07_425675	70	13	230/233	230/233	JJ
10_1101-2021_01_07_425675	70	14	positions	position	NNS
10_1101-2021_01_07_425675	70	15	of	of	IN
10_1101-2021_01_07_425675	70	16	the	the	DT
10_1101-2021_01_07_425675	70	17	variable	variable	JJ
10_1101-2021_01_07_425675	70	18	domains	domain	NNS
10_1101-2021_01_07_425675	70	19	in	in	IN
10_1101-2021_01_07_425675	70	20	Herceptin	Herceptin	NNP
10_1101-2021_01_07_425675	70	21	.	.	.
10_1101-2021_01_07_425675	71	1	145	145	CD
10_1101-2021_01_07_425675	71	2	146	146	CD
10_1101-2021_01_07_425675	71	3	147	147	CD
10_1101-2021_01_07_425675	71	4	Figure	figure	NN
10_1101-2021_01_07_425675	71	5	2	2	CD
10_1101-2021_01_07_425675	71	6	.	.	.
10_1101-2021_01_07_425675	72	1	Mass	Mass	NNP
10_1101-2021_01_07_425675	72	2	spectrometry	spectrometry	NNP
10_1101-2021_01_07_425675	72	3	based	base	VBN
10_1101-2021_01_07_425675	72	4	de	de	FW
10_1101-2021_01_07_425675	72	5	novo	novo	NNP
10_1101-2021_01_07_425675	72	6	sequence	sequence	NN
10_1101-2021_01_07_425675	72	7	of	of	IN
10_1101-2021_01_07_425675	72	8	the	the	DT
10_1101-2021_01_07_425675	72	9	mouse	mouse	NN
10_1101-2021_01_07_425675	72	10	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	72	11	anti	anti	JJ
10_1101-2021_01_07_425675	72	12	-	-	JJ
10_1101-2021_01_07_425675	72	13	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	72	14	-	-	HYPH
10_1101-2021_01_07_425675	72	15	M2	M2	NNP
10_1101-2021_01_07_425675	72	16	antibody	antibody	NN
10_1101-2021_01_07_425675	72	17	.	.	.
10_1101-2021_01_07_425675	73	1	148	148	CD
10_1101-2021_01_07_425675	73	2	The	the	DT
10_1101-2021_01_07_425675	73	3	variable	variable	JJ
10_1101-2021_01_07_425675	73	4	regions	region	NNS
10_1101-2021_01_07_425675	73	5	of	of	IN
10_1101-2021_01_07_425675	73	6	the	the	DT
10_1101-2021_01_07_425675	73	7	Heavy	heavy	JJ
10_1101-2021_01_07_425675	73	8	(	(	-LRB-
10_1101-2021_01_07_425675	73	9	A	a	NN
10_1101-2021_01_07_425675	73	10	)	)	-RRB-
10_1101-2021_01_07_425675	73	11	and	and	CC
10_1101-2021_01_07_425675	73	12	Light	Light	NNP
10_1101-2021_01_07_425675	73	13	Chains	Chains	NNPS
10_1101-2021_01_07_425675	73	14	(	(	-LRB-
10_1101-2021_01_07_425675	73	15	B	b	NN
10_1101-2021_01_07_425675	73	16	)	)	-RRB-
10_1101-2021_01_07_425675	73	17	are	be	VBP
10_1101-2021_01_07_425675	73	18	shown	show	VBN
10_1101-2021_01_07_425675	73	19	.	.	.
10_1101-2021_01_07_425675	74	1	The	the	DT
10_1101-2021_01_07_425675	74	2	MS	MS	NNP
10_1101-2021_01_07_425675	74	3	-	-	HYPH
10_1101-2021_01_07_425675	74	4	based	base	VBN
10_1101-2021_01_07_425675	74	5	sequence	sequence	NN
10_1101-2021_01_07_425675	74	6	is	be	VBZ
10_1101-2021_01_07_425675	74	7	shown	show	VBN
10_1101-2021_01_07_425675	74	8	149	149	CD
10_1101-2021_01_07_425675	74	9	alongside	alongside	IN
10_1101-2021_01_07_425675	74	10	the	the	DT
10_1101-2021_01_07_425675	74	11	previously	previously	RB
10_1101-2021_01_07_425675	74	12	published	publish	VBN
10_1101-2021_01_07_425675	74	13	sequenced	sequence	VBN
10_1101-2021_01_07_425675	74	14	in	in	IN
10_1101-2021_01_07_425675	74	15	the	the	DT
10_1101-2021_01_07_425675	74	16	crystal	crystal	NN
10_1101-2021_01_07_425675	74	17	structure	structure	NN
10_1101-2021_01_07_425675	74	18	of	of	IN
10_1101-2021_01_07_425675	74	19	the	the	DT
10_1101-2021_01_07_425675	74	20	Fab	Fab	NNP
10_1101-2021_01_07_425675	74	21	(	(	-LRB-
10_1101-2021_01_07_425675	74	22	PDB	PDB	NNP
10_1101-2021_01_07_425675	74	23	ID	ID	NNP
10_1101-2021_01_07_425675	74	24	:	:	:
10_1101-2021_01_07_425675	74	25	2G60	2g60	LS
10_1101-2021_01_07_425675	74	26	)	)	-RRB-
10_1101-2021_01_07_425675	74	27	,	,	,
10_1101-2021_01_07_425675	74	28	and	and	CC
10_1101-2021_01_07_425675	74	29	150	150	CD
10_1101-2021_01_07_425675	74	30	germline	germline	NN
10_1101-2021_01_07_425675	74	31	sequence	sequence	NN
10_1101-2021_01_07_425675	74	32	(	(	-LRB-
10_1101-2021_01_07_425675	74	33	IMGT	IMGT	NNP
10_1101-2021_01_07_425675	74	34	-	-	HYPH
10_1101-2021_01_07_425675	74	35	DomainGapAlign	domaingapalign	NN
10_1101-2021_01_07_425675	74	36	;	;	:
10_1101-2021_01_07_425675	74	37	IGHV1	ighv1	LS
10_1101-2021_01_07_425675	74	38	-	-	HYPH
10_1101-2021_01_07_425675	74	39	04	04	CD
10_1101-2021_01_07_425675	74	40	/	/	SYM
10_1101-2021_01_07_425675	74	41	IGHJ2	IGHJ2	NNS
10_1101-2021_01_07_425675	74	42	;	;	:
10_1101-2021_01_07_425675	74	43	IGKV1	igkv1	CD
10_1101-2021_01_07_425675	74	44	-	-	SYM
10_1101-2021_01_07_425675	74	45	117	117	CD
10_1101-2021_01_07_425675	74	46	/	/	SYM
10_1101-2021_01_07_425675	74	47	IGKJ1	igkj1	NN
10_1101-2021_01_07_425675	74	48	)	)	-RRB-
10_1101-2021_01_07_425675	74	49	.	.	.
10_1101-2021_01_07_425675	75	1	Differential	differential	NN
10_1101-2021_01_07_425675	75	2	residues	residue	NNS
10_1101-2021_01_07_425675	75	3	151	151	CD
10_1101-2021_01_07_425675	75	4	are	be	VBP
10_1101-2021_01_07_425675	75	5	highlighted	highlight	VBN
10_1101-2021_01_07_425675	75	6	by	by	IN
10_1101-2021_01_07_425675	75	7	asterisks	asterisk	NNS
10_1101-2021_01_07_425675	75	8	(	(	-LRB-
10_1101-2021_01_07_425675	75	9	*	*	NFP
10_1101-2021_01_07_425675	75	10	)	)	-RRB-
10_1101-2021_01_07_425675	75	11	.	.	.
10_1101-2021_01_07_425675	76	1	Exemplary	Exemplary	NNP
10_1101-2021_01_07_425675	76	2	MS	MS	NNP
10_1101-2021_01_07_425675	76	3	/	/	SYM
10_1101-2021_01_07_425675	76	4	MS	MS	NNP
10_1101-2021_01_07_425675	76	5	spectra	spectra	NNP
10_1101-2021_01_07_425675	76	6	in	in	IN
10_1101-2021_01_07_425675	76	7	support	support	NN
10_1101-2021_01_07_425675	76	8	of	of	IN
10_1101-2021_01_07_425675	76	9	the	the	DT
10_1101-2021_01_07_425675	76	10	assigned	assign	VBN
10_1101-2021_01_07_425675	76	11	sequences	sequence	NNS
10_1101-2021_01_07_425675	76	12	are	be	VBP
10_1101-2021_01_07_425675	76	13	shown	show	VBN
10_1101-2021_01_07_425675	76	14	152	152	CD
10_1101-2021_01_07_425675	76	15	below	below	IN
10_1101-2021_01_07_425675	76	16	the	the	DT
10_1101-2021_01_07_425675	76	17	alignments	alignment	NNS
10_1101-2021_01_07_425675	76	18	.	.	.
10_1101-2021_01_07_425675	77	1	Peptide	peptide	JJ
10_1101-2021_01_07_425675	77	2	sequence	sequence	NN
10_1101-2021_01_07_425675	77	3	and	and	CC
10_1101-2021_01_07_425675	77	4	fragment	fragment	NN
10_1101-2021_01_07_425675	77	5	coverage	coverage	NN
10_1101-2021_01_07_425675	77	6	are	be	VBP
10_1101-2021_01_07_425675	77	7	indicated	indicate	VBN
10_1101-2021_01_07_425675	77	8	on	on	IN
10_1101-2021_01_07_425675	77	9	top	top	NN
10_1101-2021_01_07_425675	77	10	of	of	IN
10_1101-2021_01_07_425675	77	11	the	the	DT
10_1101-2021_01_07_425675	77	12	spectra	spectra	NNP
10_1101-2021_01_07_425675	77	13	,	,	,
10_1101-2021_01_07_425675	77	14	with	with	IN
10_1101-2021_01_07_425675	77	15	153	153	CD
10_1101-2021_01_07_425675	77	16	b	b	NN
10_1101-2021_01_07_425675	77	17	/	/	SYM
10_1101-2021_01_07_425675	77	18	c	c	NNP
10_1101-2021_01_07_425675	77	19	ions	ion	NNS
10_1101-2021_01_07_425675	77	20	indicated	indicate	VBN
10_1101-2021_01_07_425675	77	21	in	in	IN
10_1101-2021_01_07_425675	77	22	blue	blue	NNP
10_1101-2021_01_07_425675	77	23	,	,	,
10_1101-2021_01_07_425675	77	24	y	y	NNP
10_1101-2021_01_07_425675	77	25	/	/	SYM
10_1101-2021_01_07_425675	77	26	z	z	NNP
10_1101-2021_01_07_425675	77	27	ions	ion	NNS
10_1101-2021_01_07_425675	77	28	in	in	IN
10_1101-2021_01_07_425675	77	29	red	red	NN
10_1101-2021_01_07_425675	77	30	.	.	.
10_1101-2021_01_07_425675	78	1	The	the	DT
10_1101-2021_01_07_425675	78	2	same	same	JJ
10_1101-2021_01_07_425675	78	3	coloring	coloring	NN
10_1101-2021_01_07_425675	78	4	is	be	VBZ
10_1101-2021_01_07_425675	78	5	used	use	VBN
10_1101-2021_01_07_425675	78	6	to	to	TO
10_1101-2021_01_07_425675	78	7	annotate	annotate	VB
10_1101-2021_01_07_425675	78	8	peaks	peak	NNS
10_1101-2021_01_07_425675	78	9	in	in	IN
10_1101-2021_01_07_425675	78	10	the	the	DT
10_1101-2021_01_07_425675	78	11	spectra	spectra	NNP
10_1101-2021_01_07_425675	78	12	,	,	,
10_1101-2021_01_07_425675	78	13	with	with	IN
10_1101-2021_01_07_425675	78	14	154	154	CD
10_1101-2021_01_07_425675	78	15	additional	additional	JJ
10_1101-2021_01_07_425675	78	16	peaks	peak	NNS
10_1101-2021_01_07_425675	78	17	such	such	JJ
10_1101-2021_01_07_425675	78	18	as	as	IN
10_1101-2021_01_07_425675	78	19	intact	intact	JJ
10_1101-2021_01_07_425675	78	20	/	/	SYM
10_1101-2021_01_07_425675	78	21	charge	charge	VB
10_1101-2021_01_07_425675	78	22	reduced	reduce	VBN
10_1101-2021_01_07_425675	78	23	precursors	precursor	NNS
10_1101-2021_01_07_425675	78	24	,	,	,
10_1101-2021_01_07_425675	78	25	neutral	neutral	JJ
10_1101-2021_01_07_425675	78	26	losses	loss	NNS
10_1101-2021_01_07_425675	78	27	and	and	CC
10_1101-2021_01_07_425675	78	28	immonium	immonium	NN
10_1101-2021_01_07_425675	78	29	ions	ion	NNS
10_1101-2021_01_07_425675	78	30	indicated	indicate	VBN
10_1101-2021_01_07_425675	78	31	in	in	IN
10_1101-2021_01_07_425675	78	32	155	155	CD
10_1101-2021_01_07_425675	78	33	green	green	JJ
10_1101-2021_01_07_425675	78	34	.	.	.
10_1101-2021_01_07_425675	79	1	Note	note	VB
10_1101-2021_01_07_425675	79	2	that	that	DT
10_1101-2021_01_07_425675	79	3	to	to	TO
10_1101-2021_01_07_425675	79	4	prevent	prevent	VB
10_1101-2021_01_07_425675	79	5	overlapping	overlap	VBG
10_1101-2021_01_07_425675	79	6	peak	peak	NN
10_1101-2021_01_07_425675	79	7	labels	label	NNS
10_1101-2021_01_07_425675	79	8	,	,	,
10_1101-2021_01_07_425675	79	9	only	only	RB
10_1101-2021_01_07_425675	79	10	a	a	DT
10_1101-2021_01_07_425675	79	11	subset	subset	NN
10_1101-2021_01_07_425675	79	12	of	of	IN
10_1101-2021_01_07_425675	79	13	successfully	successfully	RB
10_1101-2021_01_07_425675	79	14	matched	match	VBN
10_1101-2021_01_07_425675	79	15	peaks	peak	NNS
10_1101-2021_01_07_425675	79	16	is	be	VBZ
10_1101-2021_01_07_425675	79	17	156	156	CD
10_1101-2021_01_07_425675	79	18	annotated	annotate	VBN
10_1101-2021_01_07_425675	79	19	.	.	.
10_1101-2021_01_07_425675	80	1	157	157	CD
10_1101-2021_01_07_425675	80	2	158	158	CD
10_1101-2021_01_07_425675	80	3	.CC	.CC	:
10_1101-2021_01_07_425675	80	4	-	-	:
10_1101-2021_01_07_425675	80	5	BY	by	IN
10_1101-2021_01_07_425675	80	6	4.0	4.0	CD
10_1101-2021_01_07_425675	80	7	International	International	NNP
10_1101-2021_01_07_425675	80	8	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	80	9	under	under	IN
10_1101-2021_01_07_425675	80	10	a	a	DT
10_1101-2021_01_07_425675	80	11	(	(	-LRB-
10_1101-2021_01_07_425675	80	12	which	which	WDT
10_1101-2021_01_07_425675	80	13	was	be	VBD
10_1101-2021_01_07_425675	80	14	not	not	RB
10_1101-2021_01_07_425675	80	15	certified	certify	VBN
10_1101-2021_01_07_425675	80	16	by	by	IN
10_1101-2021_01_07_425675	80	17	peer	peer	NN
10_1101-2021_01_07_425675	80	18	review	review	NN
10_1101-2021_01_07_425675	80	19	)	)	-RRB-
10_1101-2021_01_07_425675	80	20	is	be	VBZ
10_1101-2021_01_07_425675	80	21	the	the	DT
10_1101-2021_01_07_425675	80	22	author	author	NN
10_1101-2021_01_07_425675	80	23	/	/	SYM
10_1101-2021_01_07_425675	80	24	funder	funder	NN
10_1101-2021_01_07_425675	80	25	,	,	,
10_1101-2021_01_07_425675	80	26	who	who	WP
10_1101-2021_01_07_425675	80	27	has	have	VBZ
10_1101-2021_01_07_425675	80	28	granted	grant	VBN
10_1101-2021_01_07_425675	80	29	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	80	30	a	a	DT
10_1101-2021_01_07_425675	80	31	license	license	NN
10_1101-2021_01_07_425675	80	32	to	to	TO
10_1101-2021_01_07_425675	80	33	display	display	VB
10_1101-2021_01_07_425675	80	34	the	the	DT
10_1101-2021_01_07_425675	80	35	preprint	preprint	NN
10_1101-2021_01_07_425675	80	36	in	in	IN
10_1101-2021_01_07_425675	80	37	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	80	38	.	.	.
10_1101-2021_01_07_425675	81	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	81	2	is	be	VBZ
10_1101-2021_01_07_425675	81	3	made	make	VBN
10_1101-2021_01_07_425675	81	4	The	the	DT
10_1101-2021_01_07_425675	81	5	copyright	copyright	NN
10_1101-2021_01_07_425675	81	6	holder	holder	NN
10_1101-2021_01_07_425675	81	7	for	for	IN
10_1101-2021_01_07_425675	81	8	this	this	DT
10_1101-2021_01_07_425675	81	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	81	10	version	version	NN
10_1101-2021_01_07_425675	81	11	posted	post	VBD
10_1101-2021_01_07_425675	81	12	January	January	NNP
10_1101-2021_01_07_425675	81	13	8	8	CD
10_1101-2021_01_07_425675	81	14	,	,	,
10_1101-2021_01_07_425675	81	15	2021	2021	CD
10_1101-2021_01_07_425675	81	16	.	.	.
10_1101-2021_01_07_425675	81	17	;	;	:
10_1101-2021_01_07_425675	81	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	81	19	:	:	:
10_1101-2021_01_07_425675	81	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	81	21	preprint	preprint	NN
10_1101-2021_01_07_425675	81	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NNP
10_1101-2021_01_07_425675	81	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	81	24	8	8	CD
10_1101-2021_01_07_425675	81	25	We	-PRON-	PRP
10_1101-2021_01_07_425675	81	26	next	next	RB
10_1101-2021_01_07_425675	81	27	applied	apply	VBD
10_1101-2021_01_07_425675	81	28	our	-PRON-	PRP$
10_1101-2021_01_07_425675	81	29	sequencing	sequence	VBG
10_1101-2021_01_07_425675	81	30	protocol	protocol	NN
10_1101-2021_01_07_425675	81	31	to	to	IN
10_1101-2021_01_07_425675	81	32	the	the	DT
10_1101-2021_01_07_425675	81	33	mouse	mouse	NN
10_1101-2021_01_07_425675	81	34	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	81	35	anti	anti	JJ
10_1101-2021_01_07_425675	81	36	-	-	JJ
10_1101-2021_01_07_425675	81	37	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	81	38	-	-	HYPH
10_1101-2021_01_07_425675	81	39	M2	M2	NNP
10_1101-2021_01_07_425675	81	40	antibody	antibody	NN
10_1101-2021_01_07_425675	81	41	as	as	IN
10_1101-2021_01_07_425675	81	42	a	a	DT
10_1101-2021_01_07_425675	81	43	159	159	CD
10_1101-2021_01_07_425675	81	44	test	test	NN
10_1101-2021_01_07_425675	81	45	case	case	NN
10_1101-2021_01_07_425675	81	46	24	24	CD
10_1101-2021_01_07_425675	81	47	.	.	.
10_1101-2021_01_07_425675	82	1	Despite	despite	IN
10_1101-2021_01_07_425675	82	2	the	the	DT
10_1101-2021_01_07_425675	82	3	widespread	widespread	JJ
10_1101-2021_01_07_425675	82	4	use	use	NN
10_1101-2021_01_07_425675	82	5	of	of	IN
10_1101-2021_01_07_425675	82	6	anti	anti	JJ
10_1101-2021_01_07_425675	82	7	-	-	JJ
10_1101-2021_01_07_425675	82	8	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	82	9	-	-	HYPH
10_1101-2021_01_07_425675	82	10	M2	m2	NN
10_1101-2021_01_07_425675	82	11	to	to	TO
10_1101-2021_01_07_425675	82	12	detect	detect	VB
10_1101-2021_01_07_425675	82	13	and	and	CC
10_1101-2021_01_07_425675	82	14	purify	purify	VB
10_1101-2021_01_07_425675	82	15	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	82	16	-	-	HYPH
10_1101-2021_01_07_425675	82	17	tagged	tag	VBN
10_1101-2021_01_07_425675	82	18	160	160	CD
10_1101-2021_01_07_425675	82	19	proteins	protein	NNS
10_1101-2021_01_07_425675	82	20	32	32	CD
10_1101-2021_01_07_425675	82	21	,	,	,
10_1101-2021_01_07_425675	82	22	the	the	DT
10_1101-2021_01_07_425675	82	23	only	only	JJ
10_1101-2021_01_07_425675	82	24	publicly	publicly	RB
10_1101-2021_01_07_425675	82	25	available	available	JJ
10_1101-2021_01_07_425675	82	26	sequences	sequence	NNS
10_1101-2021_01_07_425675	82	27	can	can	MD
10_1101-2021_01_07_425675	82	28	be	be	VB
10_1101-2021_01_07_425675	82	29	found	find	VBN
10_1101-2021_01_07_425675	82	30	in	in	IN
10_1101-2021_01_07_425675	82	31	the	the	DT
10_1101-2021_01_07_425675	82	32	crystal	crystal	NN
10_1101-2021_01_07_425675	82	33	structure	structure	NN
10_1101-2021_01_07_425675	82	34	of	of	IN
10_1101-2021_01_07_425675	82	35	the	the	DT
10_1101-2021_01_07_425675	82	36	Fab	Fab	NNP
10_1101-2021_01_07_425675	82	37	161	161	CD
10_1101-2021_01_07_425675	82	38	33	33	CD
10_1101-2021_01_07_425675	82	39	.	.	.
10_1101-2021_01_07_425675	83	1	The	the	DT
10_1101-2021_01_07_425675	83	2	modelled	model	VBN
10_1101-2021_01_07_425675	83	3	sequence	sequence	NN
10_1101-2021_01_07_425675	83	4	of	of	IN
10_1101-2021_01_07_425675	83	5	the	the	DT
10_1101-2021_01_07_425675	83	6	original	original	JJ
10_1101-2021_01_07_425675	83	7	crystal	crystal	NN
10_1101-2021_01_07_425675	83	8	structure	structure	NN
10_1101-2021_01_07_425675	83	9	had	have	VBD
10_1101-2021_01_07_425675	83	10	to	to	TO
10_1101-2021_01_07_425675	83	11	be	be	VB
10_1101-2021_01_07_425675	83	12	inferred	infer	VBN
10_1101-2021_01_07_425675	83	13	from	from	IN
10_1101-2021_01_07_425675	83	14	germline	germline	NN
10_1101-2021_01_07_425675	83	15	162	162	CD
10_1101-2021_01_07_425675	83	16	sequences	sequence	NNS
10_1101-2021_01_07_425675	83	17	that	that	WDT
10_1101-2021_01_07_425675	83	18	could	could	MD
10_1101-2021_01_07_425675	83	19	match	match	VB
10_1101-2021_01_07_425675	83	20	the	the	DT
10_1101-2021_01_07_425675	83	21	experimental	experimental	JJ
10_1101-2021_01_07_425675	83	22	electron	electron	NNP
10_1101-2021_01_07_425675	83	23	density	density	NN
10_1101-2021_01_07_425675	83	24	and	and	CC
10_1101-2021_01_07_425675	83	25	also	also	RB
10_1101-2021_01_07_425675	83	26	includes	include	VBZ
10_1101-2021_01_07_425675	83	27	many	many	JJ
10_1101-2021_01_07_425675	83	28	163	163	CD
10_1101-2021_01_07_425675	83	29	placeholder	placeholder	NN
10_1101-2021_01_07_425675	83	30	Alanines	alanine	NNS
10_1101-2021_01_07_425675	83	31	at	at	IN
10_1101-2021_01_07_425675	83	32	positions	position	NNS
10_1101-2021_01_07_425675	83	33	that	that	WDT
10_1101-2021_01_07_425675	83	34	could	could	MD
10_1101-2021_01_07_425675	83	35	not	not	RB
10_1101-2021_01_07_425675	83	36	be	be	VB
10_1101-2021_01_07_425675	83	37	straightforwardly	straightforwardly	RB
10_1101-2021_01_07_425675	83	38	interpreted	interpret	VBN
10_1101-2021_01_07_425675	83	39	.	.	.
10_1101-2021_01_07_425675	84	1	The	the	DT
10_1101-2021_01_07_425675	84	2	full	full	JJ
10_1101-2021_01_07_425675	84	3	anti-164	anti-164	NN
10_1101-2021_01_07_425675	84	4	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	84	5	-	-	HYPH
10_1101-2021_01_07_425675	84	6	M2	M2	NNP
10_1101-2021_01_07_425675	84	7	dataset	dataset	NN
10_1101-2021_01_07_425675	84	8	from	from	IN
10_1101-2021_01_07_425675	84	9	the	the	DT
10_1101-2021_01_07_425675	84	10	9	9	CD
10_1101-2021_01_07_425675	84	11	proteases	protease	NNS
10_1101-2021_01_07_425675	84	12	included	include	VBD
10_1101-2021_01_07_425675	84	13	3371	3371	CD
10_1101-2021_01_07_425675	84	14	peptide	peptide	NN
10_1101-2021_01_07_425675	84	15	reads	read	NNS
10_1101-2021_01_07_425675	84	16	(	(	-LRB-
10_1101-2021_01_07_425675	84	17	with	with	IN
10_1101-2021_01_07_425675	84	18	scores	score	NNS
10_1101-2021_01_07_425675	84	19	>	>	NNP
10_1101-2021_01_07_425675	84	20	=	=	SYM
10_1101-2021_01_07_425675	84	21	500	500	CD
10_1101-2021_01_07_425675	84	22	)	)	-RRB-
10_1101-2021_01_07_425675	84	23	;	;	:
10_1101-2021_01_07_425675	84	24	1983	1983	CD
10_1101-2021_01_07_425675	84	25	165	165	CD
10_1101-2021_01_07_425675	84	26	with	with	IN
10_1101-2021_01_07_425675	84	27	superior	superior	JJ
10_1101-2021_01_07_425675	84	28	stepped	step	VBN
10_1101-2021_01_07_425675	84	29	HCD	HCD	NNP
10_1101-2021_01_07_425675	84	30	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	84	31	spectra	spectra	NNP
10_1101-2021_01_07_425675	84	32	,	,	,
10_1101-2021_01_07_425675	84	33	and	and	CC
10_1101-2021_01_07_425675	84	34	1388	1388	CD
10_1101-2021_01_07_425675	84	35	with	with	IN
10_1101-2021_01_07_425675	84	36	superior	superior	JJ
10_1101-2021_01_07_425675	84	37	EThcD	EThcD	NNP
10_1101-2021_01_07_425675	84	38	spectra	spectra	NNP
10_1101-2021_01_07_425675	84	39	.	.	.
10_1101-2021_01_07_425675	85	1	We	-PRON-	PRP
10_1101-2021_01_07_425675	85	2	166	166	CD
10_1101-2021_01_07_425675	85	3	achieved	achieve	VBD
10_1101-2021_01_07_425675	85	4	full	full	JJ
10_1101-2021_01_07_425675	85	5	sequence	sequence	NN
10_1101-2021_01_07_425675	85	6	coverage	coverage	NN
10_1101-2021_01_07_425675	85	7	of	of	IN
10_1101-2021_01_07_425675	85	8	the	the	DT
10_1101-2021_01_07_425675	85	9	variable	variable	JJ
10_1101-2021_01_07_425675	85	10	regions	region	NNS
10_1101-2021_01_07_425675	85	11	of	of	IN
10_1101-2021_01_07_425675	85	12	both	both	CC
10_1101-2021_01_07_425675	85	13	heavy	heavy	JJ
10_1101-2021_01_07_425675	85	14	and	and	CC
10_1101-2021_01_07_425675	85	15	light	light	JJ
10_1101-2021_01_07_425675	85	16	chains	chain	NNS
10_1101-2021_01_07_425675	85	17	,	,	,
10_1101-2021_01_07_425675	85	18	with	with	IN
10_1101-2021_01_07_425675	85	19	a	a	DT
10_1101-2021_01_07_425675	85	20	167	167	CD
10_1101-2021_01_07_425675	85	21	median	median	JJ
10_1101-2021_01_07_425675	85	22	depth	depth	NN
10_1101-2021_01_07_425675	85	23	of	of	IN
10_1101-2021_01_07_425675	85	24	coverage	coverage	NN
10_1101-2021_01_07_425675	85	25	in	in	IN
10_1101-2021_01_07_425675	85	26	the	the	DT
10_1101-2021_01_07_425675	85	27	CDRs	cdr	NNS
10_1101-2021_01_07_425675	85	28	ranging	range	VBG
10_1101-2021_01_07_425675	85	29	from	from	IN
10_1101-2021_01_07_425675	85	30	32	32	CD
10_1101-2021_01_07_425675	85	31	to	to	TO
10_1101-2021_01_07_425675	85	32	192	192	CD
10_1101-2021_01_07_425675	85	33	(	(	-LRB-
10_1101-2021_01_07_425675	85	34	see	see	VB
10_1101-2021_01_07_425675	85	35	Table	table	NN
10_1101-2021_01_07_425675	85	36	S1	s1	NN
10_1101-2021_01_07_425675	85	37	)	)	-RRB-
10_1101-2021_01_07_425675	85	38	.	.	.
10_1101-2021_01_07_425675	86	1	As	as	IN
10_1101-2021_01_07_425675	86	2	for	for	IN
10_1101-2021_01_07_425675	86	3	Herceptin	Herceptin	NNP
10_1101-2021_01_07_425675	86	4	,	,	,
10_1101-2021_01_07_425675	86	5	168	168	CD
10_1101-2021_01_07_425675	86	6	the	the	DT
10_1101-2021_01_07_425675	86	7	depth	depth	NN
10_1101-2021_01_07_425675	86	8	of	of	IN
10_1101-2021_01_07_425675	86	9	coverage	coverage	NN
10_1101-2021_01_07_425675	86	10	was	be	VBD
10_1101-2021_01_07_425675	86	11	better	well	JJR
10_1101-2021_01_07_425675	86	12	in	in	IN
10_1101-2021_01_07_425675	86	13	the	the	DT
10_1101-2021_01_07_425675	86	14	light	light	JJ
10_1101-2021_01_07_425675	86	15	chain	chain	NN
10_1101-2021_01_07_425675	86	16	compared	compare	VBN
10_1101-2021_01_07_425675	86	17	to	to	IN
10_1101-2021_01_07_425675	86	18	the	the	DT
10_1101-2021_01_07_425675	86	19	heavy	heavy	JJ
10_1101-2021_01_07_425675	86	20	chain	chain	NN
10_1101-2021_01_07_425675	86	21	(	(	-LRB-
10_1101-2021_01_07_425675	86	22	see	see	VB
10_1101-2021_01_07_425675	86	23	Figure	Figure	NNP
10_1101-2021_01_07_425675	86	24	S1	S1	NNP
10_1101-2021_01_07_425675	86	25	-	-	:
10_1101-2021_01_07_425675	86	26	169	169	CD
10_1101-2021_01_07_425675	86	27	S2	s2	NN
10_1101-2021_01_07_425675	86	28	)	)	-RRB-
10_1101-2021_01_07_425675	86	29	.	.	.
10_1101-2021_01_07_425675	87	1	The	the	DT
10_1101-2021_01_07_425675	87	2	full	full	JJ
10_1101-2021_01_07_425675	87	3	MS	MS	NNP
10_1101-2021_01_07_425675	87	4	-	-	HYPH
10_1101-2021_01_07_425675	87	5	based	base	VBN
10_1101-2021_01_07_425675	87	6	anti	anti	JJ
10_1101-2021_01_07_425675	87	7	-	-	JJ
10_1101-2021_01_07_425675	87	8	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	87	9	-	-	HYPH
10_1101-2021_01_07_425675	87	10	M2	m2	NN
10_1101-2021_01_07_425675	87	11	sequences	sequence	NNS
10_1101-2021_01_07_425675	87	12	can	can	MD
10_1101-2021_01_07_425675	87	13	be	be	VB
10_1101-2021_01_07_425675	87	14	found	find	VBN
10_1101-2021_01_07_425675	87	15	in	in	IN
10_1101-2021_01_07_425675	87	16	FASTA	FASTA	NNP
10_1101-2021_01_07_425675	87	17	format	format	NN
10_1101-2021_01_07_425675	87	18	in	in	IN
10_1101-2021_01_07_425675	87	19	the	the	DT
10_1101-2021_01_07_425675	87	20	170	170	CD
10_1101-2021_01_07_425675	87	21	supplementary	supplementary	JJ
10_1101-2021_01_07_425675	87	22	information	information	NN
10_1101-2021_01_07_425675	87	23	.	.	.
10_1101-2021_01_07_425675	88	1	171	171	CD
10_1101-2021_01_07_425675	88	2	172	172	CD
10_1101-2021_01_07_425675	88	3	173	173	CD
10_1101-2021_01_07_425675	88	4	Figure	figure	NN
10_1101-2021_01_07_425675	88	5	3	3	CD
10_1101-2021_01_07_425675	88	6	.	.	.
10_1101-2021_01_07_425675	89	1	Validation	validation	NN
10_1101-2021_01_07_425675	89	2	of	of	IN
10_1101-2021_01_07_425675	89	3	the	the	DT
10_1101-2021_01_07_425675	89	4	MS	MS	NNP
10_1101-2021_01_07_425675	89	5	-	-	HYPH
10_1101-2021_01_07_425675	89	6	based	base	VBN
10_1101-2021_01_07_425675	89	7	anti	anti	JJ
10_1101-2021_01_07_425675	89	8	-	-	JJ
10_1101-2021_01_07_425675	89	9	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	89	10	-	-	HYPH
10_1101-2021_01_07_425675	89	11	M2	M2	NNP
10_1101-2021_01_07_425675	89	12	sequence	sequence	NN
10_1101-2021_01_07_425675	89	13	.	.	.
10_1101-2021_01_07_425675	90	1	A	a	LS
10_1101-2021_01_07_425675	90	2	)	)	-RRB-
10_1101-2021_01_07_425675	90	3	the	the	DT
10_1101-2021_01_07_425675	90	4	previously	previously	RB
10_1101-2021_01_07_425675	90	5	published	publish	VBN
10_1101-2021_01_07_425675	90	6	crystal	crystal	NN
10_1101-2021_01_07_425675	90	7	structure	structure	NN
10_1101-2021_01_07_425675	90	8	174	174	CD
10_1101-2021_01_07_425675	90	9	of	of	IN
10_1101-2021_01_07_425675	90	10	the	the	DT
10_1101-2021_01_07_425675	90	11	anti	anti	JJ
10_1101-2021_01_07_425675	90	12	-	-	JJ
10_1101-2021_01_07_425675	90	13	FLAG	flag	JJ
10_1101-2021_01_07_425675	90	14	-	-	HYPH
10_1101-2021_01_07_425675	90	15	M2	M2	NNP
10_1101-2021_01_07_425675	90	16	FAb	FAb	NNP
10_1101-2021_01_07_425675	90	17	was	be	VBD
10_1101-2021_01_07_425675	90	18	remodeled	remodel	VBN
10_1101-2021_01_07_425675	90	19	with	with	IN
10_1101-2021_01_07_425675	90	20	the	the	DT
10_1101-2021_01_07_425675	90	21	experimentally	experimentally	RB
10_1101-2021_01_07_425675	90	22	determined	determine	VBN
10_1101-2021_01_07_425675	90	23	sequence	sequence	NN
10_1101-2021_01_07_425675	90	24	,	,	,
10_1101-2021_01_07_425675	90	25	shown	show	VBN
10_1101-2021_01_07_425675	90	26	in	in	IN
10_1101-2021_01_07_425675	90	27	surface	surface	NN
10_1101-2021_01_07_425675	90	28	175	175	CD
10_1101-2021_01_07_425675	90	29	rendering	render	VBG
10_1101-2021_01_07_425675	90	30	with	with	IN
10_1101-2021_01_07_425675	90	31	CDRs	cdr	NNS
10_1101-2021_01_07_425675	90	32	and	and	CC
10_1101-2021_01_07_425675	90	33	differential	differential	NN
10_1101-2021_01_07_425675	90	34	residues	residue	NNS
10_1101-2021_01_07_425675	90	35	highlighted	highlight	VBN
10_1101-2021_01_07_425675	90	36	in	in	IN
10_1101-2021_01_07_425675	90	37	colors	color	NNS
10_1101-2021_01_07_425675	90	38	.	.	.
10_1101-2021_01_07_425675	91	1	B	b	NN
10_1101-2021_01_07_425675	91	2	)	)	-RRB-
10_1101-2021_01_07_425675	91	3	2Fo	2fo	CD
10_1101-2021_01_07_425675	91	4	-	-	:
10_1101-2021_01_07_425675	91	5	Fc	Fc	NNP
10_1101-2021_01_07_425675	91	6	electron	electron	NN
10_1101-2021_01_07_425675	91	7	density	density	NN
10_1101-2021_01_07_425675	91	8	of	of	IN
10_1101-2021_01_07_425675	91	9	the	the	DT
10_1101-2021_01_07_425675	91	10	new	new	JJ
10_1101-2021_01_07_425675	91	11	176	176	CD
10_1101-2021_01_07_425675	91	12	refined	refined	JJ
10_1101-2021_01_07_425675	91	13	map	map	NN
10_1101-2021_01_07_425675	91	14	contoured	contour	VBD
10_1101-2021_01_07_425675	91	15	at	at	IN
10_1101-2021_01_07_425675	91	16	1	1	CD
10_1101-2021_01_07_425675	91	17	RMSD	RMSD	NNP
10_1101-2021_01_07_425675	91	18	is	be	VBZ
10_1101-2021_01_07_425675	91	19	shown	show	VBN
10_1101-2021_01_07_425675	91	20	in	in	IN
10_1101-2021_01_07_425675	91	21	blue	blue	JJ
10_1101-2021_01_07_425675	91	22	and	and	CC
10_1101-2021_01_07_425675	91	23	Fo	Fo	NNP
10_1101-2021_01_07_425675	91	24	-	-	HYPH
10_1101-2021_01_07_425675	91	25	Fc	Fc	NNP
10_1101-2021_01_07_425675	91	26	positive	positive	JJ
10_1101-2021_01_07_425675	91	27	difference	difference	NN
10_1101-2021_01_07_425675	91	28	density	density	NN
10_1101-2021_01_07_425675	91	29	of	of	IN
10_1101-2021_01_07_425675	91	30	the	the	DT
10_1101-2021_01_07_425675	91	31	original	original	JJ
10_1101-2021_01_07_425675	91	32	177	177	CD
10_1101-2021_01_07_425675	91	33	deposited	deposit	VBN
10_1101-2021_01_07_425675	91	34	map	map	NN
10_1101-2021_01_07_425675	91	35	contoured	contour	VBD
10_1101-2021_01_07_425675	91	36	at	at	IN
10_1101-2021_01_07_425675	91	37	1.7	1.7	CD
10_1101-2021_01_07_425675	91	38	RMSD	RMSD	NNP
10_1101-2021_01_07_425675	91	39	in	in	IN
10_1101-2021_01_07_425675	91	40	green	green	NN
10_1101-2021_01_07_425675	91	41	around	around	IN
10_1101-2021_01_07_425675	91	42	the	the	DT
10_1101-2021_01_07_425675	91	43	CDR	cdr	NN
10_1101-2021_01_07_425675	91	44	loops	loop	NNS
10_1101-2021_01_07_425675	91	45	of	of	IN
10_1101-2021_01_07_425675	91	46	the	the	DT
10_1101-2021_01_07_425675	91	47	heavy	heavy	JJ
10_1101-2021_01_07_425675	91	48	and	and	CC
10_1101-2021_01_07_425675	91	49	light	light	JJ
10_1101-2021_01_07_425675	91	50	chains	chain	NNS
10_1101-2021_01_07_425675	91	51	.	.	.
10_1101-2021_01_07_425675	92	1	178	178	CD
10_1101-2021_01_07_425675	92	2	Differential	differential	NN
10_1101-2021_01_07_425675	92	3	residues	residue	NNS
10_1101-2021_01_07_425675	92	4	between	between	IN
10_1101-2021_01_07_425675	92	5	the	the	DT
10_1101-2021_01_07_425675	92	6	published	publish	VBN
10_1101-2021_01_07_425675	92	7	crystal	crystal	NN
10_1101-2021_01_07_425675	92	8	structure	structure	NN
10_1101-2021_01_07_425675	92	9	and	and	CC
10_1101-2021_01_07_425675	92	10	the	the	DT
10_1101-2021_01_07_425675	92	11	model	model	NN
10_1101-2021_01_07_425675	92	12	based	base	VBN
10_1101-2021_01_07_425675	92	13	on	on	IN
10_1101-2021_01_07_425675	92	14	our	-PRON-	PRP$
10_1101-2021_01_07_425675	92	15	antibody	antibody	NN
10_1101-2021_01_07_425675	92	16	179	179	CD
10_1101-2021_01_07_425675	92	17	sequencing	sequencing	NN
10_1101-2021_01_07_425675	92	18	are	be	VBP
10_1101-2021_01_07_425675	92	19	indicated	indicate	VBN
10_1101-2021_01_07_425675	92	20	in	in	IN
10_1101-2021_01_07_425675	92	21	purple	purple	NN
10_1101-2021_01_07_425675	92	22	.	.	.
10_1101-2021_01_07_425675	93	1	C	C	NNP
10_1101-2021_01_07_425675	93	2	)	)	-RRB-
10_1101-2021_01_07_425675	93	3	Western	western	JJ
10_1101-2021_01_07_425675	93	4	blot	blot	NN
10_1101-2021_01_07_425675	93	5	validation	validation	NN
10_1101-2021_01_07_425675	93	6	of	of	IN
10_1101-2021_01_07_425675	93	7	the	the	DT
10_1101-2021_01_07_425675	93	8	synthetic	synthetic	JJ
10_1101-2021_01_07_425675	93	9	recombinant	recombinant	JJ
10_1101-2021_01_07_425675	93	10	anti	anti	JJ
10_1101-2021_01_07_425675	93	11	-	-	JJ
10_1101-2021_01_07_425675	93	12	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	93	13	-	-	HYPH
10_1101-2021_01_07_425675	93	14	M2	M2	NNP
10_1101-2021_01_07_425675	93	15	180	180	CD
10_1101-2021_01_07_425675	93	16	antibody	antibody	NN
10_1101-2021_01_07_425675	93	17	produced	produce	VBN
10_1101-2021_01_07_425675	93	18	with	with	IN
10_1101-2021_01_07_425675	93	19	the	the	DT
10_1101-2021_01_07_425675	93	20	experimentally	experimentally	RB
10_1101-2021_01_07_425675	93	21	determined	determine	VBN
10_1101-2021_01_07_425675	93	22	sequence	sequence	NN
10_1101-2021_01_07_425675	93	23	demonstrate	demonstrate	NN
10_1101-2021_01_07_425675	93	24	equivalent	equivalent	JJ
10_1101-2021_01_07_425675	93	25	FLAG	flag	NN
10_1101-2021_01_07_425675	93	26	-	-	HYPH
10_1101-2021_01_07_425675	93	27	tag	tag	NN
10_1101-2021_01_07_425675	93	28	binding	bind	VBG
10_1101-2021_01_07_425675	93	29	181	181	CD
10_1101-2021_01_07_425675	93	30	compared	compare	VBN
10_1101-2021_01_07_425675	93	31	to	to	IN
10_1101-2021_01_07_425675	93	32	commercial	commercial	JJ
10_1101-2021_01_07_425675	93	33	anti	anti	JJ
10_1101-2021_01_07_425675	93	34	-	-	JJ
10_1101-2021_01_07_425675	93	35	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	93	36	-	-	HYPH
10_1101-2021_01_07_425675	93	37	M2	M2	NNP
10_1101-2021_01_07_425675	93	38	(	(	-LRB-
10_1101-2021_01_07_425675	93	39	see	see	VB
10_1101-2021_01_07_425675	93	40	also	also	RB
10_1101-2021_01_07_425675	93	41	Figure	Figure	NNP
10_1101-2021_01_07_425675	93	42	S3	S3	NNP
10_1101-2021_01_07_425675	93	43	)	)	-RRB-
10_1101-2021_01_07_425675	93	44	.	.	.
10_1101-2021_01_07_425675	94	1	182	182	CD
10_1101-2021_01_07_425675	94	2	183	183	CD
10_1101-2021_01_07_425675	94	3	.CC	.CC	,
10_1101-2021_01_07_425675	94	4	-	-	:
10_1101-2021_01_07_425675	94	5	BY	by	IN
10_1101-2021_01_07_425675	94	6	4.0	4.0	CD
10_1101-2021_01_07_425675	94	7	International	International	NNP
10_1101-2021_01_07_425675	94	8	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	94	9	under	under	IN
10_1101-2021_01_07_425675	94	10	a	a	DT
10_1101-2021_01_07_425675	94	11	(	(	-LRB-
10_1101-2021_01_07_425675	94	12	which	which	WDT
10_1101-2021_01_07_425675	94	13	was	be	VBD
10_1101-2021_01_07_425675	94	14	not	not	RB
10_1101-2021_01_07_425675	94	15	certified	certify	VBN
10_1101-2021_01_07_425675	94	16	by	by	IN
10_1101-2021_01_07_425675	94	17	peer	peer	NN
10_1101-2021_01_07_425675	94	18	review	review	NN
10_1101-2021_01_07_425675	94	19	)	)	-RRB-
10_1101-2021_01_07_425675	94	20	is	be	VBZ
10_1101-2021_01_07_425675	94	21	the	the	DT
10_1101-2021_01_07_425675	94	22	author	author	NN
10_1101-2021_01_07_425675	94	23	/	/	SYM
10_1101-2021_01_07_425675	94	24	funder	funder	NN
10_1101-2021_01_07_425675	94	25	,	,	,
10_1101-2021_01_07_425675	94	26	who	who	WP
10_1101-2021_01_07_425675	94	27	has	have	VBZ
10_1101-2021_01_07_425675	94	28	granted	grant	VBN
10_1101-2021_01_07_425675	94	29	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	94	30	a	a	DT
10_1101-2021_01_07_425675	94	31	license	license	NN
10_1101-2021_01_07_425675	94	32	to	to	TO
10_1101-2021_01_07_425675	94	33	display	display	VB
10_1101-2021_01_07_425675	94	34	the	the	DT
10_1101-2021_01_07_425675	94	35	preprint	preprint	NN
10_1101-2021_01_07_425675	94	36	in	in	IN
10_1101-2021_01_07_425675	94	37	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	94	38	.	.	.
10_1101-2021_01_07_425675	95	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	95	2	is	be	VBZ
10_1101-2021_01_07_425675	95	3	made	make	VBN
10_1101-2021_01_07_425675	95	4	The	the	DT
10_1101-2021_01_07_425675	95	5	copyright	copyright	NN
10_1101-2021_01_07_425675	95	6	holder	holder	NN
10_1101-2021_01_07_425675	95	7	for	for	IN
10_1101-2021_01_07_425675	95	8	this	this	DT
10_1101-2021_01_07_425675	95	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	95	10	version	version	NN
10_1101-2021_01_07_425675	95	11	posted	post	VBD
10_1101-2021_01_07_425675	95	12	January	January	NNP
10_1101-2021_01_07_425675	95	13	8	8	CD
10_1101-2021_01_07_425675	95	14	,	,	,
10_1101-2021_01_07_425675	95	15	2021	2021	CD
10_1101-2021_01_07_425675	95	16	.	.	.
10_1101-2021_01_07_425675	95	17	;	;	:
10_1101-2021_01_07_425675	95	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	95	19	:	:	:
10_1101-2021_01_07_425675	95	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	95	21	preprint	preprint	NN
10_1101-2021_01_07_425675	95	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NN
10_1101-2021_01_07_425675	95	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	95	24	9	9	CD
10_1101-2021_01_07_425675	95	25	The	the	DT
10_1101-2021_01_07_425675	95	26	MS	MS	NNP
10_1101-2021_01_07_425675	95	27	-	-	HYPH
10_1101-2021_01_07_425675	95	28	based	base	VBN
10_1101-2021_01_07_425675	95	29	sequences	sequence	NNS
10_1101-2021_01_07_425675	95	30	of	of	IN
10_1101-2021_01_07_425675	95	31	anti	anti	JJ
10_1101-2021_01_07_425675	95	32	-	-	JJ
10_1101-2021_01_07_425675	95	33	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	95	34	-	-	HYPH
10_1101-2021_01_07_425675	95	35	M2	M2	NNP
10_1101-2021_01_07_425675	95	36	are	be	VBP
10_1101-2021_01_07_425675	95	37	shown	show	VBN
10_1101-2021_01_07_425675	95	38	alongside	alongside	IN
10_1101-2021_01_07_425675	95	39	the	the	DT
10_1101-2021_01_07_425675	95	40	crystal	crystal	NN
10_1101-2021_01_07_425675	95	41	structure	structure	NN
10_1101-2021_01_07_425675	95	42	sequences	sequence	VBZ
10_1101-2021_01_07_425675	95	43	184	184	CD
10_1101-2021_01_07_425675	95	44	and	and	CC
10_1101-2021_01_07_425675	95	45	the	the	DT
10_1101-2021_01_07_425675	95	46	inferred	inferred	JJ
10_1101-2021_01_07_425675	95	47	germline	germline	NN
10_1101-2021_01_07_425675	95	48	precursors	precursor	NNS
10_1101-2021_01_07_425675	95	49	with	with	IN
10_1101-2021_01_07_425675	95	50	exemplary	exemplary	JJ
10_1101-2021_01_07_425675	95	51	MS	MS	NNP
10_1101-2021_01_07_425675	95	52	/	/	SYM
10_1101-2021_01_07_425675	95	53	MS	MS	NNP
10_1101-2021_01_07_425675	95	54	spectra	spectra	NNP
10_1101-2021_01_07_425675	95	55	for	for	IN
10_1101-2021_01_07_425675	95	56	the	the	DT
10_1101-2021_01_07_425675	95	57	CDRs	cdr	NNS
10_1101-2021_01_07_425675	95	58	in	in	IN
10_1101-2021_01_07_425675	95	59	Figure	Figure	NNP
10_1101-2021_01_07_425675	95	60	2	2	CD
10_1101-2021_01_07_425675	95	61	.	.	.
10_1101-2021_01_07_425675	96	1	185	185	CD
10_1101-2021_01_07_425675	96	2	The	the	DT
10_1101-2021_01_07_425675	96	3	experimentally	experimentally	RB
10_1101-2021_01_07_425675	96	4	determined	determine	VBN
10_1101-2021_01_07_425675	96	5	sequence	sequence	NN
10_1101-2021_01_07_425675	96	6	reveals	reveal	VBZ
10_1101-2021_01_07_425675	96	7	that	that	IN
10_1101-2021_01_07_425675	96	8	anti	anti	JJ
10_1101-2021_01_07_425675	96	9	-	-	JJ
10_1101-2021_01_07_425675	96	10	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	96	11	-	-	HYPH
10_1101-2021_01_07_425675	96	12	M2	M2	NNP
10_1101-2021_01_07_425675	96	13	is	be	VBZ
10_1101-2021_01_07_425675	96	14	a	a	DT
10_1101-2021_01_07_425675	96	15	mouse	mouse	NN
10_1101-2021_01_07_425675	96	16	IgG1	igg1	NN
10_1101-2021_01_07_425675	96	17	,	,	,
10_1101-2021_01_07_425675	96	18	with	with	IN
10_1101-2021_01_07_425675	96	19	an	an	DT
10_1101-2021_01_07_425675	96	20	186	186	CD
10_1101-2021_01_07_425675	96	21	IGHV1	ighv1	CD
10_1101-2021_01_07_425675	96	22	-	-	HYPH
10_1101-2021_01_07_425675	96	23	04	04	CD
10_1101-2021_01_07_425675	96	24	/	/	SYM
10_1101-2021_01_07_425675	96	25	IGHJ2	ighj2	NN
10_1101-2021_01_07_425675	96	26	heavy	heavy	JJ
10_1101-2021_01_07_425675	96	27	chain	chain	NN
10_1101-2021_01_07_425675	96	28	and	and	CC
10_1101-2021_01_07_425675	96	29	IGKV1	igkv1	CD
10_1101-2021_01_07_425675	96	30	-	-	SYM
10_1101-2021_01_07_425675	96	31	117	117	CD
10_1101-2021_01_07_425675	96	32	/	/	SYM
10_1101-2021_01_07_425675	96	33	IGKJ1	igkj1	NN
10_1101-2021_01_07_425675	96	34	kappa	kappa	NNP
10_1101-2021_01_07_425675	96	35	light	light	JJ
10_1101-2021_01_07_425675	96	36	chain	chain	NN
10_1101-2021_01_07_425675	96	37	.	.	.
10_1101-2021_01_07_425675	97	1	The	the	DT
10_1101-2021_01_07_425675	97	2	experimentally	experimentally	RB
10_1101-2021_01_07_425675	97	3	187	187	CD
10_1101-2021_01_07_425675	97	4	determined	determine	VBN
10_1101-2021_01_07_425675	97	5	sequence	sequence	NN
10_1101-2021_01_07_425675	97	6	differs	differ	NNS
10_1101-2021_01_07_425675	97	7	at	at	IN
10_1101-2021_01_07_425675	97	8	34	34	CD
10_1101-2021_01_07_425675	97	9	and	and	CC
10_1101-2021_01_07_425675	97	10	9	9	CD
10_1101-2021_01_07_425675	97	11	positions	position	NNS
10_1101-2021_01_07_425675	97	12	in	in	IN
10_1101-2021_01_07_425675	97	13	the	the	DT
10_1101-2021_01_07_425675	97	14	heavy	heavy	JJ
10_1101-2021_01_07_425675	97	15	and	and	CC
10_1101-2021_01_07_425675	97	16	light	light	JJ
10_1101-2021_01_07_425675	97	17	chain	chain	NN
10_1101-2021_01_07_425675	97	18	of	of	IN
10_1101-2021_01_07_425675	97	19	the	the	DT
10_1101-2021_01_07_425675	97	20	Fab	Fab	NNP
10_1101-2021_01_07_425675	97	21	crystal	crystal	NN
10_1101-2021_01_07_425675	97	22	188	188	CD
10_1101-2021_01_07_425675	97	23	structure	structure	NN
10_1101-2021_01_07_425675	97	24	,	,	,
10_1101-2021_01_07_425675	97	25	respectively	respectively	RB
10_1101-2021_01_07_425675	97	26	.	.	.
10_1101-2021_01_07_425675	98	1	To	to	TO
10_1101-2021_01_07_425675	98	2	validate	validate	VB
10_1101-2021_01_07_425675	98	3	the	the	DT
10_1101-2021_01_07_425675	98	4	experimentally	experimentally	RB
10_1101-2021_01_07_425675	98	5	determined	determine	VBN
10_1101-2021_01_07_425675	98	6	sequences	sequence	NNS
10_1101-2021_01_07_425675	98	7	,	,	,
10_1101-2021_01_07_425675	98	8	we	-PRON-	PRP
10_1101-2021_01_07_425675	98	9	remodeled	remodel	VBD
10_1101-2021_01_07_425675	98	10	the	the	DT
10_1101-2021_01_07_425675	98	11	189	189	CD
10_1101-2021_01_07_425675	98	12	crystal	crystal	NN
10_1101-2021_01_07_425675	98	13	structure	structure	NN
10_1101-2021_01_07_425675	98	14	using	use	VBG
10_1101-2021_01_07_425675	98	15	the	the	DT
10_1101-2021_01_07_425675	98	16	MS	MS	NNP
10_1101-2021_01_07_425675	98	17	-	-	HYPH
10_1101-2021_01_07_425675	98	18	based	base	VBN
10_1101-2021_01_07_425675	98	19	heavy	heavy	JJ
10_1101-2021_01_07_425675	98	20	and	and	CC
10_1101-2021_01_07_425675	98	21	light	light	JJ
10_1101-2021_01_07_425675	98	22	chains	chain	NNS
10_1101-2021_01_07_425675	98	23	,	,	,
10_1101-2021_01_07_425675	98	24	resulting	result	VBG
10_1101-2021_01_07_425675	98	25	in	in	IN
10_1101-2021_01_07_425675	98	26	much	much	JJ
10_1101-2021_01_07_425675	98	27	improved	improve	VBN
10_1101-2021_01_07_425675	98	28	model	model	NN
10_1101-2021_01_07_425675	98	29	190	190	CD
10_1101-2021_01_07_425675	98	30	statistics	statistic	NNS
10_1101-2021_01_07_425675	98	31	(	(	-LRB-
10_1101-2021_01_07_425675	98	32	see	see	VB
10_1101-2021_01_07_425675	98	33	Figure	figure	NN
10_1101-2021_01_07_425675	98	34	3	3	CD
10_1101-2021_01_07_425675	98	35	and	and	CC
10_1101-2021_01_07_425675	98	36	Table	Table	NNP
10_1101-2021_01_07_425675	98	37	S2	S2	NNP
10_1101-2021_01_07_425675	98	38	)	)	-RRB-
10_1101-2021_01_07_425675	98	39	.	.	.
10_1101-2021_01_07_425675	99	1	The	the	DT
10_1101-2021_01_07_425675	99	2	experimental	experimental	JJ
10_1101-2021_01_07_425675	99	3	electron	electron	NN
10_1101-2021_01_07_425675	99	4	densities	density	NNS
10_1101-2021_01_07_425675	99	5	show	show	VBP
10_1101-2021_01_07_425675	99	6	excellent	excellent	JJ
10_1101-2021_01_07_425675	99	7	support	support	NN
10_1101-2021_01_07_425675	99	8	191	191	CD
10_1101-2021_01_07_425675	99	9	of	of	IN
10_1101-2021_01_07_425675	99	10	the	the	DT
10_1101-2021_01_07_425675	99	11	MS	MS	NNP
10_1101-2021_01_07_425675	99	12	-	-	HYPH
10_1101-2021_01_07_425675	99	13	based	base	VBN
10_1101-2021_01_07_425675	99	14	sequence	sequence	NN
10_1101-2021_01_07_425675	99	15	(	(	-LRB-
10_1101-2021_01_07_425675	99	16	as	as	IN
10_1101-2021_01_07_425675	99	17	shown	show	VBN
10_1101-2021_01_07_425675	99	18	for	for	IN
10_1101-2021_01_07_425675	99	19	the	the	DT
10_1101-2021_01_07_425675	99	20	CDRs	cdr	NNS
10_1101-2021_01_07_425675	99	21	in	in	IN
10_1101-2021_01_07_425675	99	22	Figure	Figure	NNP
10_1101-2021_01_07_425675	99	23	3B	3b	NN
10_1101-2021_01_07_425675	99	24	)	)	-RRB-
10_1101-2021_01_07_425675	99	25	.	.	.
10_1101-2021_01_07_425675	100	1	A	a	DT
10_1101-2021_01_07_425675	100	2	notable	notable	JJ
10_1101-2021_01_07_425675	100	3	exception	exception	NN
10_1101-2021_01_07_425675	100	4	is	be	VBZ
10_1101-2021_01_07_425675	100	5	L51	L51	NNP
10_1101-2021_01_07_425675	100	6	in	in	IN
10_1101-2021_01_07_425675	100	7	192	192	CD
10_1101-2021_01_07_425675	100	8	CDRH2	CDRH2	NNS
10_1101-2021_01_07_425675	100	9	of	of	IN
10_1101-2021_01_07_425675	100	10	the	the	DT
10_1101-2021_01_07_425675	100	11	heavy	heavy	JJ
10_1101-2021_01_07_425675	100	12	chain	chain	NN
10_1101-2021_01_07_425675	100	13	.	.	.
10_1101-2021_01_07_425675	101	1	The	the	DT
10_1101-2021_01_07_425675	101	2	MS	MS	NNP
10_1101-2021_01_07_425675	101	3	-	-	HYPH
10_1101-2021_01_07_425675	101	4	based	base	VBN
10_1101-2021_01_07_425675	101	5	sequence	sequence	NN
10_1101-2021_01_07_425675	101	6	was	be	VBD
10_1101-2021_01_07_425675	101	7	assigned	assign	VBN
10_1101-2021_01_07_425675	101	8	as	as	IN
10_1101-2021_01_07_425675	101	9	Leucine	Leucine	NNP
10_1101-2021_01_07_425675	101	10	,	,	,
10_1101-2021_01_07_425675	101	11	but	but	CC
10_1101-2021_01_07_425675	101	12	the	the	DT
10_1101-2021_01_07_425675	101	13	193	193	CD
10_1101-2021_01_07_425675	101	14	experimental	experimental	JJ
10_1101-2021_01_07_425675	101	15	electron	electron	NNP
10_1101-2021_01_07_425675	101	16	density	density	NN
10_1101-2021_01_07_425675	101	17	supports	support	VBZ
10_1101-2021_01_07_425675	101	18	assignment	assignment	NN
10_1101-2021_01_07_425675	101	19	of	of	IN
10_1101-2021_01_07_425675	101	20	the	the	DT
10_1101-2021_01_07_425675	101	21	isomer	isomer	NN
10_1101-2021_01_07_425675	101	22	Isoleucine	Isoleucine	NNP
10_1101-2021_01_07_425675	101	23	instead	instead	RB
10_1101-2021_01_07_425675	101	24	(	(	-LRB-
10_1101-2021_01_07_425675	101	25	see	see	VB
10_1101-2021_01_07_425675	101	26	Figure	Figure	NNP
10_1101-2021_01_07_425675	101	27	194	194	CD
10_1101-2021_01_07_425675	101	28	S3	S3	NNP
10_1101-2021_01_07_425675	101	29	)	)	-RRB-
10_1101-2021_01_07_425675	101	30	.	.	.
10_1101-2021_01_07_425675	102	1	In	in	IN
10_1101-2021_01_07_425675	102	2	contrast	contrast	NN
10_1101-2021_01_07_425675	102	3	to	to	IN
10_1101-2021_01_07_425675	102	4	the	the	DT
10_1101-2021_01_07_425675	102	5	original	original	JJ
10_1101-2021_01_07_425675	102	6	model	model	NN
10_1101-2021_01_07_425675	102	7	our	-PRON-	PRP$
10_1101-2021_01_07_425675	102	8	new	new	JJ
10_1101-2021_01_07_425675	102	9	MS	MS	NNP
10_1101-2021_01_07_425675	102	10	-	-	HYPH
10_1101-2021_01_07_425675	102	11	based	base	VBN
10_1101-2021_01_07_425675	102	12	model	model	NN
10_1101-2021_01_07_425675	102	13	reveals	reveal	VBZ
10_1101-2021_01_07_425675	102	14	a	a	DT
10_1101-2021_01_07_425675	102	15	predominantly	predominantly	RB
10_1101-2021_01_07_425675	102	16	positively	positively	RB
10_1101-2021_01_07_425675	102	17	195	195	CD
10_1101-2021_01_07_425675	102	18	charged	charge	VBN
10_1101-2021_01_07_425675	102	19	paratope	paratope	NN
10_1101-2021_01_07_425675	102	20	(	(	-LRB-
10_1101-2021_01_07_425675	102	21	see	see	VB
10_1101-2021_01_07_425675	102	22	Figure	Figure	NNP
10_1101-2021_01_07_425675	102	23	S4	S4	NNP
10_1101-2021_01_07_425675	102	24	)	)	-RRB-
10_1101-2021_01_07_425675	102	25	,	,	,
10_1101-2021_01_07_425675	102	26	which	which	WDT
10_1101-2021_01_07_425675	102	27	potentially	potentially	RB
10_1101-2021_01_07_425675	102	28	complements	complement	VBZ
10_1101-2021_01_07_425675	102	29	the	the	DT
10_1101-2021_01_07_425675	102	30	-3	-3	NNP
10_1101-2021_01_07_425675	102	31	net	net	JJ
10_1101-2021_01_07_425675	102	32	charge	charge	NN
10_1101-2021_01_07_425675	102	33	of	of	IN
10_1101-2021_01_07_425675	102	34	the	the	DT
10_1101-2021_01_07_425675	102	35	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	102	36	196	196	CD
10_1101-2021_01_07_425675	102	37	tag	tag	NN
10_1101-2021_01_07_425675	102	38	epitope	epitope	NN
10_1101-2021_01_07_425675	102	39	(	(	-LRB-
10_1101-2021_01_07_425675	102	40	DYKDDDDK	DYKDDDDK	NNP
10_1101-2021_01_07_425675	102	41	)	)	-RRB-
10_1101-2021_01_07_425675	102	42	to	to	TO
10_1101-2021_01_07_425675	102	43	mediate	mediate	VB
10_1101-2021_01_07_425675	102	44	binding	binding	NN
10_1101-2021_01_07_425675	102	45	.	.	.
10_1101-2021_01_07_425675	103	1	The	the	DT
10_1101-2021_01_07_425675	103	2	experimentally	experimentally	RB
10_1101-2021_01_07_425675	103	3	determined	determine	VBN
10_1101-2021_01_07_425675	103	4	anti	anti	JJ
10_1101-2021_01_07_425675	103	5	-	-	JJ
10_1101-2021_01_07_425675	103	6	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	103	7	-	-	HYPH
10_1101-2021_01_07_425675	103	8	M2	M2	NNP
10_1101-2021_01_07_425675	103	9	197	197	CD
10_1101-2021_01_07_425675	103	10	sequence	sequence	NN
10_1101-2021_01_07_425675	103	11	,	,	,
10_1101-2021_01_07_425675	103	12	with	with	IN
10_1101-2021_01_07_425675	103	13	the	the	DT
10_1101-2021_01_07_425675	103	14	L51I	l51i	JJ
10_1101-2021_01_07_425675	103	15	correction	correction	NN
10_1101-2021_01_07_425675	103	16	,	,	,
10_1101-2021_01_07_425675	103	17	was	be	VBD
10_1101-2021_01_07_425675	103	18	further	further	RB
10_1101-2021_01_07_425675	103	19	validated	validate	VBN
10_1101-2021_01_07_425675	103	20	by	by	IN
10_1101-2021_01_07_425675	103	21	testing	test	VBG
10_1101-2021_01_07_425675	103	22	binding	binding	NN
10_1101-2021_01_07_425675	103	23	of	of	IN
10_1101-2021_01_07_425675	103	24	the	the	DT
10_1101-2021_01_07_425675	103	25	synthetic	synthetic	JJ
10_1101-2021_01_07_425675	103	26	198	198	CD
10_1101-2021_01_07_425675	103	27	recombinant	recombinant	JJ
10_1101-2021_01_07_425675	103	28	antibody	antibody	NN
10_1101-2021_01_07_425675	103	29	to	to	IN
10_1101-2021_01_07_425675	103	30	a	a	DT
10_1101-2021_01_07_425675	103	31	purified	purify	VBN
10_1101-2021_01_07_425675	103	32	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	103	33	-	-	HYPH
10_1101-2021_01_07_425675	103	34	tagged	tag	VBN
10_1101-2021_01_07_425675	103	35	protein	protein	NN
10_1101-2021_01_07_425675	103	36	in	in	IN
10_1101-2021_01_07_425675	103	37	Western	western	JJ
10_1101-2021_01_07_425675	103	38	blot	blot	NN
10_1101-2021_01_07_425675	103	39	analysis	analysis	NN
10_1101-2021_01_07_425675	103	40	(	(	-LRB-
10_1101-2021_01_07_425675	103	41	see	see	VB
10_1101-2021_01_07_425675	103	42	Figure	Figure	NNP
10_1101-2021_01_07_425675	103	43	3C	3c	NN
10_1101-2021_01_07_425675	103	44	199	199	CD
10_1101-2021_01_07_425675	103	45	and	and	CC
10_1101-2021_01_07_425675	103	46	S5	S5	NNP
10_1101-2021_01_07_425675	103	47	)	)	-RRB-
10_1101-2021_01_07_425675	103	48	.	.	.
10_1101-2021_01_07_425675	104	1	The	the	DT
10_1101-2021_01_07_425675	104	2	synthetic	synthetic	JJ
10_1101-2021_01_07_425675	104	3	recombinant	recombinant	JJ
10_1101-2021_01_07_425675	104	4	antibody	antibody	NN
10_1101-2021_01_07_425675	104	5	showed	show	VBD
10_1101-2021_01_07_425675	104	6	equivalent	equivalent	JJ
10_1101-2021_01_07_425675	104	7	binding	binding	NN
10_1101-2021_01_07_425675	104	8	compared	compare	VBN
10_1101-2021_01_07_425675	104	9	to	to	IN
10_1101-2021_01_07_425675	104	10	the	the	DT
10_1101-2021_01_07_425675	104	11	original	original	JJ
10_1101-2021_01_07_425675	104	12	200	200	CD
10_1101-2021_01_07_425675	104	13	antibody	antibody	NN
10_1101-2021_01_07_425675	104	14	sample	sample	NN
10_1101-2021_01_07_425675	104	15	used	use	VBN
10_1101-2021_01_07_425675	104	16	for	for	IN
10_1101-2021_01_07_425675	104	17	sequencing	sequencing	NN
10_1101-2021_01_07_425675	104	18	,	,	,
10_1101-2021_01_07_425675	104	19	confirming	confirm	VBG
10_1101-2021_01_07_425675	104	20	that	that	IN
10_1101-2021_01_07_425675	104	21	the	the	DT
10_1101-2021_01_07_425675	104	22	experimentally	experimentally	RB
10_1101-2021_01_07_425675	104	23	determined	determine	VBN
10_1101-2021_01_07_425675	104	24	sequence	sequence	NN
10_1101-2021_01_07_425675	104	25	201	201	CD
10_1101-2021_01_07_425675	104	26	is	be	VBZ
10_1101-2021_01_07_425675	104	27	reliable	reliable	JJ
10_1101-2021_01_07_425675	104	28	to	to	TO
10_1101-2021_01_07_425675	104	29	obtain	obtain	VB
10_1101-2021_01_07_425675	104	30	the	the	DT
10_1101-2021_01_07_425675	104	31	recombinant	recombinant	JJ
10_1101-2021_01_07_425675	104	32	antibody	antibody	NN
10_1101-2021_01_07_425675	104	33	product	product	NN
10_1101-2021_01_07_425675	104	34	with	with	IN
10_1101-2021_01_07_425675	104	35	the	the	DT
10_1101-2021_01_07_425675	104	36	desired	desire	VBN
10_1101-2021_01_07_425675	104	37	functional	functional	JJ
10_1101-2021_01_07_425675	104	38	profile	profile	NN
10_1101-2021_01_07_425675	104	39	.	.	.
10_1101-2021_01_07_425675	105	1	202	202	CD
10_1101-2021_01_07_425675	105	2	203	203	CD
10_1101-2021_01_07_425675	105	3	Discussion	discussion	NN
10_1101-2021_01_07_425675	105	4	204	204	CD
10_1101-2021_01_07_425675	105	5	There	there	EX
10_1101-2021_01_07_425675	105	6	are	be	VBP
10_1101-2021_01_07_425675	105	7	four	four	CD
10_1101-2021_01_07_425675	105	8	other	other	JJ
10_1101-2021_01_07_425675	105	9	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	105	10	antibody	antibody	NN
10_1101-2021_01_07_425675	105	11	sequences	sequence	NNS
10_1101-2021_01_07_425675	105	12	against	against	IN
10_1101-2021_01_07_425675	105	13	the	the	DT
10_1101-2021_01_07_425675	105	14	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	105	15	tag	tag	NN
10_1101-2021_01_07_425675	105	16	publicly	publicly	RB
10_1101-2021_01_07_425675	105	17	available	available	JJ
10_1101-2021_01_07_425675	105	18	205	205	CD
10_1101-2021_01_07_425675	105	19	through	through	IN
10_1101-2021_01_07_425675	105	20	the	the	DT
10_1101-2021_01_07_425675	105	21	ABCD	ABCD	NNP
10_1101-2021_01_07_425675	105	22	(	(	-LRB-
10_1101-2021_01_07_425675	105	23	AntiBodies	AntiBodies	NNP
10_1101-2021_01_07_425675	105	24	Chemically	chemically	RB
10_1101-2021_01_07_425675	105	25	Defined	define	VBN
10_1101-2021_01_07_425675	105	26	)	)	-RRB-
10_1101-2021_01_07_425675	105	27	database	database	NN
10_1101-2021_01_07_425675	105	28	34	34	CD
10_1101-2021_01_07_425675	105	29	-	-	SYM
10_1101-2021_01_07_425675	105	30	36	36	CD
10_1101-2021_01_07_425675	105	31	.	.	.
10_1101-2021_01_07_425675	106	1	Comparison	comparison	NN
10_1101-2021_01_07_425675	106	2	of	of	IN
10_1101-2021_01_07_425675	106	3	the	the	DT
10_1101-2021_01_07_425675	106	4	CDRs	cdr	NNS
10_1101-2021_01_07_425675	106	5	of	of	IN
10_1101-2021_01_07_425675	106	6	206	206	CD
10_1101-2021_01_07_425675	106	7	anti	anti	JJ
10_1101-2021_01_07_425675	106	8	-	-	JJ
10_1101-2021_01_07_425675	106	9	FLAG	flag	JJ
10_1101-2021_01_07_425675	106	10	-	-	HYPH
10_1101-2021_01_07_425675	106	11	M2	M2	NNP
10_1101-2021_01_07_425675	106	12	with	with	IN
10_1101-2021_01_07_425675	106	13	these	these	DT
10_1101-2021_01_07_425675	106	14	additional	additional	JJ
10_1101-2021_01_07_425675	106	15	four	four	CD
10_1101-2021_01_07_425675	106	16	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	106	17	antibodies	antibody	NNS
10_1101-2021_01_07_425675	106	18	reveals	reveal	VBZ
10_1101-2021_01_07_425675	106	19	a	a	DT
10_1101-2021_01_07_425675	106	20	few	few	JJ
10_1101-2021_01_07_425675	106	21	common	common	JJ
10_1101-2021_01_07_425675	106	22	motifs	motif	NNS
10_1101-2021_01_07_425675	106	23	that	that	IN
10_1101-2021_01_07_425675	106	24	207	207	CD
10_1101-2021_01_07_425675	106	25	may	may	MD
10_1101-2021_01_07_425675	106	26	determine	determine	VB
10_1101-2021_01_07_425675	106	27	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	106	28	-	-	HYPH
10_1101-2021_01_07_425675	106	29	tag	tag	NN
10_1101-2021_01_07_425675	106	30	binding	binding	NN
10_1101-2021_01_07_425675	106	31	specificity	specificity	NN
10_1101-2021_01_07_425675	106	32	(	(	-LRB-
10_1101-2021_01_07_425675	106	33	see	see	VB
10_1101-2021_01_07_425675	106	34	Table	Table	NNP
10_1101-2021_01_07_425675	106	35	S3	S3	NNP
10_1101-2021_01_07_425675	106	36	)	)	-RRB-
10_1101-2021_01_07_425675	106	37	.	.	.
10_1101-2021_01_07_425675	107	1	In	in	IN
10_1101-2021_01_07_425675	107	2	the	the	DT
10_1101-2021_01_07_425675	107	3	heavy	heavy	JJ
10_1101-2021_01_07_425675	107	4	chain	chain	NN
10_1101-2021_01_07_425675	107	5	,	,	,
10_1101-2021_01_07_425675	107	6	the	the	DT
10_1101-2021_01_07_425675	107	7	only	only	JJ
10_1101-2021_01_07_425675	107	8	common	common	JJ
10_1101-2021_01_07_425675	107	9	208	208	CD
10_1101-2021_01_07_425675	107	10	motif	motif	NN
10_1101-2021_01_07_425675	107	11	between	between	IN
10_1101-2021_01_07_425675	107	12	all	all	DT
10_1101-2021_01_07_425675	107	13	five	five	CD
10_1101-2021_01_07_425675	107	14	monoclonals	monoclonal	NNS
10_1101-2021_01_07_425675	107	15	is	be	VBZ
10_1101-2021_01_07_425675	107	16	that	that	IN
10_1101-2021_01_07_425675	107	17	the	the	DT
10_1101-2021_01_07_425675	107	18	first	first	JJ
10_1101-2021_01_07_425675	107	19	three	three	CD
10_1101-2021_01_07_425675	107	20	residues	residue	NNS
10_1101-2021_01_07_425675	107	21	of	of	IN
10_1101-2021_01_07_425675	107	22	CDRH1	cdrh1	NN
10_1101-2021_01_07_425675	107	23	follow	follow	VB
10_1101-2021_01_07_425675	107	24	a	a	DT
10_1101-2021_01_07_425675	107	25	GXS	GXS	NNP
10_1101-2021_01_07_425675	107	26	209	209	CD
10_1101-2021_01_07_425675	107	27	sequence	sequence	NN
10_1101-2021_01_07_425675	107	28	.	.	.
10_1101-2021_01_07_425675	108	1	In	in	IN
10_1101-2021_01_07_425675	108	2	addition	addition	NN
10_1101-2021_01_07_425675	108	3	,	,	,
10_1101-2021_01_07_425675	108	4	the	the	DT
10_1101-2021_01_07_425675	108	5	last	last	JJ
10_1101-2021_01_07_425675	108	6	three	three	CD
10_1101-2021_01_07_425675	108	7	residues	residue	NNS
10_1101-2021_01_07_425675	108	8	of	of	IN
10_1101-2021_01_07_425675	108	9	CDRH3	CDRH3	NNS
10_1101-2021_01_07_425675	108	10	of	of	IN
10_1101-2021_01_07_425675	108	11	anti	anti	JJ
10_1101-2021_01_07_425675	108	12	-	-	JJ
10_1101-2021_01_07_425675	108	13	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	108	14	-	-	HYPH
10_1101-2021_01_07_425675	108	15	M2	M2	NNP
10_1101-2021_01_07_425675	108	16	are	be	VBP
10_1101-2021_01_07_425675	108	17	YDY	YDY	NNP
10_1101-2021_01_07_425675	108	18	,	,	,
10_1101-2021_01_07_425675	108	19	similar	similar	JJ
10_1101-2021_01_07_425675	108	20	to	to	IN
10_1101-2021_01_07_425675	108	21	210	210	CD
10_1101-2021_01_07_425675	108	22	MDY	MDY	NNP
10_1101-2021_01_07_425675	108	23	in	in	IN
10_1101-2021_01_07_425675	108	24	H28	H28	NNP
10_1101-2021_01_07_425675	108	25	,	,	,
10_1101-2021_01_07_425675	108	26	and	and	CC
10_1101-2021_01_07_425675	108	27	YDF	YDF	NNP
10_1101-2021_01_07_425675	108	28	in	in	IN
10_1101-2021_01_07_425675	108	29	EEh13.6	EEh13.6	NNP
10_1101-2021_01_07_425675	108	30	(	(	-LRB-
10_1101-2021_01_07_425675	108	31	and	and	CC
10_1101-2021_01_07_425675	108	32	EEh14.3	EEh14.3	NNP
10_1101-2021_01_07_425675	108	33	also	also	RB
10_1101-2021_01_07_425675	108	34	ends	end	VBZ
10_1101-2021_01_07_425675	108	35	CDRH3	CDRH3	NNS
10_1101-2021_01_07_425675	108	36	with	with	IN
10_1101-2021_01_07_425675	108	37	an	an	DT
10_1101-2021_01_07_425675	108	38	aromatic	aromatic	JJ
10_1101-2021_01_07_425675	108	39	F	F	NNP
10_1101-2021_01_07_425675	108	40	residue	residue	NN
10_1101-2021_01_07_425675	108	41	)	)	-RRB-
10_1101-2021_01_07_425675	108	42	.	.	.
10_1101-2021_01_07_425675	109	1	211	211	CD
10_1101-2021_01_07_425675	109	2	In	in	IN
10_1101-2021_01_07_425675	109	3	contrast	contrast	NN
10_1101-2021_01_07_425675	109	4	to	to	IN
10_1101-2021_01_07_425675	109	5	the	the	DT
10_1101-2021_01_07_425675	109	6	heavy	heavy	JJ
10_1101-2021_01_07_425675	109	7	chain	chain	NN
10_1101-2021_01_07_425675	109	8	,	,	,
10_1101-2021_01_07_425675	109	9	the	the	DT
10_1101-2021_01_07_425675	109	10	CDRs	cdr	NNS
10_1101-2021_01_07_425675	109	11	of	of	IN
10_1101-2021_01_07_425675	109	12	the	the	DT
10_1101-2021_01_07_425675	109	13	light	light	JJ
10_1101-2021_01_07_425675	109	14	chain	chain	NN
10_1101-2021_01_07_425675	109	15	are	be	VBP
10_1101-2021_01_07_425675	109	16	almost	almost	RB
10_1101-2021_01_07_425675	109	17	completely	completely	RB
10_1101-2021_01_07_425675	109	18	conserved	conserve	VBN
10_1101-2021_01_07_425675	109	19	in	in	IN
10_1101-2021_01_07_425675	109	20	212	212	CD
10_1101-2021_01_07_425675	109	21	4/5	4/5	CD
10_1101-2021_01_07_425675	109	22	monoclonals	monoclonal	NNS
10_1101-2021_01_07_425675	109	23	with	with	IN
10_1101-2021_01_07_425675	109	24	only	only	RB
10_1101-2021_01_07_425675	109	25	minimal	minimal	JJ
10_1101-2021_01_07_425675	109	26	differences	difference	NNS
10_1101-2021_01_07_425675	109	27	compared	compare	VBN
10_1101-2021_01_07_425675	109	28	to	to	IN
10_1101-2021_01_07_425675	109	29	germline	germline	NN
10_1101-2021_01_07_425675	109	30	.	.	.
10_1101-2021_01_07_425675	110	1	The	the	DT
10_1101-2021_01_07_425675	110	2	anti	anti	JJ
10_1101-2021_01_07_425675	110	3	-	-	JJ
10_1101-2021_01_07_425675	110	4	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	110	5	-	-	HYPH
10_1101-2021_01_07_425675	110	6	M2	M2	NNP
10_1101-2021_01_07_425675	110	7	and	and	CC
10_1101-2021_01_07_425675	110	8	H28	H28	NNP
10_1101-2021_01_07_425675	110	9	213	213	CD
10_1101-2021_01_07_425675	110	10	monoclonals	monoclonal	NNS
10_1101-2021_01_07_425675	110	11	were	be	VBD
10_1101-2021_01_07_425675	110	12	specifically	specifically	RB
10_1101-2021_01_07_425675	110	13	raised	raise	VBN
10_1101-2021_01_07_425675	110	14	in	in	IN
10_1101-2021_01_07_425675	110	15	mice	mouse	NNS
10_1101-2021_01_07_425675	110	16	against	against	IN
10_1101-2021_01_07_425675	110	17	the	the	DT
10_1101-2021_01_07_425675	110	18	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	110	19	-	-	HYPH
10_1101-2021_01_07_425675	110	20	tag	tag	NN
10_1101-2021_01_07_425675	110	21	epitope	epitope	NN
10_1101-2021_01_07_425675	110	22	24	24	CD
10_1101-2021_01_07_425675	110	23	,	,	,
10_1101-2021_01_07_425675	110	24	35	35	CD
10_1101-2021_01_07_425675	110	25	,	,	,
10_1101-2021_01_07_425675	110	26	whereas	whereas	IN
10_1101-2021_01_07_425675	110	27	the	the	DT
10_1101-2021_01_07_425675	110	28	214	214	CD
10_1101-2021_01_07_425675	110	29	computationally	computationally	RB
10_1101-2021_01_07_425675	110	30	designed	design	VBN
10_1101-2021_01_07_425675	110	31	EEh13.6	eeh13.6	JJ
10_1101-2021_01_07_425675	110	32	and	and	CC
10_1101-2021_01_07_425675	110	33	EEh14.3	eeh14.3	JJ
10_1101-2021_01_07_425675	110	34	monoclonals	monoclonal	NNS
10_1101-2021_01_07_425675	110	35	contain	contain	VBP
10_1101-2021_01_07_425675	110	36	the	the	DT
10_1101-2021_01_07_425675	110	37	same	same	JJ
10_1101-2021_01_07_425675	110	38	light	light	JJ
10_1101-2021_01_07_425675	110	39	chain	chain	NN
10_1101-2021_01_07_425675	110	40	from	from	IN
10_1101-2021_01_07_425675	110	41	215	215	CD
10_1101-2021_01_07_425675	110	42	an	an	DT
10_1101-2021_01_07_425675	110	43	EE	ee	NN
10_1101-2021_01_07_425675	110	44	-	-	HYPH
10_1101-2021_01_07_425675	110	45	dipeptide	dipeptide	NN
10_1101-2021_01_07_425675	110	46	tag	tag	NN
10_1101-2021_01_07_425675	110	47	directed	direct	VBN
10_1101-2021_01_07_425675	110	48	antibody	antibody	NN
10_1101-2021_01_07_425675	110	49	34	34	CD
10_1101-2021_01_07_425675	110	50	.	.	.
10_1101-2021_01_07_425675	111	1	This	this	DT
10_1101-2021_01_07_425675	111	2	suggests	suggest	VBZ
10_1101-2021_01_07_425675	111	3	that	that	IN
10_1101-2021_01_07_425675	111	4	the	the	DT
10_1101-2021_01_07_425675	111	5	IGKV1	igkv1	CD
10_1101-2021_01_07_425675	111	6	-	-	SYM
10_1101-2021_01_07_425675	111	7	117	117	CD
10_1101-2021_01_07_425675	111	8	/	/	SYM
10_1101-2021_01_07_425675	111	9	IGKJ1	igkj1	NN
10_1101-2021_01_07_425675	111	10	light	light	JJ
10_1101-2021_01_07_425675	111	11	chain	chain	NN
10_1101-2021_01_07_425675	111	12	may	may	MD
10_1101-2021_01_07_425675	111	13	216	216	CD
10_1101-2021_01_07_425675	111	14	.CC	.CC	:
10_1101-2021_01_07_425675	111	15	-	-	:
10_1101-2021_01_07_425675	111	16	BY	by	IN
10_1101-2021_01_07_425675	111	17	4.0	4.0	CD
10_1101-2021_01_07_425675	111	18	International	International	NNP
10_1101-2021_01_07_425675	111	19	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	111	20	under	under	IN
10_1101-2021_01_07_425675	111	21	a	a	DT
10_1101-2021_01_07_425675	111	22	(	(	-LRB-
10_1101-2021_01_07_425675	111	23	which	which	WDT
10_1101-2021_01_07_425675	111	24	was	be	VBD
10_1101-2021_01_07_425675	111	25	not	not	RB
10_1101-2021_01_07_425675	111	26	certified	certify	VBN
10_1101-2021_01_07_425675	111	27	by	by	IN
10_1101-2021_01_07_425675	111	28	peer	peer	NN
10_1101-2021_01_07_425675	111	29	review	review	NN
10_1101-2021_01_07_425675	111	30	)	)	-RRB-
10_1101-2021_01_07_425675	111	31	is	be	VBZ
10_1101-2021_01_07_425675	111	32	the	the	DT
10_1101-2021_01_07_425675	111	33	author	author	NN
10_1101-2021_01_07_425675	111	34	/	/	SYM
10_1101-2021_01_07_425675	111	35	funder	funder	NN
10_1101-2021_01_07_425675	111	36	,	,	,
10_1101-2021_01_07_425675	111	37	who	who	WP
10_1101-2021_01_07_425675	111	38	has	have	VBZ
10_1101-2021_01_07_425675	111	39	granted	grant	VBN
10_1101-2021_01_07_425675	111	40	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	111	41	a	a	DT
10_1101-2021_01_07_425675	111	42	license	license	NN
10_1101-2021_01_07_425675	111	43	to	to	TO
10_1101-2021_01_07_425675	111	44	display	display	VB
10_1101-2021_01_07_425675	111	45	the	the	DT
10_1101-2021_01_07_425675	111	46	preprint	preprint	NN
10_1101-2021_01_07_425675	111	47	in	in	IN
10_1101-2021_01_07_425675	111	48	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	111	49	.	.	.
10_1101-2021_01_07_425675	112	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	112	2	is	be	VBZ
10_1101-2021_01_07_425675	112	3	made	make	VBN
10_1101-2021_01_07_425675	112	4	The	the	DT
10_1101-2021_01_07_425675	112	5	copyright	copyright	NN
10_1101-2021_01_07_425675	112	6	holder	holder	NN
10_1101-2021_01_07_425675	112	7	for	for	IN
10_1101-2021_01_07_425675	112	8	this	this	DT
10_1101-2021_01_07_425675	112	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	112	10	version	version	NN
10_1101-2021_01_07_425675	112	11	posted	post	VBD
10_1101-2021_01_07_425675	112	12	January	January	NNP
10_1101-2021_01_07_425675	112	13	8	8	CD
10_1101-2021_01_07_425675	112	14	,	,	,
10_1101-2021_01_07_425675	112	15	2021	2021	CD
10_1101-2021_01_07_425675	112	16	.	.	.
10_1101-2021_01_07_425675	112	17	;	;	:
10_1101-2021_01_07_425675	112	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	112	19	:	:	:
10_1101-2021_01_07_425675	112	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	112	21	preprint	preprint	NN
10_1101-2021_01_07_425675	112	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NNP
10_1101-2021_01_07_425675	112	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	112	24	10	10	CD
10_1101-2021_01_07_425675	112	25	be	be	VBP
10_1101-2021_01_07_425675	112	26	a	a	DT
10_1101-2021_01_07_425675	112	27	common	common	JJ
10_1101-2021_01_07_425675	112	28	determinant	determinant	NN
10_1101-2021_01_07_425675	112	29	of	of	IN
10_1101-2021_01_07_425675	112	30	binding	bind	VBG
10_1101-2021_01_07_425675	112	31	to	to	IN
10_1101-2021_01_07_425675	112	32	a	a	DT
10_1101-2021_01_07_425675	112	33	small	small	JJ
10_1101-2021_01_07_425675	112	34	negatively	negatively	RB
10_1101-2021_01_07_425675	112	35	charged	charge	VBN
10_1101-2021_01_07_425675	112	36	peptide	peptide	NN
10_1101-2021_01_07_425675	112	37	epitope	epitope	NN
10_1101-2021_01_07_425675	112	38	like	like	IN
10_1101-2021_01_07_425675	112	39	the	the	DT
10_1101-2021_01_07_425675	112	40	FLAG-217	flag-217	JJ
10_1101-2021_01_07_425675	112	41	tag	tag	NN
10_1101-2021_01_07_425675	112	42	and	and	CC
10_1101-2021_01_07_425675	112	43	is	be	VBZ
10_1101-2021_01_07_425675	112	44	readily	readily	RB
10_1101-2021_01_07_425675	112	45	available	available	JJ
10_1101-2021_01_07_425675	112	46	as	as	IN
10_1101-2021_01_07_425675	112	47	a	a	DT
10_1101-2021_01_07_425675	112	48	hardcoded	hardcode	VBN
10_1101-2021_01_07_425675	112	49	germline	germline	NN
10_1101-2021_01_07_425675	112	50	sequence	sequence	NN
10_1101-2021_01_07_425675	112	51	in	in	IN
10_1101-2021_01_07_425675	112	52	the	the	DT
10_1101-2021_01_07_425675	112	53	mouse	mouse	NN
10_1101-2021_01_07_425675	112	54	antibody	antibody	NN
10_1101-2021_01_07_425675	112	55	repertoire	repertoire	NNP
10_1101-2021_01_07_425675	112	56	.	.	.
10_1101-2021_01_07_425675	113	1	218	218	CD
10_1101-2021_01_07_425675	113	2	The	the	DT
10_1101-2021_01_07_425675	113	3	availability	availability	NN
10_1101-2021_01_07_425675	113	4	of	of	IN
10_1101-2021_01_07_425675	113	5	the	the	DT
10_1101-2021_01_07_425675	113	6	anti	anti	JJ
10_1101-2021_01_07_425675	113	7	-	-	JJ
10_1101-2021_01_07_425675	113	8	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	113	9	-	-	HYPH
10_1101-2021_01_07_425675	113	10	M2	M2	NNP
10_1101-2021_01_07_425675	113	11	sequences	sequence	NNS
10_1101-2021_01_07_425675	113	12	may	may	MD
10_1101-2021_01_07_425675	113	13	contribute	contribute	VB
10_1101-2021_01_07_425675	113	14	to	to	IN
10_1101-2021_01_07_425675	113	15	the	the	DT
10_1101-2021_01_07_425675	113	16	wider	wide	JJR
10_1101-2021_01_07_425675	113	17	use	use	NN
10_1101-2021_01_07_425675	113	18	of	of	IN
10_1101-2021_01_07_425675	113	19	this	this	DT
10_1101-2021_01_07_425675	113	20	important	important	JJ
10_1101-2021_01_07_425675	113	21	219	219	CD
10_1101-2021_01_07_425675	113	22	research	research	NN
10_1101-2021_01_07_425675	113	23	tool	tool	NN
10_1101-2021_01_07_425675	113	24	,	,	,
10_1101-2021_01_07_425675	113	25	as	as	RB
10_1101-2021_01_07_425675	113	26	well	well	RB
10_1101-2021_01_07_425675	113	27	as	as	IN
10_1101-2021_01_07_425675	113	28	the	the	DT
10_1101-2021_01_07_425675	113	29	development	development	NN
10_1101-2021_01_07_425675	113	30	and	and	CC
10_1101-2021_01_07_425675	113	31	engineering	engineering	NN
10_1101-2021_01_07_425675	113	32	of	of	IN
10_1101-2021_01_07_425675	113	33	better	well	JJR
10_1101-2021_01_07_425675	113	34	FLAG	flag	NN
10_1101-2021_01_07_425675	113	35	-	-	HYPH
10_1101-2021_01_07_425675	113	36	tag	tag	NN
10_1101-2021_01_07_425675	113	37	directed	direct	VBN
10_1101-2021_01_07_425675	113	38	antibodies	antibody	NNS
10_1101-2021_01_07_425675	113	39	.	.	.
10_1101-2021_01_07_425675	114	1	220	220	CD
10_1101-2021_01_07_425675	114	2	This	this	DT
10_1101-2021_01_07_425675	114	3	example	example	NN
10_1101-2021_01_07_425675	114	4	illustrates	illustrate	VBZ
10_1101-2021_01_07_425675	114	5	that	that	IN
10_1101-2021_01_07_425675	114	6	our	-PRON-	PRP$
10_1101-2021_01_07_425675	114	7	MS	MS	NNP
10_1101-2021_01_07_425675	114	8	-	-	HYPH
10_1101-2021_01_07_425675	114	9	based	base	VBN
10_1101-2021_01_07_425675	114	10	sequencing	sequence	VBG
10_1101-2021_01_07_425675	114	11	protocol	protocol	NN
10_1101-2021_01_07_425675	114	12	yields	yield	NNS
10_1101-2021_01_07_425675	114	13	robust	robust	JJ
10_1101-2021_01_07_425675	114	14	and	and	CC
10_1101-2021_01_07_425675	114	15	reliable	reliable	JJ
10_1101-2021_01_07_425675	114	16	221	221	CD
10_1101-2021_01_07_425675	114	17	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	114	18	antibody	antibody	NN
10_1101-2021_01_07_425675	114	19	sequences	sequence	NNS
10_1101-2021_01_07_425675	114	20	.	.	.
10_1101-2021_01_07_425675	115	1	The	the	DT
10_1101-2021_01_07_425675	115	2	protocol	protocol	NN
10_1101-2021_01_07_425675	115	3	described	describe	VBN
10_1101-2021_01_07_425675	115	4	here	here	RB
10_1101-2021_01_07_425675	115	5	also	also	RB
10_1101-2021_01_07_425675	115	6	formed	form	VBD
10_1101-2021_01_07_425675	115	7	the	the	DT
10_1101-2021_01_07_425675	115	8	basis	basis	NN
10_1101-2021_01_07_425675	115	9	of	of	IN
10_1101-2021_01_07_425675	115	10	a	a	DT
10_1101-2021_01_07_425675	115	11	recent	recent	JJ
10_1101-2021_01_07_425675	115	12	222	222	CD
10_1101-2021_01_07_425675	115	13	application	application	NN
10_1101-2021_01_07_425675	115	14	where	where	WRB
10_1101-2021_01_07_425675	115	15	we	-PRON-	PRP
10_1101-2021_01_07_425675	115	16	sequenced	sequence	VBD
10_1101-2021_01_07_425675	115	17	an	an	DT
10_1101-2021_01_07_425675	115	18	antibody	antibody	NN
10_1101-2021_01_07_425675	115	19	directly	directly	RB
10_1101-2021_01_07_425675	115	20	from	from	IN
10_1101-2021_01_07_425675	115	21	patient	patient	NN
10_1101-2021_01_07_425675	115	22	-	-	HYPH
10_1101-2021_01_07_425675	115	23	derived	derive	VBN
10_1101-2021_01_07_425675	115	24	serum	serum	NN
10_1101-2021_01_07_425675	115	25	,	,	,
10_1101-2021_01_07_425675	115	26	using	use	VBG
10_1101-2021_01_07_425675	115	27	a	a	DT
10_1101-2021_01_07_425675	115	28	223	223	CD
10_1101-2021_01_07_425675	115	29	combination	combination	NN
10_1101-2021_01_07_425675	115	30	with	with	IN
10_1101-2021_01_07_425675	115	31	top	top	RB
10_1101-2021_01_07_425675	115	32	-	-	HYPH
10_1101-2021_01_07_425675	115	33	down	down	RP
10_1101-2021_01_07_425675	115	34	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	115	35	of	of	IN
10_1101-2021_01_07_425675	115	36	the	the	DT
10_1101-2021_01_07_425675	115	37	isolated	isolate	VBN
10_1101-2021_01_07_425675	115	38	Fab	Fab	NNP
10_1101-2021_01_07_425675	115	39	fragment	fragment	NN
10_1101-2021_01_07_425675	115	40	37	37	CD
10_1101-2021_01_07_425675	115	41	.	.	.
10_1101-2021_01_07_425675	116	1	The	the	DT
10_1101-2021_01_07_425675	116	2	dual	dual	JJ
10_1101-2021_01_07_425675	116	3	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	116	4	224	224	CD
10_1101-2021_01_07_425675	116	5	strategy	strategy	NN
10_1101-2021_01_07_425675	116	6	yields	yield	NNS
10_1101-2021_01_07_425675	116	7	high	high	JJ
10_1101-2021_01_07_425675	116	8	-	-	HYPH
10_1101-2021_01_07_425675	116	9	quality	quality	NN
10_1101-2021_01_07_425675	116	10	spectra	spectra	NN
10_1101-2021_01_07_425675	116	11	suitable	suitable	JJ
10_1101-2021_01_07_425675	116	12	for	for	IN
10_1101-2021_01_07_425675	116	13	de	de	FW
10_1101-2021_01_07_425675	116	14	novo	novo	NNP
10_1101-2021_01_07_425675	116	15	sequencing	sequencing	NNP
10_1101-2021_01_07_425675	116	16	and	and	CC
10_1101-2021_01_07_425675	116	17	may	may	MD
10_1101-2021_01_07_425675	116	18	further	further	RB
10_1101-2021_01_07_425675	116	19	contribute	contribute	VB
10_1101-2021_01_07_425675	116	20	to	to	IN
10_1101-2021_01_07_425675	116	21	225	225	CD
10_1101-2021_01_07_425675	116	22	the	the	DT
10_1101-2021_01_07_425675	116	23	exciting	exciting	JJ
10_1101-2021_01_07_425675	116	24	prospect	prospect	NN
10_1101-2021_01_07_425675	116	25	of	of	IN
10_1101-2021_01_07_425675	116	26	a	a	DT
10_1101-2021_01_07_425675	116	27	new	new	JJ
10_1101-2021_01_07_425675	116	28	era	era	NN
10_1101-2021_01_07_425675	116	29	of	of	IN
10_1101-2021_01_07_425675	116	30	serology	serology	NN
10_1101-2021_01_07_425675	116	31	in	in	IN
10_1101-2021_01_07_425675	116	32	which	which	WDT
10_1101-2021_01_07_425675	116	33	antibody	antibody	NN
10_1101-2021_01_07_425675	116	34	sequences	sequence	NNS
10_1101-2021_01_07_425675	116	35	can	can	MD
10_1101-2021_01_07_425675	116	36	be	be	VB
10_1101-2021_01_07_425675	116	37	directly	directly	RB
10_1101-2021_01_07_425675	116	38	226	226	CD
10_1101-2021_01_07_425675	116	39	obtained	obtain	VBN
10_1101-2021_01_07_425675	116	40	from	from	IN
10_1101-2021_01_07_425675	116	41	bodily	bodily	NNP
10_1101-2021_01_07_425675	116	42	fluids	fluid	NNS
10_1101-2021_01_07_425675	116	43	.	.	.
10_1101-2021_01_07_425675	117	1	227	227	CD
10_1101-2021_01_07_425675	117	2	228	228	CD
10_1101-2021_01_07_425675	117	3	229	229	CD
10_1101-2021_01_07_425675	117	4	Methods	method	NNS
10_1101-2021_01_07_425675	117	5	230	230	CD
10_1101-2021_01_07_425675	117	6	Sample	sample	NN
10_1101-2021_01_07_425675	117	7	preparation	preparation	NN
10_1101-2021_01_07_425675	117	8	231	231	CD
10_1101-2021_01_07_425675	117	9	Anti	Anti	NNP
10_1101-2021_01_07_425675	117	10	-	-	NNP
10_1101-2021_01_07_425675	117	11	Flag	Flag	NNP
10_1101-2021_01_07_425675	117	12	M2	M2	NNP
10_1101-2021_01_07_425675	117	13	antibody	antibody	NN
10_1101-2021_01_07_425675	117	14	was	be	VBD
10_1101-2021_01_07_425675	117	15	purchased	purchase	VBN
10_1101-2021_01_07_425675	117	16	from	from	IN
10_1101-2021_01_07_425675	117	17	Sigma	Sigma	NNP
10_1101-2021_01_07_425675	117	18	(	(	-LRB-
10_1101-2021_01_07_425675	117	19	catalogue	catalogue	NN
10_1101-2021_01_07_425675	117	20	number	number	NN
10_1101-2021_01_07_425675	117	21	F1804	F1804	NNP
10_1101-2021_01_07_425675	117	22	)	)	-RRB-
10_1101-2021_01_07_425675	117	23	.	.	.
10_1101-2021_01_07_425675	118	1	Herceptin	Herceptin	NNP
10_1101-2021_01_07_425675	118	2	was	be	VBD
10_1101-2021_01_07_425675	118	3	232	232	CD
10_1101-2021_01_07_425675	118	4	provided	provide	VBN
10_1101-2021_01_07_425675	118	5	by	by	IN
10_1101-2021_01_07_425675	118	6	Roche	Roche	NNP
10_1101-2021_01_07_425675	118	7	(	(	-LRB-
10_1101-2021_01_07_425675	118	8	Penzberg	Penzberg	NNP
10_1101-2021_01_07_425675	118	9	,	,	,
10_1101-2021_01_07_425675	118	10	Germany	Germany	NNP
10_1101-2021_01_07_425675	118	11	)	)	-RRB-
10_1101-2021_01_07_425675	118	12	.	.	.
10_1101-2021_01_07_425675	119	1	27	27	CD
10_1101-2021_01_07_425675	119	2	μg	μg	DT
10_1101-2021_01_07_425675	119	3	of	of	IN
10_1101-2021_01_07_425675	119	4	each	each	DT
10_1101-2021_01_07_425675	119	5	sample	sample	NN
10_1101-2021_01_07_425675	119	6	was	be	VBD
10_1101-2021_01_07_425675	119	7	denatured	denature	VBN
10_1101-2021_01_07_425675	119	8	in	in	IN
10_1101-2021_01_07_425675	119	9	2	2	CD
10_1101-2021_01_07_425675	119	10	%	%	NN
10_1101-2021_01_07_425675	119	11	sodium	sodium	NN
10_1101-2021_01_07_425675	119	12	233	233	CD
10_1101-2021_01_07_425675	119	13	deoxycholate	deoxycholate	NN
10_1101-2021_01_07_425675	119	14	(	(	-LRB-
10_1101-2021_01_07_425675	119	15	SDC	SDC	NNP
10_1101-2021_01_07_425675	119	16	)	)	-RRB-
10_1101-2021_01_07_425675	119	17	,	,	,
10_1101-2021_01_07_425675	119	18	200	200	CD
10_1101-2021_01_07_425675	119	19	mM	mM	NNP
10_1101-2021_01_07_425675	119	20	Tris	Tris	NNP
10_1101-2021_01_07_425675	119	21	-	-	HYPH
10_1101-2021_01_07_425675	119	22	HCl	HCl	NNP
10_1101-2021_01_07_425675	119	23	,	,	,
10_1101-2021_01_07_425675	119	24	10	10	CD
10_1101-2021_01_07_425675	119	25	mM	mm	NN
10_1101-2021_01_07_425675	119	26	tris(2-carboxyethyl)phosphine	tris(2-carboxyethyl)phosphine	NNP
10_1101-2021_01_07_425675	119	27	(	(	-LRB-
10_1101-2021_01_07_425675	119	28	TCEP	TCEP	NNP
10_1101-2021_01_07_425675	119	29	)	)	-RRB-
10_1101-2021_01_07_425675	119	30	,	,	,
10_1101-2021_01_07_425675	119	31	pH	pH	NNP
10_1101-2021_01_07_425675	119	32	8.0	8.0	CD
10_1101-2021_01_07_425675	119	33	at	at	IN
10_1101-2021_01_07_425675	119	34	234	234	CD
10_1101-2021_01_07_425675	119	35	95	95	CD
10_1101-2021_01_07_425675	119	36	°	°	,
10_1101-2021_01_07_425675	119	37	C	C	NNP
10_1101-2021_01_07_425675	119	38	for	for	IN
10_1101-2021_01_07_425675	119	39	10	10	CD
10_1101-2021_01_07_425675	119	40	min	min	NN
10_1101-2021_01_07_425675	119	41	,	,	,
10_1101-2021_01_07_425675	119	42	followed	follow	VBN
10_1101-2021_01_07_425675	119	43	with	with	IN
10_1101-2021_01_07_425675	119	44	30	30	CD
10_1101-2021_01_07_425675	119	45	min	min	NN
10_1101-2021_01_07_425675	119	46	incubation	incubation	NN
10_1101-2021_01_07_425675	119	47	at	at	IN
10_1101-2021_01_07_425675	119	48	37	37	CD
10_1101-2021_01_07_425675	119	49	°	°	,
10_1101-2021_01_07_425675	119	50	C	C	NNP
10_1101-2021_01_07_425675	119	51	for	for	IN
10_1101-2021_01_07_425675	119	52	reduction	reduction	NN
10_1101-2021_01_07_425675	119	53	.	.	.
10_1101-2021_01_07_425675	120	1	Sample	Sample	NNP
10_1101-2021_01_07_425675	120	2	was	be	VBD
10_1101-2021_01_07_425675	120	3	then	then	RB
10_1101-2021_01_07_425675	120	4	alkylated	alkylate	VBN
10_1101-2021_01_07_425675	120	5	235	235	CD
10_1101-2021_01_07_425675	120	6	by	by	IN
10_1101-2021_01_07_425675	120	7	adding	add	VBG
10_1101-2021_01_07_425675	120	8	iodoacetic	iodoacetic	JJ
10_1101-2021_01_07_425675	120	9	acid	acid	NN
10_1101-2021_01_07_425675	120	10	to	to	IN
10_1101-2021_01_07_425675	120	11	a	a	DT
10_1101-2021_01_07_425675	120	12	final	final	JJ
10_1101-2021_01_07_425675	120	13	concentration	concentration	NN
10_1101-2021_01_07_425675	120	14	of	of	IN
10_1101-2021_01_07_425675	120	15	40	40	CD
10_1101-2021_01_07_425675	120	16	mM	mm	NN
10_1101-2021_01_07_425675	120	17	and	and	CC
10_1101-2021_01_07_425675	120	18	incubated	incubate	VBD
10_1101-2021_01_07_425675	120	19	in	in	IN
10_1101-2021_01_07_425675	120	20	the	the	DT
10_1101-2021_01_07_425675	120	21	dark	dark	NN
10_1101-2021_01_07_425675	120	22	at	at	IN
10_1101-2021_01_07_425675	120	23	room	room	NN
10_1101-2021_01_07_425675	120	24	236	236	CD
10_1101-2021_01_07_425675	120	25	temperature	temperature	NN
10_1101-2021_01_07_425675	120	26	for	for	IN
10_1101-2021_01_07_425675	120	27	45	45	CD
10_1101-2021_01_07_425675	120	28	min	min	NN
10_1101-2021_01_07_425675	120	29	.	.	.
10_1101-2021_01_07_425675	121	1	3	3	LS
10_1101-2021_01_07_425675	121	2	μg	μg	NNP
10_1101-2021_01_07_425675	121	3	Sample	Sample	NNP
10_1101-2021_01_07_425675	121	4	was	be	VBD
10_1101-2021_01_07_425675	121	5	then	then	RB
10_1101-2021_01_07_425675	121	6	digested	digest	VBN
10_1101-2021_01_07_425675	121	7	by	by	IN
10_1101-2021_01_07_425675	121	8	one	one	CD
10_1101-2021_01_07_425675	121	9	of	of	IN
10_1101-2021_01_07_425675	121	10	the	the	DT
10_1101-2021_01_07_425675	121	11	following	follow	VBG
10_1101-2021_01_07_425675	121	12	proteases	protease	NNS
10_1101-2021_01_07_425675	121	13	:	:	:
10_1101-2021_01_07_425675	121	14	trypsin	trypsin	NNP
10_1101-2021_01_07_425675	121	15	,	,	,
10_1101-2021_01_07_425675	121	16	237	237	CD
10_1101-2021_01_07_425675	121	17	chymotrypsin	chymotrypsin	NN
10_1101-2021_01_07_425675	121	18	,	,	,
10_1101-2021_01_07_425675	121	19	lysN	lysn	CD
10_1101-2021_01_07_425675	121	20	,	,	,
10_1101-2021_01_07_425675	121	21	lysC	lysC	NNP
10_1101-2021_01_07_425675	121	22	,	,	,
10_1101-2021_01_07_425675	121	23	gluC	gluC	NNP
10_1101-2021_01_07_425675	121	24	,	,	,
10_1101-2021_01_07_425675	121	25	aspN	aspn	CD
10_1101-2021_01_07_425675	121	26	,	,	,
10_1101-2021_01_07_425675	121	27	aLP	alp	RB
10_1101-2021_01_07_425675	121	28	,	,	,
10_1101-2021_01_07_425675	121	29	thermolysin	thermolysin	NN
10_1101-2021_01_07_425675	121	30	and	and	CC
10_1101-2021_01_07_425675	121	31	elastase	elastase	NN
10_1101-2021_01_07_425675	121	32	in	in	IN
10_1101-2021_01_07_425675	121	33	a	a	DT
10_1101-2021_01_07_425675	121	34	1:50	1:50	CD
10_1101-2021_01_07_425675	121	35	ratio	ratio	NN
10_1101-2021_01_07_425675	121	36	(	(	-LRB-
10_1101-2021_01_07_425675	121	37	w	w	NNP
10_1101-2021_01_07_425675	121	38	:	:	:
10_1101-2021_01_07_425675	121	39	w	w	NNP
10_1101-2021_01_07_425675	121	40	)	)	-RRB-
10_1101-2021_01_07_425675	121	41	in	in	IN
10_1101-2021_01_07_425675	121	42	a	a	DT
10_1101-2021_01_07_425675	121	43	238	238	CD
10_1101-2021_01_07_425675	121	44	total	total	JJ
10_1101-2021_01_07_425675	121	45	volume	volume	NN
10_1101-2021_01_07_425675	121	46	of	of	IN
10_1101-2021_01_07_425675	121	47	100	100	CD
10_1101-2021_01_07_425675	121	48	uL	uL	NNP
10_1101-2021_01_07_425675	121	49	of	of	IN
10_1101-2021_01_07_425675	121	50	50	50	CD
10_1101-2021_01_07_425675	121	51	mM	mM	NNP
10_1101-2021_01_07_425675	121	52	ammonium	ammonium	NN
10_1101-2021_01_07_425675	121	53	bicarbonate	bicarbonate	NN
10_1101-2021_01_07_425675	121	54	at	at	IN
10_1101-2021_01_07_425675	121	55	37	37	CD
10_1101-2021_01_07_425675	121	56	°	°	,
10_1101-2021_01_07_425675	121	57	C	C	NNP
10_1101-2021_01_07_425675	121	58	for	for	IN
10_1101-2021_01_07_425675	121	59	4	4	CD
10_1101-2021_01_07_425675	121	60	h.	h.	NN
10_1101-2021_01_07_425675	121	61	After	after	IN
10_1101-2021_01_07_425675	121	62	digestion	digestion	NN
10_1101-2021_01_07_425675	121	63	,	,	,
10_1101-2021_01_07_425675	121	64	SDC	SDC	NNP
10_1101-2021_01_07_425675	121	65	239	239	CD
10_1101-2021_01_07_425675	121	66	was	be	VBD
10_1101-2021_01_07_425675	121	67	removed	remove	VBN
10_1101-2021_01_07_425675	121	68	by	by	IN
10_1101-2021_01_07_425675	121	69	adding	add	VBG
10_1101-2021_01_07_425675	121	70	2	2	CD
10_1101-2021_01_07_425675	121	71	uL	uL	NNP
10_1101-2021_01_07_425675	121	72	formic	formic	NN
10_1101-2021_01_07_425675	121	73	acid	acid	NN
10_1101-2021_01_07_425675	121	74	(	(	-LRB-
10_1101-2021_01_07_425675	121	75	FA	FA	NNP
10_1101-2021_01_07_425675	121	76	)	)	-RRB-
10_1101-2021_01_07_425675	121	77	and	and	CC
10_1101-2021_01_07_425675	121	78	centrifugation	centrifugation	NN
10_1101-2021_01_07_425675	121	79	at	at	IN
10_1101-2021_01_07_425675	121	80	14000	14000	CD
10_1101-2021_01_07_425675	121	81	g	g	NN
10_1101-2021_01_07_425675	121	82	for	for	IN
10_1101-2021_01_07_425675	121	83	20	20	CD
10_1101-2021_01_07_425675	121	84	min	min	NN
10_1101-2021_01_07_425675	121	85	.	.	.
10_1101-2021_01_07_425675	122	1	Following	follow	VBG
10_1101-2021_01_07_425675	122	2	240	240	CD
10_1101-2021_01_07_425675	122	3	centrifugation	centrifugation	NN
10_1101-2021_01_07_425675	122	4	,	,	,
10_1101-2021_01_07_425675	122	5	the	the	DT
10_1101-2021_01_07_425675	122	6	supernatant	supernatant	NN
10_1101-2021_01_07_425675	122	7	containing	contain	VBG
10_1101-2021_01_07_425675	122	8	the	the	DT
10_1101-2021_01_07_425675	122	9	peptides	peptide	NNS
10_1101-2021_01_07_425675	122	10	was	be	VBD
10_1101-2021_01_07_425675	122	11	collected	collect	VBN
10_1101-2021_01_07_425675	122	12	for	for	IN
10_1101-2021_01_07_425675	122	13	desalting	desalt	VBG
10_1101-2021_01_07_425675	122	14	on	on	IN
10_1101-2021_01_07_425675	122	15	a	a	DT
10_1101-2021_01_07_425675	122	16	30	30	CD
10_1101-2021_01_07_425675	122	17	µm	µm	NNP
10_1101-2021_01_07_425675	122	18	241	241	CD
10_1101-2021_01_07_425675	122	19	Oasis	oasis	NN
10_1101-2021_01_07_425675	122	20	HLB	HLB	NNP
10_1101-2021_01_07_425675	122	21	96-well	96-well	CD
10_1101-2021_01_07_425675	122	22	plate	plate	NN
10_1101-2021_01_07_425675	122	23	(	(	-LRB-
10_1101-2021_01_07_425675	122	24	Waters	Waters	NNP
10_1101-2021_01_07_425675	122	25	)	)	-RRB-
10_1101-2021_01_07_425675	122	26	.	.	.
10_1101-2021_01_07_425675	123	1	The	the	DT
10_1101-2021_01_07_425675	123	2	Oasis	Oasis	NNP
10_1101-2021_01_07_425675	123	3	HLB	HLB	NNP
10_1101-2021_01_07_425675	123	4	sorbent	sorbent	JJ
10_1101-2021_01_07_425675	123	5	was	be	VBD
10_1101-2021_01_07_425675	123	6	activated	activate	VBN
10_1101-2021_01_07_425675	123	7	with	with	IN
10_1101-2021_01_07_425675	123	8	100	100	CD
10_1101-2021_01_07_425675	123	9	%	%	NN
10_1101-2021_01_07_425675	123	10	acetonitrile	acetonitrile	JJ
10_1101-2021_01_07_425675	123	11	242	242	CD
10_1101-2021_01_07_425675	123	12	and	and	CC
10_1101-2021_01_07_425675	123	13	subsequently	subsequently	RB
10_1101-2021_01_07_425675	123	14	equilibrated	equilibrate	VBN
10_1101-2021_01_07_425675	123	15	with	with	IN
10_1101-2021_01_07_425675	123	16	10	10	CD
10_1101-2021_01_07_425675	123	17	%	%	NN
10_1101-2021_01_07_425675	123	18	formic	formic	NN
10_1101-2021_01_07_425675	123	19	acid	acid	NN
10_1101-2021_01_07_425675	123	20	in	in	IN
10_1101-2021_01_07_425675	123	21	water	water	NN
10_1101-2021_01_07_425675	123	22	.	.	.
10_1101-2021_01_07_425675	124	1	Next	next	RB
10_1101-2021_01_07_425675	124	2	,	,	,
10_1101-2021_01_07_425675	124	3	peptides	peptide	NNS
10_1101-2021_01_07_425675	124	4	were	be	VBD
10_1101-2021_01_07_425675	124	5	bound	bind	VBN
10_1101-2021_01_07_425675	124	6	to	to	IN
10_1101-2021_01_07_425675	124	7	the	the	DT
10_1101-2021_01_07_425675	124	8	243	243	CD
10_1101-2021_01_07_425675	124	9	sorbent	sorbent	JJ
10_1101-2021_01_07_425675	124	10	,	,	,
10_1101-2021_01_07_425675	124	11	washed	wash	VBD
10_1101-2021_01_07_425675	124	12	twice	twice	RB
10_1101-2021_01_07_425675	124	13	with	with	IN
10_1101-2021_01_07_425675	124	14	10	10	CD
10_1101-2021_01_07_425675	124	15	%	%	NN
10_1101-2021_01_07_425675	124	16	formic	formic	NN
10_1101-2021_01_07_425675	124	17	acid	acid	NN
10_1101-2021_01_07_425675	124	18	in	in	IN
10_1101-2021_01_07_425675	124	19	water	water	NN
10_1101-2021_01_07_425675	124	20	and	and	CC
10_1101-2021_01_07_425675	124	21	eluted	elute	VBD
10_1101-2021_01_07_425675	124	22	with	with	IN
10_1101-2021_01_07_425675	124	23	100	100	CD
10_1101-2021_01_07_425675	124	24	µL	µl	CD
10_1101-2021_01_07_425675	124	25	of	of	IN
10_1101-2021_01_07_425675	124	26	50	50	CD
10_1101-2021_01_07_425675	124	27	%	%	NN
10_1101-2021_01_07_425675	124	28	244	244	CD
10_1101-2021_01_07_425675	124	29	acetonitrile/5	acetonitrile/5	CD
10_1101-2021_01_07_425675	124	30	%	%	NN
10_1101-2021_01_07_425675	124	31	formic	formic	NN
10_1101-2021_01_07_425675	124	32	acid	acid	NN
10_1101-2021_01_07_425675	124	33	in	in	IN
10_1101-2021_01_07_425675	124	34	water	water	NN
10_1101-2021_01_07_425675	124	35	(	(	-LRB-
10_1101-2021_01_07_425675	124	36	v	v	NN
10_1101-2021_01_07_425675	124	37	/	/	SYM
10_1101-2021_01_07_425675	124	38	v	v	NNP
10_1101-2021_01_07_425675	124	39	)	)	-RRB-
10_1101-2021_01_07_425675	124	40	.	.	.
10_1101-2021_01_07_425675	125	1	The	the	DT
10_1101-2021_01_07_425675	125	2	eluted	elute	VBN
10_1101-2021_01_07_425675	125	3	peptides	peptide	NNS
10_1101-2021_01_07_425675	125	4	were	be	VBD
10_1101-2021_01_07_425675	125	5	vacuum	vacuum	NN
10_1101-2021_01_07_425675	125	6	-	-	HYPH
10_1101-2021_01_07_425675	125	7	dried	dry	VBN
10_1101-2021_01_07_425675	125	8	and	and	CC
10_1101-2021_01_07_425675	125	9	245	245	CD
10_1101-2021_01_07_425675	125	10	reconstituted	reconstitute	VBD
10_1101-2021_01_07_425675	125	11	in	in	IN
10_1101-2021_01_07_425675	125	12	100	100	CD
10_1101-2021_01_07_425675	125	13	µL	µl	$
10_1101-2021_01_07_425675	125	14	2	2	CD
10_1101-2021_01_07_425675	125	15	%	%	NN
10_1101-2021_01_07_425675	125	16	FA	fa	NN
10_1101-2021_01_07_425675	125	17	.	.	.
10_1101-2021_01_07_425675	126	1	246	246	CD
10_1101-2021_01_07_425675	126	2	247	247	CD
10_1101-2021_01_07_425675	126	3	.CC	.CC	:
10_1101-2021_01_07_425675	126	4	-	-	:
10_1101-2021_01_07_425675	126	5	BY	by	IN
10_1101-2021_01_07_425675	126	6	4.0	4.0	CD
10_1101-2021_01_07_425675	126	7	International	International	NNP
10_1101-2021_01_07_425675	126	8	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	126	9	under	under	IN
10_1101-2021_01_07_425675	126	10	a	a	DT
10_1101-2021_01_07_425675	126	11	(	(	-LRB-
10_1101-2021_01_07_425675	126	12	which	which	WDT
10_1101-2021_01_07_425675	126	13	was	be	VBD
10_1101-2021_01_07_425675	126	14	not	not	RB
10_1101-2021_01_07_425675	126	15	certified	certify	VBN
10_1101-2021_01_07_425675	126	16	by	by	IN
10_1101-2021_01_07_425675	126	17	peer	peer	NN
10_1101-2021_01_07_425675	126	18	review	review	NN
10_1101-2021_01_07_425675	126	19	)	)	-RRB-
10_1101-2021_01_07_425675	126	20	is	be	VBZ
10_1101-2021_01_07_425675	126	21	the	the	DT
10_1101-2021_01_07_425675	126	22	author	author	NN
10_1101-2021_01_07_425675	126	23	/	/	SYM
10_1101-2021_01_07_425675	126	24	funder	funder	NN
10_1101-2021_01_07_425675	126	25	,	,	,
10_1101-2021_01_07_425675	126	26	who	who	WP
10_1101-2021_01_07_425675	126	27	has	have	VBZ
10_1101-2021_01_07_425675	126	28	granted	grant	VBN
10_1101-2021_01_07_425675	126	29	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	126	30	a	a	DT
10_1101-2021_01_07_425675	126	31	license	license	NN
10_1101-2021_01_07_425675	126	32	to	to	TO
10_1101-2021_01_07_425675	126	33	display	display	VB
10_1101-2021_01_07_425675	126	34	the	the	DT
10_1101-2021_01_07_425675	126	35	preprint	preprint	NN
10_1101-2021_01_07_425675	126	36	in	in	IN
10_1101-2021_01_07_425675	126	37	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	126	38	.	.	.
10_1101-2021_01_07_425675	127	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	127	2	is	be	VBZ
10_1101-2021_01_07_425675	127	3	made	make	VBN
10_1101-2021_01_07_425675	127	4	The	the	DT
10_1101-2021_01_07_425675	127	5	copyright	copyright	NN
10_1101-2021_01_07_425675	127	6	holder	holder	NN
10_1101-2021_01_07_425675	127	7	for	for	IN
10_1101-2021_01_07_425675	127	8	this	this	DT
10_1101-2021_01_07_425675	127	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	127	10	version	version	NN
10_1101-2021_01_07_425675	127	11	posted	post	VBD
10_1101-2021_01_07_425675	127	12	January	January	NNP
10_1101-2021_01_07_425675	127	13	8	8	CD
10_1101-2021_01_07_425675	127	14	,	,	,
10_1101-2021_01_07_425675	127	15	2021	2021	CD
10_1101-2021_01_07_425675	127	16	.	.	.
10_1101-2021_01_07_425675	127	17	;	;	:
10_1101-2021_01_07_425675	127	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	127	19	:	:	:
10_1101-2021_01_07_425675	127	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	127	21	preprint	preprint	NN
10_1101-2021_01_07_425675	127	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NNP
10_1101-2021_01_07_425675	127	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	127	24	11	11	CD
10_1101-2021_01_07_425675	127	25	Mass	Mass	NNP
10_1101-2021_01_07_425675	127	26	Spectrometry	Spectrometry	NNP
10_1101-2021_01_07_425675	127	27	248	248	CD
10_1101-2021_01_07_425675	127	28	The	the	DT
10_1101-2021_01_07_425675	127	29	digested	digest	VBN
10_1101-2021_01_07_425675	127	30	peptides	peptide	NNS
10_1101-2021_01_07_425675	127	31	(	(	-LRB-
10_1101-2021_01_07_425675	127	32	single	single	JJ
10_1101-2021_01_07_425675	127	33	injection	injection	NN
10_1101-2021_01_07_425675	127	34	of	of	IN
10_1101-2021_01_07_425675	127	35	0.2	0.2	CD
10_1101-2021_01_07_425675	127	36	ug	ug	NNS
10_1101-2021_01_07_425675	127	37	)	)	-RRB-
10_1101-2021_01_07_425675	127	38	were	be	VBD
10_1101-2021_01_07_425675	127	39	separated	separate	VBN
10_1101-2021_01_07_425675	127	40	by	by	IN
10_1101-2021_01_07_425675	127	41	online	online	JJ
10_1101-2021_01_07_425675	127	42	reversed	reversed	JJ
10_1101-2021_01_07_425675	127	43	phase	phase	NN
10_1101-2021_01_07_425675	127	44	249	249	CD
10_1101-2021_01_07_425675	127	45	chromatography	chromatography	NN
10_1101-2021_01_07_425675	127	46	on	on	IN
10_1101-2021_01_07_425675	127	47	an	an	DT
10_1101-2021_01_07_425675	127	48	Agilent	Agilent	NNP
10_1101-2021_01_07_425675	127	49	1290	1290	CD
10_1101-2021_01_07_425675	127	50	UHPLC	UHPLC	NNP
10_1101-2021_01_07_425675	127	51	(	(	-LRB-
10_1101-2021_01_07_425675	127	52	column	column	NN
10_1101-2021_01_07_425675	127	53	packed	pack	VBN
10_1101-2021_01_07_425675	127	54	with	with	IN
10_1101-2021_01_07_425675	127	55	Poroshell	Poroshell	NNP
10_1101-2021_01_07_425675	127	56	120	120	CD
10_1101-2021_01_07_425675	127	57	EC	EC	NNP
10_1101-2021_01_07_425675	127	58	C18	C18	NNP
10_1101-2021_01_07_425675	127	59	;	;	:
10_1101-2021_01_07_425675	127	60	250	250	CD
10_1101-2021_01_07_425675	127	61	dimensions	dimension	NNS
10_1101-2021_01_07_425675	127	62	50	50	CD
10_1101-2021_01_07_425675	127	63	cm	cm	NNS
10_1101-2021_01_07_425675	127	64	x	x	NNP
10_1101-2021_01_07_425675	127	65	75	75	CD
10_1101-2021_01_07_425675	127	66	µm	µm	NNP
10_1101-2021_01_07_425675	127	67	,	,	,
10_1101-2021_01_07_425675	127	68	2.7	2.7	CD
10_1101-2021_01_07_425675	127	69	µm	µm	NNP
10_1101-2021_01_07_425675	127	70	,	,	,
10_1101-2021_01_07_425675	127	71	Agilent	Agilent	NNP
10_1101-2021_01_07_425675	127	72	Technologies	Technologies	NNP
10_1101-2021_01_07_425675	127	73	)	)	-RRB-
10_1101-2021_01_07_425675	127	74	coupled	couple	VBD
10_1101-2021_01_07_425675	127	75	to	to	IN
10_1101-2021_01_07_425675	127	76	a	a	DT
10_1101-2021_01_07_425675	127	77	Thermo	Thermo	NNP
10_1101-2021_01_07_425675	127	78	Scientific	Scientific	NNP
10_1101-2021_01_07_425675	127	79	Orbitrap	Orbitrap	NNP
10_1101-2021_01_07_425675	127	80	251	251	NNP
10_1101-2021_01_07_425675	127	81	Fusion	Fusion	NNP
10_1101-2021_01_07_425675	127	82	mass	mass	NN
10_1101-2021_01_07_425675	127	83	spectrometer	spectrometer	NN
10_1101-2021_01_07_425675	127	84	.	.	.
10_1101-2021_01_07_425675	128	1	Samples	sample	NNS
10_1101-2021_01_07_425675	128	2	were	be	VBD
10_1101-2021_01_07_425675	128	3	eluted	elute	VBN
10_1101-2021_01_07_425675	128	4	over	over	IN
10_1101-2021_01_07_425675	128	5	a	a	DT
10_1101-2021_01_07_425675	128	6	90	90	CD
10_1101-2021_01_07_425675	128	7	min	min	NN
10_1101-2021_01_07_425675	128	8	gradient	gradient	NN
10_1101-2021_01_07_425675	128	9	from	from	IN
10_1101-2021_01_07_425675	128	10	0	0	CD
10_1101-2021_01_07_425675	128	11	%	%	NN
10_1101-2021_01_07_425675	128	12	to	to	TO
10_1101-2021_01_07_425675	128	13	35	35	CD
10_1101-2021_01_07_425675	128	14	%	%	NN
10_1101-2021_01_07_425675	128	15	252	252	CD
10_1101-2021_01_07_425675	128	16	acetonitrile	acetonitrile	NN
10_1101-2021_01_07_425675	128	17	at	at	IN
10_1101-2021_01_07_425675	128	18	a	a	DT
10_1101-2021_01_07_425675	128	19	flow	flow	NN
10_1101-2021_01_07_425675	128	20	rate	rate	NN
10_1101-2021_01_07_425675	128	21	of	of	IN
10_1101-2021_01_07_425675	128	22	0.3	0.3	CD
10_1101-2021_01_07_425675	128	23	μL	μL	NNP
10_1101-2021_01_07_425675	128	24	/	/	SYM
10_1101-2021_01_07_425675	128	25	min	min	NNP
10_1101-2021_01_07_425675	128	26	.	.	.
10_1101-2021_01_07_425675	129	1	Peptides	peptide	NNS
10_1101-2021_01_07_425675	129	2	were	be	VBD
10_1101-2021_01_07_425675	129	3	analyzed	analyze	VBN
10_1101-2021_01_07_425675	129	4	with	with	IN
10_1101-2021_01_07_425675	129	5	a	a	DT
10_1101-2021_01_07_425675	129	6	resolution	resolution	NN
10_1101-2021_01_07_425675	129	7	setting	setting	NN
10_1101-2021_01_07_425675	129	8	of	of	IN
10_1101-2021_01_07_425675	129	9	60000	60000	CD
10_1101-2021_01_07_425675	129	10	253	253	CD
10_1101-2021_01_07_425675	129	11	in	in	IN
10_1101-2021_01_07_425675	129	12	MS1	MS1	NNP
10_1101-2021_01_07_425675	129	13	.	.	.
10_1101-2021_01_07_425675	130	1	MS1	MS1	NNP
10_1101-2021_01_07_425675	130	2	scans	scan	NNS
10_1101-2021_01_07_425675	130	3	were	be	VBD
10_1101-2021_01_07_425675	130	4	obtained	obtain	VBN
10_1101-2021_01_07_425675	130	5	with	with	IN
10_1101-2021_01_07_425675	130	6	standard	standard	JJ
10_1101-2021_01_07_425675	130	7	AGC	AGC	NNP
10_1101-2021_01_07_425675	130	8	target	target	NN
10_1101-2021_01_07_425675	130	9	,	,	,
10_1101-2021_01_07_425675	130	10	maximum	maximum	JJ
10_1101-2021_01_07_425675	130	11	injection	injection	NN
10_1101-2021_01_07_425675	130	12	time	time	NN
10_1101-2021_01_07_425675	130	13	of	of	IN
10_1101-2021_01_07_425675	130	14	50	50	CD
10_1101-2021_01_07_425675	130	15	ms	m	NNS
10_1101-2021_01_07_425675	130	16	,	,	,
10_1101-2021_01_07_425675	130	17	254	254	CD
10_1101-2021_01_07_425675	130	18	and	and	CC
10_1101-2021_01_07_425675	130	19	scan	scan	NNP
10_1101-2021_01_07_425675	130	20	range	range	NNP
10_1101-2021_01_07_425675	130	21	350	350	CD
10_1101-2021_01_07_425675	130	22	-	-	HYPH
10_1101-2021_01_07_425675	130	23	2000	2000	CD
10_1101-2021_01_07_425675	130	24	.	.	.
10_1101-2021_01_07_425675	131	1	The	the	DT
10_1101-2021_01_07_425675	131	2	precursors	precursor	NNS
10_1101-2021_01_07_425675	131	3	were	be	VBD
10_1101-2021_01_07_425675	131	4	selected	select	VBN
10_1101-2021_01_07_425675	131	5	with	with	IN
10_1101-2021_01_07_425675	131	6	a	a	DT
10_1101-2021_01_07_425675	131	7	3	3	CD
10_1101-2021_01_07_425675	131	8	m	m	NN
10_1101-2021_01_07_425675	131	9	/	/	SYM
10_1101-2021_01_07_425675	131	10	z	z	NN
10_1101-2021_01_07_425675	131	11	window	window	NN
10_1101-2021_01_07_425675	131	12	and	and	CC
10_1101-2021_01_07_425675	131	13	fragmented	fragment	VBN
10_1101-2021_01_07_425675	131	14	by	by	IN
10_1101-2021_01_07_425675	131	15	255	255	CD
10_1101-2021_01_07_425675	131	16	stepped	step	VBD
10_1101-2021_01_07_425675	131	17	HCD	HCD	NNP
10_1101-2021_01_07_425675	131	18	as	as	RB
10_1101-2021_01_07_425675	131	19	well	well	RB
10_1101-2021_01_07_425675	131	20	as	as	IN
10_1101-2021_01_07_425675	131	21	EThcD.	ethcd.	RB
10_1101-2021_01_07_425675	132	1	The	the	DT
10_1101-2021_01_07_425675	132	2	stepped	stepped	JJ
10_1101-2021_01_07_425675	132	3	HCD	HCD	NNP
10_1101-2021_01_07_425675	132	4	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	132	5	included	include	VBD
10_1101-2021_01_07_425675	132	6	steps	step	NNS
10_1101-2021_01_07_425675	132	7	of	of	IN
10_1101-2021_01_07_425675	132	8	25	25	CD
10_1101-2021_01_07_425675	132	9	%	%	NN
10_1101-2021_01_07_425675	132	10	,	,	,
10_1101-2021_01_07_425675	132	11	35	35	CD
10_1101-2021_01_07_425675	132	12	%	%	NN
10_1101-2021_01_07_425675	132	13	256	256	CD
10_1101-2021_01_07_425675	132	14	and	and	CC
10_1101-2021_01_07_425675	132	15	50	50	CD
10_1101-2021_01_07_425675	132	16	%	%	NN
10_1101-2021_01_07_425675	132	17	NCE	NCE	NNP
10_1101-2021_01_07_425675	132	18	.	.	.
10_1101-2021_01_07_425675	133	1	EThcD	EThcD	NNP
10_1101-2021_01_07_425675	133	2	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	133	3	was	be	VBD
10_1101-2021_01_07_425675	133	4	performed	perform	VBN
10_1101-2021_01_07_425675	133	5	with	with	IN
10_1101-2021_01_07_425675	133	6	calibrated	calibrate	VBN
10_1101-2021_01_07_425675	133	7	charge	charge	NN
10_1101-2021_01_07_425675	133	8	-	-	HYPH
10_1101-2021_01_07_425675	133	9	dependent	dependent	JJ
10_1101-2021_01_07_425675	133	10	ETD	ETD	NNP
10_1101-2021_01_07_425675	133	11	257	257	CD
10_1101-2021_01_07_425675	133	12	parameters	parameter	NNS
10_1101-2021_01_07_425675	133	13	and	and	CC
10_1101-2021_01_07_425675	133	14	27	27	CD
10_1101-2021_01_07_425675	133	15	%	%	NN
10_1101-2021_01_07_425675	133	16	NCE	NCE	NNP
10_1101-2021_01_07_425675	133	17	supplemental	supplemental	JJ
10_1101-2021_01_07_425675	133	18	activation	activation	NN
10_1101-2021_01_07_425675	133	19	.	.	.
10_1101-2021_01_07_425675	134	1	For	for	IN
10_1101-2021_01_07_425675	134	2	both	both	DT
10_1101-2021_01_07_425675	134	3	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	134	4	types	type	NNS
10_1101-2021_01_07_425675	134	5	,	,	,
10_1101-2021_01_07_425675	134	6	ms2	ms2	NNP
10_1101-2021_01_07_425675	134	7	scan	scan	NNP
10_1101-2021_01_07_425675	134	8	were	be	VBD
10_1101-2021_01_07_425675	134	9	258	258	CD
10_1101-2021_01_07_425675	134	10	acquired	acquire	VBN
10_1101-2021_01_07_425675	134	11	at	at	IN
10_1101-2021_01_07_425675	134	12	30000	30000	CD
10_1101-2021_01_07_425675	134	13	resolution	resolution	NN
10_1101-2021_01_07_425675	134	14	,	,	,
10_1101-2021_01_07_425675	134	15	800	800	CD
10_1101-2021_01_07_425675	134	16	%	%	NN
10_1101-2021_01_07_425675	134	17	Normalized	Normalized	NNP
10_1101-2021_01_07_425675	134	18	AGC	AGC	NNP
10_1101-2021_01_07_425675	134	19	target	target	NN
10_1101-2021_01_07_425675	134	20	,	,	,
10_1101-2021_01_07_425675	134	21	250	250	CD
10_1101-2021_01_07_425675	134	22	ms	ms	NN
10_1101-2021_01_07_425675	134	23	maximum	maximum	JJ
10_1101-2021_01_07_425675	134	24	injection	injection	NN
10_1101-2021_01_07_425675	134	25	time	time	NN
10_1101-2021_01_07_425675	134	26	,	,	,
10_1101-2021_01_07_425675	134	27	259	259	CD
10_1101-2021_01_07_425675	134	28	scan	scan	JJ
10_1101-2021_01_07_425675	134	29	range	range	NN
10_1101-2021_01_07_425675	134	30	120	120	CD
10_1101-2021_01_07_425675	134	31	-	-	SYM
10_1101-2021_01_07_425675	134	32	3500	3500	CD
10_1101-2021_01_07_425675	134	33	.	.	.
10_1101-2021_01_07_425675	135	1	260	260	CD
10_1101-2021_01_07_425675	135	2	261	261	CD
10_1101-2021_01_07_425675	135	3	MS	MS	NNP
10_1101-2021_01_07_425675	135	4	Data	Data	NNP
10_1101-2021_01_07_425675	135	5	Analysis	Analysis	NNP
10_1101-2021_01_07_425675	135	6	262	262	CD
10_1101-2021_01_07_425675	135	7	Automated	Automated	NNP
10_1101-2021_01_07_425675	135	8	de	de	NNP
10_1101-2021_01_07_425675	135	9	novo	novo	NNP
10_1101-2021_01_07_425675	135	10	sequencing	sequencing	NN
10_1101-2021_01_07_425675	135	11	was	be	VBD
10_1101-2021_01_07_425675	135	12	performed	perform	VBN
10_1101-2021_01_07_425675	135	13	with	with	IN
10_1101-2021_01_07_425675	135	14	Supernovo	Supernovo	NNP
10_1101-2021_01_07_425675	135	15	(	(	-LRB-
10_1101-2021_01_07_425675	135	16	version	version	NN
10_1101-2021_01_07_425675	135	17	3.10	3.10	CD
10_1101-2021_01_07_425675	135	18	,	,	,
10_1101-2021_01_07_425675	135	19	Protein	Protein	NNP
10_1101-2021_01_07_425675	135	20	Metrics	Metrics	NNP
10_1101-2021_01_07_425675	135	21	263	263	CD
10_1101-2021_01_07_425675	135	22	Inc.	Inc.	NNP
10_1101-2021_01_07_425675	135	23	)	)	-RRB-
10_1101-2021_01_07_425675	135	24	.	.	.
10_1101-2021_01_07_425675	136	1	Custom	custom	NN
10_1101-2021_01_07_425675	136	2	parameters	parameter	NNS
10_1101-2021_01_07_425675	136	3	were	be	VBD
10_1101-2021_01_07_425675	136	4	used	use	VBN
10_1101-2021_01_07_425675	136	5	as	as	IN
10_1101-2021_01_07_425675	136	6	follows	follow	VBZ
10_1101-2021_01_07_425675	136	7	:	:	:
10_1101-2021_01_07_425675	136	8	non	non	JJ
10_1101-2021_01_07_425675	136	9	-	-	JJ
10_1101-2021_01_07_425675	136	10	specific	specific	JJ
10_1101-2021_01_07_425675	136	11	digestion	digestion	NN
10_1101-2021_01_07_425675	136	12	;	;	:
10_1101-2021_01_07_425675	136	13	precursor	precursor	NN
10_1101-2021_01_07_425675	136	14	and	and	CC
10_1101-2021_01_07_425675	136	15	product	product	NN
10_1101-2021_01_07_425675	136	16	264	264	CD
10_1101-2021_01_07_425675	136	17	mass	mass	NN
10_1101-2021_01_07_425675	136	18	tolerance	tolerance	NN
10_1101-2021_01_07_425675	136	19	was	be	VBD
10_1101-2021_01_07_425675	136	20	set	set	VBN
10_1101-2021_01_07_425675	136	21	to	to	IN
10_1101-2021_01_07_425675	136	22	12	12	CD
10_1101-2021_01_07_425675	136	23	ppm	ppm	NN
10_1101-2021_01_07_425675	136	24	and	and	CC
10_1101-2021_01_07_425675	136	25	0.02	0.02	CD
10_1101-2021_01_07_425675	136	26	Da	Da	NNP
10_1101-2021_01_07_425675	136	27	respectively	respectively	RB
10_1101-2021_01_07_425675	136	28	;	;	:
10_1101-2021_01_07_425675	136	29	carboxymethylation	carboxymethylation	NN
10_1101-2021_01_07_425675	136	30	(	(	-LRB-
10_1101-2021_01_07_425675	136	31	+58.005479	+58.005479	NNP
10_1101-2021_01_07_425675	136	32	)	)	-RRB-
10_1101-2021_01_07_425675	136	33	265	265	CD
10_1101-2021_01_07_425675	136	34	on	on	IN
10_1101-2021_01_07_425675	136	35	cysteine	cysteine	NN
10_1101-2021_01_07_425675	136	36	was	be	VBD
10_1101-2021_01_07_425675	136	37	set	set	VBN
10_1101-2021_01_07_425675	136	38	as	as	IN
10_1101-2021_01_07_425675	136	39	fixed	fix	VBN
10_1101-2021_01_07_425675	136	40	modification	modification	NN
10_1101-2021_01_07_425675	136	41	;	;	:
10_1101-2021_01_07_425675	136	42	oxidation	oxidation	NN
10_1101-2021_01_07_425675	136	43	on	on	IN
10_1101-2021_01_07_425675	136	44	methionine	methionine	NNP
10_1101-2021_01_07_425675	136	45	and	and	CC
10_1101-2021_01_07_425675	136	46	tryptophan	tryptophan	NNP
10_1101-2021_01_07_425675	136	47	was	be	VBD
10_1101-2021_01_07_425675	136	48	set	set	VBN
10_1101-2021_01_07_425675	136	49	as	as	IN
10_1101-2021_01_07_425675	136	50	266	266	CD
10_1101-2021_01_07_425675	136	51	variable	variable	JJ
10_1101-2021_01_07_425675	136	52	common	common	JJ
10_1101-2021_01_07_425675	136	53	1	1	CD
10_1101-2021_01_07_425675	136	54	modification	modification	NN
10_1101-2021_01_07_425675	136	55	;	;	:
10_1101-2021_01_07_425675	136	56	carboxymethylation	carboxymethylation	NN
10_1101-2021_01_07_425675	136	57	on	on	IN
10_1101-2021_01_07_425675	136	58	the	the	DT
10_1101-2021_01_07_425675	136	59	N	n	NN
10_1101-2021_01_07_425675	136	60	-	-	HYPH
10_1101-2021_01_07_425675	136	61	terminus	terminus	NN
10_1101-2021_01_07_425675	136	62	,	,	,
10_1101-2021_01_07_425675	136	63	pyroglutamic	pyroglutamic	JJ
10_1101-2021_01_07_425675	136	64	acid	acid	NN
10_1101-2021_01_07_425675	136	65	267	267	CD
10_1101-2021_01_07_425675	136	66	conversion	conversion	NN
10_1101-2021_01_07_425675	136	67	of	of	IN
10_1101-2021_01_07_425675	136	68	glutamine	glutamine	NN
10_1101-2021_01_07_425675	136	69	and	and	CC
10_1101-2021_01_07_425675	136	70	glutamic	glutamic	NN
10_1101-2021_01_07_425675	136	71	acid	acid	NN
10_1101-2021_01_07_425675	136	72	on	on	IN
10_1101-2021_01_07_425675	136	73	the	the	DT
10_1101-2021_01_07_425675	136	74	N	n	NN
10_1101-2021_01_07_425675	136	75	-	-	HYPH
10_1101-2021_01_07_425675	136	76	terminus	terminus	NN
10_1101-2021_01_07_425675	136	77	,	,	,
10_1101-2021_01_07_425675	136	78	deamidation	deamidation	NN
10_1101-2021_01_07_425675	136	79	on	on	IN
10_1101-2021_01_07_425675	136	80	268	268	CD
10_1101-2021_01_07_425675	136	81	asparagine	asparagine	NN
10_1101-2021_01_07_425675	136	82	/	/	SYM
10_1101-2021_01_07_425675	136	83	glutamine	glutamine	NN
10_1101-2021_01_07_425675	136	84	were	be	VBD
10_1101-2021_01_07_425675	136	85	set	set	VBN
10_1101-2021_01_07_425675	136	86	as	as	IN
10_1101-2021_01_07_425675	136	87	variable	variable	JJ
10_1101-2021_01_07_425675	136	88	rare	rare	JJ
10_1101-2021_01_07_425675	136	89	1	1	CD
10_1101-2021_01_07_425675	136	90	modifications	modification	NNS
10_1101-2021_01_07_425675	136	91	.	.	.
10_1101-2021_01_07_425675	137	1	Peptides	peptide	NNS
10_1101-2021_01_07_425675	137	2	were	be	VBD
10_1101-2021_01_07_425675	137	3	filtered	filter	VBN
10_1101-2021_01_07_425675	137	4	for	for	IN
10_1101-2021_01_07_425675	137	5	score	score	NN
10_1101-2021_01_07_425675	137	6	269	269	CD
10_1101-2021_01_07_425675	137	7	>	>	NNS
10_1101-2021_01_07_425675	137	8	=	=	SYM
10_1101-2021_01_07_425675	137	9	500	500	CD
10_1101-2021_01_07_425675	137	10	for	for	IN
10_1101-2021_01_07_425675	137	11	the	the	DT
10_1101-2021_01_07_425675	137	12	final	final	JJ
10_1101-2021_01_07_425675	137	13	evaluation	evaluation	NN
10_1101-2021_01_07_425675	137	14	of	of	IN
10_1101-2021_01_07_425675	137	15	spectrum	spectrum	NN
10_1101-2021_01_07_425675	137	16	quality	quality	NN
10_1101-2021_01_07_425675	137	17	and	and	CC
10_1101-2021_01_07_425675	137	18	(	(	-LRB-
10_1101-2021_01_07_425675	137	19	depth	depth	NN
10_1101-2021_01_07_425675	137	20	of	of	IN
10_1101-2021_01_07_425675	137	21	)	)	-RRB-
10_1101-2021_01_07_425675	137	22	coverage	coverage	NN
10_1101-2021_01_07_425675	137	23	.	.	.
10_1101-2021_01_07_425675	138	1	Supernovo	Supernovo	NNP
10_1101-2021_01_07_425675	138	2	generates	generate	VBZ
10_1101-2021_01_07_425675	138	3	270	270	CD
10_1101-2021_01_07_425675	138	4	peptide	peptide	JJ
10_1101-2021_01_07_425675	138	5	groups	group	NNS
10_1101-2021_01_07_425675	138	6	for	for	IN
10_1101-2021_01_07_425675	138	7	redundant	redundant	JJ
10_1101-2021_01_07_425675	138	8	MS	MS	NNP
10_1101-2021_01_07_425675	138	9	/	/	SYM
10_1101-2021_01_07_425675	138	10	MS	MS	NNP
10_1101-2021_01_07_425675	138	11	spectra	spectra	NNP
10_1101-2021_01_07_425675	138	12	,	,	,
10_1101-2021_01_07_425675	138	13	including	include	VBG
10_1101-2021_01_07_425675	138	14	also	also	RB
10_1101-2021_01_07_425675	138	15	when	when	WRB
10_1101-2021_01_07_425675	138	16	stepped	step	VBN
10_1101-2021_01_07_425675	138	17	HCD	HCD	NNP
10_1101-2021_01_07_425675	138	18	and	and	CC
10_1101-2021_01_07_425675	138	19	EThcD	EThcD	NNP
10_1101-2021_01_07_425675	138	20	271	271	CD
10_1101-2021_01_07_425675	138	21	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	138	22	on	on	IN
10_1101-2021_01_07_425675	138	23	the	the	DT
10_1101-2021_01_07_425675	138	24	same	same	JJ
10_1101-2021_01_07_425675	138	25	precursor	precursor	NN
10_1101-2021_01_07_425675	138	26	both	both	CC
10_1101-2021_01_07_425675	138	27	generate	generate	VBP
10_1101-2021_01_07_425675	138	28	good	good	JJ
10_1101-2021_01_07_425675	138	29	peptide	peptide	NN
10_1101-2021_01_07_425675	138	30	-	-	HYPH
10_1101-2021_01_07_425675	138	31	spectrum	spectrum	NN
10_1101-2021_01_07_425675	138	32	matches	match	NNS
10_1101-2021_01_07_425675	138	33	.	.	.
10_1101-2021_01_07_425675	139	1	In	in	IN
10_1101-2021_01_07_425675	139	2	these	these	DT
10_1101-2021_01_07_425675	139	3	272	272	CD
10_1101-2021_01_07_425675	139	4	cases	case	NNS
10_1101-2021_01_07_425675	139	5	only	only	RB
10_1101-2021_01_07_425675	139	6	the	the	DT
10_1101-2021_01_07_425675	139	7	best	well	RBS
10_1101-2021_01_07_425675	139	8	-	-	HYPH
10_1101-2021_01_07_425675	139	9	matched	match	VBN
10_1101-2021_01_07_425675	139	10	spectrum	spectrum	NN
10_1101-2021_01_07_425675	139	11	is	be	VBZ
10_1101-2021_01_07_425675	139	12	counted	count	VBN
10_1101-2021_01_07_425675	139	13	as	as	IN
10_1101-2021_01_07_425675	139	14	representative	representative	NN
10_1101-2021_01_07_425675	139	15	for	for	IN
10_1101-2021_01_07_425675	139	16	that	that	DT
10_1101-2021_01_07_425675	139	17	group	group	NN
10_1101-2021_01_07_425675	139	18	.	.	.
10_1101-2021_01_07_425675	140	1	This	this	DT
10_1101-2021_01_07_425675	140	2	criterium	criterium	NN
10_1101-2021_01_07_425675	140	3	273	273	CD
10_1101-2021_01_07_425675	140	4	was	be	VBD
10_1101-2021_01_07_425675	140	5	used	use	VBN
10_1101-2021_01_07_425675	140	6	in	in	IN
10_1101-2021_01_07_425675	140	7	counting	count	VBG
10_1101-2021_01_07_425675	140	8	the	the	DT
10_1101-2021_01_07_425675	140	9	number	number	NN
10_1101-2021_01_07_425675	140	10	of	of	IN
10_1101-2021_01_07_425675	140	11	peptide	peptide	NN
10_1101-2021_01_07_425675	140	12	reads	read	NNS
10_1101-2021_01_07_425675	140	13	reported	report	VBN
10_1101-2021_01_07_425675	140	14	in	in	IN
10_1101-2021_01_07_425675	140	15	Table	table	NN
10_1101-2021_01_07_425675	140	16	S1	S1	NNS
10_1101-2021_01_07_425675	140	17	.	.	.
10_1101-2021_01_07_425675	141	1	Germline	germline	JJ
10_1101-2021_01_07_425675	141	2	sequences	sequence	NNS
10_1101-2021_01_07_425675	141	3	and	and	CC
10_1101-2021_01_07_425675	141	4	274	274	CD
10_1101-2021_01_07_425675	141	5	CDR	cdr	NN
10_1101-2021_01_07_425675	141	6	boundaries	boundary	NNS
10_1101-2021_01_07_425675	141	7	were	be	VBD
10_1101-2021_01_07_425675	141	8	inferred	infer	VBN
10_1101-2021_01_07_425675	141	9	using	use	VBG
10_1101-2021_01_07_425675	141	10	IMGT	IMGT	NNP
10_1101-2021_01_07_425675	141	11	/	/	SYM
10_1101-2021_01_07_425675	141	12	DomainGapAlign	DomainGapAlign	NNP
10_1101-2021_01_07_425675	141	13	38	38	CD
10_1101-2021_01_07_425675	141	14	-	-	SYM
10_1101-2021_01_07_425675	141	15	39	39	CD
10_1101-2021_01_07_425675	141	16	.	.	.
10_1101-2021_01_07_425675	142	1	275	275	CD
10_1101-2021_01_07_425675	142	2	276	276	CD
10_1101-2021_01_07_425675	142	3	277	277	CD
10_1101-2021_01_07_425675	142	4	278	278	CD
10_1101-2021_01_07_425675	142	5	.CC	.CC	,
10_1101-2021_01_07_425675	142	6	-	-	:
10_1101-2021_01_07_425675	142	7	BY	by	IN
10_1101-2021_01_07_425675	142	8	4.0	4.0	CD
10_1101-2021_01_07_425675	142	9	International	International	NNP
10_1101-2021_01_07_425675	142	10	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	142	11	under	under	IN
10_1101-2021_01_07_425675	142	12	a	a	DT
10_1101-2021_01_07_425675	142	13	(	(	-LRB-
10_1101-2021_01_07_425675	142	14	which	which	WDT
10_1101-2021_01_07_425675	142	15	was	be	VBD
10_1101-2021_01_07_425675	142	16	not	not	RB
10_1101-2021_01_07_425675	142	17	certified	certify	VBN
10_1101-2021_01_07_425675	142	18	by	by	IN
10_1101-2021_01_07_425675	142	19	peer	peer	NN
10_1101-2021_01_07_425675	142	20	review	review	NN
10_1101-2021_01_07_425675	142	21	)	)	-RRB-
10_1101-2021_01_07_425675	142	22	is	be	VBZ
10_1101-2021_01_07_425675	142	23	the	the	DT
10_1101-2021_01_07_425675	142	24	author	author	NN
10_1101-2021_01_07_425675	142	25	/	/	SYM
10_1101-2021_01_07_425675	142	26	funder	funder	NN
10_1101-2021_01_07_425675	142	27	,	,	,
10_1101-2021_01_07_425675	142	28	who	who	WP
10_1101-2021_01_07_425675	142	29	has	have	VBZ
10_1101-2021_01_07_425675	142	30	granted	grant	VBN
10_1101-2021_01_07_425675	142	31	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	142	32	a	a	DT
10_1101-2021_01_07_425675	142	33	license	license	NN
10_1101-2021_01_07_425675	142	34	to	to	TO
10_1101-2021_01_07_425675	142	35	display	display	VB
10_1101-2021_01_07_425675	142	36	the	the	DT
10_1101-2021_01_07_425675	142	37	preprint	preprint	NN
10_1101-2021_01_07_425675	142	38	in	in	IN
10_1101-2021_01_07_425675	142	39	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	142	40	.	.	.
10_1101-2021_01_07_425675	143	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	143	2	is	be	VBZ
10_1101-2021_01_07_425675	143	3	made	make	VBN
10_1101-2021_01_07_425675	143	4	The	the	DT
10_1101-2021_01_07_425675	143	5	copyright	copyright	NN
10_1101-2021_01_07_425675	143	6	holder	holder	NN
10_1101-2021_01_07_425675	143	7	for	for	IN
10_1101-2021_01_07_425675	143	8	this	this	DT
10_1101-2021_01_07_425675	143	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	143	10	version	version	NN
10_1101-2021_01_07_425675	143	11	posted	post	VBD
10_1101-2021_01_07_425675	143	12	January	January	NNP
10_1101-2021_01_07_425675	143	13	8	8	CD
10_1101-2021_01_07_425675	143	14	,	,	,
10_1101-2021_01_07_425675	143	15	2021	2021	CD
10_1101-2021_01_07_425675	143	16	.	.	.
10_1101-2021_01_07_425675	143	17	;	;	:
10_1101-2021_01_07_425675	143	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	143	19	:	:	:
10_1101-2021_01_07_425675	143	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	143	21	preprint	preprint	NN
10_1101-2021_01_07_425675	143	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NNP
10_1101-2021_01_07_425675	143	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	143	24	12	12	CD
10_1101-2021_01_07_425675	143	25	Revision	Revision	NNP
10_1101-2021_01_07_425675	143	26	of	of	IN
10_1101-2021_01_07_425675	143	27	the	the	DT
10_1101-2021_01_07_425675	143	28	anti	anti	JJ
10_1101-2021_01_07_425675	143	29	-	-	JJ
10_1101-2021_01_07_425675	143	30	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	143	31	-	-	HYPH
10_1101-2021_01_07_425675	143	32	M2	M2	NNP
10_1101-2021_01_07_425675	143	33	Fab	Fab	NNP
10_1101-2021_01_07_425675	143	34	crystal	crystal	NN
10_1101-2021_01_07_425675	143	35	structure	structure	NN
10_1101-2021_01_07_425675	143	36	model	model	NN
10_1101-2021_01_07_425675	143	37	279	279	CD
10_1101-2021_01_07_425675	143	38	As	as	IN
10_1101-2021_01_07_425675	143	39	a	a	DT
10_1101-2021_01_07_425675	143	40	starting	starting	NN
10_1101-2021_01_07_425675	143	41	point	point	NN
10_1101-2021_01_07_425675	143	42	for	for	IN
10_1101-2021_01_07_425675	143	43	model	model	NN
10_1101-2021_01_07_425675	143	44	building	building	NN
10_1101-2021_01_07_425675	143	45	,	,	,
10_1101-2021_01_07_425675	143	46	the	the	DT
10_1101-2021_01_07_425675	143	47	reflection	reflection	NN
10_1101-2021_01_07_425675	143	48	file	file	NN
10_1101-2021_01_07_425675	143	49	and	and	CC
10_1101-2021_01_07_425675	143	50	coordinates	coordinate	NNS
10_1101-2021_01_07_425675	143	51	of	of	IN
10_1101-2021_01_07_425675	143	52	the	the	DT
10_1101-2021_01_07_425675	143	53	published	publish	VBN
10_1101-2021_01_07_425675	143	54	anti-280	anti-280	PRP$
10_1101-2021_01_07_425675	143	55	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	143	56	-	-	HYPH
10_1101-2021_01_07_425675	143	57	M2	M2	NNP
10_1101-2021_01_07_425675	143	58	Fab	Fab	NNP
10_1101-2021_01_07_425675	143	59	crystal	crystal	NN
10_1101-2021_01_07_425675	143	60	structure	structure	NN
10_1101-2021_01_07_425675	143	61	were	be	VBD
10_1101-2021_01_07_425675	143	62	used	use	VBN
10_1101-2021_01_07_425675	143	63	(	(	-LRB-
10_1101-2021_01_07_425675	143	64	PDB	PDB	NNP
10_1101-2021_01_07_425675	143	65	ID	ID	NNP
10_1101-2021_01_07_425675	143	66	:	:	:
10_1101-2021_01_07_425675	143	67	2G60	2g60	LS
10_1101-2021_01_07_425675	143	68	)	)	-RRB-
10_1101-2021_01_07_425675	143	69	33	33	CD
10_1101-2021_01_07_425675	143	70	.	.	.
10_1101-2021_01_07_425675	144	1	Care	care	NN
10_1101-2021_01_07_425675	144	2	was	be	VBD
10_1101-2021_01_07_425675	144	3	taken	take	VBN
10_1101-2021_01_07_425675	144	4	to	to	TO
10_1101-2021_01_07_425675	144	5	use	use	VB
10_1101-2021_01_07_425675	144	6	the	the	DT
10_1101-2021_01_07_425675	144	7	original	original	JJ
10_1101-2021_01_07_425675	144	8	281	281	CD
10_1101-2021_01_07_425675	144	9	Rfree	Rfree	NNP
10_1101-2021_01_07_425675	144	10	labels	label	NNS
10_1101-2021_01_07_425675	144	11	of	of	IN
10_1101-2021_01_07_425675	144	12	the	the	DT
10_1101-2021_01_07_425675	144	13	deposited	deposited	JJ
10_1101-2021_01_07_425675	144	14	reflection	reflection	NN
10_1101-2021_01_07_425675	144	15	file	file	NN
10_1101-2021_01_07_425675	144	16	for	for	IN
10_1101-2021_01_07_425675	144	17	refinement	refinement	NN
10_1101-2021_01_07_425675	144	18	,	,	,
10_1101-2021_01_07_425675	144	19	so	so	IN
10_1101-2021_01_07_425675	144	20	as	as	IN
10_1101-2021_01_07_425675	144	21	not	not	RB
10_1101-2021_01_07_425675	144	22	to	to	TO
10_1101-2021_01_07_425675	144	23	introduce	introduce	VB
10_1101-2021_01_07_425675	144	24	extra	extra	JJ
10_1101-2021_01_07_425675	144	25	model	model	NN
10_1101-2021_01_07_425675	144	26	bias	bias	NN
10_1101-2021_01_07_425675	144	27	.	.	.
10_1101-2021_01_07_425675	145	1	282	282	CD
10_1101-2021_01_07_425675	145	2	Differential	differential	NN
10_1101-2021_01_07_425675	145	3	residues	residue	NNS
10_1101-2021_01_07_425675	145	4	between	between	IN
10_1101-2021_01_07_425675	145	5	this	this	DT
10_1101-2021_01_07_425675	145	6	structure	structure	NN
10_1101-2021_01_07_425675	145	7	and	and	CC
10_1101-2021_01_07_425675	145	8	our	-PRON-	PRP$
10_1101-2021_01_07_425675	145	9	mass	mass	NN
10_1101-2021_01_07_425675	145	10	spectrometry	spectrometry	NN
10_1101-2021_01_07_425675	145	11	-	-	HYPH
10_1101-2021_01_07_425675	145	12	derived	derive	VBN
10_1101-2021_01_07_425675	145	13	anti	anti	JJ
10_1101-2021_01_07_425675	145	14	-	-	JJ
10_1101-2021_01_07_425675	145	15	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	145	16	283	283	CD
10_1101-2021_01_07_425675	145	17	sequence	sequence	NN
10_1101-2021_01_07_425675	145	18	were	be	VBD
10_1101-2021_01_07_425675	145	19	manually	manually	RB
10_1101-2021_01_07_425675	145	20	mutated	mutate	VBN
10_1101-2021_01_07_425675	145	21	and	and	CC
10_1101-2021_01_07_425675	145	22	fitted	fit	VBN
10_1101-2021_01_07_425675	145	23	in	in	IN
10_1101-2021_01_07_425675	145	24	the	the	DT
10_1101-2021_01_07_425675	145	25	density	density	NN
10_1101-2021_01_07_425675	145	26	using	use	VBG
10_1101-2021_01_07_425675	145	27	Coot	Coot	NNP
10_1101-2021_01_07_425675	145	28	40	40	CD
10_1101-2021_01_07_425675	145	29	.	.	.
10_1101-2021_01_07_425675	146	1	Many	many	JJ
10_1101-2021_01_07_425675	146	2	spurious	spurious	JJ
10_1101-2021_01_07_425675	146	3	water	water	NN
10_1101-2021_01_07_425675	146	4	284	284	CD
10_1101-2021_01_07_425675	146	5	molecules	molecule	NNS
10_1101-2021_01_07_425675	146	6	that	that	WDT
10_1101-2021_01_07_425675	146	7	caused	cause	VBD
10_1101-2021_01_07_425675	146	8	severe	severe	JJ
10_1101-2021_01_07_425675	146	9	steric	steric	JJ
10_1101-2021_01_07_425675	146	10	clashes	clash	NNS
10_1101-2021_01_07_425675	146	11	in	in	IN
10_1101-2021_01_07_425675	146	12	the	the	DT
10_1101-2021_01_07_425675	146	13	original	original	JJ
10_1101-2021_01_07_425675	146	14	model	model	NN
10_1101-2021_01_07_425675	146	15	were	be	VBD
10_1101-2021_01_07_425675	146	16	also	also	RB
10_1101-2021_01_07_425675	146	17	manually	manually	RB
10_1101-2021_01_07_425675	146	18	removed	remove	VBN
10_1101-2021_01_07_425675	146	19	in	in	IN
10_1101-2021_01_07_425675	146	20	285	285	CD
10_1101-2021_01_07_425675	146	21	Coot	Coot	NNP
10_1101-2021_01_07_425675	146	22	.	.	.
10_1101-2021_01_07_425675	147	1	Densities	density	NNS
10_1101-2021_01_07_425675	147	2	for	for	IN
10_1101-2021_01_07_425675	147	3	two	two	CD
10_1101-2021_01_07_425675	147	4	sulfate	sulfate	NN
10_1101-2021_01_07_425675	147	5	and	and	CC
10_1101-2021_01_07_425675	147	6	one	one	CD
10_1101-2021_01_07_425675	147	7	chloride	chloride	NN
10_1101-2021_01_07_425675	147	8	ion	ion	NN
10_1101-2021_01_07_425675	147	9	were	be	VBD
10_1101-2021_01_07_425675	147	10	identified	identify	VBN
10_1101-2021_01_07_425675	147	11	and	and	CC
10_1101-2021_01_07_425675	147	12	built	build	VBN
10_1101-2021_01_07_425675	147	13	into	into	IN
10_1101-2021_01_07_425675	147	14	the	the	DT
10_1101-2021_01_07_425675	147	15	model	model	NN
10_1101-2021_01_07_425675	147	16	.	.	.
10_1101-2021_01_07_425675	148	1	The	the	DT
10_1101-2021_01_07_425675	148	2	286	286	CD
10_1101-2021_01_07_425675	148	3	original	original	JJ
10_1101-2021_01_07_425675	148	4	crystallization	crystallization	NN
10_1101-2021_01_07_425675	148	5	solution	solution	NN
10_1101-2021_01_07_425675	148	6	contained	contain	VBD
10_1101-2021_01_07_425675	148	7	0.1	0.1	CD
10_1101-2021_01_07_425675	148	8	M	M	NNP
10_1101-2021_01_07_425675	148	9	ammonium	ammonium	NN
10_1101-2021_01_07_425675	148	10	sulfate	sulfate	NN
10_1101-2021_01_07_425675	148	11	.	.	.
10_1101-2021_01_07_425675	149	1	Iterative	iterative	JJ
10_1101-2021_01_07_425675	149	2	cycles	cycle	NNS
10_1101-2021_01_07_425675	149	3	of	of	IN
10_1101-2021_01_07_425675	149	4	model	model	NN
10_1101-2021_01_07_425675	149	5	287	287	CD
10_1101-2021_01_07_425675	149	6	geometry	geometry	NN
10_1101-2021_01_07_425675	149	7	optimization	optimization	NN
10_1101-2021_01_07_425675	149	8	in	in	IN
10_1101-2021_01_07_425675	149	9	real	real	JJ
10_1101-2021_01_07_425675	149	10	space	space	NN
10_1101-2021_01_07_425675	149	11	in	in	IN
10_1101-2021_01_07_425675	149	12	Coot	Coot	NNP
10_1101-2021_01_07_425675	149	13	and	and	CC
10_1101-2021_01_07_425675	149	14	reciprocal	reciprocal	JJ
10_1101-2021_01_07_425675	149	15	space	space	NN
10_1101-2021_01_07_425675	149	16	refinement	refinement	NN
10_1101-2021_01_07_425675	149	17	by	by	IN
10_1101-2021_01_07_425675	149	18	Phenix	Phenix	NNP
10_1101-2021_01_07_425675	149	19	were	be	VBD
10_1101-2021_01_07_425675	149	20	used	use	VBN
10_1101-2021_01_07_425675	149	21	288	288	CD
10_1101-2021_01_07_425675	149	22	to	to	TO
10_1101-2021_01_07_425675	149	23	generate	generate	VB
10_1101-2021_01_07_425675	149	24	the	the	DT
10_1101-2021_01_07_425675	149	25	final	final	JJ
10_1101-2021_01_07_425675	149	26	model	model	NN
10_1101-2021_01_07_425675	149	27	,	,	,
10_1101-2021_01_07_425675	149	28	which	which	WDT
10_1101-2021_01_07_425675	149	29	was	be	VBD
10_1101-2021_01_07_425675	149	30	validated	validate	VBN
10_1101-2021_01_07_425675	149	31	with	with	IN
10_1101-2021_01_07_425675	149	32	Molprobity	Molprobity	NNP
10_1101-2021_01_07_425675	149	33	41	41	CD
10_1101-2021_01_07_425675	149	34	-	-	SYM
10_1101-2021_01_07_425675	149	35	42	42	CD
10_1101-2021_01_07_425675	149	36	.	.	.
10_1101-2021_01_07_425675	150	1	289	289	CD
10_1101-2021_01_07_425675	150	2	290	290	CD
10_1101-2021_01_07_425675	150	3	Cloning	clone	VBG
10_1101-2021_01_07_425675	150	4	and	and	CC
10_1101-2021_01_07_425675	150	5	expression	expression	NN
10_1101-2021_01_07_425675	150	6	of	of	IN
10_1101-2021_01_07_425675	150	7	synthetic	synthetic	JJ
10_1101-2021_01_07_425675	150	8	recombinant	recombinant	JJ
10_1101-2021_01_07_425675	150	9	anti	anti	JJ
10_1101-2021_01_07_425675	150	10	-	-	JJ
10_1101-2021_01_07_425675	150	11	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	150	12	-	-	HYPH
10_1101-2021_01_07_425675	150	13	M2	M2	NNP
10_1101-2021_01_07_425675	150	14	291	291	CD
10_1101-2021_01_07_425675	150	15	To	to	TO
10_1101-2021_01_07_425675	150	16	recombinantly	recombinantly	RB
10_1101-2021_01_07_425675	150	17	express	express	VB
10_1101-2021_01_07_425675	150	18	full	full	JJ
10_1101-2021_01_07_425675	150	19	-	-	HYPH
10_1101-2021_01_07_425675	150	20	length	length	NN
10_1101-2021_01_07_425675	150	21	anti	anti	JJ
10_1101-2021_01_07_425675	150	22	-	-	JJ
10_1101-2021_01_07_425675	150	23	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	150	24	-	-	HYPH
10_1101-2021_01_07_425675	150	25	M2	M2	NNP
10_1101-2021_01_07_425675	150	26	,	,	,
10_1101-2021_01_07_425675	150	27	the	the	DT
10_1101-2021_01_07_425675	150	28	proteomic	proteomic	JJ
10_1101-2021_01_07_425675	150	29	sequences	sequence	NNS
10_1101-2021_01_07_425675	150	30	of	of	IN
10_1101-2021_01_07_425675	150	31	both	both	CC
10_1101-2021_01_07_425675	150	32	the	the	DT
10_1101-2021_01_07_425675	150	33	light	light	JJ
10_1101-2021_01_07_425675	150	34	292	292	CD
10_1101-2021_01_07_425675	150	35	and	and	CC
10_1101-2021_01_07_425675	150	36	heavy	heavy	JJ
10_1101-2021_01_07_425675	150	37	chains	chain	NNS
10_1101-2021_01_07_425675	150	38	were	be	VBD
10_1101-2021_01_07_425675	150	39	reverse	reverse	JJ
10_1101-2021_01_07_425675	150	40	-	-	HYPH
10_1101-2021_01_07_425675	150	41	translated	translate	VBN
10_1101-2021_01_07_425675	150	42	and	and	CC
10_1101-2021_01_07_425675	150	43	codon	codon	NNP
10_1101-2021_01_07_425675	150	44	optimized	optimize	VBN
10_1101-2021_01_07_425675	150	45	for	for	IN
10_1101-2021_01_07_425675	150	46	expression	expression	NN
10_1101-2021_01_07_425675	150	47	in	in	IN
10_1101-2021_01_07_425675	150	48	human	human	JJ
10_1101-2021_01_07_425675	150	49	cells	cell	NNS
10_1101-2021_01_07_425675	150	50	293	293	CD
10_1101-2021_01_07_425675	150	51	using	use	VBG
10_1101-2021_01_07_425675	150	52	the	the	DT
10_1101-2021_01_07_425675	150	53	Integrated	Integrated	NNP
10_1101-2021_01_07_425675	150	54	DNA	DNA	NNP
10_1101-2021_01_07_425675	150	55	Technologies	Technologies	NNPS
10_1101-2021_01_07_425675	150	56	(	(	-LRB-
10_1101-2021_01_07_425675	150	57	IDT	IDT	NNP
10_1101-2021_01_07_425675	150	58	)	)	-RRB-
10_1101-2021_01_07_425675	150	59	web	web	NN
10_1101-2021_01_07_425675	150	60	tool	tool	NN
10_1101-2021_01_07_425675	150	61	(	(	-LRB-
10_1101-2021_01_07_425675	150	62	http://www.idtdna.com/CodonOpt	http://www.idtdna.com/codonopt	NN
10_1101-2021_01_07_425675	150	63	)	)	-RRB-
10_1101-2021_01_07_425675	150	64	43	43	CD
10_1101-2021_01_07_425675	150	65	.	.	.
10_1101-2021_01_07_425675	151	1	For	for	IN
10_1101-2021_01_07_425675	151	2	294	294	CD
10_1101-2021_01_07_425675	151	3	the	the	DT
10_1101-2021_01_07_425675	151	4	linker	linker	NN
10_1101-2021_01_07_425675	151	5	and	and	CC
10_1101-2021_01_07_425675	151	6	Fc	Fc	NNP
10_1101-2021_01_07_425675	151	7	region	region	NN
10_1101-2021_01_07_425675	151	8	of	of	IN
10_1101-2021_01_07_425675	151	9	the	the	DT
10_1101-2021_01_07_425675	151	10	heavy	heavy	JJ
10_1101-2021_01_07_425675	151	11	chain	chain	NN
10_1101-2021_01_07_425675	151	12	,	,	,
10_1101-2021_01_07_425675	151	13	the	the	DT
10_1101-2021_01_07_425675	151	14	standard	standard	JJ
10_1101-2021_01_07_425675	151	15	mouse	mouse	NN
10_1101-2021_01_07_425675	151	16	Ig	Ig	NNP
10_1101-2021_01_07_425675	151	17	gamma-1	gamma-1	NNP
10_1101-2021_01_07_425675	151	18	(	(	-LRB-
10_1101-2021_01_07_425675	151	19	IGHG1	IGHG1	NNP
10_1101-2021_01_07_425675	151	20	)	)	-RRB-
10_1101-2021_01_07_425675	151	21	amino	amino	NN
10_1101-2021_01_07_425675	151	22	acid	acid	NN
10_1101-2021_01_07_425675	151	23	295	295	CD
10_1101-2021_01_07_425675	151	24	sequence	sequence	NN
10_1101-2021_01_07_425675	151	25	(	(	-LRB-
10_1101-2021_01_07_425675	151	26	Uniprot	Uniprot	NNP
10_1101-2021_01_07_425675	151	27	P01868.1	P01868.1	NNP
10_1101-2021_01_07_425675	151	28	)	)	-RRB-
10_1101-2021_01_07_425675	151	29	was	be	VBD
10_1101-2021_01_07_425675	151	30	used	use	VBN
10_1101-2021_01_07_425675	151	31	.	.	.
10_1101-2021_01_07_425675	152	1	An	an	DT
10_1101-2021_01_07_425675	152	2	N	n	CD
10_1101-2021_01_07_425675	152	3	-	-	HYPH
10_1101-2021_01_07_425675	152	4	terminal	terminal	NN
10_1101-2021_01_07_425675	152	5	secretion	secretion	NN
10_1101-2021_01_07_425675	152	6	signal	signal	NN
10_1101-2021_01_07_425675	152	7	peptide	peptide	NNP
10_1101-2021_01_07_425675	152	8	derived	derive	VBN
10_1101-2021_01_07_425675	152	9	from	from	IN
10_1101-2021_01_07_425675	152	10	296	296	CD
10_1101-2021_01_07_425675	152	11	human	human	JJ
10_1101-2021_01_07_425675	152	12	IgG	IgG	NNP
10_1101-2021_01_07_425675	152	13	light	light	NN
10_1101-2021_01_07_425675	152	14	chain	chain	NN
10_1101-2021_01_07_425675	152	15	(	(	-LRB-
10_1101-2021_01_07_425675	152	16	MEAPAQLLFLLLLWLPDTTG	MEAPAQLLFLLLLWLPDTTG	NNP
10_1101-2021_01_07_425675	152	17	)	)	-RRB-
10_1101-2021_01_07_425675	152	18	was	be	VBD
10_1101-2021_01_07_425675	152	19	added	add	VBN
10_1101-2021_01_07_425675	152	20	to	to	IN
10_1101-2021_01_07_425675	152	21	the	the	DT
10_1101-2021_01_07_425675	152	22	N	n	NN
10_1101-2021_01_07_425675	152	23	-	-	HYPH
10_1101-2021_01_07_425675	152	24	termini	termini	NN
10_1101-2021_01_07_425675	152	25	of	of	IN
10_1101-2021_01_07_425675	152	26	both	both	CC
10_1101-2021_01_07_425675	152	27	heavy	heavy	JJ
10_1101-2021_01_07_425675	152	28	297	297	CD
10_1101-2021_01_07_425675	152	29	and	and	CC
10_1101-2021_01_07_425675	152	30	light	light	JJ
10_1101-2021_01_07_425675	152	31	chains	chain	NNS
10_1101-2021_01_07_425675	152	32	.	.	.
10_1101-2021_01_07_425675	153	1	BamHI	BamHI	NNP
10_1101-2021_01_07_425675	153	2	and	and	CC
10_1101-2021_01_07_425675	153	3	NotI	NotI	NNP
10_1101-2021_01_07_425675	153	4	restriction	restriction	NN
10_1101-2021_01_07_425675	153	5	sites	site	NNS
10_1101-2021_01_07_425675	153	6	were	be	VBD
10_1101-2021_01_07_425675	153	7	added	add	VBN
10_1101-2021_01_07_425675	153	8	to	to	IN
10_1101-2021_01_07_425675	153	9	the	the	DT
10_1101-2021_01_07_425675	153	10	5	5	CD
10_1101-2021_01_07_425675	153	11	’	'	''
10_1101-2021_01_07_425675	153	12	and	and	CC
10_1101-2021_01_07_425675	153	13	3	3	CD
10_1101-2021_01_07_425675	153	14	’	'	''
10_1101-2021_01_07_425675	153	15	ends	end	NNS
10_1101-2021_01_07_425675	153	16	of	of	IN
10_1101-2021_01_07_425675	153	17	the	the	DT
10_1101-2021_01_07_425675	153	18	coding	code	VBG
10_1101-2021_01_07_425675	153	19	298	298	CD
10_1101-2021_01_07_425675	153	20	regions	region	NNS
10_1101-2021_01_07_425675	153	21	,	,	,
10_1101-2021_01_07_425675	153	22	respectively	respectively	RB
10_1101-2021_01_07_425675	153	23	.	.	.
10_1101-2021_01_07_425675	154	1	Only	only	RB
10_1101-2021_01_07_425675	154	2	for	for	IN
10_1101-2021_01_07_425675	154	3	the	the	DT
10_1101-2021_01_07_425675	154	4	light	light	JJ
10_1101-2021_01_07_425675	154	5	chain	chain	NN
10_1101-2021_01_07_425675	154	6	,	,	,
10_1101-2021_01_07_425675	154	7	a	a	DT
10_1101-2021_01_07_425675	154	8	double	double	JJ
10_1101-2021_01_07_425675	154	9	stop	stop	NN
10_1101-2021_01_07_425675	154	10	codon	codon	NN
10_1101-2021_01_07_425675	154	11	was	be	VBD
10_1101-2021_01_07_425675	154	12	introduced	introduce	VBN
10_1101-2021_01_07_425675	154	13	at	at	IN
10_1101-2021_01_07_425675	154	14	the	the	DT
10_1101-2021_01_07_425675	154	15	3	3	CD
10_1101-2021_01_07_425675	154	16	’	'	''
10_1101-2021_01_07_425675	154	17	site	site	NN
10_1101-2021_01_07_425675	154	18	299	299	CD
10_1101-2021_01_07_425675	154	19	before	before	IN
10_1101-2021_01_07_425675	154	20	the	the	DT
10_1101-2021_01_07_425675	154	21	NotI	NotI	NNP
10_1101-2021_01_07_425675	154	22	restriction	restriction	NN
10_1101-2021_01_07_425675	154	23	site	site	NN
10_1101-2021_01_07_425675	154	24	.	.	.
10_1101-2021_01_07_425675	155	1	The	the	DT
10_1101-2021_01_07_425675	155	2	coding	code	VBG
10_1101-2021_01_07_425675	155	3	regions	region	NNS
10_1101-2021_01_07_425675	155	4	were	be	VBD
10_1101-2021_01_07_425675	155	5	subcloned	subclone	VBN
10_1101-2021_01_07_425675	155	6	using	use	VBG
10_1101-2021_01_07_425675	155	7	BamHI	BamHI	NNP
10_1101-2021_01_07_425675	155	8	and	and	CC
10_1101-2021_01_07_425675	155	9	NotI	NotI	NNP
10_1101-2021_01_07_425675	155	10	300	300	CD
10_1101-2021_01_07_425675	155	11	restriction	restriction	NN
10_1101-2021_01_07_425675	155	12	-	-	HYPH
10_1101-2021_01_07_425675	155	13	ligation	ligation	NN
10_1101-2021_01_07_425675	155	14	into	into	IN
10_1101-2021_01_07_425675	155	15	a	a	DT
10_1101-2021_01_07_425675	155	16	pRK5	pRK5	NNP
10_1101-2021_01_07_425675	155	17	expression	expression	NN
10_1101-2021_01_07_425675	155	18	vector	vector	NN
10_1101-2021_01_07_425675	155	19	with	with	IN
10_1101-2021_01_07_425675	155	20	a	a	DT
10_1101-2021_01_07_425675	155	21	C	c	NN
10_1101-2021_01_07_425675	155	22	-	-	HYPH
10_1101-2021_01_07_425675	155	23	terminal	terminal	JJ
10_1101-2021_01_07_425675	155	24	octahistidine	octahistidine	NN
10_1101-2021_01_07_425675	155	25	tag	tag	NN
10_1101-2021_01_07_425675	155	26	between	between	IN
10_1101-2021_01_07_425675	155	27	the	the	DT
10_1101-2021_01_07_425675	155	28	301	301	CD
10_1101-2021_01_07_425675	155	29	NotI	NotI	NNP
10_1101-2021_01_07_425675	155	30	site	site	NN
10_1101-2021_01_07_425675	155	31	and	and	CC
10_1101-2021_01_07_425675	155	32	a	a	DT
10_1101-2021_01_07_425675	155	33	double	double	JJ
10_1101-2021_01_07_425675	155	34	stop	stop	NN
10_1101-2021_01_07_425675	155	35	codon	codon	NNP
10_1101-2021_01_07_425675	155	36	3	3	CD
10_1101-2021_01_07_425675	155	37	’	'	''
10_1101-2021_01_07_425675	155	38	of	of	IN
10_1101-2021_01_07_425675	155	39	the	the	DT
10_1101-2021_01_07_425675	155	40	insert	insert	NN
10_1101-2021_01_07_425675	155	41	,	,	,
10_1101-2021_01_07_425675	155	42	so	so	IN
10_1101-2021_01_07_425675	155	43	that	that	IN
10_1101-2021_01_07_425675	155	44	only	only	RB
10_1101-2021_01_07_425675	155	45	the	the	DT
10_1101-2021_01_07_425675	155	46	heavy	heavy	JJ
10_1101-2021_01_07_425675	155	47	chain	chain	NN
10_1101-2021_01_07_425675	155	48	has	have	VBZ
10_1101-2021_01_07_425675	155	49	a	a	DT
10_1101-2021_01_07_425675	155	50	C	C	NNP
10_1101-2021_01_07_425675	155	51	-	-	HYPH
10_1101-2021_01_07_425675	155	52	terminal	terminal	JJ
10_1101-2021_01_07_425675	155	53	302	302	CD
10_1101-2021_01_07_425675	155	54	AAAHHHHHHHH	AAAHHHHHHHH	NNP
10_1101-2021_01_07_425675	155	55	sequence	sequence	NN
10_1101-2021_01_07_425675	155	56	for	for	IN
10_1101-2021_01_07_425675	155	57	Nickel	nickel	NN
10_1101-2021_01_07_425675	155	58	-	-	HYPH
10_1101-2021_01_07_425675	155	59	affinity	affinity	NN
10_1101-2021_01_07_425675	155	60	purification	purification	NN
10_1101-2021_01_07_425675	155	61	(	(	-LRB-
10_1101-2021_01_07_425675	155	62	the	the	DT
10_1101-2021_01_07_425675	155	63	triple	triple	JJ
10_1101-2021_01_07_425675	155	64	alanine	alanine	NN
10_1101-2021_01_07_425675	155	65	resulting	result	VBG
10_1101-2021_01_07_425675	155	66	from	from	IN
10_1101-2021_01_07_425675	155	67	the	the	DT
10_1101-2021_01_07_425675	155	68	NotI	NotI	NNP
10_1101-2021_01_07_425675	155	69	303	303	CD
10_1101-2021_01_07_425675	155	70	site	site	NN
10_1101-2021_01_07_425675	155	71	)	)	-RRB-
10_1101-2021_01_07_425675	155	72	.	.	.
10_1101-2021_01_07_425675	156	1	The	the	DT
10_1101-2021_01_07_425675	156	2	L51I	l51i	JJ
10_1101-2021_01_07_425675	156	3	correction	correction	NN
10_1101-2021_01_07_425675	156	4	in	in	IN
10_1101-2021_01_07_425675	156	5	the	the	DT
10_1101-2021_01_07_425675	156	6	heavy	heavy	JJ
10_1101-2021_01_07_425675	156	7	chain	chain	NN
10_1101-2021_01_07_425675	156	8	was	be	VBD
10_1101-2021_01_07_425675	156	9	introduced	introduce	VBN
10_1101-2021_01_07_425675	156	10	later	later	RB
10_1101-2021_01_07_425675	156	11	(	(	-LRB-
10_1101-2021_01_07_425675	156	12	after	after	IN
10_1101-2021_01_07_425675	156	13	observing	observe	VBG
10_1101-2021_01_07_425675	156	14	it	-PRON-	PRP
10_1101-2021_01_07_425675	156	15	in	in	IN
10_1101-2021_01_07_425675	156	16	the	the	DT
10_1101-2021_01_07_425675	156	17	crystal	crystal	NN
10_1101-2021_01_07_425675	156	18	304	304	CD
10_1101-2021_01_07_425675	156	19	structure	structure	NN
10_1101-2021_01_07_425675	156	20	)	)	-RRB-
10_1101-2021_01_07_425675	156	21	by	by	IN
10_1101-2021_01_07_425675	156	22	IVA	IVA	NNP
10_1101-2021_01_07_425675	156	23	cloning	clone	VBG
10_1101-2021_01_07_425675	156	24	44	44	CD
10_1101-2021_01_07_425675	156	25	.	.	.
10_1101-2021_01_07_425675	157	1	Expression	expression	NN
10_1101-2021_01_07_425675	157	2	plasmids	plasmid	NNS
10_1101-2021_01_07_425675	157	3	for	for	IN
10_1101-2021_01_07_425675	157	4	the	the	DT
10_1101-2021_01_07_425675	157	5	heavy	heavy	JJ
10_1101-2021_01_07_425675	157	6	and	and	CC
10_1101-2021_01_07_425675	157	7	light	light	JJ
10_1101-2021_01_07_425675	157	8	chain	chain	NN
10_1101-2021_01_07_425675	157	9	were	be	VBD
10_1101-2021_01_07_425675	157	10	mixed	mix	VBN
10_1101-2021_01_07_425675	157	11	in	in	IN
10_1101-2021_01_07_425675	157	12	a	a	DT
10_1101-2021_01_07_425675	157	13	305	305	CD
10_1101-2021_01_07_425675	157	14	1:1	1:1	NNS
10_1101-2021_01_07_425675	157	15	(	(	-LRB-
10_1101-2021_01_07_425675	157	16	w	w	NNP
10_1101-2021_01_07_425675	157	17	/	/	SYM
10_1101-2021_01_07_425675	157	18	w	w	NNP
10_1101-2021_01_07_425675	157	19	)	)	-RRB-
10_1101-2021_01_07_425675	157	20	ratio	ratio	NN
10_1101-2021_01_07_425675	157	21	for	for	IN
10_1101-2021_01_07_425675	157	22	transient	transient	JJ
10_1101-2021_01_07_425675	157	23	transfection	transfection	NN
10_1101-2021_01_07_425675	157	24	in	in	IN
10_1101-2021_01_07_425675	157	25	HEK293	HEK293	NNP
10_1101-2021_01_07_425675	157	26	cells	cell	NNS
10_1101-2021_01_07_425675	157	27	with	with	IN
10_1101-2021_01_07_425675	157	28	polyethylenimine	polyethylenimine	NN
10_1101-2021_01_07_425675	157	29	,	,	,
10_1101-2021_01_07_425675	157	30	following	follow	VBG
10_1101-2021_01_07_425675	157	31	standard	standard	JJ
10_1101-2021_01_07_425675	157	32	306	306	CD
10_1101-2021_01_07_425675	157	33	procedures	procedure	NNS
10_1101-2021_01_07_425675	157	34	.	.	.
10_1101-2021_01_07_425675	158	1	Medium	Medium	NNP
10_1101-2021_01_07_425675	158	2	was	be	VBD
10_1101-2021_01_07_425675	158	3	collected	collect	VBN
10_1101-2021_01_07_425675	158	4	6	6	CD
10_1101-2021_01_07_425675	158	5	days	day	NNS
10_1101-2021_01_07_425675	158	6	after	after	IN
10_1101-2021_01_07_425675	158	7	transfection	transfection	NN
10_1101-2021_01_07_425675	158	8	and	and	CC
10_1101-2021_01_07_425675	158	9	cells	cell	NNS
10_1101-2021_01_07_425675	158	10	were	be	VBD
10_1101-2021_01_07_425675	158	11	spun	spin	VBN
10_1101-2021_01_07_425675	158	12	down	down	RP
10_1101-2021_01_07_425675	158	13	by	by	IN
10_1101-2021_01_07_425675	158	14	307	307	CD
10_1101-2021_01_07_425675	158	15	10	10	CD
10_1101-2021_01_07_425675	158	16	 	 	_SP
10_1101-2021_01_07_425675	158	17	minutes	minute	NNS
10_1101-2021_01_07_425675	158	18	of	of	IN
10_1101-2021_01_07_425675	158	19	centrifugation	centrifugation	NN
10_1101-2021_01_07_425675	158	20	at	at	IN
10_1101-2021_01_07_425675	158	21	1000	1000	CD
10_1101-2021_01_07_425675	158	22	 	 	_SP
10_1101-2021_01_07_425675	158	23	g.	g.	NNP
10_1101-2021_01_07_425675	158	24	Antibody	Antibody	NNP
10_1101-2021_01_07_425675	158	25	was	be	VBD
10_1101-2021_01_07_425675	158	26	directly	directly	RB
10_1101-2021_01_07_425675	158	27	purified	purify	VBN
10_1101-2021_01_07_425675	158	28	from	from	IN
10_1101-2021_01_07_425675	158	29	the	the	DT
10_1101-2021_01_07_425675	158	30	supernatant	supernatant	JJ
10_1101-2021_01_07_425675	158	31	using	use	VBG
10_1101-2021_01_07_425675	158	32	308	308	CD
10_1101-2021_01_07_425675	158	33	Ni	Ni	NNP
10_1101-2021_01_07_425675	158	34	-	-	HYPH
10_1101-2021_01_07_425675	158	35	sepharose	sepharose	JJ
10_1101-2021_01_07_425675	158	36	excel	excel	NNP
10_1101-2021_01_07_425675	158	37	resin	resin	NN
10_1101-2021_01_07_425675	158	38	(	(	-LRB-
10_1101-2021_01_07_425675	158	39	Cytiva	Cytiva	NNP
10_1101-2021_01_07_425675	158	40	Lifes	Lifes	NNP
10_1101-2021_01_07_425675	158	41	Sciences	Sciences	NNPS
10_1101-2021_01_07_425675	158	42	)	)	-RRB-
10_1101-2021_01_07_425675	158	43	,	,	,
10_1101-2021_01_07_425675	158	44	washing	wash	VBG
10_1101-2021_01_07_425675	158	45	with	with	IN
10_1101-2021_01_07_425675	158	46	500	500	CD
10_1101-2021_01_07_425675	158	47	mM	mM	NNP
10_1101-2021_01_07_425675	158	48	NaCl	NaCl	NNP
10_1101-2021_01_07_425675	158	49	,	,	,
10_1101-2021_01_07_425675	158	50	2	2	CD
10_1101-2021_01_07_425675	158	51	mM	mm	NN
10_1101-2021_01_07_425675	158	52	CaCl2	cacl2	NN
10_1101-2021_01_07_425675	158	53	,	,	,
10_1101-2021_01_07_425675	158	54	15	15	CD
10_1101-2021_01_07_425675	158	55	309	309	CD
10_1101-2021_01_07_425675	158	56	.CC	.CC	:
10_1101-2021_01_07_425675	158	57	-	-	:
10_1101-2021_01_07_425675	158	58	BY	by	IN
10_1101-2021_01_07_425675	158	59	4.0	4.0	CD
10_1101-2021_01_07_425675	158	60	International	International	NNP
10_1101-2021_01_07_425675	158	61	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	158	62	under	under	IN
10_1101-2021_01_07_425675	158	63	a	a	DT
10_1101-2021_01_07_425675	158	64	(	(	-LRB-
10_1101-2021_01_07_425675	158	65	which	which	WDT
10_1101-2021_01_07_425675	158	66	was	be	VBD
10_1101-2021_01_07_425675	158	67	not	not	RB
10_1101-2021_01_07_425675	158	68	certified	certify	VBN
10_1101-2021_01_07_425675	158	69	by	by	IN
10_1101-2021_01_07_425675	158	70	peer	peer	NN
10_1101-2021_01_07_425675	158	71	review	review	NN
10_1101-2021_01_07_425675	158	72	)	)	-RRB-
10_1101-2021_01_07_425675	158	73	is	be	VBZ
10_1101-2021_01_07_425675	158	74	the	the	DT
10_1101-2021_01_07_425675	158	75	author	author	NN
10_1101-2021_01_07_425675	158	76	/	/	SYM
10_1101-2021_01_07_425675	158	77	funder	funder	NN
10_1101-2021_01_07_425675	158	78	,	,	,
10_1101-2021_01_07_425675	158	79	who	who	WP
10_1101-2021_01_07_425675	158	80	has	have	VBZ
10_1101-2021_01_07_425675	158	81	granted	grant	VBN
10_1101-2021_01_07_425675	158	82	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	158	83	a	a	DT
10_1101-2021_01_07_425675	158	84	license	license	NN
10_1101-2021_01_07_425675	158	85	to	to	TO
10_1101-2021_01_07_425675	158	86	display	display	VB
10_1101-2021_01_07_425675	158	87	the	the	DT
10_1101-2021_01_07_425675	158	88	preprint	preprint	NN
10_1101-2021_01_07_425675	158	89	in	in	IN
10_1101-2021_01_07_425675	158	90	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	158	91	.	.	.
10_1101-2021_01_07_425675	159	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	159	2	is	be	VBZ
10_1101-2021_01_07_425675	159	3	made	make	VBN
10_1101-2021_01_07_425675	159	4	The	the	DT
10_1101-2021_01_07_425675	159	5	copyright	copyright	NN
10_1101-2021_01_07_425675	159	6	holder	holder	NN
10_1101-2021_01_07_425675	159	7	for	for	IN
10_1101-2021_01_07_425675	159	8	this	this	DT
10_1101-2021_01_07_425675	159	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	159	10	version	version	NN
10_1101-2021_01_07_425675	159	11	posted	post	VBD
10_1101-2021_01_07_425675	159	12	January	January	NNP
10_1101-2021_01_07_425675	159	13	8	8	CD
10_1101-2021_01_07_425675	159	14	,	,	,
10_1101-2021_01_07_425675	159	15	2021	2021	CD
10_1101-2021_01_07_425675	159	16	.	.	.
10_1101-2021_01_07_425675	159	17	;	;	:
10_1101-2021_01_07_425675	159	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	159	19	:	:	:
10_1101-2021_01_07_425675	159	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	159	21	preprint	preprint	NN
10_1101-2021_01_07_425675	159	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NNP
10_1101-2021_01_07_425675	159	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	NNP
10_1101-2021_01_07_425675	159	24	13	13	CD
10_1101-2021_01_07_425675	159	25	mM	mM	NNP
10_1101-2021_01_07_425675	159	26	imidazole	imidazole	NN
10_1101-2021_01_07_425675	159	27	,	,	,
10_1101-2021_01_07_425675	159	28	20	20	CD
10_1101-2021_01_07_425675	159	29	mM	mm	NN
10_1101-2021_01_07_425675	159	30	HEPES	hepe	NNS
10_1101-2021_01_07_425675	159	31	pH	ph	NN
10_1101-2021_01_07_425675	159	32	7.8	7.8	CD
10_1101-2021_01_07_425675	159	33	and	and	CC
10_1101-2021_01_07_425675	159	34	eluting	elute	VBG
10_1101-2021_01_07_425675	159	35	with	with	IN
10_1101-2021_01_07_425675	159	36	500	500	CD
10_1101-2021_01_07_425675	159	37	mM	mM	NNP
10_1101-2021_01_07_425675	159	38	NaCl	NaCl	NNP
10_1101-2021_01_07_425675	159	39	,	,	,
10_1101-2021_01_07_425675	159	40	2	2	CD
10_1101-2021_01_07_425675	159	41	mM	mm	NN
10_1101-2021_01_07_425675	159	42	CaCl2	cacl2	NN
10_1101-2021_01_07_425675	159	43	,	,	,
10_1101-2021_01_07_425675	159	44	200	200	CD
10_1101-2021_01_07_425675	159	45	mM	mM	NNP
10_1101-2021_01_07_425675	159	46	310	310	CD
10_1101-2021_01_07_425675	159	47	imidazole	imidazole	NN
10_1101-2021_01_07_425675	159	48	,	,	,
10_1101-2021_01_07_425675	159	49	20	20	CD
10_1101-2021_01_07_425675	159	50	mM	mm	NN
10_1101-2021_01_07_425675	159	51	HEPES	hepe	NNS
10_1101-2021_01_07_425675	159	52	pH	pH	NNP
10_1101-2021_01_07_425675	159	53	7.8	7.8	CD
10_1101-2021_01_07_425675	159	54	.	.	.
10_1101-2021_01_07_425675	160	1	311	311	CD
10_1101-2021_01_07_425675	160	2	312	312	CD
10_1101-2021_01_07_425675	160	3	Western	western	JJ
10_1101-2021_01_07_425675	160	4	blot	blot	NN
10_1101-2021_01_07_425675	160	5	validation	validation	NN
10_1101-2021_01_07_425675	160	6	of	of	IN
10_1101-2021_01_07_425675	160	7	anti	anti	JJ
10_1101-2021_01_07_425675	160	8	-	-	JJ
10_1101-2021_01_07_425675	160	9	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	160	10	-	-	HYPH
10_1101-2021_01_07_425675	160	11	M2	M2	NNP
10_1101-2021_01_07_425675	160	12	binding	bind	VBG
10_1101-2021_01_07_425675	160	13	313	313	CD
10_1101-2021_01_07_425675	160	14	To	to	TO
10_1101-2021_01_07_425675	160	15	test	test	VB
10_1101-2021_01_07_425675	160	16	binding	bind	VBG
10_1101-2021_01_07_425675	160	17	of	of	IN
10_1101-2021_01_07_425675	160	18	our	-PRON-	PRP$
10_1101-2021_01_07_425675	160	19	recombinant	recombinant	JJ
10_1101-2021_01_07_425675	160	20	anti	anti	JJ
10_1101-2021_01_07_425675	160	21	-	-	JJ
10_1101-2021_01_07_425675	160	22	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	160	23	-	-	HYPH
10_1101-2021_01_07_425675	160	24	M2	m2	NN
10_1101-2021_01_07_425675	160	25	to	to	IN
10_1101-2021_01_07_425675	160	26	the	the	DT
10_1101-2021_01_07_425675	160	27	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	160	28	-	-	HYPH
10_1101-2021_01_07_425675	160	29	tag	tag	NN
10_1101-2021_01_07_425675	160	30	epitope	epitope	NN
10_1101-2021_01_07_425675	160	31	,	,	,
10_1101-2021_01_07_425675	160	32	compared	compare	VBN
10_1101-2021_01_07_425675	160	33	to	to	IN
10_1101-2021_01_07_425675	160	34	the	the	DT
10_1101-2021_01_07_425675	160	35	314	314	CD
10_1101-2021_01_07_425675	160	36	commercially	commercially	RB
10_1101-2021_01_07_425675	160	37	available	available	JJ
10_1101-2021_01_07_425675	160	38	anti	anti	JJ
10_1101-2021_01_07_425675	160	39	-	-	JJ
10_1101-2021_01_07_425675	160	40	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	160	41	-	-	HYPH
10_1101-2021_01_07_425675	160	42	M2	M2	NNP
10_1101-2021_01_07_425675	160	43	(	(	-LRB-
10_1101-2021_01_07_425675	160	44	Sigma	Sigma	NNP
10_1101-2021_01_07_425675	160	45	)	)	-RRB-
10_1101-2021_01_07_425675	160	46	,	,	,
10_1101-2021_01_07_425675	160	47	we	-PRON-	PRP
10_1101-2021_01_07_425675	160	48	used	use	VBD
10_1101-2021_01_07_425675	160	49	both	both	DT
10_1101-2021_01_07_425675	160	50	antibodies	antibody	NNS
10_1101-2021_01_07_425675	160	51	to	to	TO
10_1101-2021_01_07_425675	160	52	probe	probe	VB
10_1101-2021_01_07_425675	160	53	Western	western	JJ
10_1101-2021_01_07_425675	160	54	blots	blot	NNS
10_1101-2021_01_07_425675	160	55	315	315	CD
10_1101-2021_01_07_425675	160	56	of	of	IN
10_1101-2021_01_07_425675	160	57	a	a	DT
10_1101-2021_01_07_425675	160	58	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	160	59	-	-	HYPH
10_1101-2021_01_07_425675	160	60	tagged	tag	VBN
10_1101-2021_01_07_425675	160	61	protein	protein	NN
10_1101-2021_01_07_425675	160	62	in	in	IN
10_1101-2021_01_07_425675	160	63	parallel	parallel	NN
10_1101-2021_01_07_425675	160	64	.	.	.
10_1101-2021_01_07_425675	161	1	Purified	Purified	NNP
10_1101-2021_01_07_425675	161	2	Rabies	Rabies	NNPS
10_1101-2021_01_07_425675	161	3	virus	virus	NN
10_1101-2021_01_07_425675	161	4	glycoprotein	glycoprotein	NN
10_1101-2021_01_07_425675	161	5	ectodomain	ectodomain	NN
10_1101-2021_01_07_425675	161	6	(	(	-LRB-
10_1101-2021_01_07_425675	161	7	SAD	SAD	NNP
10_1101-2021_01_07_425675	161	8	B19	B19	NNP
10_1101-2021_01_07_425675	161	9	316	316	CD
10_1101-2021_01_07_425675	161	10	strain	strain	NN
10_1101-2021_01_07_425675	161	11	,	,	,
10_1101-2021_01_07_425675	161	12	UNIPROT	UNIPROT	NNP
10_1101-2021_01_07_425675	161	13	residues	residue	VBZ
10_1101-2021_01_07_425675	161	14	20	20	CD
10_1101-2021_01_07_425675	161	15	-	-	SYM
10_1101-2021_01_07_425675	161	16	450	450	CD
10_1101-2021_01_07_425675	161	17	)	)	-RRB-
10_1101-2021_01_07_425675	161	18	with	with	IN
10_1101-2021_01_07_425675	161	19	or	or	CC
10_1101-2021_01_07_425675	161	20	without	without	IN
10_1101-2021_01_07_425675	161	21	a	a	DT
10_1101-2021_01_07_425675	161	22	C	c	NN
10_1101-2021_01_07_425675	161	23	-	-	HYPH
10_1101-2021_01_07_425675	161	24	terminal	terminal	JJ
10_1101-2021_01_07_425675	161	25	FLAG	flag	NN
10_1101-2021_01_07_425675	161	26	-	-	HYPH
10_1101-2021_01_07_425675	161	27	tag	tag	NN
10_1101-2021_01_07_425675	161	28	followed	follow	VBN
10_1101-2021_01_07_425675	161	29	by	by	IN
10_1101-2021_01_07_425675	161	30	a	a	DT
10_1101-2021_01_07_425675	161	31	foldon	foldon	JJ
10_1101-2021_01_07_425675	161	32	317	317	CD
10_1101-2021_01_07_425675	161	33	trimerization	trimerization	NN
10_1101-2021_01_07_425675	161	34	domain	domain	NN
10_1101-2021_01_07_425675	161	35	and	and	CC
10_1101-2021_01_07_425675	161	36	an	an	DT
10_1101-2021_01_07_425675	161	37	octahistidine	octahistidine	NN
10_1101-2021_01_07_425675	161	38	tag	tag	NN
10_1101-2021_01_07_425675	161	39	was	be	VBD
10_1101-2021_01_07_425675	161	40	heated	heat	VBN
10_1101-2021_01_07_425675	161	41	to	to	IN
10_1101-2021_01_07_425675	161	42	95	95	CD
10_1101-2021_01_07_425675	161	43	°	°	,
10_1101-2021_01_07_425675	161	44	C	C	NNP
10_1101-2021_01_07_425675	161	45	in	in	IN
10_1101-2021_01_07_425675	161	46	XT	XT	NNP
10_1101-2021_01_07_425675	161	47	sample	sample	NN
10_1101-2021_01_07_425675	161	48	buffer	buffer	NN
10_1101-2021_01_07_425675	161	49	(	(	-LRB-
10_1101-2021_01_07_425675	161	50	Biorad	Biorad	NNP
10_1101-2021_01_07_425675	161	51	)	)	-RRB-
10_1101-2021_01_07_425675	161	52	318	318	CD
10_1101-2021_01_07_425675	161	53	for	for	IN
10_1101-2021_01_07_425675	161	54	5	5	CD
10_1101-2021_01_07_425675	161	55	minutes	minute	NNS
10_1101-2021_01_07_425675	161	56	.	.	.
10_1101-2021_01_07_425675	162	1	Samples	sample	NNS
10_1101-2021_01_07_425675	162	2	were	be	VBD
10_1101-2021_01_07_425675	162	3	run	run	VBN
10_1101-2021_01_07_425675	162	4	twice	twice	RB
10_1101-2021_01_07_425675	162	5	on	on	IN
10_1101-2021_01_07_425675	162	6	a	a	DT
10_1101-2021_01_07_425675	162	7	Criterion	Criterion	NNP
10_1101-2021_01_07_425675	162	8	XT	XT	NNP
10_1101-2021_01_07_425675	162	9	4	4	CD
10_1101-2021_01_07_425675	162	10	-	-	SYM
10_1101-2021_01_07_425675	162	11	12	12	CD
10_1101-2021_01_07_425675	162	12	%	%	NN
10_1101-2021_01_07_425675	162	13	polyacrylamide	polyacrylamide	NN
10_1101-2021_01_07_425675	162	14	gel	gel	NN
10_1101-2021_01_07_425675	162	15	(	(	-LRB-
10_1101-2021_01_07_425675	162	16	Biorad	Biorad	NNP
10_1101-2021_01_07_425675	162	17	)	)	-RRB-
10_1101-2021_01_07_425675	162	18	in	in	IN
10_1101-2021_01_07_425675	162	19	319	319	CD
10_1101-2021_01_07_425675	162	20	MES	MES	NNP
10_1101-2021_01_07_425675	162	21	XT	XT	NNP
10_1101-2021_01_07_425675	162	22	buffer	buffer	NN
10_1101-2021_01_07_425675	162	23	(	(	-LRB-
10_1101-2021_01_07_425675	162	24	Biorad	Biorad	NNP
10_1101-2021_01_07_425675	162	25	)	)	-RRB-
10_1101-2021_01_07_425675	162	26	before	before	IN
10_1101-2021_01_07_425675	162	27	Western	western	JJ
10_1101-2021_01_07_425675	162	28	blot	blot	NN
10_1101-2021_01_07_425675	162	29	transfer	transfer	VBP
10_1101-2021_01_07_425675	162	30	to	to	IN
10_1101-2021_01_07_425675	162	31	a	a	DT
10_1101-2021_01_07_425675	162	32	nitrocellulose	nitrocellulose	NN
10_1101-2021_01_07_425675	162	33	membrane	membrane	NN
10_1101-2021_01_07_425675	162	34	in	in	IN
10_1101-2021_01_07_425675	162	35	tris	tris	NNP
10_1101-2021_01_07_425675	162	36	-	-	HYPH
10_1101-2021_01_07_425675	162	37	glycine	glycine	NNP
10_1101-2021_01_07_425675	162	38	320	320	CD
10_1101-2021_01_07_425675	162	39	buffer	buffer	NN
10_1101-2021_01_07_425675	162	40	(	(	-LRB-
10_1101-2021_01_07_425675	162	41	Biorad	Biorad	NNP
10_1101-2021_01_07_425675	162	42	)	)	-RRB-
10_1101-2021_01_07_425675	162	43	with	with	IN
10_1101-2021_01_07_425675	162	44	20	20	CD
10_1101-2021_01_07_425675	162	45	%	%	NN
10_1101-2021_01_07_425675	162	46	methanol	methanol	NN
10_1101-2021_01_07_425675	162	47	.	.	.
10_1101-2021_01_07_425675	163	1	The	the	DT
10_1101-2021_01_07_425675	163	2	membrane	membrane	NN
10_1101-2021_01_07_425675	163	3	was	be	VBD
10_1101-2021_01_07_425675	163	4	blocked	block	VBN
10_1101-2021_01_07_425675	163	5	with	with	IN
10_1101-2021_01_07_425675	163	6	5	5	CD
10_1101-2021_01_07_425675	163	7	%	%	NN
10_1101-2021_01_07_425675	163	8	(	(	-LRB-
10_1101-2021_01_07_425675	163	9	w	w	NNP
10_1101-2021_01_07_425675	163	10	/	/	SYM
10_1101-2021_01_07_425675	163	11	v	v	NNP
10_1101-2021_01_07_425675	163	12	)	)	-RRB-
10_1101-2021_01_07_425675	163	13	dry	dry	JJ
10_1101-2021_01_07_425675	163	14	non	non	JJ
10_1101-2021_01_07_425675	163	15	-	-	JJ
10_1101-2021_01_07_425675	163	16	fat	fat	JJ
10_1101-2021_01_07_425675	163	17	milk	milk	NN
10_1101-2021_01_07_425675	163	18	in	in	IN
10_1101-2021_01_07_425675	163	19	321	321	CD
10_1101-2021_01_07_425675	163	20	phosphate	phosphate	RB
10_1101-2021_01_07_425675	163	21	-	-	HYPH
10_1101-2021_01_07_425675	163	22	buffered	buffer	VBN
10_1101-2021_01_07_425675	163	23	saline	saline	NN
10_1101-2021_01_07_425675	163	24	(	(	-LRB-
10_1101-2021_01_07_425675	163	25	PBS	PBS	NNP
10_1101-2021_01_07_425675	163	26	)	)	-RRB-
10_1101-2021_01_07_425675	163	27	overnight	overnight	RB
10_1101-2021_01_07_425675	163	28	at	at	IN
10_1101-2021_01_07_425675	163	29	4	4	CD
10_1101-2021_01_07_425675	163	30	°	°	NNS
10_1101-2021_01_07_425675	163	31	C	C	NNP
10_1101-2021_01_07_425675	163	32	.	.	.
10_1101-2021_01_07_425675	164	1	The	the	DT
10_1101-2021_01_07_425675	164	2	membrane	membrane	NN
10_1101-2021_01_07_425675	164	3	was	be	VBD
10_1101-2021_01_07_425675	164	4	cut	cut	VBN
10_1101-2021_01_07_425675	164	5	in	in	IN
10_1101-2021_01_07_425675	164	6	two	two	CD
10_1101-2021_01_07_425675	164	7	(	(	-LRB-
10_1101-2021_01_07_425675	164	8	one	one	CD
10_1101-2021_01_07_425675	164	9	half	half	NN
10_1101-2021_01_07_425675	164	10	for	for	IN
10_1101-2021_01_07_425675	164	11	322	322	CD
10_1101-2021_01_07_425675	164	12	the	the	DT
10_1101-2021_01_07_425675	164	13	commercial	commercial	NN
10_1101-2021_01_07_425675	164	14	and	and	CC
10_1101-2021_01_07_425675	164	15	one	one	CD
10_1101-2021_01_07_425675	164	16	half	half	NN
10_1101-2021_01_07_425675	164	17	for	for	IN
10_1101-2021_01_07_425675	164	18	the	the	DT
10_1101-2021_01_07_425675	164	19	recombinant	recombinant	JJ
10_1101-2021_01_07_425675	164	20	anti	anti	JJ
10_1101-2021_01_07_425675	164	21	-	-	JJ
10_1101-2021_01_07_425675	164	22	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	164	23	-	-	HYPH
10_1101-2021_01_07_425675	164	24	M2	m2	NN
10_1101-2021_01_07_425675	164	25	)	)	-RRB-
10_1101-2021_01_07_425675	164	26	and	and	CC
10_1101-2021_01_07_425675	164	27	each	each	DT
10_1101-2021_01_07_425675	164	28	half	half	NN
10_1101-2021_01_07_425675	164	29	was	be	VBD
10_1101-2021_01_07_425675	164	30	probed	probe	VBN
10_1101-2021_01_07_425675	164	31	with	with	IN
10_1101-2021_01_07_425675	164	32	323	323	CD
10_1101-2021_01_07_425675	164	33	either	either	CC
10_1101-2021_01_07_425675	164	34	commercial	commercial	NN
10_1101-2021_01_07_425675	164	35	(	(	-LRB-
10_1101-2021_01_07_425675	164	36	Sigma	Sigma	NNP
10_1101-2021_01_07_425675	164	37	)	)	-RRB-
10_1101-2021_01_07_425675	164	38	or	or	CC
10_1101-2021_01_07_425675	164	39	recombinant	recombinant	VB
10_1101-2021_01_07_425675	164	40	anti	anti	JJ
10_1101-2021_01_07_425675	164	41	-	-	JJ
10_1101-2021_01_07_425675	164	42	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	164	43	-	-	HYPH
10_1101-2021_01_07_425675	164	44	M2	M2	NNP
10_1101-2021_01_07_425675	164	45	at	at	IN
10_1101-2021_01_07_425675	164	46	1	1	CD
10_1101-2021_01_07_425675	164	47	µg	µg	NN
10_1101-2021_01_07_425675	164	48	/	/	SYM
10_1101-2021_01_07_425675	164	49	mL	mL	NNP
10_1101-2021_01_07_425675	164	50	in	in	IN
10_1101-2021_01_07_425675	164	51	PBS	PBS	NNP
10_1101-2021_01_07_425675	164	52	for	for	IN
10_1101-2021_01_07_425675	164	53	45	45	CD
10_1101-2021_01_07_425675	164	54	minutes	minute	NNS
10_1101-2021_01_07_425675	164	55	.	.	.
10_1101-2021_01_07_425675	165	1	After	after	IN
10_1101-2021_01_07_425675	165	2	324	324	CD
10_1101-2021_01_07_425675	165	3	washing	wash	VBG
10_1101-2021_01_07_425675	165	4	three	three	CD
10_1101-2021_01_07_425675	165	5	times	time	NNS
10_1101-2021_01_07_425675	165	6	with	with	IN
10_1101-2021_01_07_425675	165	7	PBST	PBST	NNP
10_1101-2021_01_07_425675	165	8	(	(	-LRB-
10_1101-2021_01_07_425675	165	9	PBS	PBS	NNP
10_1101-2021_01_07_425675	165	10	with	with	IN
10_1101-2021_01_07_425675	165	11	0.1	0.1	CD
10_1101-2021_01_07_425675	165	12	%	%	NN
10_1101-2021_01_07_425675	165	13	v	v	NN
10_1101-2021_01_07_425675	165	14	/	/	SYM
10_1101-2021_01_07_425675	165	15	v	v	NN
10_1101-2021_01_07_425675	165	16	Tween20	Tween20	NNP
10_1101-2021_01_07_425675	165	17	)	)	-RRB-
10_1101-2021_01_07_425675	165	18	,	,	,
10_1101-2021_01_07_425675	165	19	polyclonal	polyclonal	JJ
10_1101-2021_01_07_425675	165	20	goat	goat	NNP
10_1101-2021_01_07_425675	165	21	anti	anti	JJ
10_1101-2021_01_07_425675	165	22	-	-	JJ
10_1101-2021_01_07_425675	165	23	mouse	mouse	NN
10_1101-2021_01_07_425675	165	24	fused	fuse	VBD
10_1101-2021_01_07_425675	165	25	325	325	CD
10_1101-2021_01_07_425675	165	26	to	to	TO
10_1101-2021_01_07_425675	165	27	horseradish	horseradish	VB
10_1101-2021_01_07_425675	165	28	peroxidase	peroxidase	NN
10_1101-2021_01_07_425675	165	29	(	(	-LRB-
10_1101-2021_01_07_425675	165	30	HRP	HRP	NNP
10_1101-2021_01_07_425675	165	31	)	)	-RRB-
10_1101-2021_01_07_425675	165	32	was	be	VBD
10_1101-2021_01_07_425675	165	33	used	use	VBN
10_1101-2021_01_07_425675	165	34	to	to	TO
10_1101-2021_01_07_425675	165	35	detect	detect	VB
10_1101-2021_01_07_425675	165	36	binding	binding	NN
10_1101-2021_01_07_425675	165	37	of	of	IN
10_1101-2021_01_07_425675	165	38	anti	anti	JJ
10_1101-2021_01_07_425675	165	39	-	-	JJ
10_1101-2021_01_07_425675	165	40	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	165	41	-	-	HYPH
10_1101-2021_01_07_425675	165	42	M2	m2	NN
10_1101-2021_01_07_425675	165	43	to	to	IN
10_1101-2021_01_07_425675	165	44	the	the	DT
10_1101-2021_01_07_425675	165	45	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	165	46	-	-	HYPH
10_1101-2021_01_07_425675	165	47	tagged	tag	VBN
10_1101-2021_01_07_425675	165	48	326	326	CD
10_1101-2021_01_07_425675	165	49	protein	protein	NN
10_1101-2021_01_07_425675	165	50	for	for	IN
10_1101-2021_01_07_425675	165	51	both	both	DT
10_1101-2021_01_07_425675	165	52	membranes	membrane	NNS
10_1101-2021_01_07_425675	165	53	.	.	.
10_1101-2021_01_07_425675	166	1	The	the	DT
10_1101-2021_01_07_425675	166	2	membranes	membrane	NNS
10_1101-2021_01_07_425675	166	3	were	be	VBD
10_1101-2021_01_07_425675	166	4	washed	wash	VBN
10_1101-2021_01_07_425675	166	5	three	three	CD
10_1101-2021_01_07_425675	166	6	more	more	JJR
10_1101-2021_01_07_425675	166	7	times	time	NNS
10_1101-2021_01_07_425675	166	8	with	with	IN
10_1101-2021_01_07_425675	166	9	PBST	PBST	NNP
10_1101-2021_01_07_425675	166	10	before	before	IN
10_1101-2021_01_07_425675	166	11	327	327	CD
10_1101-2021_01_07_425675	166	12	applying	apply	VBG
10_1101-2021_01_07_425675	166	13	enhanced	enhanced	JJ
10_1101-2021_01_07_425675	166	14	chemiluminescence	chemiluminescence	NN
10_1101-2021_01_07_425675	166	15	(	(	-LRB-
10_1101-2021_01_07_425675	166	16	ECL	ECL	NNP
10_1101-2021_01_07_425675	166	17	;	;	:
10_1101-2021_01_07_425675	166	18	Pierce	pierce	NN
10_1101-2021_01_07_425675	166	19	)	)	-RRB-
10_1101-2021_01_07_425675	166	20	reagent	reagent	VB
10_1101-2021_01_07_425675	166	21	to	to	TO
10_1101-2021_01_07_425675	166	22	image	image	VB
10_1101-2021_01_07_425675	166	23	the	the	DT
10_1101-2021_01_07_425675	166	24	blots	blot	NNS
10_1101-2021_01_07_425675	166	25	in	in	IN
10_1101-2021_01_07_425675	166	26	parallel	parallel	NN
10_1101-2021_01_07_425675	166	27	.	.	.
10_1101-2021_01_07_425675	167	1	328	328	CD
10_1101-2021_01_07_425675	167	2	329	329	CD
10_1101-2021_01_07_425675	167	3	Data	datum	NNS
10_1101-2021_01_07_425675	167	4	Availability	availability	NN
10_1101-2021_01_07_425675	167	5	330	330	CD
10_1101-2021_01_07_425675	167	6	The	the	DT
10_1101-2021_01_07_425675	167	7	raw	raw	JJ
10_1101-2021_01_07_425675	167	8	LC	LC	NNP
10_1101-2021_01_07_425675	167	9	-	-	HYPH
10_1101-2021_01_07_425675	167	10	MS	MS	NNP
10_1101-2021_01_07_425675	167	11	/	/	SYM
10_1101-2021_01_07_425675	167	12	MS	MS	NNP
10_1101-2021_01_07_425675	167	13	data	datum	NNS
10_1101-2021_01_07_425675	167	14	have	have	VBP
10_1101-2021_01_07_425675	167	15	been	be	VBN
10_1101-2021_01_07_425675	167	16	deposited	deposit	VBN
10_1101-2021_01_07_425675	167	17	to	to	IN
10_1101-2021_01_07_425675	167	18	the	the	DT
10_1101-2021_01_07_425675	167	19	ProteomeXchange	ProteomeXchange	NNP
10_1101-2021_01_07_425675	167	20	Consortium	Consortium	NNP
10_1101-2021_01_07_425675	167	21	via	via	IN
10_1101-2021_01_07_425675	167	22	the	the	DT
10_1101-2021_01_07_425675	167	23	331	331	CD
10_1101-2021_01_07_425675	167	24	PRIDE	PRIDE	NNP
10_1101-2021_01_07_425675	167	25	partner	partner	NN
10_1101-2021_01_07_425675	167	26	repository	repository	NN
10_1101-2021_01_07_425675	167	27	with	with	IN
10_1101-2021_01_07_425675	167	28	the	the	DT
10_1101-2021_01_07_425675	167	29	dataset	dataset	NN
10_1101-2021_01_07_425675	167	30	identifier	identifier	NN
10_1101-2021_01_07_425675	167	31	PXD023419	PXD023419	NNP
10_1101-2021_01_07_425675	167	32	.	.	.
10_1101-2021_01_07_425675	168	1	The	the	DT
10_1101-2021_01_07_425675	168	2	coordinates	coordinate	NNS
10_1101-2021_01_07_425675	168	3	and	and	CC
10_1101-2021_01_07_425675	168	4	reflection	reflection	NN
10_1101-2021_01_07_425675	168	5	332	332	CD
10_1101-2021_01_07_425675	168	6	file	file	NN
10_1101-2021_01_07_425675	168	7	with	with	IN
10_1101-2021_01_07_425675	168	8	phases	phase	NNS
10_1101-2021_01_07_425675	168	9	for	for	IN
10_1101-2021_01_07_425675	168	10	the	the	DT
10_1101-2021_01_07_425675	168	11	remodeled	remodel	VBN
10_1101-2021_01_07_425675	168	12	crystal	crystal	NN
10_1101-2021_01_07_425675	168	13	structure	structure	NN
10_1101-2021_01_07_425675	168	14	of	of	IN
10_1101-2021_01_07_425675	168	15	the	the	DT
10_1101-2021_01_07_425675	168	16	anti	anti	JJ
10_1101-2021_01_07_425675	168	17	-	-	JJ
10_1101-2021_01_07_425675	168	18	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	168	19	-	-	HYPH
10_1101-2021_01_07_425675	168	20	M2	M2	NNP
10_1101-2021_01_07_425675	168	21	Fab	Fab	NNP
10_1101-2021_01_07_425675	168	22	have	have	VBP
10_1101-2021_01_07_425675	168	23	been	be	VBN
10_1101-2021_01_07_425675	168	24	deposited	deposit	VBN
10_1101-2021_01_07_425675	168	25	333	333	CD
10_1101-2021_01_07_425675	168	26	in	in	IN
10_1101-2021_01_07_425675	168	27	the	the	DT
10_1101-2021_01_07_425675	168	28	Protein	Protein	NNP
10_1101-2021_01_07_425675	168	29	Data	Data	NNPS
10_1101-2021_01_07_425675	168	30	Bank	Bank	NNP
10_1101-2021_01_07_425675	168	31	under	under	IN
10_1101-2021_01_07_425675	168	32	accession	accession	NN
10_1101-2021_01_07_425675	168	33	code	code	NN
10_1101-2021_01_07_425675	168	34	7BG1	7bg1	CD
10_1101-2021_01_07_425675	168	35	.	.	.
10_1101-2021_01_07_425675	169	1	334	334	CD
10_1101-2021_01_07_425675	169	2	335	335	CD
10_1101-2021_01_07_425675	169	3	Acknowledgements	Acknowledgements	NNPS
10_1101-2021_01_07_425675	169	4	336	336	CD
10_1101-2021_01_07_425675	169	5	Herceptin	Herceptin	NNP
10_1101-2021_01_07_425675	169	6	was	be	VBD
10_1101-2021_01_07_425675	169	7	a	a	DT
10_1101-2021_01_07_425675	169	8	kind	kind	JJ
10_1101-2021_01_07_425675	169	9	gift	gift	NN
10_1101-2021_01_07_425675	169	10	from	from	IN
10_1101-2021_01_07_425675	169	11	Roche	Roche	NNP
10_1101-2021_01_07_425675	169	12	(	(	-LRB-
10_1101-2021_01_07_425675	169	13	Penzberg	Penzberg	NNP
10_1101-2021_01_07_425675	169	14	,	,	,
10_1101-2021_01_07_425675	169	15	Germany	Germany	NNP
10_1101-2021_01_07_425675	169	16	)	)	-RRB-
10_1101-2021_01_07_425675	169	17	.	.	.
10_1101-2021_01_07_425675	170	1	We	-PRON-	PRP
10_1101-2021_01_07_425675	170	2	would	would	MD
10_1101-2021_01_07_425675	170	3	like	like	VB
10_1101-2021_01_07_425675	170	4	to	to	TO
10_1101-2021_01_07_425675	170	5	acknowledge	acknowledge	VB
10_1101-2021_01_07_425675	170	6	337	337	CD
10_1101-2021_01_07_425675	170	7	support	support	NN
10_1101-2021_01_07_425675	170	8	by	by	IN
10_1101-2021_01_07_425675	170	9	Protein	Protein	NNP
10_1101-2021_01_07_425675	170	10	Metrics	Metrics	NNPS
10_1101-2021_01_07_425675	170	11	Inc.	Inc.	NNP
10_1101-2021_01_07_425675	170	12	through	through	IN
10_1101-2021_01_07_425675	170	13	access	access	NN
10_1101-2021_01_07_425675	170	14	to	to	IN
10_1101-2021_01_07_425675	170	15	Supernovo	Supernovo	NNP
10_1101-2021_01_07_425675	170	16	software	software	NN
10_1101-2021_01_07_425675	170	17	and	and	CC
10_1101-2021_01_07_425675	170	18	helpful	helpful	JJ
10_1101-2021_01_07_425675	170	19	discussion	discussion	NN
10_1101-2021_01_07_425675	170	20	on	on	IN
10_1101-2021_01_07_425675	170	21	338	338	CD
10_1101-2021_01_07_425675	170	22	de	de	NNP
10_1101-2021_01_07_425675	170	23	novo	novo	NNP
10_1101-2021_01_07_425675	170	24	antibody	antibody	NNP
10_1101-2021_01_07_425675	170	25	sequencing	sequencing	NNP
10_1101-2021_01_07_425675	170	26	.	.	.
10_1101-2021_01_07_425675	171	1	We	-PRON-	PRP
10_1101-2021_01_07_425675	171	2	would	would	MD
10_1101-2021_01_07_425675	171	3	like	like	VB
10_1101-2021_01_07_425675	171	4	to	to	TO
10_1101-2021_01_07_425675	171	5	thank	thank	VB
10_1101-2021_01_07_425675	171	6	everyone	everyone	NN
10_1101-2021_01_07_425675	171	7	in	in	IN
10_1101-2021_01_07_425675	171	8	the	the	DT
10_1101-2021_01_07_425675	171	9	Biomolecular	Biomolecular	NNP
10_1101-2021_01_07_425675	171	10	Mass	Mass	NNP
10_1101-2021_01_07_425675	171	11	339	339	CD
10_1101-2021_01_07_425675	171	12	.CC	.CC	:
10_1101-2021_01_07_425675	171	13	-	-	:
10_1101-2021_01_07_425675	171	14	BY	by	IN
10_1101-2021_01_07_425675	171	15	4.0	4.0	CD
10_1101-2021_01_07_425675	171	16	International	International	NNP
10_1101-2021_01_07_425675	171	17	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	171	18	under	under	IN
10_1101-2021_01_07_425675	171	19	a	a	DT
10_1101-2021_01_07_425675	171	20	(	(	-LRB-
10_1101-2021_01_07_425675	171	21	which	which	WDT
10_1101-2021_01_07_425675	171	22	was	be	VBD
10_1101-2021_01_07_425675	171	23	not	not	RB
10_1101-2021_01_07_425675	171	24	certified	certify	VBN
10_1101-2021_01_07_425675	171	25	by	by	IN
10_1101-2021_01_07_425675	171	26	peer	peer	NN
10_1101-2021_01_07_425675	171	27	review	review	NN
10_1101-2021_01_07_425675	171	28	)	)	-RRB-
10_1101-2021_01_07_425675	171	29	is	be	VBZ
10_1101-2021_01_07_425675	171	30	the	the	DT
10_1101-2021_01_07_425675	171	31	author	author	NN
10_1101-2021_01_07_425675	171	32	/	/	SYM
10_1101-2021_01_07_425675	171	33	funder	funder	NN
10_1101-2021_01_07_425675	171	34	,	,	,
10_1101-2021_01_07_425675	171	35	who	who	WP
10_1101-2021_01_07_425675	171	36	has	have	VBZ
10_1101-2021_01_07_425675	171	37	granted	grant	VBN
10_1101-2021_01_07_425675	171	38	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	171	39	a	a	DT
10_1101-2021_01_07_425675	171	40	license	license	NN
10_1101-2021_01_07_425675	171	41	to	to	TO
10_1101-2021_01_07_425675	171	42	display	display	VB
10_1101-2021_01_07_425675	171	43	the	the	DT
10_1101-2021_01_07_425675	171	44	preprint	preprint	NN
10_1101-2021_01_07_425675	171	45	in	in	IN
10_1101-2021_01_07_425675	171	46	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	171	47	.	.	.
10_1101-2021_01_07_425675	172	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	172	2	is	be	VBZ
10_1101-2021_01_07_425675	172	3	made	make	VBN
10_1101-2021_01_07_425675	172	4	The	the	DT
10_1101-2021_01_07_425675	172	5	copyright	copyright	NN
10_1101-2021_01_07_425675	172	6	holder	holder	NN
10_1101-2021_01_07_425675	172	7	for	for	IN
10_1101-2021_01_07_425675	172	8	this	this	DT
10_1101-2021_01_07_425675	172	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	172	10	version	version	NN
10_1101-2021_01_07_425675	172	11	posted	post	VBD
10_1101-2021_01_07_425675	172	12	January	January	NNP
10_1101-2021_01_07_425675	172	13	8	8	CD
10_1101-2021_01_07_425675	172	14	,	,	,
10_1101-2021_01_07_425675	172	15	2021	2021	CD
10_1101-2021_01_07_425675	172	16	.	.	.
10_1101-2021_01_07_425675	172	17	;	;	:
10_1101-2021_01_07_425675	172	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	172	19	:	:	:
10_1101-2021_01_07_425675	172	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	172	21	preprint	preprint	NN
10_1101-2021_01_07_425675	172	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NN
10_1101-2021_01_07_425675	172	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	172	24	14	14	CD
10_1101-2021_01_07_425675	172	25	Spectrometry	Spectrometry	NNP
10_1101-2021_01_07_425675	172	26	and	and	CC
10_1101-2021_01_07_425675	172	27	Proteomics	Proteomics	NNP
10_1101-2021_01_07_425675	172	28	group	group	NN
10_1101-2021_01_07_425675	172	29	at	at	IN
10_1101-2021_01_07_425675	172	30	Utrecht	Utrecht	NNP
10_1101-2021_01_07_425675	172	31	University	University	NNP
10_1101-2021_01_07_425675	172	32	for	for	IN
10_1101-2021_01_07_425675	172	33	support	support	NN
10_1101-2021_01_07_425675	172	34	and	and	CC
10_1101-2021_01_07_425675	172	35	helpful	helpful	JJ
10_1101-2021_01_07_425675	172	36	discussions	discussion	NNS
10_1101-2021_01_07_425675	172	37	.	.	.
10_1101-2021_01_07_425675	173	1	340	340	CD
10_1101-2021_01_07_425675	173	2	This	this	DT
10_1101-2021_01_07_425675	173	3	research	research	NN
10_1101-2021_01_07_425675	173	4	was	be	VBD
10_1101-2021_01_07_425675	173	5	funded	fund	VBN
10_1101-2021_01_07_425675	173	6	by	by	IN
10_1101-2021_01_07_425675	173	7	the	the	DT
10_1101-2021_01_07_425675	173	8	Dutch	Dutch	NNP
10_1101-2021_01_07_425675	173	9	Research	Research	NNP
10_1101-2021_01_07_425675	173	10	Council	Council	NNP
10_1101-2021_01_07_425675	173	11	NWO	NWO	NNP
10_1101-2021_01_07_425675	173	12	Gravitation	Gravitation	NNP
10_1101-2021_01_07_425675	173	13	2013	2013	CD
10_1101-2021_01_07_425675	173	14	BOO	BOO	NNP
10_1101-2021_01_07_425675	173	15	,	,	,
10_1101-2021_01_07_425675	173	16	Institute	Institute	NNP
10_1101-2021_01_07_425675	173	17	341	341	CD
10_1101-2021_01_07_425675	173	18	for	for	IN
10_1101-2021_01_07_425675	173	19	Chemical	Chemical	NNP
10_1101-2021_01_07_425675	173	20	Immunology	Immunology	NNP
10_1101-2021_01_07_425675	173	21	(	(	-LRB-
10_1101-2021_01_07_425675	173	22	ICI	ICI	NNP
10_1101-2021_01_07_425675	173	23	;	;	:
10_1101-2021_01_07_425675	173	24	024.002.009	024.002.009	NNP
10_1101-2021_01_07_425675	173	25	)	)	-RRB-
10_1101-2021_01_07_425675	173	26	.	.	.
10_1101-2021_01_07_425675	174	1	342	342	CD
10_1101-2021_01_07_425675	174	2	343	343	CD
10_1101-2021_01_07_425675	174	3	Author	author	NN
10_1101-2021_01_07_425675	174	4	Contributions	contribution	NNS
10_1101-2021_01_07_425675	174	5	344	344	CD
10_1101-2021_01_07_425675	174	6	WP	WP	NNP
10_1101-2021_01_07_425675	174	7	and	and	CC
10_1101-2021_01_07_425675	174	8	JS	JS	NNP
10_1101-2021_01_07_425675	174	9	conceived	conceive	VBD
10_1101-2021_01_07_425675	174	10	of	of	IN
10_1101-2021_01_07_425675	174	11	the	the	DT
10_1101-2021_01_07_425675	174	12	project	project	NN
10_1101-2021_01_07_425675	174	13	.	.	.
10_1101-2021_01_07_425675	175	1	WP	WP	NNP
10_1101-2021_01_07_425675	175	2	carried	carry	VBD
10_1101-2021_01_07_425675	175	3	out	out	RP
10_1101-2021_01_07_425675	175	4	the	the	DT
10_1101-2021_01_07_425675	175	5	MS	MS	NNP
10_1101-2021_01_07_425675	175	6	experiments	experiment	NNS
10_1101-2021_01_07_425675	175	7	.	.	.
10_1101-2021_01_07_425675	176	1	WP	WP	NNP
10_1101-2021_01_07_425675	176	2	and	and	CC
10_1101-2021_01_07_425675	176	3	JS	JS	NNP
10_1101-2021_01_07_425675	176	4	analyzed	analyze	VBD
10_1101-2021_01_07_425675	176	5	345	345	CD
10_1101-2021_01_07_425675	176	6	the	the	DT
10_1101-2021_01_07_425675	176	7	MS	MS	NNP
10_1101-2021_01_07_425675	176	8	data	datum	NNS
10_1101-2021_01_07_425675	176	9	.	.	.
10_1101-2021_01_07_425675	177	1	MFP	MFP	NNP
10_1101-2021_01_07_425675	177	2	remodeled	remodel	VBD
10_1101-2021_01_07_425675	177	3	the	the	DT
10_1101-2021_01_07_425675	177	4	crystal	crystal	NN
10_1101-2021_01_07_425675	177	5	structure	structure	NN
10_1101-2021_01_07_425675	177	6	.	.	.
10_1101-2021_01_07_425675	178	1	MFP	MFP	NNP
10_1101-2021_01_07_425675	178	2	cloned	clone	VBD
10_1101-2021_01_07_425675	178	3	and	and	CC
10_1101-2021_01_07_425675	178	4	produced	produce	VBD
10_1101-2021_01_07_425675	178	5	the	the	DT
10_1101-2021_01_07_425675	178	6	synthetic	synthetic	JJ
10_1101-2021_01_07_425675	178	7	346	346	CD
10_1101-2021_01_07_425675	178	8	recombinant	recombinant	JJ
10_1101-2021_01_07_425675	178	9	antibody	antibody	NN
10_1101-2021_01_07_425675	178	10	and	and	CC
10_1101-2021_01_07_425675	178	11	carried	carry	VBD
10_1101-2021_01_07_425675	178	12	out	out	RP
10_1101-2021_01_07_425675	178	13	Western	western	JJ
10_1101-2021_01_07_425675	178	14	blotting	blotting	NN
10_1101-2021_01_07_425675	178	15	.	.	.
10_1101-2021_01_07_425675	179	1	JS	JS	NNP
10_1101-2021_01_07_425675	179	2	supervised	supervise	VBD
10_1101-2021_01_07_425675	179	3	the	the	DT
10_1101-2021_01_07_425675	179	4	project	project	NN
10_1101-2021_01_07_425675	179	5	.	.	.
10_1101-2021_01_07_425675	180	1	JS	JS	NNP
10_1101-2021_01_07_425675	180	2	wrote	write	VBD
10_1101-2021_01_07_425675	180	3	the	the	DT
10_1101-2021_01_07_425675	180	4	347	347	CD
10_1101-2021_01_07_425675	180	5	first	first	JJ
10_1101-2021_01_07_425675	180	6	draft	draft	NN
10_1101-2021_01_07_425675	180	7	and	and	CC
10_1101-2021_01_07_425675	180	8	all	all	DT
10_1101-2021_01_07_425675	180	9	authors	author	NNS
10_1101-2021_01_07_425675	180	10	contributed	contribute	VBD
10_1101-2021_01_07_425675	180	11	to	to	IN
10_1101-2021_01_07_425675	180	12	preparing	prepare	VBG
10_1101-2021_01_07_425675	180	13	the	the	DT
10_1101-2021_01_07_425675	180	14	final	final	JJ
10_1101-2021_01_07_425675	180	15	version	version	NN
10_1101-2021_01_07_425675	180	16	of	of	IN
10_1101-2021_01_07_425675	180	17	the	the	DT
10_1101-2021_01_07_425675	180	18	manuscript	manuscript	NN
10_1101-2021_01_07_425675	180	19	.	.	.
10_1101-2021_01_07_425675	181	1	348	348	CD
10_1101-2021_01_07_425675	181	2	349	349	CD
10_1101-2021_01_07_425675	181	3	Competing	Competing	NNP
10_1101-2021_01_07_425675	181	4	Interests	Interests	NNPS
10_1101-2021_01_07_425675	181	5	350	350	CD
10_1101-2021_01_07_425675	181	6	The	the	DT
10_1101-2021_01_07_425675	181	7	authors	author	NNS
10_1101-2021_01_07_425675	181	8	declare	declare	VBP
10_1101-2021_01_07_425675	181	9	no	no	DT
10_1101-2021_01_07_425675	181	10	competing	compete	VBG
10_1101-2021_01_07_425675	181	11	interests	interest	NNS
10_1101-2021_01_07_425675	181	12	351	351	CD
10_1101-2021_01_07_425675	181	13	352	352	CD
10_1101-2021_01_07_425675	181	14	References	reference	NNS
10_1101-2021_01_07_425675	181	15	353	353	CD
10_1101-2021_01_07_425675	181	16	1	1	CD
10_1101-2021_01_07_425675	181	17	.	.	.
10_1101-2021_01_07_425675	182	1	Tonegawa	Tonegawa	NNP
10_1101-2021_01_07_425675	182	2	,	,	,
10_1101-2021_01_07_425675	182	3	S.	S.	NNP
10_1101-2021_01_07_425675	182	4	,	,	,
10_1101-2021_01_07_425675	182	5	Somatic	somatic	JJ
10_1101-2021_01_07_425675	182	6	generation	generation	NN
10_1101-2021_01_07_425675	182	7	of	of	IN
10_1101-2021_01_07_425675	182	8	antibody	antibody	NN
10_1101-2021_01_07_425675	182	9	diversity	diversity	NN
10_1101-2021_01_07_425675	182	10	.	.	.
10_1101-2021_01_07_425675	183	1	Nature	nature	NN
10_1101-2021_01_07_425675	183	2	1983	1983	CD
10_1101-2021_01_07_425675	183	3	,	,	,
10_1101-2021_01_07_425675	183	4	302	302	CD
10_1101-2021_01_07_425675	183	5	(	(	-LRB-
10_1101-2021_01_07_425675	183	6	5909	5909	CD
10_1101-2021_01_07_425675	183	7	)	)	-RRB-
10_1101-2021_01_07_425675	183	8	,	,	,
10_1101-2021_01_07_425675	183	9	575	575	CD
10_1101-2021_01_07_425675	183	10	-	-	SYM
10_1101-2021_01_07_425675	183	11	354	354	CD
10_1101-2021_01_07_425675	183	12	581	581	CD
10_1101-2021_01_07_425675	183	13	.	.	.
10_1101-2021_01_07_425675	184	1	355	355	CD
10_1101-2021_01_07_425675	184	2	2	2	CD
10_1101-2021_01_07_425675	184	3	.	.	.
10_1101-2021_01_07_425675	185	1	Watson	Watson	NNP
10_1101-2021_01_07_425675	185	2	,	,	,
10_1101-2021_01_07_425675	185	3	C.	C.	NNP
10_1101-2021_01_07_425675	185	4	T.	T.	NNP
10_1101-2021_01_07_425675	185	5	;	;	:
10_1101-2021_01_07_425675	185	6	Glanville	Glanville	NNP
10_1101-2021_01_07_425675	185	7	,	,	,
10_1101-2021_01_07_425675	185	8	J.	J.	NNP
10_1101-2021_01_07_425675	185	9	;	;	:
10_1101-2021_01_07_425675	185	10	Marasco	Marasco	NNP
10_1101-2021_01_07_425675	185	11	,	,	,
10_1101-2021_01_07_425675	185	12	W.	W.	NNP
10_1101-2021_01_07_425675	185	13	A.	A.	NNP
10_1101-2021_01_07_425675	185	14	,	,	,
10_1101-2021_01_07_425675	185	15	The	the	DT
10_1101-2021_01_07_425675	185	16	individual	individual	NN
10_1101-2021_01_07_425675	185	17	and	and	CC
10_1101-2021_01_07_425675	185	18	population	population	NN
10_1101-2021_01_07_425675	185	19	genetics	genetic	NNS
10_1101-2021_01_07_425675	185	20	of	of	IN
10_1101-2021_01_07_425675	185	21	356	356	CD
10_1101-2021_01_07_425675	185	22	antibody	antibody	NN
10_1101-2021_01_07_425675	185	23	immunity	immunity	NN
10_1101-2021_01_07_425675	185	24	.	.	.
10_1101-2021_01_07_425675	186	1	Trends	trend	NNS
10_1101-2021_01_07_425675	186	2	in	in	IN
10_1101-2021_01_07_425675	186	3	immunology	immunology	NN
10_1101-2021_01_07_425675	186	4	2017	2017	CD
10_1101-2021_01_07_425675	186	5	,	,	,
10_1101-2021_01_07_425675	186	6	38	38	CD
10_1101-2021_01_07_425675	186	7	(	(	-LRB-
10_1101-2021_01_07_425675	186	8	7	7	CD
10_1101-2021_01_07_425675	186	9	)	)	-RRB-
10_1101-2021_01_07_425675	186	10	,	,	,
10_1101-2021_01_07_425675	186	11	459	459	CD
10_1101-2021_01_07_425675	186	12	-	-	SYM
10_1101-2021_01_07_425675	186	13	470	470	CD
10_1101-2021_01_07_425675	186	14	.	.	.
10_1101-2021_01_07_425675	187	1	357	357	CD
10_1101-2021_01_07_425675	187	2	3	3	CD
10_1101-2021_01_07_425675	187	3	.	.	.
10_1101-2021_01_07_425675	188	1	Carter	Carter	NNP
10_1101-2021_01_07_425675	188	2	,	,	,
10_1101-2021_01_07_425675	188	3	P.	P.	NNP
10_1101-2021_01_07_425675	188	4	J.	J.	NNP
10_1101-2021_01_07_425675	188	5	;	;	:
10_1101-2021_01_07_425675	188	6	Lazar	Lazar	NNP
10_1101-2021_01_07_425675	188	7	,	,	,
10_1101-2021_01_07_425675	188	8	G.	G.	NNP
10_1101-2021_01_07_425675	188	9	A.	A.	NNP
10_1101-2021_01_07_425675	188	10	,	,	,
10_1101-2021_01_07_425675	188	11	Next	Next	NNP
10_1101-2021_01_07_425675	188	12	generation	generation	NN
10_1101-2021_01_07_425675	188	13	antibody	antibody	NN
10_1101-2021_01_07_425675	188	14	drugs	drug	NNS
10_1101-2021_01_07_425675	188	15	:	:	:
10_1101-2021_01_07_425675	188	16	pursuit	pursuit	NN
10_1101-2021_01_07_425675	188	17	of	of	IN
10_1101-2021_01_07_425675	188	18	the'high	the'high	NNP
10_1101-2021_01_07_425675	188	19	-	-	HYPH
10_1101-2021_01_07_425675	188	20	hanging	hang	VBG
10_1101-2021_01_07_425675	188	21	358	358	CD
10_1101-2021_01_07_425675	188	22	fruit	fruit	NN
10_1101-2021_01_07_425675	188	23	'	'	''
10_1101-2021_01_07_425675	188	24	.	.	.
10_1101-2021_01_07_425675	189	1	Nature	Nature	NNP
10_1101-2021_01_07_425675	189	2	Reviews	Reviews	NNPS
10_1101-2021_01_07_425675	189	3	Drug	Drug	NNP
10_1101-2021_01_07_425675	189	4	Discovery	Discovery	NNP
10_1101-2021_01_07_425675	189	5	2018	2018	CD
10_1101-2021_01_07_425675	189	6	,	,	,
10_1101-2021_01_07_425675	189	7	17	17	CD
10_1101-2021_01_07_425675	189	8	(	(	-LRB-
10_1101-2021_01_07_425675	189	9	3	3	CD
10_1101-2021_01_07_425675	189	10	)	)	-RRB-
10_1101-2021_01_07_425675	189	11	,	,	,
10_1101-2021_01_07_425675	189	12	197	197	CD
10_1101-2021_01_07_425675	189	13	.	.	.
10_1101-2021_01_07_425675	190	1	359	359	CD
10_1101-2021_01_07_425675	190	2	4	4	CD
10_1101-2021_01_07_425675	190	3	.	.	.
10_1101-2021_01_07_425675	191	1	Grilo	Grilo	NNP
10_1101-2021_01_07_425675	191	2	,	,	,
10_1101-2021_01_07_425675	191	3	A.	A.	NNP
10_1101-2021_01_07_425675	191	4	L.	L.	NNP
10_1101-2021_01_07_425675	191	5	;	;	:
10_1101-2021_01_07_425675	191	6	Mantalaris	Mantalaris	NNP
10_1101-2021_01_07_425675	191	7	,	,	,
10_1101-2021_01_07_425675	191	8	A.	A.	NNP
10_1101-2021_01_07_425675	191	9	,	,	,
10_1101-2021_01_07_425675	191	10	The	the	DT
10_1101-2021_01_07_425675	191	11	increasingly	increasingly	RB
10_1101-2021_01_07_425675	191	12	human	human	JJ
10_1101-2021_01_07_425675	191	13	and	and	CC
10_1101-2021_01_07_425675	191	14	profitable	profitable	JJ
10_1101-2021_01_07_425675	191	15	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	191	16	antibody	antibody	NN
10_1101-2021_01_07_425675	191	17	360	360	CD
10_1101-2021_01_07_425675	191	18	market	market	NN
10_1101-2021_01_07_425675	191	19	.	.	.
10_1101-2021_01_07_425675	192	1	Trends	trend	NNS
10_1101-2021_01_07_425675	192	2	in	in	IN
10_1101-2021_01_07_425675	192	3	biotechnology	biotechnology	NN
10_1101-2021_01_07_425675	192	4	2019	2019	CD
10_1101-2021_01_07_425675	192	5	,	,	,
10_1101-2021_01_07_425675	192	6	37	37	CD
10_1101-2021_01_07_425675	192	7	(	(	-LRB-
10_1101-2021_01_07_425675	192	8	1	1	CD
10_1101-2021_01_07_425675	192	9	)	)	-RRB-
10_1101-2021_01_07_425675	192	10	,	,	,
10_1101-2021_01_07_425675	192	11	9	9	CD
10_1101-2021_01_07_425675	192	12	-	-	SYM
10_1101-2021_01_07_425675	192	13	16	16	CD
10_1101-2021_01_07_425675	192	14	.	.	.
10_1101-2021_01_07_425675	193	1	361	361	CD
10_1101-2021_01_07_425675	193	2	5	5	CD
10_1101-2021_01_07_425675	193	3	.	.	.
10_1101-2021_01_07_425675	194	1	Baker	Baker	NNP
10_1101-2021_01_07_425675	194	2	,	,	,
10_1101-2021_01_07_425675	194	3	M.	M.	NNP
10_1101-2021_01_07_425675	194	4	,	,	,
10_1101-2021_01_07_425675	194	5	Blame	blame	VB
10_1101-2021_01_07_425675	194	6	it	-PRON-	PRP
10_1101-2021_01_07_425675	194	7	on	on	IN
10_1101-2021_01_07_425675	194	8	the	the	DT
10_1101-2021_01_07_425675	194	9	antibodies	antibody	NNS
10_1101-2021_01_07_425675	194	10	.	.	.
10_1101-2021_01_07_425675	195	1	Nature	nature	NN
10_1101-2021_01_07_425675	195	2	2015	2015	CD
10_1101-2021_01_07_425675	195	3	,	,	,
10_1101-2021_01_07_425675	195	4	521	521	CD
10_1101-2021_01_07_425675	195	5	(	(	-LRB-
10_1101-2021_01_07_425675	195	6	7552	7552	CD
10_1101-2021_01_07_425675	195	7	)	)	-RRB-
10_1101-2021_01_07_425675	195	8	,	,	,
10_1101-2021_01_07_425675	195	9	274	274	CD
10_1101-2021_01_07_425675	195	10	.	.	.
10_1101-2021_01_07_425675	196	1	362	362	CD
10_1101-2021_01_07_425675	196	2	6	6	CD
10_1101-2021_01_07_425675	196	3	.	.	.
10_1101-2021_01_07_425675	197	1	Uhlen	Uhlen	NNP
10_1101-2021_01_07_425675	197	2	,	,	,
10_1101-2021_01_07_425675	197	3	M.	M.	NNP
10_1101-2021_01_07_425675	197	4	;	;	:
10_1101-2021_01_07_425675	197	5	Bandrowski	Bandrowski	NNP
10_1101-2021_01_07_425675	197	6	,	,	,
10_1101-2021_01_07_425675	197	7	A.	a.	NN
10_1101-2021_01_07_425675	197	8	;	;	:
10_1101-2021_01_07_425675	197	9	Carr	Carr	NNP
10_1101-2021_01_07_425675	197	10	,	,	,
10_1101-2021_01_07_425675	197	11	S.	S.	NNP
10_1101-2021_01_07_425675	197	12	;	;	:
10_1101-2021_01_07_425675	197	13	Edwards	Edwards	NNP
10_1101-2021_01_07_425675	197	14	,	,	,
10_1101-2021_01_07_425675	197	15	A.	a.	NN
10_1101-2021_01_07_425675	197	16	;	;	:
10_1101-2021_01_07_425675	197	17	Ellenberg	Ellenberg	NNP
10_1101-2021_01_07_425675	197	18	,	,	,
10_1101-2021_01_07_425675	197	19	J.	J.	NNP
10_1101-2021_01_07_425675	197	20	;	;	:
10_1101-2021_01_07_425675	197	21	Lundberg	Lundberg	NNP
10_1101-2021_01_07_425675	197	22	,	,	,
10_1101-2021_01_07_425675	197	23	E.	E.	NNP
10_1101-2021_01_07_425675	197	24	;	;	:
10_1101-2021_01_07_425675	197	25	Rimm	Rimm	NNP
10_1101-2021_01_07_425675	197	26	,	,	,
10_1101-2021_01_07_425675	197	27	D.	D.	NNP
10_1101-2021_01_07_425675	197	28	363	363	CD
10_1101-2021_01_07_425675	197	29	L.	L.	NNP
10_1101-2021_01_07_425675	197	30	;	;	:
10_1101-2021_01_07_425675	197	31	Rodriguez	Rodriguez	NNP
10_1101-2021_01_07_425675	197	32	,	,	,
10_1101-2021_01_07_425675	197	33	H.	H.	NNP
10_1101-2021_01_07_425675	197	34	;	;	:
10_1101-2021_01_07_425675	197	35	Hiltke	Hiltke	NNP
10_1101-2021_01_07_425675	197	36	,	,	,
10_1101-2021_01_07_425675	197	37	T.	T.	NNP
10_1101-2021_01_07_425675	197	38	;	;	:
10_1101-2021_01_07_425675	197	39	Snyder	Snyder	NNP
10_1101-2021_01_07_425675	197	40	,	,	,
10_1101-2021_01_07_425675	197	41	M.	M.	NNP
10_1101-2021_01_07_425675	197	42	,	,	,
10_1101-2021_01_07_425675	197	43	A	a	DT
10_1101-2021_01_07_425675	197	44	proposal	proposal	NN
10_1101-2021_01_07_425675	197	45	for	for	IN
10_1101-2021_01_07_425675	197	46	validation	validation	NN
10_1101-2021_01_07_425675	197	47	of	of	IN
10_1101-2021_01_07_425675	197	48	antibodies	antibody	NNS
10_1101-2021_01_07_425675	197	49	.	.	.
10_1101-2021_01_07_425675	198	1	Nature	nature	NN
10_1101-2021_01_07_425675	198	2	methods	method	NNS
10_1101-2021_01_07_425675	198	3	364	364	CD
10_1101-2021_01_07_425675	198	4	2016	2016	CD
10_1101-2021_01_07_425675	198	5	,	,	,
10_1101-2021_01_07_425675	198	6	13	13	CD
10_1101-2021_01_07_425675	198	7	(	(	-LRB-
10_1101-2021_01_07_425675	198	8	10	10	CD
10_1101-2021_01_07_425675	198	9	)	)	-RRB-
10_1101-2021_01_07_425675	198	10	,	,	,
10_1101-2021_01_07_425675	198	11	823	823	CD
10_1101-2021_01_07_425675	198	12	-	-	SYM
10_1101-2021_01_07_425675	198	13	827	827	CD
10_1101-2021_01_07_425675	198	14	.	.	.
10_1101-2021_01_07_425675	199	1	365	365	CD
10_1101-2021_01_07_425675	199	2	7	7	CD
10_1101-2021_01_07_425675	199	3	.	.	.
10_1101-2021_01_07_425675	200	1	Fischer	Fischer	NNP
10_1101-2021_01_07_425675	200	2	,	,	,
10_1101-2021_01_07_425675	200	3	N.	N.	NNP
10_1101-2021_01_07_425675	200	4	In	In	NNP
10_1101-2021_01_07_425675	200	5	Sequencing	Sequencing	NNP
10_1101-2021_01_07_425675	200	6	antibody	antibody	NN
10_1101-2021_01_07_425675	200	7	repertoires	repertoire	VBZ
10_1101-2021_01_07_425675	200	8	:	:	:
10_1101-2021_01_07_425675	200	9	the	the	DT
10_1101-2021_01_07_425675	200	10	next	next	JJ
10_1101-2021_01_07_425675	200	11	generation	generation	NN
10_1101-2021_01_07_425675	200	12	,	,	,
10_1101-2021_01_07_425675	200	13	MAbs	MAbs	NNP
10_1101-2021_01_07_425675	200	14	,	,	,
10_1101-2021_01_07_425675	200	15	Taylor	Taylor	NNP
10_1101-2021_01_07_425675	200	16	&	&	CC
10_1101-2021_01_07_425675	200	17	366	366	CD
10_1101-2021_01_07_425675	200	18	Francis	Francis	NNP
10_1101-2021_01_07_425675	200	19	:	:	:
10_1101-2021_01_07_425675	200	20	2011	2011	CD
10_1101-2021_01_07_425675	200	21	;	;	:
10_1101-2021_01_07_425675	200	22	pp	pp	NNP
10_1101-2021_01_07_425675	200	23	17	17	CD
10_1101-2021_01_07_425675	200	24	-	-	SYM
10_1101-2021_01_07_425675	200	25	20	20	CD
10_1101-2021_01_07_425675	200	26	.	.	.
10_1101-2021_01_07_425675	201	1	367	367	CD
10_1101-2021_01_07_425675	201	2	8	8	CD
10_1101-2021_01_07_425675	201	3	.	.	.
10_1101-2021_01_07_425675	202	1	Georgiou	Georgiou	NNP
10_1101-2021_01_07_425675	202	2	,	,	,
10_1101-2021_01_07_425675	202	3	G.	G.	NNP
10_1101-2021_01_07_425675	202	4	;	;	:
10_1101-2021_01_07_425675	202	5	Ippolito	Ippolito	NNP
10_1101-2021_01_07_425675	202	6	,	,	,
10_1101-2021_01_07_425675	202	7	G.	G.	NNP
10_1101-2021_01_07_425675	202	8	C.	C.	NNP
10_1101-2021_01_07_425675	202	9	;	;	:
10_1101-2021_01_07_425675	202	10	Beausang	Beausang	NNP
10_1101-2021_01_07_425675	202	11	,	,	,
10_1101-2021_01_07_425675	202	12	J.	J.	NNP
10_1101-2021_01_07_425675	202	13	;	;	:
10_1101-2021_01_07_425675	202	14	Busse	Busse	NNP
10_1101-2021_01_07_425675	202	15	,	,	,
10_1101-2021_01_07_425675	202	16	C.	C.	NNP
10_1101-2021_01_07_425675	202	17	E.	E.	NNP
10_1101-2021_01_07_425675	202	18	;	;	:
10_1101-2021_01_07_425675	202	19	Wardemann	Wardemann	NNP
10_1101-2021_01_07_425675	202	20	,	,	,
10_1101-2021_01_07_425675	202	21	H.	H.	NNP
10_1101-2021_01_07_425675	202	22	;	;	:
10_1101-2021_01_07_425675	202	23	Quake	Quake	NNP
10_1101-2021_01_07_425675	202	24	,	,	,
10_1101-2021_01_07_425675	202	25	S.	S.	NNP
10_1101-2021_01_07_425675	202	26	R.	R.	NNP
10_1101-2021_01_07_425675	202	27	,	,	,
10_1101-2021_01_07_425675	202	28	368	368	CD
10_1101-2021_01_07_425675	202	29	The	the	DT
10_1101-2021_01_07_425675	202	30	promise	promise	NN
10_1101-2021_01_07_425675	202	31	and	and	CC
10_1101-2021_01_07_425675	202	32	challenge	challenge	NN
10_1101-2021_01_07_425675	202	33	of	of	IN
10_1101-2021_01_07_425675	202	34	high	high	JJ
10_1101-2021_01_07_425675	202	35	-	-	HYPH
10_1101-2021_01_07_425675	202	36	throughput	throughput	NN
10_1101-2021_01_07_425675	202	37	sequencing	sequencing	NN
10_1101-2021_01_07_425675	202	38	of	of	IN
10_1101-2021_01_07_425675	202	39	the	the	DT
10_1101-2021_01_07_425675	202	40	antibody	antibody	NN
10_1101-2021_01_07_425675	202	41	repertoire	repertoire	NN
10_1101-2021_01_07_425675	202	42	.	.	.
10_1101-2021_01_07_425675	203	1	Nature	nature	NN
10_1101-2021_01_07_425675	203	2	369	369	CD
10_1101-2021_01_07_425675	203	3	biotechnology	biotechnology	NN
10_1101-2021_01_07_425675	203	4	2014	2014	CD
10_1101-2021_01_07_425675	203	5	,	,	,
10_1101-2021_01_07_425675	203	6	32	32	CD
10_1101-2021_01_07_425675	203	7	(	(	-LRB-
10_1101-2021_01_07_425675	203	8	2	2	CD
10_1101-2021_01_07_425675	203	9	)	)	-RRB-
10_1101-2021_01_07_425675	203	10	,	,	,
10_1101-2021_01_07_425675	203	11	158	158	CD
10_1101-2021_01_07_425675	203	12	-	-	SYM
10_1101-2021_01_07_425675	203	13	168	168	CD
10_1101-2021_01_07_425675	203	14	.	.	.
10_1101-2021_01_07_425675	204	1	370	370	CD
10_1101-2021_01_07_425675	204	2	.CC	.CC	:
10_1101-2021_01_07_425675	204	3	-	-	:
10_1101-2021_01_07_425675	204	4	BY	by	IN
10_1101-2021_01_07_425675	204	5	4.0	4.0	CD
10_1101-2021_01_07_425675	204	6	International	International	NNP
10_1101-2021_01_07_425675	204	7	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	204	8	under	under	IN
10_1101-2021_01_07_425675	204	9	a	a	DT
10_1101-2021_01_07_425675	204	10	(	(	-LRB-
10_1101-2021_01_07_425675	204	11	which	which	WDT
10_1101-2021_01_07_425675	204	12	was	be	VBD
10_1101-2021_01_07_425675	204	13	not	not	RB
10_1101-2021_01_07_425675	204	14	certified	certify	VBN
10_1101-2021_01_07_425675	204	15	by	by	IN
10_1101-2021_01_07_425675	204	16	peer	peer	NN
10_1101-2021_01_07_425675	204	17	review	review	NN
10_1101-2021_01_07_425675	204	18	)	)	-RRB-
10_1101-2021_01_07_425675	204	19	is	be	VBZ
10_1101-2021_01_07_425675	204	20	the	the	DT
10_1101-2021_01_07_425675	204	21	author	author	NN
10_1101-2021_01_07_425675	204	22	/	/	SYM
10_1101-2021_01_07_425675	204	23	funder	funder	NN
10_1101-2021_01_07_425675	204	24	,	,	,
10_1101-2021_01_07_425675	204	25	who	who	WP
10_1101-2021_01_07_425675	204	26	has	have	VBZ
10_1101-2021_01_07_425675	204	27	granted	grant	VBN
10_1101-2021_01_07_425675	204	28	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	204	29	a	a	DT
10_1101-2021_01_07_425675	204	30	license	license	NN
10_1101-2021_01_07_425675	204	31	to	to	TO
10_1101-2021_01_07_425675	204	32	display	display	VB
10_1101-2021_01_07_425675	204	33	the	the	DT
10_1101-2021_01_07_425675	204	34	preprint	preprint	NN
10_1101-2021_01_07_425675	204	35	in	in	IN
10_1101-2021_01_07_425675	204	36	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	204	37	.	.	.
10_1101-2021_01_07_425675	205	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	205	2	is	be	VBZ
10_1101-2021_01_07_425675	205	3	made	make	VBN
10_1101-2021_01_07_425675	205	4	The	the	DT
10_1101-2021_01_07_425675	205	5	copyright	copyright	NN
10_1101-2021_01_07_425675	205	6	holder	holder	NN
10_1101-2021_01_07_425675	205	7	for	for	IN
10_1101-2021_01_07_425675	205	8	this	this	DT
10_1101-2021_01_07_425675	205	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	205	10	version	version	NN
10_1101-2021_01_07_425675	205	11	posted	post	VBD
10_1101-2021_01_07_425675	205	12	January	January	NNP
10_1101-2021_01_07_425675	205	13	8	8	CD
10_1101-2021_01_07_425675	205	14	,	,	,
10_1101-2021_01_07_425675	205	15	2021	2021	CD
10_1101-2021_01_07_425675	205	16	.	.	.
10_1101-2021_01_07_425675	205	17	;	;	:
10_1101-2021_01_07_425675	205	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	205	19	:	:	:
10_1101-2021_01_07_425675	205	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	205	21	preprint	preprint	NN
10_1101-2021_01_07_425675	205	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NNP
10_1101-2021_01_07_425675	205	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	NNP
10_1101-2021_01_07_425675	205	24	15	15	CD
10_1101-2021_01_07_425675	205	25	9	9	CD
10_1101-2021_01_07_425675	205	26	.	.	.
10_1101-2021_01_07_425675	206	1	Robinson	Robinson	NNP
10_1101-2021_01_07_425675	206	2	,	,	,
10_1101-2021_01_07_425675	206	3	W.	W.	NNP
10_1101-2021_01_07_425675	206	4	H.	H.	NNP
10_1101-2021_01_07_425675	206	5	,	,	,
10_1101-2021_01_07_425675	206	6	Sequencing	sequence	VBG
10_1101-2021_01_07_425675	206	7	the	the	DT
10_1101-2021_01_07_425675	206	8	functional	functional	JJ
10_1101-2021_01_07_425675	206	9	antibody	antibody	NN
10_1101-2021_01_07_425675	206	10	repertoire	repertoire	NN
10_1101-2021_01_07_425675	206	11	—	—	:
10_1101-2021_01_07_425675	206	12	diagnostic	diagnostic	JJ
10_1101-2021_01_07_425675	206	13	and	and	CC
10_1101-2021_01_07_425675	206	14	371	371	CD
10_1101-2021_01_07_425675	206	15	therapeutic	therapeutic	JJ
10_1101-2021_01_07_425675	206	16	discovery	discovery	NN
10_1101-2021_01_07_425675	206	17	.	.	.
10_1101-2021_01_07_425675	207	1	Nature	Nature	NNP
10_1101-2021_01_07_425675	207	2	Reviews	Reviews	NNPS
10_1101-2021_01_07_425675	207	3	Rheumatology	Rheumatology	NNP
10_1101-2021_01_07_425675	207	4	2015	2015	CD
10_1101-2021_01_07_425675	207	5	,	,	,
10_1101-2021_01_07_425675	207	6	11	11	CD
10_1101-2021_01_07_425675	207	7	(	(	-LRB-
10_1101-2021_01_07_425675	207	8	3	3	CD
10_1101-2021_01_07_425675	207	9	)	)	-RRB-
10_1101-2021_01_07_425675	207	10	,	,	,
10_1101-2021_01_07_425675	207	11	171	171	CD
10_1101-2021_01_07_425675	207	12	.	.	.
10_1101-2021_01_07_425675	208	1	372	372	CD
10_1101-2021_01_07_425675	208	2	10	10	CD
10_1101-2021_01_07_425675	208	3	.	.	.
10_1101-2021_01_07_425675	209	1	Boutz	Boutz	NNP
10_1101-2021_01_07_425675	209	2	,	,	,
10_1101-2021_01_07_425675	209	3	D.	D.	NNP
10_1101-2021_01_07_425675	209	4	R.	R.	NNP
10_1101-2021_01_07_425675	209	5	;	;	:
10_1101-2021_01_07_425675	209	6	Horton	Horton	NNP
10_1101-2021_01_07_425675	209	7	,	,	,
10_1101-2021_01_07_425675	209	8	A.	A.	NNP
10_1101-2021_01_07_425675	209	9	P.	P.	NNP
10_1101-2021_01_07_425675	209	10	;	;	:
10_1101-2021_01_07_425675	209	11	Wine	Wine	NNP
10_1101-2021_01_07_425675	209	12	,	,	,
10_1101-2021_01_07_425675	209	13	Y.	Y.	NNP
10_1101-2021_01_07_425675	209	14	;	;	:
10_1101-2021_01_07_425675	209	15	Lavinder	Lavinder	NNP
10_1101-2021_01_07_425675	209	16	,	,	,
10_1101-2021_01_07_425675	209	17	J.	J.	NNP
10_1101-2021_01_07_425675	209	18	J.	J.	NNP
10_1101-2021_01_07_425675	209	19	;	;	:
10_1101-2021_01_07_425675	209	20	Georgiou	Georgiou	NNP
10_1101-2021_01_07_425675	209	21	,	,	,
10_1101-2021_01_07_425675	209	22	G.	G.	NNP
10_1101-2021_01_07_425675	209	23	;	;	:
10_1101-2021_01_07_425675	209	24	Marcotte	Marcotte	NNP
10_1101-2021_01_07_425675	209	25	,	,	,
10_1101-2021_01_07_425675	209	26	E.	E.	NNP
10_1101-2021_01_07_425675	209	27	M.	M.	NNP
10_1101-2021_01_07_425675	209	28	,	,	,
10_1101-2021_01_07_425675	209	29	373	373	CD
10_1101-2021_01_07_425675	209	30	Proteomic	proteomic	JJ
10_1101-2021_01_07_425675	209	31	identification	identification	NN
10_1101-2021_01_07_425675	209	32	of	of	IN
10_1101-2021_01_07_425675	209	33	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	209	34	antibodies	antibody	NNS
10_1101-2021_01_07_425675	209	35	from	from	IN
10_1101-2021_01_07_425675	209	36	serum	serum	NNP
10_1101-2021_01_07_425675	209	37	.	.	.
10_1101-2021_01_07_425675	210	1	Analytical	analytical	JJ
10_1101-2021_01_07_425675	210	2	chemistry	chemistry	NN
10_1101-2021_01_07_425675	210	3	2014	2014	CD
10_1101-2021_01_07_425675	210	4	,	,	,
10_1101-2021_01_07_425675	210	5	86	86	CD
10_1101-2021_01_07_425675	210	6	374	374	CD
10_1101-2021_01_07_425675	210	7	(	(	-LRB-
10_1101-2021_01_07_425675	210	8	10	10	CD
10_1101-2021_01_07_425675	210	9	)	)	-RRB-
10_1101-2021_01_07_425675	210	10	,	,	,
10_1101-2021_01_07_425675	210	11	4758	4758	CD
10_1101-2021_01_07_425675	210	12	-	-	SYM
10_1101-2021_01_07_425675	210	13	4766	4766	CD
10_1101-2021_01_07_425675	210	14	.	.	.
10_1101-2021_01_07_425675	211	1	375	375	CD
10_1101-2021_01_07_425675	211	2	11	11	CD
10_1101-2021_01_07_425675	211	3	.	.	.
10_1101-2021_01_07_425675	212	1	Castellana	Castellana	NNP
10_1101-2021_01_07_425675	212	2	,	,	,
10_1101-2021_01_07_425675	212	3	N.	N.	NNP
10_1101-2021_01_07_425675	212	4	E.	E.	NNP
10_1101-2021_01_07_425675	212	5	;	;	:
10_1101-2021_01_07_425675	212	6	McCutcheon	McCutcheon	NNP
10_1101-2021_01_07_425675	212	7	,	,	,
10_1101-2021_01_07_425675	212	8	K.	K.	NNP
10_1101-2021_01_07_425675	212	9	;	;	:
10_1101-2021_01_07_425675	212	10	Pham	Pham	NNP
10_1101-2021_01_07_425675	212	11	,	,	,
10_1101-2021_01_07_425675	212	12	V.	V.	NNP
10_1101-2021_01_07_425675	212	13	C.	C.	NNP
10_1101-2021_01_07_425675	212	14	;	;	:
10_1101-2021_01_07_425675	212	15	Harden	Harden	NNP
10_1101-2021_01_07_425675	212	16	,	,	,
10_1101-2021_01_07_425675	212	17	K.	K.	NNP
10_1101-2021_01_07_425675	212	18	;	;	:
10_1101-2021_01_07_425675	212	19	Nguyen	Nguyen	NNP
10_1101-2021_01_07_425675	212	20	,	,	,
10_1101-2021_01_07_425675	212	21	A.	a.	NN
10_1101-2021_01_07_425675	212	22	;	;	:
10_1101-2021_01_07_425675	212	23	Young	Young	NNP
10_1101-2021_01_07_425675	212	24	,	,	,
10_1101-2021_01_07_425675	212	25	J.	J.	NNP
10_1101-2021_01_07_425675	212	26	;	;	:
10_1101-2021_01_07_425675	212	27	376	376	CD
10_1101-2021_01_07_425675	212	28	Adams	Adams	NNP
10_1101-2021_01_07_425675	212	29	,	,	,
10_1101-2021_01_07_425675	212	30	C.	C.	NNP
10_1101-2021_01_07_425675	212	31	;	;	:
10_1101-2021_01_07_425675	212	32	Schroeder	Schroeder	NNP
10_1101-2021_01_07_425675	212	33	,	,	,
10_1101-2021_01_07_425675	212	34	K.	K.	NNP
10_1101-2021_01_07_425675	212	35	;	;	:
10_1101-2021_01_07_425675	212	36	Arnott	Arnott	NNP
10_1101-2021_01_07_425675	212	37	,	,	,
10_1101-2021_01_07_425675	212	38	D.	D.	NNP
10_1101-2021_01_07_425675	212	39	;	;	:
10_1101-2021_01_07_425675	212	40	Bafna	Bafna	NNP
10_1101-2021_01_07_425675	212	41	,	,	,
10_1101-2021_01_07_425675	212	42	V.	V.	NNP
10_1101-2021_01_07_425675	212	43	,	,	,
10_1101-2021_01_07_425675	212	44	Resurrection	Resurrection	NNP
10_1101-2021_01_07_425675	212	45	of	of	IN
10_1101-2021_01_07_425675	212	46	a	a	DT
10_1101-2021_01_07_425675	212	47	clinical	clinical	JJ
10_1101-2021_01_07_425675	212	48	antibody	antibody	NN
10_1101-2021_01_07_425675	212	49	:	:	:
10_1101-2021_01_07_425675	212	50	Template	template	NN
10_1101-2021_01_07_425675	212	51	377	377	CD
10_1101-2021_01_07_425675	212	52	proteogenomic	proteogenomic	NN
10_1101-2021_01_07_425675	212	53	de	de	FW
10_1101-2021_01_07_425675	212	54	novo	novo	NNP
10_1101-2021_01_07_425675	212	55	proteomic	proteomic	NNP
10_1101-2021_01_07_425675	212	56	sequencing	sequencing	NNP
10_1101-2021_01_07_425675	212	57	and	and	CC
10_1101-2021_01_07_425675	212	58	reverse	reverse	VB
10_1101-2021_01_07_425675	212	59	engineering	engineering	NN
10_1101-2021_01_07_425675	212	60	of	of	IN
10_1101-2021_01_07_425675	212	61	an	an	DT
10_1101-2021_01_07_425675	212	62	anti	anti	JJ
10_1101-2021_01_07_425675	212	63	-	-	JJ
10_1101-2021_01_07_425675	212	64	lymphotoxin-378	lymphotoxin-378	JJ
10_1101-2021_01_07_425675	212	65	α	α	NNP
10_1101-2021_01_07_425675	212	66	antibody	antibody	NN
10_1101-2021_01_07_425675	212	67	.	.	.
10_1101-2021_01_07_425675	213	1	Proteomics	proteomic	NNS
10_1101-2021_01_07_425675	213	2	2011	2011	CD
10_1101-2021_01_07_425675	213	3	,	,	,
10_1101-2021_01_07_425675	213	4	11	11	CD
10_1101-2021_01_07_425675	213	5	(	(	-LRB-
10_1101-2021_01_07_425675	213	6	3	3	CD
10_1101-2021_01_07_425675	213	7	)	)	-RRB-
10_1101-2021_01_07_425675	213	8	,	,	,
10_1101-2021_01_07_425675	213	9	395	395	CD
10_1101-2021_01_07_425675	213	10	-	-	SYM
10_1101-2021_01_07_425675	213	11	405	405	CD
10_1101-2021_01_07_425675	213	12	.	.	.
10_1101-2021_01_07_425675	214	1	379	379	CD
10_1101-2021_01_07_425675	214	2	12	12	CD
10_1101-2021_01_07_425675	214	3	.	.	.
10_1101-2021_01_07_425675	215	1	Chen	Chen	NNP
10_1101-2021_01_07_425675	215	2	,	,	,
10_1101-2021_01_07_425675	215	3	J.	J.	NNP
10_1101-2021_01_07_425675	215	4	;	;	:
10_1101-2021_01_07_425675	215	5	Zheng	Zheng	NNP
10_1101-2021_01_07_425675	215	6	,	,	,
10_1101-2021_01_07_425675	215	7	Q.	Q.	NNP
10_1101-2021_01_07_425675	215	8	;	;	:
10_1101-2021_01_07_425675	215	9	Hammers	Hammers	NNP
10_1101-2021_01_07_425675	215	10	,	,	,
10_1101-2021_01_07_425675	215	11	C.	C.	NNP
10_1101-2021_01_07_425675	215	12	M.	M.	NNP
10_1101-2021_01_07_425675	215	13	;	;	:
10_1101-2021_01_07_425675	215	14	Ellebrecht	Ellebrecht	NNP
10_1101-2021_01_07_425675	215	15	,	,	,
10_1101-2021_01_07_425675	215	16	C.	C.	NNP
10_1101-2021_01_07_425675	215	17	T.	T.	NNP
10_1101-2021_01_07_425675	215	18	;	;	:
10_1101-2021_01_07_425675	215	19	Mukherjee	Mukherjee	NNP
10_1101-2021_01_07_425675	215	20	,	,	,
10_1101-2021_01_07_425675	215	21	E.	E.	NNP
10_1101-2021_01_07_425675	215	22	M.	M.	NNP
10_1101-2021_01_07_425675	215	23	;	;	:
10_1101-2021_01_07_425675	215	24	Tang	Tang	NNP
10_1101-2021_01_07_425675	215	25	,	,	,
10_1101-2021_01_07_425675	215	26	H.-Y.	H.-Y.	NNP
10_1101-2021_01_07_425675	216	1	;	;	:
10_1101-2021_01_07_425675	216	2	380	380	CD
10_1101-2021_01_07_425675	216	3	Lin	Lin	NNP
10_1101-2021_01_07_425675	216	4	,	,	,
10_1101-2021_01_07_425675	216	5	C.	C.	NNP
10_1101-2021_01_07_425675	216	6	;	;	:
10_1101-2021_01_07_425675	216	7	Yuan	Yuan	NNP
10_1101-2021_01_07_425675	216	8	,	,	,
10_1101-2021_01_07_425675	216	9	H.	H.	NNP
10_1101-2021_01_07_425675	216	10	;	;	:
10_1101-2021_01_07_425675	216	11	Pan	Pan	NNP
10_1101-2021_01_07_425675	216	12	,	,	,
10_1101-2021_01_07_425675	216	13	M.	M.	NNP
10_1101-2021_01_07_425675	216	14	;	;	:
10_1101-2021_01_07_425675	216	15	Langenhan	Langenhan	NNP
10_1101-2021_01_07_425675	216	16	,	,	,
10_1101-2021_01_07_425675	216	17	J.	J.	NNP
10_1101-2021_01_07_425675	216	18	,	,	,
10_1101-2021_01_07_425675	216	19	Proteomic	proteomic	JJ
10_1101-2021_01_07_425675	216	20	analysis	analysis	NN
10_1101-2021_01_07_425675	216	21	of	of	IN
10_1101-2021_01_07_425675	216	22	pemphigus	pemphigus	JJ
10_1101-2021_01_07_425675	216	23	autoantibodies	autoantibody	NNS
10_1101-2021_01_07_425675	216	24	381	381	CD
10_1101-2021_01_07_425675	216	25	indicates	indicate	VBZ
10_1101-2021_01_07_425675	216	26	a	a	DT
10_1101-2021_01_07_425675	216	27	larger	large	JJR
10_1101-2021_01_07_425675	216	28	,	,	,
10_1101-2021_01_07_425675	216	29	more	more	RBR
10_1101-2021_01_07_425675	216	30	diverse	diverse	JJ
10_1101-2021_01_07_425675	216	31	,	,	,
10_1101-2021_01_07_425675	216	32	and	and	CC
10_1101-2021_01_07_425675	216	33	more	more	RBR
10_1101-2021_01_07_425675	216	34	dynamic	dynamic	JJ
10_1101-2021_01_07_425675	216	35	repertoire	repertoire	NN
10_1101-2021_01_07_425675	216	36	than	than	IN
10_1101-2021_01_07_425675	216	37	determined	determine	VBN
10_1101-2021_01_07_425675	216	38	by	by	IN
10_1101-2021_01_07_425675	216	39	B	b	NN
10_1101-2021_01_07_425675	216	40	cell	cell	NN
10_1101-2021_01_07_425675	216	41	382	382	CD
10_1101-2021_01_07_425675	216	42	genetics	genetic	NNS
10_1101-2021_01_07_425675	216	43	.	.	.
10_1101-2021_01_07_425675	217	1	Cell	cell	NN
10_1101-2021_01_07_425675	217	2	reports	report	VBZ
10_1101-2021_01_07_425675	217	3	2017	2017	CD
10_1101-2021_01_07_425675	217	4	,	,	,
10_1101-2021_01_07_425675	217	5	18	18	CD
10_1101-2021_01_07_425675	217	6	(	(	-LRB-
10_1101-2021_01_07_425675	217	7	1	1	CD
10_1101-2021_01_07_425675	217	8	)	)	-RRB-
10_1101-2021_01_07_425675	217	9	,	,	,
10_1101-2021_01_07_425675	217	10	237	237	CD
10_1101-2021_01_07_425675	217	11	-	-	SYM
10_1101-2021_01_07_425675	217	12	247	247	CD
10_1101-2021_01_07_425675	217	13	.	.	.
10_1101-2021_01_07_425675	218	1	383	383	CD
10_1101-2021_01_07_425675	218	2	13	13	CD
10_1101-2021_01_07_425675	218	3	.	.	.
10_1101-2021_01_07_425675	219	1	Cheung	Cheung	NNP
10_1101-2021_01_07_425675	219	2	,	,	,
10_1101-2021_01_07_425675	219	3	W.	W.	NNP
10_1101-2021_01_07_425675	219	4	C.	C.	NNP
10_1101-2021_01_07_425675	219	5	;	;	:
10_1101-2021_01_07_425675	219	6	Beausoleil	Beausoleil	NNP
10_1101-2021_01_07_425675	219	7	,	,	,
10_1101-2021_01_07_425675	219	8	S.	S.	NNP
10_1101-2021_01_07_425675	219	9	A.	A.	NNP
10_1101-2021_01_07_425675	219	10	;	;	:
10_1101-2021_01_07_425675	219	11	Zhang	Zhang	NNP
10_1101-2021_01_07_425675	219	12	,	,	,
10_1101-2021_01_07_425675	219	13	X.	X.	NNP
10_1101-2021_01_07_425675	219	14	;	;	:
10_1101-2021_01_07_425675	219	15	Sato	Sato	NNP
10_1101-2021_01_07_425675	219	16	,	,	,
10_1101-2021_01_07_425675	219	17	S.	S.	NNP
10_1101-2021_01_07_425675	219	18	;	;	:
10_1101-2021_01_07_425675	219	19	Schieferl	Schieferl	NNP
10_1101-2021_01_07_425675	219	20	,	,	,
10_1101-2021_01_07_425675	219	21	S.	S.	NNP
10_1101-2021_01_07_425675	219	22	M.	M.	NNP
10_1101-2021_01_07_425675	219	23	;	;	:
10_1101-2021_01_07_425675	219	24	Wieler	Wieler	NNP
10_1101-2021_01_07_425675	219	25	,	,	,
10_1101-2021_01_07_425675	219	26	J.	J.	NNP
10_1101-2021_01_07_425675	219	27	S.	S.	NNP
10_1101-2021_01_07_425675	219	28	;	;	:
10_1101-2021_01_07_425675	219	29	384	384	CD
10_1101-2021_01_07_425675	219	30	Beaudet	Beaudet	NNP
10_1101-2021_01_07_425675	219	31	,	,	,
10_1101-2021_01_07_425675	219	32	J.	J.	NNP
10_1101-2021_01_07_425675	219	33	G.	G.	NNP
10_1101-2021_01_07_425675	219	34	;	;	:
10_1101-2021_01_07_425675	219	35	Ramenani	Ramenani	NNP
10_1101-2021_01_07_425675	219	36	,	,	,
10_1101-2021_01_07_425675	219	37	R.	R.	NNP
10_1101-2021_01_07_425675	219	38	K.	K.	NNP
10_1101-2021_01_07_425675	219	39	;	;	:
10_1101-2021_01_07_425675	219	40	Popova	Popova	NNP
10_1101-2021_01_07_425675	219	41	,	,	,
10_1101-2021_01_07_425675	219	42	L.	L.	NNP
10_1101-2021_01_07_425675	219	43	;	;	:
10_1101-2021_01_07_425675	219	44	Comb	Comb	NNP
10_1101-2021_01_07_425675	219	45	,	,	,
10_1101-2021_01_07_425675	219	46	M.	M.	NNP
10_1101-2021_01_07_425675	219	47	J.	J.	NNP
10_1101-2021_01_07_425675	219	48	,	,	,
10_1101-2021_01_07_425675	219	49	A	a	DT
10_1101-2021_01_07_425675	219	50	proteomics	proteomic	NNS
10_1101-2021_01_07_425675	219	51	approach	approach	NN
10_1101-2021_01_07_425675	219	52	for	for	IN
10_1101-2021_01_07_425675	219	53	the	the	DT
10_1101-2021_01_07_425675	219	54	385	385	CD
10_1101-2021_01_07_425675	219	55	identification	identification	NN
10_1101-2021_01_07_425675	219	56	and	and	CC
10_1101-2021_01_07_425675	219	57	cloning	clone	VBG
10_1101-2021_01_07_425675	219	58	of	of	IN
10_1101-2021_01_07_425675	219	59	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	219	60	antibodies	antibody	NNS
10_1101-2021_01_07_425675	219	61	from	from	IN
10_1101-2021_01_07_425675	219	62	serum	serum	NNP
10_1101-2021_01_07_425675	219	63	.	.	.
10_1101-2021_01_07_425675	220	1	Nature	nature	NN
10_1101-2021_01_07_425675	220	2	biotechnology	biotechnology	NN
10_1101-2021_01_07_425675	220	3	2012	2012	CD
10_1101-2021_01_07_425675	220	4	,	,	,
10_1101-2021_01_07_425675	220	5	30	30	CD
10_1101-2021_01_07_425675	220	6	386	386	CD
10_1101-2021_01_07_425675	220	7	(	(	-LRB-
10_1101-2021_01_07_425675	220	8	5	5	CD
10_1101-2021_01_07_425675	220	9	)	)	-RRB-
10_1101-2021_01_07_425675	220	10	,	,	,
10_1101-2021_01_07_425675	220	11	447	447	CD
10_1101-2021_01_07_425675	220	12	-	-	SYM
10_1101-2021_01_07_425675	220	13	452	452	CD
10_1101-2021_01_07_425675	220	14	.	.	.
10_1101-2021_01_07_425675	221	1	387	387	CD
10_1101-2021_01_07_425675	221	2	14	14	CD
10_1101-2021_01_07_425675	221	3	.	.	.
10_1101-2021_01_07_425675	222	1	Guthals	guthal	NNS
10_1101-2021_01_07_425675	222	2	,	,	,
10_1101-2021_01_07_425675	222	3	A.	a.	NN
10_1101-2021_01_07_425675	222	4	;	;	:
10_1101-2021_01_07_425675	222	5	Gan	Gan	NNP
10_1101-2021_01_07_425675	222	6	,	,	,
10_1101-2021_01_07_425675	222	7	Y.	Y.	NNP
10_1101-2021_01_07_425675	222	8	;	;	:
10_1101-2021_01_07_425675	222	9	Murray	Murray	NNP
10_1101-2021_01_07_425675	222	10	,	,	,
10_1101-2021_01_07_425675	222	11	L.	L.	NNP
10_1101-2021_01_07_425675	222	12	;	;	:
10_1101-2021_01_07_425675	222	13	Chen	Chen	NNP
10_1101-2021_01_07_425675	222	14	,	,	,
10_1101-2021_01_07_425675	222	15	Y.	Y.	NNP
10_1101-2021_01_07_425675	222	16	;	;	:
10_1101-2021_01_07_425675	222	17	Stinson	Stinson	NNP
10_1101-2021_01_07_425675	222	18	,	,	,
10_1101-2021_01_07_425675	222	19	J.	J.	NNP
10_1101-2021_01_07_425675	222	20	;	;	:
10_1101-2021_01_07_425675	222	21	Nakamura	Nakamura	NNP
10_1101-2021_01_07_425675	222	22	,	,	,
10_1101-2021_01_07_425675	222	23	G.	G.	NNP
10_1101-2021_01_07_425675	222	24	;	;	:
10_1101-2021_01_07_425675	222	25	Lill	Lill	NNP
10_1101-2021_01_07_425675	222	26	,	,	,
10_1101-2021_01_07_425675	222	27	J.	J.	NNP
10_1101-2021_01_07_425675	222	28	R.	R.	NNP
10_1101-2021_01_07_425675	222	29	;	;	:
10_1101-2021_01_07_425675	222	30	388	388	CD
10_1101-2021_01_07_425675	222	31	Sandoval	Sandoval	NNP
10_1101-2021_01_07_425675	222	32	,	,	,
10_1101-2021_01_07_425675	222	33	W.	W.	NNP
10_1101-2021_01_07_425675	222	34	;	;	:
10_1101-2021_01_07_425675	222	35	Bandeira	Bandeira	NNP
10_1101-2021_01_07_425675	222	36	,	,	,
10_1101-2021_01_07_425675	222	37	N.	N.	NNP
10_1101-2021_01_07_425675	222	38	,	,	,
10_1101-2021_01_07_425675	222	39	De	De	NNP
10_1101-2021_01_07_425675	222	40	novo	novo	NNP
10_1101-2021_01_07_425675	222	41	MS	MS	NNP
10_1101-2021_01_07_425675	222	42	/	/	SYM
10_1101-2021_01_07_425675	222	43	MS	MS	NNP
10_1101-2021_01_07_425675	222	44	sequencing	sequencing	NN
10_1101-2021_01_07_425675	222	45	of	of	IN
10_1101-2021_01_07_425675	222	46	native	native	JJ
10_1101-2021_01_07_425675	222	47	human	human	JJ
10_1101-2021_01_07_425675	222	48	antibodies	antibody	NNS
10_1101-2021_01_07_425675	222	49	.	.	.
10_1101-2021_01_07_425675	223	1	Journal	Journal	NNP
10_1101-2021_01_07_425675	223	2	of	of	IN
10_1101-2021_01_07_425675	223	3	389	389	CD
10_1101-2021_01_07_425675	223	4	proteome	proteome	NN
10_1101-2021_01_07_425675	223	5	research	research	NN
10_1101-2021_01_07_425675	223	6	2017	2017	CD
10_1101-2021_01_07_425675	223	7	,	,	,
10_1101-2021_01_07_425675	223	8	16	16	CD
10_1101-2021_01_07_425675	223	9	(	(	-LRB-
10_1101-2021_01_07_425675	223	10	1	1	CD
10_1101-2021_01_07_425675	223	11	)	)	-RRB-
10_1101-2021_01_07_425675	223	12	,	,	,
10_1101-2021_01_07_425675	223	13	45	45	CD
10_1101-2021_01_07_425675	223	14	-	-	SYM
10_1101-2021_01_07_425675	223	15	54	54	CD
10_1101-2021_01_07_425675	223	16	.	.	.
10_1101-2021_01_07_425675	224	1	390	390	CD
10_1101-2021_01_07_425675	224	2	15	15	CD
10_1101-2021_01_07_425675	224	3	.	.	.
10_1101-2021_01_07_425675	225	1	Lee	Lee	NNP
10_1101-2021_01_07_425675	225	2	,	,	,
10_1101-2021_01_07_425675	225	3	J.	J.	NNP
10_1101-2021_01_07_425675	225	4	;	;	:
10_1101-2021_01_07_425675	225	5	Boutz	Boutz	NNP
10_1101-2021_01_07_425675	225	6	,	,	,
10_1101-2021_01_07_425675	225	7	D.	D.	NNP
10_1101-2021_01_07_425675	225	8	R.	R.	NNP
10_1101-2021_01_07_425675	225	9	;	;	:
10_1101-2021_01_07_425675	225	10	Chromikova	Chromikova	NNP
10_1101-2021_01_07_425675	225	11	,	,	,
10_1101-2021_01_07_425675	225	12	V.	V.	NNP
10_1101-2021_01_07_425675	225	13	;	;	:
10_1101-2021_01_07_425675	225	14	Joyce	Joyce	NNP
10_1101-2021_01_07_425675	225	15	,	,	,
10_1101-2021_01_07_425675	225	16	M.	M.	NNP
10_1101-2021_01_07_425675	225	17	G.	G.	NNP
10_1101-2021_01_07_425675	225	18	;	;	:
10_1101-2021_01_07_425675	225	19	Vollmers	Vollmers	NNP
10_1101-2021_01_07_425675	225	20	,	,	,
10_1101-2021_01_07_425675	225	21	C.	C.	NNP
10_1101-2021_01_07_425675	225	22	;	;	:
10_1101-2021_01_07_425675	225	23	Leung	Leung	NNP
10_1101-2021_01_07_425675	225	24	,	,	,
10_1101-2021_01_07_425675	225	25	K.	K.	NNP
10_1101-2021_01_07_425675	225	26	;	;	:
10_1101-2021_01_07_425675	225	27	Horton	Horton	NNP
10_1101-2021_01_07_425675	225	28	,	,	,
10_1101-2021_01_07_425675	225	29	A.	a.	NN
10_1101-2021_01_07_425675	226	1	391	391	CD
10_1101-2021_01_07_425675	226	2	P.	P.	NNP
10_1101-2021_01_07_425675	226	3	;	;	:
10_1101-2021_01_07_425675	226	4	DeKosky	DeKosky	NNP
10_1101-2021_01_07_425675	226	5	,	,	,
10_1101-2021_01_07_425675	226	6	B.	B.	NNP
10_1101-2021_01_07_425675	226	7	J.	J.	NNP
10_1101-2021_01_07_425675	226	8	;	;	:
10_1101-2021_01_07_425675	226	9	Lee	Lee	NNP
10_1101-2021_01_07_425675	226	10	,	,	,
10_1101-2021_01_07_425675	226	11	C.-H.	C.-H.	NNP
10_1101-2021_01_07_425675	226	12	;	;	:
10_1101-2021_01_07_425675	226	13	Lavinder	Lavinder	NNP
10_1101-2021_01_07_425675	226	14	,	,	,
10_1101-2021_01_07_425675	226	15	J.	J.	NNP
10_1101-2021_01_07_425675	226	16	J.	J.	NNP
10_1101-2021_01_07_425675	226	17	,	,	,
10_1101-2021_01_07_425675	226	18	Molecular	Molecular	NNP
10_1101-2021_01_07_425675	226	19	-	-	HYPH
10_1101-2021_01_07_425675	226	20	level	level	NN
10_1101-2021_01_07_425675	226	21	analysis	analysis	NN
10_1101-2021_01_07_425675	226	22	of	of	IN
10_1101-2021_01_07_425675	226	23	the	the	DT
10_1101-2021_01_07_425675	226	24	serum	serum	NNP
10_1101-2021_01_07_425675	226	25	antibody	antibody	NN
10_1101-2021_01_07_425675	226	26	392	392	CD
10_1101-2021_01_07_425675	226	27	repertoire	repertoire	NN
10_1101-2021_01_07_425675	226	28	in	in	IN
10_1101-2021_01_07_425675	226	29	young	young	JJ
10_1101-2021_01_07_425675	226	30	adults	adult	NNS
10_1101-2021_01_07_425675	226	31	before	before	IN
10_1101-2021_01_07_425675	226	32	and	and	CC
10_1101-2021_01_07_425675	226	33	after	after	IN
10_1101-2021_01_07_425675	226	34	seasonal	seasonal	JJ
10_1101-2021_01_07_425675	226	35	influenza	influenza	NN
10_1101-2021_01_07_425675	226	36	vaccination	vaccination	NN
10_1101-2021_01_07_425675	226	37	.	.	.
10_1101-2021_01_07_425675	227	1	Nature	nature	NN
10_1101-2021_01_07_425675	227	2	medicine	medicine	NN
10_1101-2021_01_07_425675	227	3	393	393	CD
10_1101-2021_01_07_425675	227	4	2016	2016	CD
10_1101-2021_01_07_425675	227	5	,	,	,
10_1101-2021_01_07_425675	227	6	22	22	CD
10_1101-2021_01_07_425675	227	7	(	(	-LRB-
10_1101-2021_01_07_425675	227	8	12	12	CD
10_1101-2021_01_07_425675	227	9	)	)	-RRB-
10_1101-2021_01_07_425675	227	10	,	,	,
10_1101-2021_01_07_425675	227	11	1456	1456	CD
10_1101-2021_01_07_425675	227	12	-	-	SYM
10_1101-2021_01_07_425675	227	13	1464	1464	CD
10_1101-2021_01_07_425675	227	14	.	.	.
10_1101-2021_01_07_425675	228	1	394	394	CD
10_1101-2021_01_07_425675	228	2	16	16	CD
10_1101-2021_01_07_425675	228	3	.	.	.
10_1101-2021_01_07_425675	229	1	Lee	Lee	NNP
10_1101-2021_01_07_425675	229	2	,	,	,
10_1101-2021_01_07_425675	229	3	J.	J.	NNP
10_1101-2021_01_07_425675	229	4	;	;	:
10_1101-2021_01_07_425675	229	5	Paparoditis	Paparoditis	NNP
10_1101-2021_01_07_425675	229	6	,	,	,
10_1101-2021_01_07_425675	229	7	P.	P.	NNP
10_1101-2021_01_07_425675	229	8	;	;	:
10_1101-2021_01_07_425675	229	9	Horton	Horton	NNP
10_1101-2021_01_07_425675	229	10	,	,	,
10_1101-2021_01_07_425675	229	11	A.	A.	NNP
10_1101-2021_01_07_425675	229	12	P.	P.	NNP
10_1101-2021_01_07_425675	229	13	;	;	:
10_1101-2021_01_07_425675	229	14	Frühwirth	Frühwirth	NNP
10_1101-2021_01_07_425675	229	15	,	,	,
10_1101-2021_01_07_425675	229	16	A.	A.	NNP
10_1101-2021_01_07_425675	229	17	;	;	:
10_1101-2021_01_07_425675	229	18	McDaniel	McDaniel	NNP
10_1101-2021_01_07_425675	229	19	,	,	,
10_1101-2021_01_07_425675	229	20	J.	J.	NNP
10_1101-2021_01_07_425675	229	21	R.	R.	NNP
10_1101-2021_01_07_425675	229	22	;	;	:
10_1101-2021_01_07_425675	229	23	Jung	Jung	NNP
10_1101-2021_01_07_425675	229	24	,	,	,
10_1101-2021_01_07_425675	229	25	J.	J.	NNP
10_1101-2021_01_07_425675	229	26	;	;	:
10_1101-2021_01_07_425675	229	27	Boutz	Boutz	NNP
10_1101-2021_01_07_425675	229	28	,	,	,
10_1101-2021_01_07_425675	229	29	D.	D.	NNP
10_1101-2021_01_07_425675	229	30	395	395	CD
10_1101-2021_01_07_425675	229	31	R.	R.	NNP
10_1101-2021_01_07_425675	229	32	;	;	:
10_1101-2021_01_07_425675	229	33	Hussein	Hussein	NNP
10_1101-2021_01_07_425675	229	34	,	,	,
10_1101-2021_01_07_425675	229	35	D.	D.	NNP
10_1101-2021_01_07_425675	229	36	A.	A.	NNP
10_1101-2021_01_07_425675	229	37	;	;	:
10_1101-2021_01_07_425675	229	38	Tanno	Tanno	NNP
10_1101-2021_01_07_425675	229	39	,	,	,
10_1101-2021_01_07_425675	229	40	Y.	Y.	NNP
10_1101-2021_01_07_425675	229	41	;	;	:
10_1101-2021_01_07_425675	229	42	Pappas	Pappas	NNP
10_1101-2021_01_07_425675	229	43	,	,	,
10_1101-2021_01_07_425675	229	44	L.	L.	NNP
10_1101-2021_01_07_425675	229	45	,	,	,
10_1101-2021_01_07_425675	229	46	Persistent	persistent	JJ
10_1101-2021_01_07_425675	229	47	antibody	antibody	NN
10_1101-2021_01_07_425675	229	48	clonotypes	clonotype	NNS
10_1101-2021_01_07_425675	229	49	dominate	dominate	VBP
10_1101-2021_01_07_425675	229	50	the	the	DT
10_1101-2021_01_07_425675	229	51	serum	serum	NN
10_1101-2021_01_07_425675	229	52	396	396	CD
10_1101-2021_01_07_425675	229	53	response	response	NN
10_1101-2021_01_07_425675	229	54	to	to	TO
10_1101-2021_01_07_425675	229	55	influenza	influenza	VB
10_1101-2021_01_07_425675	229	56	over	over	IN
10_1101-2021_01_07_425675	229	57	multiple	multiple	JJ
10_1101-2021_01_07_425675	229	58	years	year	NNS
10_1101-2021_01_07_425675	229	59	and	and	CC
10_1101-2021_01_07_425675	229	60	repeated	repeat	VBN
10_1101-2021_01_07_425675	229	61	vaccinations	vaccination	NNS
10_1101-2021_01_07_425675	229	62	.	.	.
10_1101-2021_01_07_425675	230	1	Cell	Cell	NNP
10_1101-2021_01_07_425675	230	2	host	host	NN
10_1101-2021_01_07_425675	230	3	&	&	CC
10_1101-2021_01_07_425675	230	4	microbe	microbe	NNP
10_1101-2021_01_07_425675	230	5	2019	2019	CD
10_1101-2021_01_07_425675	230	6	,	,	,
10_1101-2021_01_07_425675	230	7	397	397	CD
10_1101-2021_01_07_425675	230	8	25	25	CD
10_1101-2021_01_07_425675	230	9	(	(	-LRB-
10_1101-2021_01_07_425675	230	10	3	3	CD
10_1101-2021_01_07_425675	230	11	)	)	-RRB-
10_1101-2021_01_07_425675	230	12	,	,	,
10_1101-2021_01_07_425675	230	13	367	367	CD
10_1101-2021_01_07_425675	230	14	-	-	SYM
10_1101-2021_01_07_425675	230	15	376	376	CD
10_1101-2021_01_07_425675	230	16	.	.	.
10_1101-2021_01_07_425675	230	17	e5	e5	NN
10_1101-2021_01_07_425675	230	18	.	.	.
10_1101-2021_01_07_425675	231	1	398	398	CD
10_1101-2021_01_07_425675	231	2	17	17	CD
10_1101-2021_01_07_425675	231	3	.	.	.
10_1101-2021_01_07_425675	232	1	Lindesmith	Lindesmith	NNP
10_1101-2021_01_07_425675	232	2	,	,	,
10_1101-2021_01_07_425675	232	3	L.	L.	NNP
10_1101-2021_01_07_425675	232	4	C.	C.	NNP
10_1101-2021_01_07_425675	232	5	;	;	:
10_1101-2021_01_07_425675	232	6	McDaniel	McDaniel	NNP
10_1101-2021_01_07_425675	232	7	,	,	,
10_1101-2021_01_07_425675	232	8	J.	J.	NNP
10_1101-2021_01_07_425675	232	9	R.	R.	NNP
10_1101-2021_01_07_425675	232	10	;	;	:
10_1101-2021_01_07_425675	232	11	Changela	Changela	NNP
10_1101-2021_01_07_425675	232	12	,	,	,
10_1101-2021_01_07_425675	232	13	A.	A.	NNP
10_1101-2021_01_07_425675	232	14	;	;	:
10_1101-2021_01_07_425675	232	15	Verardi	Verardi	NNP
10_1101-2021_01_07_425675	232	16	,	,	,
10_1101-2021_01_07_425675	232	17	R.	R.	NNP
10_1101-2021_01_07_425675	232	18	;	;	:
10_1101-2021_01_07_425675	232	19	Kerr	Kerr	NNP
10_1101-2021_01_07_425675	232	20	,	,	,
10_1101-2021_01_07_425675	232	21	S.	S.	NNP
10_1101-2021_01_07_425675	232	22	A.	A.	NNP
10_1101-2021_01_07_425675	232	23	;	;	:
10_1101-2021_01_07_425675	232	24	Costantini	Costantini	NNP
10_1101-2021_01_07_425675	232	25	,	,	,
10_1101-2021_01_07_425675	232	26	V.	V.	NNP
10_1101-2021_01_07_425675	232	27	;	;	:
10_1101-2021_01_07_425675	232	28	399	399	CD
10_1101-2021_01_07_425675	232	29	Brewer	Brewer	NNP
10_1101-2021_01_07_425675	232	30	-	-	HYPH
10_1101-2021_01_07_425675	232	31	Jensen	Jensen	NNP
10_1101-2021_01_07_425675	232	32	,	,	,
10_1101-2021_01_07_425675	232	33	P.	P.	NNP
10_1101-2021_01_07_425675	232	34	D.	D.	NNP
10_1101-2021_01_07_425675	232	35	;	;	:
10_1101-2021_01_07_425675	232	36	Mallory	Mallory	NNP
10_1101-2021_01_07_425675	232	37	,	,	,
10_1101-2021_01_07_425675	232	38	M.	M.	NNP
10_1101-2021_01_07_425675	232	39	L.	L.	NNP
10_1101-2021_01_07_425675	232	40	;	;	:
10_1101-2021_01_07_425675	232	41	Voss	Voss	NNP
10_1101-2021_01_07_425675	232	42	,	,	,
10_1101-2021_01_07_425675	232	43	W.	W.	NNP
10_1101-2021_01_07_425675	232	44	N.	N.	NNP
10_1101-2021_01_07_425675	232	45	;	;	:
10_1101-2021_01_07_425675	232	46	Boutz	Boutz	NNP
10_1101-2021_01_07_425675	232	47	,	,	,
10_1101-2021_01_07_425675	232	48	D.	D.	NNP
10_1101-2021_01_07_425675	232	49	R.	R.	NNP
10_1101-2021_01_07_425675	232	50	,	,	,
10_1101-2021_01_07_425675	232	51	Sera	Sera	NNP
10_1101-2021_01_07_425675	232	52	antibody	antibody	NN
10_1101-2021_01_07_425675	232	53	repertoire	repertoire	NN
10_1101-2021_01_07_425675	232	54	400	400	CD
10_1101-2021_01_07_425675	232	55	analyses	analysis	NNS
10_1101-2021_01_07_425675	232	56	reveal	reveal	VB
10_1101-2021_01_07_425675	232	57	mechanisms	mechanism	NNS
10_1101-2021_01_07_425675	232	58	of	of	IN
10_1101-2021_01_07_425675	232	59	broad	broad	JJ
10_1101-2021_01_07_425675	232	60	and	and	CC
10_1101-2021_01_07_425675	232	61	pandemic	pandemic	JJ
10_1101-2021_01_07_425675	232	62	strain	strain	NN
10_1101-2021_01_07_425675	232	63	neutralizing	neutralize	VBG
10_1101-2021_01_07_425675	232	64	responses	response	NNS
10_1101-2021_01_07_425675	232	65	after	after	IN
10_1101-2021_01_07_425675	232	66	human	human	JJ
10_1101-2021_01_07_425675	232	67	401	401	CD
10_1101-2021_01_07_425675	232	68	norovirus	norovirus	NNP
10_1101-2021_01_07_425675	232	69	vaccination	vaccination	NN
10_1101-2021_01_07_425675	232	70	.	.	.
10_1101-2021_01_07_425675	233	1	Immunity	immunity	NN
10_1101-2021_01_07_425675	233	2	2019	2019	CD
10_1101-2021_01_07_425675	233	3	,	,	,
10_1101-2021_01_07_425675	233	4	50	50	CD
10_1101-2021_01_07_425675	233	5	(	(	-LRB-
10_1101-2021_01_07_425675	233	6	6	6	CD
10_1101-2021_01_07_425675	233	7	)	)	-RRB-
10_1101-2021_01_07_425675	233	8	,	,	,
10_1101-2021_01_07_425675	233	9	1530	1530	CD
10_1101-2021_01_07_425675	233	10	-	-	SYM
10_1101-2021_01_07_425675	233	11	1541	1541	CD
10_1101-2021_01_07_425675	233	12	.	.	.
10_1101-2021_01_07_425675	233	13	e8	e8	NNS
10_1101-2021_01_07_425675	233	14	.	.	.
10_1101-2021_01_07_425675	234	1	402	402	CD
10_1101-2021_01_07_425675	234	2	18	18	CD
10_1101-2021_01_07_425675	234	3	.	.	.
10_1101-2021_01_07_425675	235	1	Bandeira	Bandeira	NNP
10_1101-2021_01_07_425675	235	2	,	,	,
10_1101-2021_01_07_425675	235	3	N.	N.	NNP
10_1101-2021_01_07_425675	235	4	;	;	:
10_1101-2021_01_07_425675	235	5	Pham	Pham	NNP
10_1101-2021_01_07_425675	235	6	,	,	,
10_1101-2021_01_07_425675	235	7	V.	V.	NNP
10_1101-2021_01_07_425675	235	8	;	;	:
10_1101-2021_01_07_425675	235	9	Pevzner	Pevzner	NNP
10_1101-2021_01_07_425675	235	10	,	,	,
10_1101-2021_01_07_425675	235	11	P.	P.	NNP
10_1101-2021_01_07_425675	235	12	;	;	:
10_1101-2021_01_07_425675	235	13	Arnott	Arnott	NNP
10_1101-2021_01_07_425675	235	14	,	,	,
10_1101-2021_01_07_425675	235	15	D.	D.	NNP
10_1101-2021_01_07_425675	235	16	;	;	:
10_1101-2021_01_07_425675	235	17	Lill	Lill	NNP
10_1101-2021_01_07_425675	235	18	,	,	,
10_1101-2021_01_07_425675	235	19	J.	J.	NNP
10_1101-2021_01_07_425675	235	20	R.	R.	NNP
10_1101-2021_01_07_425675	235	21	,	,	,
10_1101-2021_01_07_425675	235	22	Automated	Automated	NNP
10_1101-2021_01_07_425675	235	23	de	de	NNP
10_1101-2021_01_07_425675	235	24	novo	novo	NNP
10_1101-2021_01_07_425675	235	25	protein	protein	NN
10_1101-2021_01_07_425675	235	26	403	403	CD
10_1101-2021_01_07_425675	235	27	sequencing	sequencing	NN
10_1101-2021_01_07_425675	235	28	of	of	IN
10_1101-2021_01_07_425675	235	29	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	235	30	antibodies	antibody	NNS
10_1101-2021_01_07_425675	235	31	.	.	.
10_1101-2021_01_07_425675	236	1	Nature	nature	NN
10_1101-2021_01_07_425675	236	2	biotechnology	biotechnology	NN
10_1101-2021_01_07_425675	236	3	2008	2008	CD
10_1101-2021_01_07_425675	236	4	,	,	,
10_1101-2021_01_07_425675	236	5	26	26	CD
10_1101-2021_01_07_425675	236	6	(	(	-LRB-
10_1101-2021_01_07_425675	236	7	12	12	CD
10_1101-2021_01_07_425675	236	8	)	)	-RRB-
10_1101-2021_01_07_425675	236	9	,	,	,
10_1101-2021_01_07_425675	236	10	1336	1336	CD
10_1101-2021_01_07_425675	236	11	-	-	SYM
10_1101-2021_01_07_425675	236	12	1338	1338	CD
10_1101-2021_01_07_425675	236	13	.	.	.
10_1101-2021_01_07_425675	237	1	404	404	CD
10_1101-2021_01_07_425675	237	2	19	19	CD
10_1101-2021_01_07_425675	237	3	.	.	.
10_1101-2021_01_07_425675	238	1	Rickert	Rickert	NNP
10_1101-2021_01_07_425675	238	2	,	,	,
10_1101-2021_01_07_425675	238	3	K.	K.	NNP
10_1101-2021_01_07_425675	238	4	W.	W.	NNP
10_1101-2021_01_07_425675	238	5	;	;	:
10_1101-2021_01_07_425675	238	6	Grinberg	Grinberg	NNP
10_1101-2021_01_07_425675	238	7	,	,	,
10_1101-2021_01_07_425675	238	8	L.	L.	NNP
10_1101-2021_01_07_425675	238	9	;	;	:
10_1101-2021_01_07_425675	238	10	Woods	Woods	NNP
10_1101-2021_01_07_425675	238	11	,	,	,
10_1101-2021_01_07_425675	238	12	R.	R.	NNP
10_1101-2021_01_07_425675	238	13	M.	M.	NNP
10_1101-2021_01_07_425675	238	14	;	;	:
10_1101-2021_01_07_425675	238	15	Wilson	Wilson	NNP
10_1101-2021_01_07_425675	238	16	,	,	,
10_1101-2021_01_07_425675	238	17	S.	S.	NNP
10_1101-2021_01_07_425675	238	18	;	;	:
10_1101-2021_01_07_425675	238	19	Bowen	Bowen	NNP
10_1101-2021_01_07_425675	238	20	,	,	,
10_1101-2021_01_07_425675	238	21	M.	M.	NNP
10_1101-2021_01_07_425675	238	22	A.	A.	NNP
10_1101-2021_01_07_425675	238	23	;	;	:
10_1101-2021_01_07_425675	238	24	Baca	Baca	NNP
10_1101-2021_01_07_425675	238	25	,	,	,
10_1101-2021_01_07_425675	238	26	M.	M.	NNP
10_1101-2021_01_07_425675	238	27	In	In	NNP
10_1101-2021_01_07_425675	238	28	405	405	CD
10_1101-2021_01_07_425675	238	29	Combining	combine	VBG
10_1101-2021_01_07_425675	238	30	phage	phage	NN
10_1101-2021_01_07_425675	238	31	display	display	NN
10_1101-2021_01_07_425675	238	32	with	with	IN
10_1101-2021_01_07_425675	238	33	de	de	FW
10_1101-2021_01_07_425675	238	34	novo	novo	NNP
10_1101-2021_01_07_425675	238	35	protein	protein	NN
10_1101-2021_01_07_425675	238	36	sequencing	sequence	VBG
10_1101-2021_01_07_425675	238	37	for	for	IN
10_1101-2021_01_07_425675	238	38	reverse	reverse	JJ
10_1101-2021_01_07_425675	238	39	engineering	engineering	NN
10_1101-2021_01_07_425675	238	40	of	of	IN
10_1101-2021_01_07_425675	238	41	406	406	CD
10_1101-2021_01_07_425675	238	42	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	238	43	antibodies	antibody	NNS
10_1101-2021_01_07_425675	238	44	,	,	,
10_1101-2021_01_07_425675	238	45	MAbs	MAbs	NNP
10_1101-2021_01_07_425675	238	46	,	,	,
10_1101-2021_01_07_425675	238	47	Taylor	Taylor	NNP
10_1101-2021_01_07_425675	238	48	&	&	CC
10_1101-2021_01_07_425675	238	49	Francis	Francis	NNP
10_1101-2021_01_07_425675	238	50	:	:	:
10_1101-2021_01_07_425675	238	51	2016	2016	CD
10_1101-2021_01_07_425675	238	52	;	;	:
10_1101-2021_01_07_425675	238	53	pp	pp	NNP
10_1101-2021_01_07_425675	238	54	501	501	CD
10_1101-2021_01_07_425675	238	55	-	-	SYM
10_1101-2021_01_07_425675	238	56	512	512	CD
10_1101-2021_01_07_425675	238	57	.	.	.
10_1101-2021_01_07_425675	239	1	407	407	CD
10_1101-2021_01_07_425675	239	2	20	20	CD
10_1101-2021_01_07_425675	239	3	.	.	.
10_1101-2021_01_07_425675	240	1	Savidor	savidor	NN
10_1101-2021_01_07_425675	240	2	,	,	,
10_1101-2021_01_07_425675	240	3	A.	a.	NN
10_1101-2021_01_07_425675	240	4	;	;	:
10_1101-2021_01_07_425675	240	5	Barzilay	Barzilay	NNP
10_1101-2021_01_07_425675	240	6	,	,	,
10_1101-2021_01_07_425675	240	7	R.	R.	NNP
10_1101-2021_01_07_425675	240	8	;	;	:
10_1101-2021_01_07_425675	240	9	Elinger	Elinger	NNP
10_1101-2021_01_07_425675	240	10	,	,	,
10_1101-2021_01_07_425675	240	11	D.	D.	NNP
10_1101-2021_01_07_425675	240	12	;	;	:
10_1101-2021_01_07_425675	240	13	Yarden	Yarden	NNP
10_1101-2021_01_07_425675	240	14	,	,	,
10_1101-2021_01_07_425675	240	15	Y.	Y.	NNP
10_1101-2021_01_07_425675	240	16	;	;	:
10_1101-2021_01_07_425675	240	17	Lindzen	Lindzen	NNP
10_1101-2021_01_07_425675	240	18	,	,	,
10_1101-2021_01_07_425675	240	19	M.	M.	NNP
10_1101-2021_01_07_425675	240	20	;	;	:
10_1101-2021_01_07_425675	240	21	Gabashvili	Gabashvili	NNP
10_1101-2021_01_07_425675	240	22	,	,	,
10_1101-2021_01_07_425675	240	23	A.	a.	NN
10_1101-2021_01_07_425675	240	24	;	;	:
10_1101-2021_01_07_425675	240	25	Tal	Tal	NNP
10_1101-2021_01_07_425675	240	26	,	,	,
10_1101-2021_01_07_425675	240	27	O.	O.	NNP
10_1101-2021_01_07_425675	241	1	A.	A.	NNP
10_1101-2021_01_07_425675	241	2	;	;	:
10_1101-2021_01_07_425675	241	3	408	408	CD
10_1101-2021_01_07_425675	241	4	Levin	Levin	NNP
10_1101-2021_01_07_425675	241	5	,	,	,
10_1101-2021_01_07_425675	241	6	Y.	Y.	NNP
10_1101-2021_01_07_425675	241	7	,	,	,
10_1101-2021_01_07_425675	241	8	Database	Database	NNP
10_1101-2021_01_07_425675	241	9	-	-	HYPH
10_1101-2021_01_07_425675	241	10	Independent	Independent	NNP
10_1101-2021_01_07_425675	241	11	Protein	Protein	NNP
10_1101-2021_01_07_425675	241	12	Sequencing	Sequencing	NNP
10_1101-2021_01_07_425675	241	13	(	(	-LRB-
10_1101-2021_01_07_425675	241	14	DiPS	dips	NN
10_1101-2021_01_07_425675	241	15	)	)	-RRB-
10_1101-2021_01_07_425675	241	16	Enables	enable	VBZ
10_1101-2021_01_07_425675	241	17	Full	full	JJ
10_1101-2021_01_07_425675	241	18	-	-	HYPH
10_1101-2021_01_07_425675	241	19	Length	length	NN
10_1101-2021_01_07_425675	241	20	de	de	IN
10_1101-2021_01_07_425675	241	21	Novo	Novo	NNP
10_1101-2021_01_07_425675	241	22	409	409	CD
10_1101-2021_01_07_425675	241	23	Protein	Protein	NNP
10_1101-2021_01_07_425675	241	24	and	and	CC
10_1101-2021_01_07_425675	241	25	Antibody	Antibody	NNP
10_1101-2021_01_07_425675	241	26	Sequence	Sequence	NNP
10_1101-2021_01_07_425675	241	27	Determination	Determination	NNP
10_1101-2021_01_07_425675	241	28	.	.	.
10_1101-2021_01_07_425675	242	1	Molecular	Molecular	NNP
10_1101-2021_01_07_425675	242	2	&	&	CC
10_1101-2021_01_07_425675	242	3	Cellular	Cellular	NNP
10_1101-2021_01_07_425675	242	4	Proteomics	Proteomics	NNP
10_1101-2021_01_07_425675	242	5	2017	2017	CD
10_1101-2021_01_07_425675	242	6	,	,	,
10_1101-2021_01_07_425675	242	7	16	16	CD
10_1101-2021_01_07_425675	242	8	(	(	-LRB-
10_1101-2021_01_07_425675	242	9	6	6	CD
10_1101-2021_01_07_425675	242	10	)	)	-RRB-
10_1101-2021_01_07_425675	242	11	,	,	,
10_1101-2021_01_07_425675	242	12	410	410	CD
10_1101-2021_01_07_425675	242	13	1151	1151	CD
10_1101-2021_01_07_425675	242	14	-	-	SYM
10_1101-2021_01_07_425675	242	15	1161	1161	CD
10_1101-2021_01_07_425675	242	16	.	.	.
10_1101-2021_01_07_425675	243	1	411	411	CD
10_1101-2021_01_07_425675	243	2	.CC	.CC	:
10_1101-2021_01_07_425675	243	3	-	-	:
10_1101-2021_01_07_425675	243	4	BY	by	IN
10_1101-2021_01_07_425675	243	5	4.0	4.0	CD
10_1101-2021_01_07_425675	243	6	International	International	NNP
10_1101-2021_01_07_425675	243	7	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	243	8	under	under	IN
10_1101-2021_01_07_425675	243	9	a	a	DT
10_1101-2021_01_07_425675	243	10	(	(	-LRB-
10_1101-2021_01_07_425675	243	11	which	which	WDT
10_1101-2021_01_07_425675	243	12	was	be	VBD
10_1101-2021_01_07_425675	243	13	not	not	RB
10_1101-2021_01_07_425675	243	14	certified	certify	VBN
10_1101-2021_01_07_425675	243	15	by	by	IN
10_1101-2021_01_07_425675	243	16	peer	peer	NN
10_1101-2021_01_07_425675	243	17	review	review	NN
10_1101-2021_01_07_425675	243	18	)	)	-RRB-
10_1101-2021_01_07_425675	243	19	is	be	VBZ
10_1101-2021_01_07_425675	243	20	the	the	DT
10_1101-2021_01_07_425675	243	21	author	author	NN
10_1101-2021_01_07_425675	243	22	/	/	SYM
10_1101-2021_01_07_425675	243	23	funder	funder	NN
10_1101-2021_01_07_425675	243	24	,	,	,
10_1101-2021_01_07_425675	243	25	who	who	WP
10_1101-2021_01_07_425675	243	26	has	have	VBZ
10_1101-2021_01_07_425675	243	27	granted	grant	VBN
10_1101-2021_01_07_425675	243	28	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	243	29	a	a	DT
10_1101-2021_01_07_425675	243	30	license	license	NN
10_1101-2021_01_07_425675	243	31	to	to	TO
10_1101-2021_01_07_425675	243	32	display	display	VB
10_1101-2021_01_07_425675	243	33	the	the	DT
10_1101-2021_01_07_425675	243	34	preprint	preprint	NN
10_1101-2021_01_07_425675	243	35	in	in	IN
10_1101-2021_01_07_425675	243	36	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	243	37	.	.	.
10_1101-2021_01_07_425675	244	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	244	2	is	be	VBZ
10_1101-2021_01_07_425675	244	3	made	make	VBN
10_1101-2021_01_07_425675	244	4	The	the	DT
10_1101-2021_01_07_425675	244	5	copyright	copyright	NN
10_1101-2021_01_07_425675	244	6	holder	holder	NN
10_1101-2021_01_07_425675	244	7	for	for	IN
10_1101-2021_01_07_425675	244	8	this	this	DT
10_1101-2021_01_07_425675	244	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	244	10	version	version	NN
10_1101-2021_01_07_425675	244	11	posted	post	VBD
10_1101-2021_01_07_425675	244	12	January	January	NNP
10_1101-2021_01_07_425675	244	13	8	8	CD
10_1101-2021_01_07_425675	244	14	,	,	,
10_1101-2021_01_07_425675	244	15	2021	2021	CD
10_1101-2021_01_07_425675	244	16	.	.	.
10_1101-2021_01_07_425675	244	17	;	;	:
10_1101-2021_01_07_425675	244	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	244	19	:	:	:
10_1101-2021_01_07_425675	244	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	244	21	preprint	preprint	NN
10_1101-2021_01_07_425675	244	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NNP
10_1101-2021_01_07_425675	244	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	NNP
10_1101-2021_01_07_425675	244	24	16	16	CD
10_1101-2021_01_07_425675	244	25	21	21	CD
10_1101-2021_01_07_425675	244	26	.	.	.
10_1101-2021_01_07_425675	245	1	Sen	Sen	NNP
10_1101-2021_01_07_425675	245	2	,	,	,
10_1101-2021_01_07_425675	245	3	K.	K.	NNP
10_1101-2021_01_07_425675	245	4	I.	I.	NNP
10_1101-2021_01_07_425675	245	5	;	;	:
10_1101-2021_01_07_425675	245	6	Tang	Tang	NNP
10_1101-2021_01_07_425675	245	7	,	,	,
10_1101-2021_01_07_425675	245	8	W.	W.	NNP
10_1101-2021_01_07_425675	245	9	H.	H.	NNP
10_1101-2021_01_07_425675	245	10	;	;	:
10_1101-2021_01_07_425675	245	11	Nayak	Nayak	NNP
10_1101-2021_01_07_425675	245	12	,	,	,
10_1101-2021_01_07_425675	245	13	S.	S.	NNP
10_1101-2021_01_07_425675	245	14	;	;	:
10_1101-2021_01_07_425675	245	15	Kil	Kil	NNP
10_1101-2021_01_07_425675	245	16	,	,	,
10_1101-2021_01_07_425675	245	17	Y.	Y.	NNP
10_1101-2021_01_07_425675	245	18	J.	J.	NNP
10_1101-2021_01_07_425675	245	19	;	;	:
10_1101-2021_01_07_425675	245	20	Bern	Bern	NNP
10_1101-2021_01_07_425675	245	21	,	,	,
10_1101-2021_01_07_425675	245	22	M.	M.	NNP
10_1101-2021_01_07_425675	245	23	;	;	:
10_1101-2021_01_07_425675	245	24	Ozoglu	Ozoglu	NNP
10_1101-2021_01_07_425675	245	25	,	,	,
10_1101-2021_01_07_425675	245	26	B.	B.	NNP
10_1101-2021_01_07_425675	245	27	;	;	:
10_1101-2021_01_07_425675	245	28	Ueberheide	Ueberheide	NNP
10_1101-2021_01_07_425675	245	29	,	,	,
10_1101-2021_01_07_425675	245	30	B.	B.	NNP
10_1101-2021_01_07_425675	245	31	;	;	:
10_1101-2021_01_07_425675	245	32	Davis	Davis	NNP
10_1101-2021_01_07_425675	245	33	,	,	,
10_1101-2021_01_07_425675	245	34	412	412	CD
10_1101-2021_01_07_425675	245	35	D.	D.	NNP
10_1101-2021_01_07_425675	245	36	;	;	:
10_1101-2021_01_07_425675	245	37	Becker	Becker	NNP
10_1101-2021_01_07_425675	245	38	,	,	,
10_1101-2021_01_07_425675	245	39	C.	C.	NNP
10_1101-2021_01_07_425675	245	40	,	,	,
10_1101-2021_01_07_425675	245	41	Automated	Automated	NNP
10_1101-2021_01_07_425675	245	42	antibody	antibody	NN
10_1101-2021_01_07_425675	245	43	de	de	NNP
10_1101-2021_01_07_425675	245	44	novo	novo	NNP
10_1101-2021_01_07_425675	245	45	sequencing	sequencing	NNP
10_1101-2021_01_07_425675	245	46	and	and	CC
10_1101-2021_01_07_425675	245	47	its	-PRON-	PRP$
10_1101-2021_01_07_425675	245	48	utility	utility	NN
10_1101-2021_01_07_425675	245	49	in	in	IN
10_1101-2021_01_07_425675	245	50	biopharmaceutical	biopharmaceutical	JJ
10_1101-2021_01_07_425675	245	51	413	413	CD
10_1101-2021_01_07_425675	245	52	discovery	discovery	NN
10_1101-2021_01_07_425675	245	53	.	.	.
10_1101-2021_01_07_425675	246	1	Journal	Journal	NNP
10_1101-2021_01_07_425675	246	2	of	of	IN
10_1101-2021_01_07_425675	246	3	The	the	DT
10_1101-2021_01_07_425675	246	4	American	American	NNP
10_1101-2021_01_07_425675	246	5	Society	Society	NNP
10_1101-2021_01_07_425675	246	6	for	for	IN
10_1101-2021_01_07_425675	246	7	Mass	Mass	NNP
10_1101-2021_01_07_425675	246	8	Spectrometry	Spectrometry	NNP
10_1101-2021_01_07_425675	246	9	2017	2017	CD
10_1101-2021_01_07_425675	246	10	,	,	,
10_1101-2021_01_07_425675	246	11	28	28	CD
10_1101-2021_01_07_425675	246	12	(	(	-LRB-
10_1101-2021_01_07_425675	246	13	5	5	CD
10_1101-2021_01_07_425675	246	14	)	)	-RRB-
10_1101-2021_01_07_425675	246	15	,	,	,
10_1101-2021_01_07_425675	246	16	803	803	CD
10_1101-2021_01_07_425675	246	17	-	-	SYM
10_1101-2021_01_07_425675	246	18	810	810	CD
10_1101-2021_01_07_425675	246	19	.	.	.
10_1101-2021_01_07_425675	247	1	414	414	CD
10_1101-2021_01_07_425675	247	2	22	22	CD
10_1101-2021_01_07_425675	247	3	.	.	.
10_1101-2021_01_07_425675	248	1	Sousa	Sousa	NNP
10_1101-2021_01_07_425675	248	2	,	,	,
10_1101-2021_01_07_425675	248	3	E.	E.	NNP
10_1101-2021_01_07_425675	248	4	;	;	:
10_1101-2021_01_07_425675	248	5	Olland	Olland	NNP
10_1101-2021_01_07_425675	248	6	,	,	,
10_1101-2021_01_07_425675	248	7	S.	S.	NNP
10_1101-2021_01_07_425675	248	8	;	;	:
10_1101-2021_01_07_425675	248	9	Shih	Shih	NNP
10_1101-2021_01_07_425675	248	10	,	,	,
10_1101-2021_01_07_425675	248	11	H.	H.	NNP
10_1101-2021_01_07_425675	248	12	H.	H.	NNP
10_1101-2021_01_07_425675	248	13	;	;	:
10_1101-2021_01_07_425675	248	14	Marquette	Marquette	NNP
10_1101-2021_01_07_425675	248	15	,	,	,
10_1101-2021_01_07_425675	248	16	K.	K.	NNP
10_1101-2021_01_07_425675	248	17	;	;	:
10_1101-2021_01_07_425675	248	18	Martone	Martone	NNP
10_1101-2021_01_07_425675	248	19	,	,	,
10_1101-2021_01_07_425675	248	20	R.	R.	NNP
10_1101-2021_01_07_425675	248	21	;	;	:
10_1101-2021_01_07_425675	248	22	Lu	Lu	NNP
10_1101-2021_01_07_425675	248	23	,	,	,
10_1101-2021_01_07_425675	248	24	Z.	Z.	NNP
10_1101-2021_01_07_425675	248	25	;	;	:
10_1101-2021_01_07_425675	248	26	Paulsen	Paulsen	NNP
10_1101-2021_01_07_425675	248	27	,	,	,
10_1101-2021_01_07_425675	248	28	J.	J.	NNP
10_1101-2021_01_07_425675	248	29	;	;	:
10_1101-2021_01_07_425675	248	30	Gill	Gill	NNP
10_1101-2021_01_07_425675	248	31	,	,	,
10_1101-2021_01_07_425675	248	32	415	415	CD
10_1101-2021_01_07_425675	248	33	D.	D.	NNP
10_1101-2021_01_07_425675	248	34	;	;	:
10_1101-2021_01_07_425675	248	35	He	-PRON-	PRP
10_1101-2021_01_07_425675	248	36	,	,	,
10_1101-2021_01_07_425675	248	37	T.	t.	NN
10_1101-2021_01_07_425675	248	38	,	,	,
10_1101-2021_01_07_425675	248	39	Primary	primary	JJ
10_1101-2021_01_07_425675	248	40	sequence	sequence	NN
10_1101-2021_01_07_425675	248	41	determination	determination	NN
10_1101-2021_01_07_425675	248	42	of	of	IN
10_1101-2021_01_07_425675	248	43	a	a	DT
10_1101-2021_01_07_425675	248	44	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	248	45	antibody	antibody	NN
10_1101-2021_01_07_425675	248	46	against	against	IN
10_1101-2021_01_07_425675	248	47	α	α	NNP
10_1101-2021_01_07_425675	248	48	-	-	HYPH
10_1101-2021_01_07_425675	248	49	synuclein	synuclein	NNP
10_1101-2021_01_07_425675	248	50	using	use	VBG
10_1101-2021_01_07_425675	248	51	416	416	CD
10_1101-2021_01_07_425675	248	52	a	a	DT
10_1101-2021_01_07_425675	248	53	novel	novel	JJ
10_1101-2021_01_07_425675	248	54	mass	mass	NN
10_1101-2021_01_07_425675	248	55	spectrometry	spectrometry	NN
10_1101-2021_01_07_425675	248	56	-	-	HYPH
10_1101-2021_01_07_425675	248	57	based	base	VBN
10_1101-2021_01_07_425675	248	58	approach	approach	NN
10_1101-2021_01_07_425675	248	59	.	.	.
10_1101-2021_01_07_425675	249	1	International	International	NNP
10_1101-2021_01_07_425675	249	2	Journal	Journal	NNP
10_1101-2021_01_07_425675	249	3	of	of	IN
10_1101-2021_01_07_425675	249	4	Mass	Mass	NNP
10_1101-2021_01_07_425675	249	5	Spectrometry	Spectrometry	NNP
10_1101-2021_01_07_425675	249	6	2012	2012	CD
10_1101-2021_01_07_425675	249	7	,	,	,
10_1101-2021_01_07_425675	249	8	417	417	CD
10_1101-2021_01_07_425675	249	9	312	312	CD
10_1101-2021_01_07_425675	249	10	,	,	,
10_1101-2021_01_07_425675	249	11	61	61	CD
10_1101-2021_01_07_425675	249	12	-	-	SYM
10_1101-2021_01_07_425675	249	13	69	69	CD
10_1101-2021_01_07_425675	249	14	.	.	.
10_1101-2021_01_07_425675	250	1	418	418	CD
10_1101-2021_01_07_425675	250	2	23	23	CD
10_1101-2021_01_07_425675	250	3	.	.	.
10_1101-2021_01_07_425675	251	1	Tran	Tran	NNP
10_1101-2021_01_07_425675	251	2	,	,	,
10_1101-2021_01_07_425675	251	3	N.	N.	NNP
10_1101-2021_01_07_425675	251	4	H.	H.	NNP
10_1101-2021_01_07_425675	251	5	;	;	:
10_1101-2021_01_07_425675	251	6	Rahman	Rahman	NNP
10_1101-2021_01_07_425675	251	7	,	,	,
10_1101-2021_01_07_425675	251	8	M.	M.	NNP
10_1101-2021_01_07_425675	251	9	Z.	Z.	NNP
10_1101-2021_01_07_425675	251	10	;	;	:
10_1101-2021_01_07_425675	251	11	He	-PRON-	PRP
10_1101-2021_01_07_425675	251	12	,	,	,
10_1101-2021_01_07_425675	251	13	L.	L.	NNP
10_1101-2021_01_07_425675	251	14	;	;	:
10_1101-2021_01_07_425675	251	15	Xin	Xin	NNP
10_1101-2021_01_07_425675	251	16	,	,	,
10_1101-2021_01_07_425675	251	17	L.	L.	NNP
10_1101-2021_01_07_425675	251	18	;	;	:
10_1101-2021_01_07_425675	251	19	Shan	Shan	NNP
10_1101-2021_01_07_425675	251	20	,	,	,
10_1101-2021_01_07_425675	251	21	B.	B.	NNP
10_1101-2021_01_07_425675	251	22	;	;	:
10_1101-2021_01_07_425675	251	23	Li	Li	NNP
10_1101-2021_01_07_425675	251	24	,	,	,
10_1101-2021_01_07_425675	251	25	M.	M.	NNP
10_1101-2021_01_07_425675	251	26	,	,	,
10_1101-2021_01_07_425675	251	27	Complete	Complete	NNP
10_1101-2021_01_07_425675	251	28	de	de	NNP
10_1101-2021_01_07_425675	251	29	novo	novo	NNP
10_1101-2021_01_07_425675	251	30	assembly	assembly	NN
10_1101-2021_01_07_425675	251	31	419	419	CD
10_1101-2021_01_07_425675	251	32	of	of	IN
10_1101-2021_01_07_425675	251	33	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	251	34	antibody	antibody	NN
10_1101-2021_01_07_425675	251	35	sequences	sequence	NNS
10_1101-2021_01_07_425675	251	36	.	.	.
10_1101-2021_01_07_425675	252	1	Scientific	scientific	JJ
10_1101-2021_01_07_425675	252	2	reports	report	NNS
10_1101-2021_01_07_425675	252	3	2016	2016	CD
10_1101-2021_01_07_425675	252	4	,	,	,
10_1101-2021_01_07_425675	252	5	6	6	CD
10_1101-2021_01_07_425675	252	6	(	(	-LRB-
10_1101-2021_01_07_425675	252	7	1	1	CD
10_1101-2021_01_07_425675	252	8	)	)	-RRB-
10_1101-2021_01_07_425675	252	9	,	,	,
10_1101-2021_01_07_425675	252	10	1	1	CD
10_1101-2021_01_07_425675	252	11	-	-	SYM
10_1101-2021_01_07_425675	252	12	10	10	CD
10_1101-2021_01_07_425675	252	13	.	.	.
10_1101-2021_01_07_425675	253	1	420	420	CD
10_1101-2021_01_07_425675	253	2	24	24	CD
10_1101-2021_01_07_425675	253	3	.	.	.
10_1101-2021_01_07_425675	254	1	Brizzard	Brizzard	NNP
10_1101-2021_01_07_425675	254	2	,	,	,
10_1101-2021_01_07_425675	254	3	B.	B.	NNP
10_1101-2021_01_07_425675	254	4	L.	L.	NNP
10_1101-2021_01_07_425675	254	5	;	;	:
10_1101-2021_01_07_425675	254	6	Chubet	Chubet	NNP
10_1101-2021_01_07_425675	254	7	,	,	,
10_1101-2021_01_07_425675	254	8	R.	R.	NNP
10_1101-2021_01_07_425675	254	9	G.	G.	NNP
10_1101-2021_01_07_425675	254	10	;	;	:
10_1101-2021_01_07_425675	254	11	Vizard	Vizard	NNP
10_1101-2021_01_07_425675	254	12	,	,	,
10_1101-2021_01_07_425675	254	13	D.	D.	NNP
10_1101-2021_01_07_425675	254	14	,	,	,
10_1101-2021_01_07_425675	254	15	Immunoaffinity	Immunoaffinity	NNP
10_1101-2021_01_07_425675	254	16	purification	purification	NN
10_1101-2021_01_07_425675	254	17	of	of	IN
10_1101-2021_01_07_425675	254	18	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	254	19	epitope-421	epitope-421	XX
10_1101-2021_01_07_425675	254	20	tagged	tag	VBN
10_1101-2021_01_07_425675	254	21	bacterial	bacterial	JJ
10_1101-2021_01_07_425675	254	22	alkaline	alkaline	NN
10_1101-2021_01_07_425675	254	23	phosphatase	phosphatase	NN
10_1101-2021_01_07_425675	254	24	using	use	VBG
10_1101-2021_01_07_425675	254	25	a	a	DT
10_1101-2021_01_07_425675	254	26	novel	novel	JJ
10_1101-2021_01_07_425675	254	27	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	254	28	antibody	antibody	NN
10_1101-2021_01_07_425675	254	29	and	and	CC
10_1101-2021_01_07_425675	254	30	peptide	peptide	JJ
10_1101-2021_01_07_425675	254	31	elution	elution	NN
10_1101-2021_01_07_425675	254	32	.	.	.
10_1101-2021_01_07_425675	255	1	422	422	CD
10_1101-2021_01_07_425675	255	2	Biotechniques	biotechnique	NNS
10_1101-2021_01_07_425675	255	3	1994	1994	CD
10_1101-2021_01_07_425675	255	4	,	,	,
10_1101-2021_01_07_425675	255	5	16	16	CD
10_1101-2021_01_07_425675	255	6	(	(	-LRB-
10_1101-2021_01_07_425675	255	7	4	4	CD
10_1101-2021_01_07_425675	255	8	)	)	-RRB-
10_1101-2021_01_07_425675	255	9	,	,	,
10_1101-2021_01_07_425675	255	10	730	730	CD
10_1101-2021_01_07_425675	255	11	-	-	SYM
10_1101-2021_01_07_425675	255	12	735	735	CD
10_1101-2021_01_07_425675	255	13	.	.	.
10_1101-2021_01_07_425675	256	1	423	423	CD
10_1101-2021_01_07_425675	256	2	25	25	CD
10_1101-2021_01_07_425675	256	3	.	.	.
10_1101-2021_01_07_425675	257	1	Sigma	Sigma	NNP
10_1101-2021_01_07_425675	257	2	-	-	HYPH
10_1101-2021_01_07_425675	257	3	Aldrich	Aldrich	NNP
10_1101-2021_01_07_425675	257	4	anti	anti	JJ
10_1101-2021_01_07_425675	257	5	-	-	JJ
10_1101-2021_01_07_425675	257	6	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	257	7	-	-	HYPH
10_1101-2021_01_07_425675	257	8	M2	M2	NNP
10_1101-2021_01_07_425675	257	9	F1804	f1804	NN
10_1101-2021_01_07_425675	257	10	product	product	NN
10_1101-2021_01_07_425675	257	11	page	page	NN
10_1101-2021_01_07_425675	257	12	.	.	.
10_1101-2021_01_07_425675	258	1	424	424	CD
10_1101-2021_01_07_425675	258	2	https://www.sigmaaldrich.com/catalog/product/sigma/f1804?lang=en&region=NL	https://www.sigmaaldrich.com/catalog/product/sigma/f1804?lang=en&region=nl	RB
10_1101-2021_01_07_425675	258	3	(	(	-LRB-
10_1101-2021_01_07_425675	258	4	accessed	access	VBN
10_1101-2021_01_07_425675	258	5	05	05	CD
10_1101-2021_01_07_425675	258	6	-	-	SYM
10_1101-2021_01_07_425675	258	7	425	425	CD
10_1101-2021_01_07_425675	258	8	01	01	CD
10_1101-2021_01_07_425675	258	9	-	-	SYM
10_1101-2021_01_07_425675	258	10	2021	2021	CD
10_1101-2021_01_07_425675	258	11	)	)	-RRB-
10_1101-2021_01_07_425675	258	12	.	.	.
10_1101-2021_01_07_425675	259	1	426	426	CD
10_1101-2021_01_07_425675	259	2	26	26	CD
10_1101-2021_01_07_425675	259	3	.	.	.
10_1101-2021_01_07_425675	260	1	Paizs	Paizs	NNP
10_1101-2021_01_07_425675	260	2	,	,	,
10_1101-2021_01_07_425675	260	3	B.	B.	NNP
10_1101-2021_01_07_425675	260	4	;	;	:
10_1101-2021_01_07_425675	260	5	Suhai	Suhai	NNP
10_1101-2021_01_07_425675	260	6	,	,	,
10_1101-2021_01_07_425675	260	7	S.	S.	NNP
10_1101-2021_01_07_425675	260	8	,	,	,
10_1101-2021_01_07_425675	260	9	Fragmentation	Fragmentation	NNP
10_1101-2021_01_07_425675	260	10	pathways	pathway	NNS
10_1101-2021_01_07_425675	260	11	of	of	IN
10_1101-2021_01_07_425675	260	12	protonated	protonate	VBN
10_1101-2021_01_07_425675	260	13	peptides	peptide	NNS
10_1101-2021_01_07_425675	260	14	.	.	.
10_1101-2021_01_07_425675	261	1	Mass	Mass	NNP
10_1101-2021_01_07_425675	261	2	427	427	CD
10_1101-2021_01_07_425675	261	3	spectrometry	spectrometry	NN
10_1101-2021_01_07_425675	261	4	reviews	review	NNS
10_1101-2021_01_07_425675	261	5	2005	2005	CD
10_1101-2021_01_07_425675	261	6	,	,	,
10_1101-2021_01_07_425675	261	7	24	24	CD
10_1101-2021_01_07_425675	261	8	(	(	-LRB-
10_1101-2021_01_07_425675	261	9	4	4	CD
10_1101-2021_01_07_425675	261	10	)	)	-RRB-
10_1101-2021_01_07_425675	261	11	,	,	,
10_1101-2021_01_07_425675	261	12	508	508	CD
10_1101-2021_01_07_425675	261	13	-	-	SYM
10_1101-2021_01_07_425675	261	14	548	548	CD
10_1101-2021_01_07_425675	261	15	.	.	.
10_1101-2021_01_07_425675	262	1	428	428	CD
10_1101-2021_01_07_425675	262	2	27	27	CD
10_1101-2021_01_07_425675	262	3	.	.	.
10_1101-2021_01_07_425675	263	1	Diedrich	Diedrich	NNP
10_1101-2021_01_07_425675	263	2	,	,	,
10_1101-2021_01_07_425675	263	3	J.	J.	NNP
10_1101-2021_01_07_425675	263	4	K.	K.	NNP
10_1101-2021_01_07_425675	263	5	;	;	:
10_1101-2021_01_07_425675	263	6	Pinto	Pinto	NNP
10_1101-2021_01_07_425675	263	7	,	,	,
10_1101-2021_01_07_425675	263	8	A.	a.	NN
10_1101-2021_01_07_425675	263	9	F.	F.	NNP
10_1101-2021_01_07_425675	263	10	;	;	:
10_1101-2021_01_07_425675	263	11	Yates	Yates	NNP
10_1101-2021_01_07_425675	263	12	III	III	NNP
10_1101-2021_01_07_425675	263	13	,	,	,
10_1101-2021_01_07_425675	263	14	J.	J.	NNP
10_1101-2021_01_07_425675	263	15	R.	R.	NNP
10_1101-2021_01_07_425675	263	16	,	,	,
10_1101-2021_01_07_425675	263	17	Energy	Energy	NNP
10_1101-2021_01_07_425675	263	18	dependence	dependence	NN
10_1101-2021_01_07_425675	263	19	of	of	IN
10_1101-2021_01_07_425675	263	20	HCD	HCD	NNP
10_1101-2021_01_07_425675	263	21	on	on	IN
10_1101-2021_01_07_425675	263	22	peptide	peptide	NN
10_1101-2021_01_07_425675	263	23	429	429	CD
10_1101-2021_01_07_425675	263	24	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	263	25	:	:	:
10_1101-2021_01_07_425675	263	26	stepped	step	VBN
10_1101-2021_01_07_425675	263	27	collisional	collisional	JJ
10_1101-2021_01_07_425675	263	28	energy	energy	NN
10_1101-2021_01_07_425675	263	29	finds	find	VBZ
10_1101-2021_01_07_425675	263	30	the	the	DT
10_1101-2021_01_07_425675	263	31	sweet	sweet	JJ
10_1101-2021_01_07_425675	263	32	spot	spot	NN
10_1101-2021_01_07_425675	263	33	.	.	.
10_1101-2021_01_07_425675	264	1	Journal	Journal	NNP
10_1101-2021_01_07_425675	264	2	of	of	IN
10_1101-2021_01_07_425675	264	3	the	the	DT
10_1101-2021_01_07_425675	264	4	American	American	NNP
10_1101-2021_01_07_425675	264	5	Society	Society	NNP
10_1101-2021_01_07_425675	264	6	430	430	CD
10_1101-2021_01_07_425675	264	7	for	for	IN
10_1101-2021_01_07_425675	264	8	Mass	Mass	NNP
10_1101-2021_01_07_425675	264	9	Spectrometry	Spectrometry	NNP
10_1101-2021_01_07_425675	264	10	2013	2013	CD
10_1101-2021_01_07_425675	264	11	,	,	,
10_1101-2021_01_07_425675	264	12	24	24	CD
10_1101-2021_01_07_425675	264	13	(	(	-LRB-
10_1101-2021_01_07_425675	264	14	11	11	CD
10_1101-2021_01_07_425675	264	15	)	)	-RRB-
10_1101-2021_01_07_425675	264	16	,	,	,
10_1101-2021_01_07_425675	264	17	1690	1690	CD
10_1101-2021_01_07_425675	264	18	-	-	SYM
10_1101-2021_01_07_425675	264	19	1699	1699	CD
10_1101-2021_01_07_425675	264	20	.	.	.
10_1101-2021_01_07_425675	265	1	431	431	CD
10_1101-2021_01_07_425675	265	2	28	28	CD
10_1101-2021_01_07_425675	265	3	.	.	.
10_1101-2021_01_07_425675	266	1	Frese	Frese	NNP
10_1101-2021_01_07_425675	266	2	,	,	,
10_1101-2021_01_07_425675	266	3	C.	C.	NNP
10_1101-2021_01_07_425675	266	4	K.	K.	NNP
10_1101-2021_01_07_425675	266	5	;	;	:
10_1101-2021_01_07_425675	266	6	Altelaar	Altelaar	NNP
10_1101-2021_01_07_425675	266	7	,	,	,
10_1101-2021_01_07_425675	266	8	A.	A.	NNP
10_1101-2021_01_07_425675	266	9	M.	M.	NNP
10_1101-2021_01_07_425675	266	10	;	;	:
10_1101-2021_01_07_425675	266	11	van	van	NNP
10_1101-2021_01_07_425675	266	12	den	den	NNP
10_1101-2021_01_07_425675	266	13	Toorn	Toorn	NNP
10_1101-2021_01_07_425675	266	14	,	,	,
10_1101-2021_01_07_425675	266	15	H.	H.	NNP
10_1101-2021_01_07_425675	266	16	;	;	:
10_1101-2021_01_07_425675	266	17	Nolting	Nolting	NNP
10_1101-2021_01_07_425675	266	18	,	,	,
10_1101-2021_01_07_425675	266	19	D.	D.	NNP
10_1101-2021_01_07_425675	266	20	;	;	:
10_1101-2021_01_07_425675	266	21	Griep	Griep	NNP
10_1101-2021_01_07_425675	266	22	-	-	HYPH
10_1101-2021_01_07_425675	266	23	Raming	Raming	NNP
10_1101-2021_01_07_425675	266	24	,	,	,
10_1101-2021_01_07_425675	266	25	J.	J.	NNP
10_1101-2021_01_07_425675	266	26	;	;	:
10_1101-2021_01_07_425675	266	27	Heck	Heck	NNP
10_1101-2021_01_07_425675	266	28	,	,	,
10_1101-2021_01_07_425675	266	29	A.	a.	NN
10_1101-2021_01_07_425675	267	1	432	432	CD
10_1101-2021_01_07_425675	267	2	J.	J.	NNP
10_1101-2021_01_07_425675	267	3	;	;	:
10_1101-2021_01_07_425675	267	4	Mohammed	Mohammed	NNP
10_1101-2021_01_07_425675	267	5	,	,	,
10_1101-2021_01_07_425675	267	6	S.	S.	NNP
10_1101-2021_01_07_425675	267	7	,	,	,
10_1101-2021_01_07_425675	267	8	Toward	toward	IN
10_1101-2021_01_07_425675	267	9	full	full	JJ
10_1101-2021_01_07_425675	267	10	peptide	peptide	NN
10_1101-2021_01_07_425675	267	11	sequence	sequence	NN
10_1101-2021_01_07_425675	267	12	coverage	coverage	NN
10_1101-2021_01_07_425675	267	13	by	by	IN
10_1101-2021_01_07_425675	267	14	dual	dual	JJ
10_1101-2021_01_07_425675	267	15	fragmentation	fragmentation	NN
10_1101-2021_01_07_425675	267	16	combining	combine	VBG
10_1101-2021_01_07_425675	267	17	433	433	CD
10_1101-2021_01_07_425675	267	18	electron	electron	NN
10_1101-2021_01_07_425675	267	19	-	-	HYPH
10_1101-2021_01_07_425675	267	20	transfer	transfer	NN
10_1101-2021_01_07_425675	267	21	and	and	CC
10_1101-2021_01_07_425675	267	22	higher	high	JJR
10_1101-2021_01_07_425675	267	23	-	-	HYPH
10_1101-2021_01_07_425675	267	24	energy	energy	NN
10_1101-2021_01_07_425675	267	25	collision	collision	NN
10_1101-2021_01_07_425675	267	26	dissociation	dissociation	NN
10_1101-2021_01_07_425675	267	27	tandem	tandem	NNP
10_1101-2021_01_07_425675	267	28	mass	mass	NNP
10_1101-2021_01_07_425675	267	29	spectrometry	spectrometry	NNP
10_1101-2021_01_07_425675	267	30	.	.	.
10_1101-2021_01_07_425675	268	1	Analytical	analytical	JJ
10_1101-2021_01_07_425675	268	2	434	434	CD
10_1101-2021_01_07_425675	268	3	chemistry	chemistry	NN
10_1101-2021_01_07_425675	268	4	2012	2012	CD
10_1101-2021_01_07_425675	268	5	,	,	,
10_1101-2021_01_07_425675	268	6	84	84	CD
10_1101-2021_01_07_425675	268	7	(	(	-LRB-
10_1101-2021_01_07_425675	268	8	22	22	CD
10_1101-2021_01_07_425675	268	9	)	)	-RRB-
10_1101-2021_01_07_425675	268	10	,	,	,
10_1101-2021_01_07_425675	268	11	9668	9668	CD
10_1101-2021_01_07_425675	268	12	-	-	SYM
10_1101-2021_01_07_425675	268	13	9673	9673	CD
10_1101-2021_01_07_425675	268	14	.	.	.
10_1101-2021_01_07_425675	269	1	435	435	CD
10_1101-2021_01_07_425675	269	2	29	29	CD
10_1101-2021_01_07_425675	269	3	.	.	.
10_1101-2021_01_07_425675	270	1	Frese	Frese	NNP
10_1101-2021_01_07_425675	270	2	,	,	,
10_1101-2021_01_07_425675	270	3	C.	C.	NNP
10_1101-2021_01_07_425675	270	4	K.	K.	NNP
10_1101-2021_01_07_425675	270	5	;	;	:
10_1101-2021_01_07_425675	270	6	Zhou	Zhou	NNP
10_1101-2021_01_07_425675	270	7	,	,	,
10_1101-2021_01_07_425675	270	8	H.	H.	NNP
10_1101-2021_01_07_425675	270	9	;	;	:
10_1101-2021_01_07_425675	270	10	Taus	Taus	NNP
10_1101-2021_01_07_425675	270	11	,	,	,
10_1101-2021_01_07_425675	270	12	T.	t.	NN
10_1101-2021_01_07_425675	270	13	;	;	:
10_1101-2021_01_07_425675	270	14	Altelaar	Altelaar	NNP
10_1101-2021_01_07_425675	270	15	,	,	,
10_1101-2021_01_07_425675	270	16	A.	a.	NN
10_1101-2021_01_07_425675	270	17	M.	M.	NNP
10_1101-2021_01_07_425675	270	18	;	;	:
10_1101-2021_01_07_425675	270	19	Mechtler	Mechtler	NNP
10_1101-2021_01_07_425675	270	20	,	,	,
10_1101-2021_01_07_425675	270	21	K.	K.	NNP
10_1101-2021_01_07_425675	270	22	;	;	:
10_1101-2021_01_07_425675	270	23	Heck	heck	UH
10_1101-2021_01_07_425675	270	24	,	,	,
10_1101-2021_01_07_425675	270	25	A.	A.	NNP
10_1101-2021_01_07_425675	270	26	J.	J.	NNP
10_1101-2021_01_07_425675	270	27	;	;	:
10_1101-2021_01_07_425675	270	28	Mohammed	Mohammed	NNP
10_1101-2021_01_07_425675	270	29	,	,	,
10_1101-2021_01_07_425675	270	30	436	436	CD
10_1101-2021_01_07_425675	270	31	S.	S.	NNP
10_1101-2021_01_07_425675	270	32	,	,	,
10_1101-2021_01_07_425675	270	33	Unambiguous	unambiguous	JJ
10_1101-2021_01_07_425675	270	34	phosphosite	phosphosite	NN
10_1101-2021_01_07_425675	270	35	localization	localization	NN
10_1101-2021_01_07_425675	270	36	using	use	VBG
10_1101-2021_01_07_425675	270	37	electron	electron	NN
10_1101-2021_01_07_425675	270	38	-	-	HYPH
10_1101-2021_01_07_425675	270	39	transfer	transfer	NN
10_1101-2021_01_07_425675	270	40	/	/	SYM
10_1101-2021_01_07_425675	270	41	higher	high	JJR
10_1101-2021_01_07_425675	270	42	-	-	HYPH
10_1101-2021_01_07_425675	270	43	energy	energy	NN
10_1101-2021_01_07_425675	270	44	collision	collision	NN
10_1101-2021_01_07_425675	270	45	437	437	CD
10_1101-2021_01_07_425675	270	46	dissociation	dissociation	NN
10_1101-2021_01_07_425675	270	47	(	(	-LRB-
10_1101-2021_01_07_425675	270	48	EThcD	EThcD	NNP
10_1101-2021_01_07_425675	270	49	)	)	-RRB-
10_1101-2021_01_07_425675	270	50	.	.	.
10_1101-2021_01_07_425675	271	1	Journal	Journal	NNP
10_1101-2021_01_07_425675	271	2	of	of	IN
10_1101-2021_01_07_425675	271	3	proteome	proteome	NNP
10_1101-2021_01_07_425675	271	4	research	research	NN
10_1101-2021_01_07_425675	271	5	2013	2013	CD
10_1101-2021_01_07_425675	271	6	,	,	,
10_1101-2021_01_07_425675	271	7	12	12	CD
10_1101-2021_01_07_425675	271	8	(	(	-LRB-
10_1101-2021_01_07_425675	271	9	3	3	CD
10_1101-2021_01_07_425675	271	10	)	)	-RRB-
10_1101-2021_01_07_425675	271	11	,	,	,
10_1101-2021_01_07_425675	271	12	1520	1520	CD
10_1101-2021_01_07_425675	271	13	-	-	SYM
10_1101-2021_01_07_425675	271	14	1525	1525	CD
10_1101-2021_01_07_425675	271	15	.	.	.
10_1101-2021_01_07_425675	272	1	438	438	CD
10_1101-2021_01_07_425675	272	2	30	30	CD
10_1101-2021_01_07_425675	272	3	.	.	.
10_1101-2021_01_07_425675	273	1	Carter	Carter	NNP
10_1101-2021_01_07_425675	273	2	,	,	,
10_1101-2021_01_07_425675	273	3	P.	P.	NNP
10_1101-2021_01_07_425675	273	4	;	;	:
10_1101-2021_01_07_425675	273	5	Presta	Presta	NNP
10_1101-2021_01_07_425675	273	6	,	,	,
10_1101-2021_01_07_425675	273	7	L.	L.	NNP
10_1101-2021_01_07_425675	273	8	;	;	:
10_1101-2021_01_07_425675	273	9	Gorman	Gorman	NNP
10_1101-2021_01_07_425675	273	10	,	,	,
10_1101-2021_01_07_425675	273	11	C.	C.	NNP
10_1101-2021_01_07_425675	273	12	M.	M.	NNP
10_1101-2021_01_07_425675	273	13	;	;	:
10_1101-2021_01_07_425675	273	14	Ridgway	Ridgway	NNP
10_1101-2021_01_07_425675	273	15	,	,	,
10_1101-2021_01_07_425675	273	16	J.	J.	NNP
10_1101-2021_01_07_425675	273	17	;	;	:
10_1101-2021_01_07_425675	273	18	Henner	Henner	NNP
10_1101-2021_01_07_425675	273	19	,	,	,
10_1101-2021_01_07_425675	273	20	D.	D.	NNP
10_1101-2021_01_07_425675	273	21	;	;	:
10_1101-2021_01_07_425675	273	22	Wong	Wong	NNP
10_1101-2021_01_07_425675	273	23	,	,	,
10_1101-2021_01_07_425675	273	24	W.	W.	NNP
10_1101-2021_01_07_425675	273	25	;	;	:
10_1101-2021_01_07_425675	273	26	Rowland	Rowland	NNP
10_1101-2021_01_07_425675	273	27	,	,	,
10_1101-2021_01_07_425675	273	28	A.	a.	NN
10_1101-2021_01_07_425675	274	1	439	439	CD
10_1101-2021_01_07_425675	274	2	M.	M.	NNP
10_1101-2021_01_07_425675	274	3	;	;	:
10_1101-2021_01_07_425675	274	4	Kotts	Kotts	NNP
10_1101-2021_01_07_425675	274	5	,	,	,
10_1101-2021_01_07_425675	274	6	C.	C.	NNP
10_1101-2021_01_07_425675	274	7	;	;	:
10_1101-2021_01_07_425675	274	8	Carver	Carver	NNP
10_1101-2021_01_07_425675	274	9	,	,	,
10_1101-2021_01_07_425675	274	10	M.	M.	NNP
10_1101-2021_01_07_425675	274	11	E.	E.	NNP
10_1101-2021_01_07_425675	274	12	;	;	:
10_1101-2021_01_07_425675	274	13	Shepard	Shepard	NNP
10_1101-2021_01_07_425675	274	14	,	,	,
10_1101-2021_01_07_425675	274	15	H.	H.	NNP
10_1101-2021_01_07_425675	274	16	M.	M.	NNP
10_1101-2021_01_07_425675	274	17	,	,	,
10_1101-2021_01_07_425675	274	18	Humanization	Humanization	NNP
10_1101-2021_01_07_425675	274	19	of	of	IN
10_1101-2021_01_07_425675	274	20	an	an	DT
10_1101-2021_01_07_425675	274	21	anti	anti	NN
10_1101-2021_01_07_425675	274	22	-	-	JJ
10_1101-2021_01_07_425675	274	23	p185HER2	p185her2	JJ
10_1101-2021_01_07_425675	274	24	antibody	antibody	NN
10_1101-2021_01_07_425675	274	25	for	for	IN
10_1101-2021_01_07_425675	274	26	440	440	CD
10_1101-2021_01_07_425675	274	27	human	human	JJ
10_1101-2021_01_07_425675	274	28	cancer	cancer	NN
10_1101-2021_01_07_425675	274	29	therapy	therapy	NN
10_1101-2021_01_07_425675	274	30	.	.	.
10_1101-2021_01_07_425675	275	1	Proceedings	proceeding	NNS
10_1101-2021_01_07_425675	275	2	of	of	IN
10_1101-2021_01_07_425675	275	3	the	the	DT
10_1101-2021_01_07_425675	275	4	National	National	NNP
10_1101-2021_01_07_425675	275	5	Academy	Academy	NNP
10_1101-2021_01_07_425675	275	6	of	of	IN
10_1101-2021_01_07_425675	275	7	Sciences	Sciences	NNPS
10_1101-2021_01_07_425675	275	8	1992	1992	CD
10_1101-2021_01_07_425675	275	9	,	,	,
10_1101-2021_01_07_425675	275	10	89	89	CD
10_1101-2021_01_07_425675	275	11	(	(	-LRB-
10_1101-2021_01_07_425675	275	12	10	10	CD
10_1101-2021_01_07_425675	275	13	)	)	-RRB-
10_1101-2021_01_07_425675	275	14	,	,	,
10_1101-2021_01_07_425675	275	15	4285	4285	CD
10_1101-2021_01_07_425675	275	16	-	-	SYM
10_1101-2021_01_07_425675	275	17	441	441	CD
10_1101-2021_01_07_425675	275	18	4289	4289	CD
10_1101-2021_01_07_425675	275	19	.	.	.
10_1101-2021_01_07_425675	276	1	442	442	CD
10_1101-2021_01_07_425675	276	2	31	31	CD
10_1101-2021_01_07_425675	276	3	.	.	.
10_1101-2021_01_07_425675	277	1	Slamon	Slamon	NNP
10_1101-2021_01_07_425675	277	2	,	,	,
10_1101-2021_01_07_425675	277	3	D.	D.	NNP
10_1101-2021_01_07_425675	277	4	J.	J.	NNP
10_1101-2021_01_07_425675	277	5	;	;	:
10_1101-2021_01_07_425675	277	6	Leyland	Leyland	NNP
10_1101-2021_01_07_425675	277	7	-	-	HYPH
10_1101-2021_01_07_425675	277	8	Jones	Jones	NNP
10_1101-2021_01_07_425675	277	9	,	,	,
10_1101-2021_01_07_425675	277	10	B.	B.	NNP
10_1101-2021_01_07_425675	277	11	;	;	:
10_1101-2021_01_07_425675	277	12	Shak	Shak	NNP
10_1101-2021_01_07_425675	277	13	,	,	,
10_1101-2021_01_07_425675	277	14	S.	S.	NNP
10_1101-2021_01_07_425675	277	15	;	;	:
10_1101-2021_01_07_425675	277	16	Fuchs	Fuchs	NNP
10_1101-2021_01_07_425675	277	17	,	,	,
10_1101-2021_01_07_425675	277	18	H.	H.	NNP
10_1101-2021_01_07_425675	277	19	;	;	:
10_1101-2021_01_07_425675	277	20	Paton	Paton	NNP
10_1101-2021_01_07_425675	277	21	,	,	,
10_1101-2021_01_07_425675	277	22	V.	V.	NNP
10_1101-2021_01_07_425675	277	23	;	;	:
10_1101-2021_01_07_425675	277	24	Bajamonde	Bajamonde	NNP
10_1101-2021_01_07_425675	277	25	,	,	,
10_1101-2021_01_07_425675	277	26	A.	a.	NN
10_1101-2021_01_07_425675	277	27	;	;	:
10_1101-2021_01_07_425675	277	28	443	443	CD
10_1101-2021_01_07_425675	277	29	Fleming	Fleming	NNP
10_1101-2021_01_07_425675	277	30	,	,	,
10_1101-2021_01_07_425675	277	31	T.	T.	NNP
10_1101-2021_01_07_425675	277	32	;	;	:
10_1101-2021_01_07_425675	277	33	Eiermann	Eiermann	NNP
10_1101-2021_01_07_425675	277	34	,	,	,
10_1101-2021_01_07_425675	277	35	W.	W.	NNP
10_1101-2021_01_07_425675	277	36	;	;	:
10_1101-2021_01_07_425675	277	37	Wolter	Wolter	NNP
10_1101-2021_01_07_425675	277	38	,	,	,
10_1101-2021_01_07_425675	277	39	J.	J.	NNP
10_1101-2021_01_07_425675	277	40	;	;	:
10_1101-2021_01_07_425675	277	41	Pegram	Pegram	NNP
10_1101-2021_01_07_425675	277	42	,	,	,
10_1101-2021_01_07_425675	277	43	M.	M.	NNP
10_1101-2021_01_07_425675	277	44	,	,	,
10_1101-2021_01_07_425675	277	45	Use	Use	NNP
10_1101-2021_01_07_425675	277	46	of	of	IN
10_1101-2021_01_07_425675	277	47	chemotherapy	chemotherapy	NN
10_1101-2021_01_07_425675	277	48	plus	plus	CC
10_1101-2021_01_07_425675	277	49	a	a	DT
10_1101-2021_01_07_425675	277	50	monoclonal	monoclonal	JJ
10_1101-2021_01_07_425675	277	51	444	444	CD
10_1101-2021_01_07_425675	277	52	antibody	antibody	NN
10_1101-2021_01_07_425675	277	53	against	against	IN
10_1101-2021_01_07_425675	277	54	HER2	HER2	NNP
10_1101-2021_01_07_425675	277	55	for	for	IN
10_1101-2021_01_07_425675	277	56	metastatic	metastatic	JJ
10_1101-2021_01_07_425675	277	57	breast	breast	NN
10_1101-2021_01_07_425675	277	58	cancer	cancer	NN
10_1101-2021_01_07_425675	277	59	that	that	WDT
10_1101-2021_01_07_425675	277	60	overexpresses	overexpresse	VBZ
10_1101-2021_01_07_425675	277	61	HER2	HER2	NNP
10_1101-2021_01_07_425675	277	62	.	.	.
10_1101-2021_01_07_425675	278	1	New	New	NNP
10_1101-2021_01_07_425675	278	2	England	England	NNP
10_1101-2021_01_07_425675	278	3	445	445	CD
10_1101-2021_01_07_425675	278	4	journal	journal	NN
10_1101-2021_01_07_425675	278	5	of	of	IN
10_1101-2021_01_07_425675	278	6	medicine	medicine	NNP
10_1101-2021_01_07_425675	278	7	2001	2001	CD
10_1101-2021_01_07_425675	278	8	,	,	,
10_1101-2021_01_07_425675	278	9	344	344	CD
10_1101-2021_01_07_425675	278	10	(	(	-LRB-
10_1101-2021_01_07_425675	278	11	11	11	CD
10_1101-2021_01_07_425675	278	12	)	)	-RRB-
10_1101-2021_01_07_425675	278	13	,	,	,
10_1101-2021_01_07_425675	278	14	783	783	CD
10_1101-2021_01_07_425675	278	15	-	-	SYM
10_1101-2021_01_07_425675	278	16	792	792	CD
10_1101-2021_01_07_425675	278	17	.	.	.
10_1101-2021_01_07_425675	279	1	446	446	CD
10_1101-2021_01_07_425675	279	2	32	32	CD
10_1101-2021_01_07_425675	279	3	.	.	.
10_1101-2021_01_07_425675	280	1	Einhauer	einhauer	VB
10_1101-2021_01_07_425675	280	2	,	,	,
10_1101-2021_01_07_425675	280	3	A.	a.	NN
10_1101-2021_01_07_425675	280	4	;	;	:
10_1101-2021_01_07_425675	280	5	Jungbauer	Jungbauer	NNP
10_1101-2021_01_07_425675	280	6	,	,	,
10_1101-2021_01_07_425675	280	7	A.	a.	NN
10_1101-2021_01_07_425675	280	8	,	,	,
10_1101-2021_01_07_425675	280	9	The	the	DT
10_1101-2021_01_07_425675	280	10	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	280	11	™	™	CD
10_1101-2021_01_07_425675	280	12	peptide	peptide	NN
10_1101-2021_01_07_425675	280	13	,	,	,
10_1101-2021_01_07_425675	280	14	a	a	DT
10_1101-2021_01_07_425675	280	15	versatile	versatile	JJ
10_1101-2021_01_07_425675	280	16	fusion	fusion	NN
10_1101-2021_01_07_425675	280	17	tag	tag	NN
10_1101-2021_01_07_425675	280	18	for	for	IN
10_1101-2021_01_07_425675	280	19	the	the	DT
10_1101-2021_01_07_425675	280	20	447	447	CD
10_1101-2021_01_07_425675	280	21	purification	purification	NN
10_1101-2021_01_07_425675	280	22	of	of	IN
10_1101-2021_01_07_425675	280	23	recombinant	recombinant	JJ
10_1101-2021_01_07_425675	280	24	proteins	protein	NNS
10_1101-2021_01_07_425675	280	25	.	.	.
10_1101-2021_01_07_425675	281	1	Journal	Journal	NNP
10_1101-2021_01_07_425675	281	2	of	of	IN
10_1101-2021_01_07_425675	281	3	biochemical	biochemical	JJ
10_1101-2021_01_07_425675	281	4	and	and	CC
10_1101-2021_01_07_425675	281	5	biophysical	biophysical	JJ
10_1101-2021_01_07_425675	281	6	methods	method	NNS
10_1101-2021_01_07_425675	281	7	2001	2001	CD
10_1101-2021_01_07_425675	281	8	,	,	,
10_1101-2021_01_07_425675	281	9	49	49	CD
10_1101-2021_01_07_425675	281	10	448	448	CD
10_1101-2021_01_07_425675	281	11	(	(	-LRB-
10_1101-2021_01_07_425675	281	12	1	1	CD
10_1101-2021_01_07_425675	281	13	-	-	SYM
10_1101-2021_01_07_425675	281	14	3	3	CD
10_1101-2021_01_07_425675	281	15	)	)	-RRB-
10_1101-2021_01_07_425675	281	16	,	,	,
10_1101-2021_01_07_425675	281	17	455	455	CD
10_1101-2021_01_07_425675	281	18	-	-	SYM
10_1101-2021_01_07_425675	281	19	465	465	CD
10_1101-2021_01_07_425675	281	20	.	.	.
10_1101-2021_01_07_425675	282	1	449	449	CD
10_1101-2021_01_07_425675	282	2	.CC	.CC	NFP
10_1101-2021_01_07_425675	282	3	-	-	:
10_1101-2021_01_07_425675	282	4	BY	by	IN
10_1101-2021_01_07_425675	282	5	4.0	4.0	CD
10_1101-2021_01_07_425675	282	6	International	International	NNP
10_1101-2021_01_07_425675	282	7	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	282	8	under	under	IN
10_1101-2021_01_07_425675	282	9	a	a	DT
10_1101-2021_01_07_425675	282	10	(	(	-LRB-
10_1101-2021_01_07_425675	282	11	which	which	WDT
10_1101-2021_01_07_425675	282	12	was	be	VBD
10_1101-2021_01_07_425675	282	13	not	not	RB
10_1101-2021_01_07_425675	282	14	certified	certify	VBN
10_1101-2021_01_07_425675	282	15	by	by	IN
10_1101-2021_01_07_425675	282	16	peer	peer	NN
10_1101-2021_01_07_425675	282	17	review	review	NN
10_1101-2021_01_07_425675	282	18	)	)	-RRB-
10_1101-2021_01_07_425675	282	19	is	be	VBZ
10_1101-2021_01_07_425675	282	20	the	the	DT
10_1101-2021_01_07_425675	282	21	author	author	NN
10_1101-2021_01_07_425675	282	22	/	/	SYM
10_1101-2021_01_07_425675	282	23	funder	funder	NN
10_1101-2021_01_07_425675	282	24	,	,	,
10_1101-2021_01_07_425675	282	25	who	who	WP
10_1101-2021_01_07_425675	282	26	has	have	VBZ
10_1101-2021_01_07_425675	282	27	granted	grant	VBN
10_1101-2021_01_07_425675	282	28	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	282	29	a	a	DT
10_1101-2021_01_07_425675	282	30	license	license	NN
10_1101-2021_01_07_425675	282	31	to	to	TO
10_1101-2021_01_07_425675	282	32	display	display	VB
10_1101-2021_01_07_425675	282	33	the	the	DT
10_1101-2021_01_07_425675	282	34	preprint	preprint	NN
10_1101-2021_01_07_425675	282	35	in	in	IN
10_1101-2021_01_07_425675	282	36	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	282	37	.	.	.
10_1101-2021_01_07_425675	283	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	283	2	is	be	VBZ
10_1101-2021_01_07_425675	283	3	made	make	VBN
10_1101-2021_01_07_425675	283	4	The	the	DT
10_1101-2021_01_07_425675	283	5	copyright	copyright	NN
10_1101-2021_01_07_425675	283	6	holder	holder	NN
10_1101-2021_01_07_425675	283	7	for	for	IN
10_1101-2021_01_07_425675	283	8	this	this	DT
10_1101-2021_01_07_425675	283	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	283	10	version	version	NN
10_1101-2021_01_07_425675	283	11	posted	post	VBD
10_1101-2021_01_07_425675	283	12	January	January	NNP
10_1101-2021_01_07_425675	283	13	8	8	CD
10_1101-2021_01_07_425675	283	14	,	,	,
10_1101-2021_01_07_425675	283	15	2021	2021	CD
10_1101-2021_01_07_425675	283	16	.	.	.
10_1101-2021_01_07_425675	283	17	;	;	:
10_1101-2021_01_07_425675	283	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	283	19	:	:	:
10_1101-2021_01_07_425675	283	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	283	21	preprint	preprint	NN
10_1101-2021_01_07_425675	283	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NNP
10_1101-2021_01_07_425675	283	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD
10_1101-2021_01_07_425675	283	24	17	17	CD
10_1101-2021_01_07_425675	283	25	33	33	CD
10_1101-2021_01_07_425675	283	26	.	.	.
10_1101-2021_01_07_425675	284	1	Roosild	roosild	VB
10_1101-2021_01_07_425675	284	2	,	,	,
10_1101-2021_01_07_425675	284	3	T.	T.	NNP
10_1101-2021_01_07_425675	284	4	P.	P.	NNP
10_1101-2021_01_07_425675	284	5	;	;	:
10_1101-2021_01_07_425675	284	6	Castronovo	Castronovo	NNP
10_1101-2021_01_07_425675	284	7	,	,	,
10_1101-2021_01_07_425675	284	8	S.	S.	NNP
10_1101-2021_01_07_425675	284	9	;	;	:
10_1101-2021_01_07_425675	284	10	Choe	Choe	NNP
10_1101-2021_01_07_425675	284	11	,	,	,
10_1101-2021_01_07_425675	284	12	S.	S.	NNP
10_1101-2021_01_07_425675	284	13	,	,	,
10_1101-2021_01_07_425675	284	14	Structure	Structure	NNP
10_1101-2021_01_07_425675	284	15	of	of	IN
10_1101-2021_01_07_425675	284	16	anti	anti	JJ
10_1101-2021_01_07_425675	284	17	-	-	JJ
10_1101-2021_01_07_425675	284	18	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	284	19	M2	M2	NNP
10_1101-2021_01_07_425675	284	20	Fab	Fab	NNP
10_1101-2021_01_07_425675	284	21	domain	domain	NN
10_1101-2021_01_07_425675	284	22	and	and	CC
10_1101-2021_01_07_425675	284	23	its	-PRON-	PRP$
10_1101-2021_01_07_425675	284	24	450	450	CD
10_1101-2021_01_07_425675	284	25	use	use	NN
10_1101-2021_01_07_425675	284	26	in	in	IN
10_1101-2021_01_07_425675	284	27	the	the	DT
10_1101-2021_01_07_425675	284	28	stabilization	stabilization	NN
10_1101-2021_01_07_425675	284	29	of	of	IN
10_1101-2021_01_07_425675	284	30	engineered	engineer	VBN
10_1101-2021_01_07_425675	284	31	membrane	membrane	NN
10_1101-2021_01_07_425675	284	32	proteins	protein	NNS
10_1101-2021_01_07_425675	284	33	.	.	.
10_1101-2021_01_07_425675	285	1	Acta	Acta	NNP
10_1101-2021_01_07_425675	285	2	Crystallographica	Crystallographica	NNP
10_1101-2021_01_07_425675	285	3	Section	Section	NNP
10_1101-2021_01_07_425675	285	4	F	F	NNP
10_1101-2021_01_07_425675	285	5	:	:	:
10_1101-2021_01_07_425675	285	6	451	451	CD
10_1101-2021_01_07_425675	285	7	Structural	Structural	NNP
10_1101-2021_01_07_425675	285	8	Biology	Biology	NNP
10_1101-2021_01_07_425675	285	9	and	and	CC
10_1101-2021_01_07_425675	285	10	Crystallization	Crystallization	NNP
10_1101-2021_01_07_425675	285	11	Communications	Communications	NNP
10_1101-2021_01_07_425675	285	12	2006	2006	CD
10_1101-2021_01_07_425675	285	13	,	,	,
10_1101-2021_01_07_425675	285	14	62	62	CD
10_1101-2021_01_07_425675	285	15	(	(	-LRB-
10_1101-2021_01_07_425675	285	16	9	9	CD
10_1101-2021_01_07_425675	285	17	)	)	-RRB-
10_1101-2021_01_07_425675	285	18	,	,	,
10_1101-2021_01_07_425675	285	19	835	835	CD
10_1101-2021_01_07_425675	285	20	-	-	SYM
10_1101-2021_01_07_425675	285	21	839	839	CD
10_1101-2021_01_07_425675	285	22	.	.	.
10_1101-2021_01_07_425675	286	1	452	452	CD
10_1101-2021_01_07_425675	286	2	34	34	CD
10_1101-2021_01_07_425675	286	3	.	.	.
10_1101-2021_01_07_425675	287	1	Entzminger	Entzminger	NNP
10_1101-2021_01_07_425675	287	2	,	,	,
10_1101-2021_01_07_425675	287	3	K.	K.	NNP
10_1101-2021_01_07_425675	287	4	C.	C.	NNP
10_1101-2021_01_07_425675	287	5	;	;	:
10_1101-2021_01_07_425675	287	6	Hyun	Hyun	NNP
10_1101-2021_01_07_425675	287	7	,	,	,
10_1101-2021_01_07_425675	287	8	J.-m	J.-m	NNP
10_1101-2021_01_07_425675	287	9	.	.	.
10_1101-2021_01_07_425675	287	10	;	;	:
10_1101-2021_01_07_425675	287	11	Pantazes	Pantazes	NNP
10_1101-2021_01_07_425675	287	12	,	,	,
10_1101-2021_01_07_425675	287	13	R.	R.	NNP
10_1101-2021_01_07_425675	287	14	J.	J.	NNP
10_1101-2021_01_07_425675	287	15	;	;	:
10_1101-2021_01_07_425675	287	16	Patterson	Patterson	NNP
10_1101-2021_01_07_425675	287	17	-	-	HYPH
10_1101-2021_01_07_425675	287	18	Orazem	Orazem	NNP
10_1101-2021_01_07_425675	287	19	,	,	,
10_1101-2021_01_07_425675	287	20	A.	A.	NNP
10_1101-2021_01_07_425675	287	21	C.	C.	NNP
10_1101-2021_01_07_425675	287	22	;	;	:
10_1101-2021_01_07_425675	287	23	Qerqez	Qerqez	NNP
10_1101-2021_01_07_425675	287	24	,	,	,
10_1101-2021_01_07_425675	287	25	A.	a.	NN
10_1101-2021_01_07_425675	287	26	N.	n.	NN
10_1101-2021_01_07_425675	287	27	;	;	:
10_1101-2021_01_07_425675	287	28	453	453	CD
10_1101-2021_01_07_425675	287	29	Frye	Frye	NNP
10_1101-2021_01_07_425675	287	30	,	,	,
10_1101-2021_01_07_425675	287	31	Z.	Z.	NNP
10_1101-2021_01_07_425675	287	32	P.	P.	NNP
10_1101-2021_01_07_425675	287	33	;	;	:
10_1101-2021_01_07_425675	287	34	Hughes	Hughes	NNP
10_1101-2021_01_07_425675	287	35	,	,	,
10_1101-2021_01_07_425675	287	36	R.	R.	NNP
10_1101-2021_01_07_425675	287	37	A.	a.	NN
10_1101-2021_01_07_425675	287	38	;	;	:
10_1101-2021_01_07_425675	287	39	Ellington	Ellington	NNP
10_1101-2021_01_07_425675	287	40	,	,	,
10_1101-2021_01_07_425675	287	41	A.	A.	NNP
10_1101-2021_01_07_425675	287	42	D.	D.	NNP
10_1101-2021_01_07_425675	287	43	;	;	:
10_1101-2021_01_07_425675	287	44	Lieberman	Lieberman	NNP
10_1101-2021_01_07_425675	287	45	,	,	,
10_1101-2021_01_07_425675	287	46	R.	R.	NNP
10_1101-2021_01_07_425675	287	47	L.	L.	NNP
10_1101-2021_01_07_425675	287	48	;	;	:
10_1101-2021_01_07_425675	287	49	Maranas	Maranas	NNP
10_1101-2021_01_07_425675	287	50	,	,	,
10_1101-2021_01_07_425675	287	51	C.	C.	NNP
10_1101-2021_01_07_425675	287	52	D.	D.	NNP
10_1101-2021_01_07_425675	287	53	,	,	,
10_1101-2021_01_07_425675	287	54	De	De	NNP
10_1101-2021_01_07_425675	287	55	novo	novo	NNP
10_1101-2021_01_07_425675	287	56	design	design	NN
10_1101-2021_01_07_425675	287	57	of	of	IN
10_1101-2021_01_07_425675	287	58	454	454	CD
10_1101-2021_01_07_425675	287	59	antibody	antibody	NN
10_1101-2021_01_07_425675	287	60	complementarity	complementarity	NN
10_1101-2021_01_07_425675	287	61	determining	determine	VBG
10_1101-2021_01_07_425675	287	62	regions	region	NNS
10_1101-2021_01_07_425675	287	63	binding	bind	VBG
10_1101-2021_01_07_425675	287	64	a	a	DT
10_1101-2021_01_07_425675	287	65	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	287	66	tetra	tetra	JJ
10_1101-2021_01_07_425675	287	67	-	-	HYPH
10_1101-2021_01_07_425675	287	68	peptide	peptide	JJ
10_1101-2021_01_07_425675	287	69	.	.	.
10_1101-2021_01_07_425675	288	1	Scientific	scientific	JJ
10_1101-2021_01_07_425675	288	2	reports	report	NNS
10_1101-2021_01_07_425675	288	3	455	455	CD
10_1101-2021_01_07_425675	288	4	2017	2017	CD
10_1101-2021_01_07_425675	288	5	,	,	,
10_1101-2021_01_07_425675	288	6	7	7	CD
10_1101-2021_01_07_425675	288	7	(	(	-LRB-
10_1101-2021_01_07_425675	288	8	1	1	CD
10_1101-2021_01_07_425675	288	9	)	)	-RRB-
10_1101-2021_01_07_425675	288	10	,	,	,
10_1101-2021_01_07_425675	288	11	1	1	CD
10_1101-2021_01_07_425675	288	12	-	-	SYM
10_1101-2021_01_07_425675	288	13	11	11	CD
10_1101-2021_01_07_425675	288	14	.	.	.
10_1101-2021_01_07_425675	289	1	456	456	CD
10_1101-2021_01_07_425675	289	2	35	35	CD
10_1101-2021_01_07_425675	289	3	.	.	.
10_1101-2021_01_07_425675	290	1	Ikeda	ikeda	NN
10_1101-2021_01_07_425675	290	2	,	,	,
10_1101-2021_01_07_425675	290	3	K.	K.	NNP
10_1101-2021_01_07_425675	290	4	;	;	:
10_1101-2021_01_07_425675	290	5	Koga	Koga	NNP
10_1101-2021_01_07_425675	290	6	,	,	,
10_1101-2021_01_07_425675	290	7	T.	t.	NN
10_1101-2021_01_07_425675	290	8	;	;	:
10_1101-2021_01_07_425675	290	9	Sasaki	Sasaki	NNP
10_1101-2021_01_07_425675	290	10	,	,	,
10_1101-2021_01_07_425675	290	11	F.	F.	NNP
10_1101-2021_01_07_425675	290	12	;	;	:
10_1101-2021_01_07_425675	290	13	Ueno	Ueno	NNP
10_1101-2021_01_07_425675	290	14	,	,	,
10_1101-2021_01_07_425675	290	15	A.	a.	NN
10_1101-2021_01_07_425675	290	16	;	;	:
10_1101-2021_01_07_425675	290	17	Saeki	Saeki	NNP
10_1101-2021_01_07_425675	290	18	,	,	,
10_1101-2021_01_07_425675	290	19	K.	K.	NNP
10_1101-2021_01_07_425675	290	20	;	;	:
10_1101-2021_01_07_425675	290	21	Okuno	Okuno	NNP
10_1101-2021_01_07_425675	290	22	,	,	,
10_1101-2021_01_07_425675	290	23	T.	T.	NNP
10_1101-2021_01_07_425675	290	24	;	;	:
10_1101-2021_01_07_425675	290	25	Yokomizo	Yokomizo	NNP
10_1101-2021_01_07_425675	290	26	,	,	,
10_1101-2021_01_07_425675	290	27	T.	T.	NNP
10_1101-2021_01_07_425675	290	28	,	,	,
10_1101-2021_01_07_425675	290	29	Generation	Generation	NNP
10_1101-2021_01_07_425675	290	30	457	457	CD
10_1101-2021_01_07_425675	290	31	and	and	CC
10_1101-2021_01_07_425675	290	32	characterization	characterization	NN
10_1101-2021_01_07_425675	290	33	of	of	IN
10_1101-2021_01_07_425675	290	34	a	a	DT
10_1101-2021_01_07_425675	290	35	human	human	JJ
10_1101-2021_01_07_425675	290	36	-	-	HYPH
10_1101-2021_01_07_425675	290	37	mouse	mouse	NN
10_1101-2021_01_07_425675	290	38	chimeric	chimeric	JJ
10_1101-2021_01_07_425675	290	39	high	high	JJ
10_1101-2021_01_07_425675	290	40	-	-	HYPH
10_1101-2021_01_07_425675	290	41	affinity	affinity	NN
10_1101-2021_01_07_425675	290	42	antibody	antibody	NN
10_1101-2021_01_07_425675	290	43	that	that	WDT
10_1101-2021_01_07_425675	290	44	detects	detect	VBZ
10_1101-2021_01_07_425675	290	45	the	the	DT
10_1101-2021_01_07_425675	290	46	458	458	CD
10_1101-2021_01_07_425675	290	47	DYKDDDDK	DYKDDDDK	NNP
10_1101-2021_01_07_425675	290	48	FLAG	FLAG	NNP
10_1101-2021_01_07_425675	290	49	peptide	peptide	NN
10_1101-2021_01_07_425675	290	50	.	.	.
10_1101-2021_01_07_425675	291	1	Biochemical	Biochemical	NNP
10_1101-2021_01_07_425675	291	2	and	and	CC
10_1101-2021_01_07_425675	291	3	Biophysical	Biophysical	NNP
10_1101-2021_01_07_425675	291	4	Research	Research	NNP
10_1101-2021_01_07_425675	291	5	Communications	Communications	NNP
10_1101-2021_01_07_425675	291	6	2017	2017	CD
10_1101-2021_01_07_425675	291	7	,	,	,
10_1101-2021_01_07_425675	291	8	486	486	CD
10_1101-2021_01_07_425675	291	9	459	459	CD
10_1101-2021_01_07_425675	291	10	(	(	-LRB-
10_1101-2021_01_07_425675	291	11	4	4	CD
10_1101-2021_01_07_425675	291	12	)	)	-RRB-
10_1101-2021_01_07_425675	291	13	,	,	,
10_1101-2021_01_07_425675	291	14	1077	1077	CD
10_1101-2021_01_07_425675	291	15	-	-	SYM
10_1101-2021_01_07_425675	291	16	1082	1082	CD
10_1101-2021_01_07_425675	291	17	.	.	.
10_1101-2021_01_07_425675	292	1	460	460	CD
10_1101-2021_01_07_425675	292	2	36	36	CD
10_1101-2021_01_07_425675	292	3	.	.	.
10_1101-2021_01_07_425675	293	1	Lima	Lima	NNP
10_1101-2021_01_07_425675	293	2	,	,	,
10_1101-2021_01_07_425675	293	3	W.	W.	NNP
10_1101-2021_01_07_425675	293	4	C.	C.	NNP
10_1101-2021_01_07_425675	293	5	;	;	:
10_1101-2021_01_07_425675	293	6	Gasteiger	Gasteiger	NNP
10_1101-2021_01_07_425675	293	7	,	,	,
10_1101-2021_01_07_425675	293	8	E.	E.	NNP
10_1101-2021_01_07_425675	293	9	;	;	:
10_1101-2021_01_07_425675	293	10	Marcatili	Marcatili	NNP
10_1101-2021_01_07_425675	293	11	,	,	,
10_1101-2021_01_07_425675	293	12	P.	P.	NNP
10_1101-2021_01_07_425675	293	13	;	;	:
10_1101-2021_01_07_425675	293	14	Duek	Duek	NNP
10_1101-2021_01_07_425675	293	15	,	,	,
10_1101-2021_01_07_425675	293	16	P.	P.	NNP
10_1101-2021_01_07_425675	293	17	;	;	:
10_1101-2021_01_07_425675	293	18	Bairoch	Bairoch	NNP
10_1101-2021_01_07_425675	293	19	,	,	,
10_1101-2021_01_07_425675	293	20	A.	a.	NN
10_1101-2021_01_07_425675	293	21	;	;	:
10_1101-2021_01_07_425675	293	22	Cosson	Cosson	NNP
10_1101-2021_01_07_425675	293	23	,	,	,
10_1101-2021_01_07_425675	293	24	P.	P.	NNP
10_1101-2021_01_07_425675	293	25	,	,	,
10_1101-2021_01_07_425675	293	26	The	the	DT
10_1101-2021_01_07_425675	293	27	ABCD	ABCD	NNP
10_1101-2021_01_07_425675	293	28	461	461	CD
10_1101-2021_01_07_425675	293	29	database	database	NN
10_1101-2021_01_07_425675	293	30	:	:	:
10_1101-2021_01_07_425675	293	31	a	a	DT
10_1101-2021_01_07_425675	293	32	repository	repository	NN
10_1101-2021_01_07_425675	293	33	for	for	IN
10_1101-2021_01_07_425675	293	34	chemically	chemically	RB
10_1101-2021_01_07_425675	293	35	defined	define	VBN
10_1101-2021_01_07_425675	293	36	antibodies	antibody	NNS
10_1101-2021_01_07_425675	293	37	.	.	.
10_1101-2021_01_07_425675	294	1	Nucleic	Nucleic	NNP
10_1101-2021_01_07_425675	294	2	acids	acid	NNS
10_1101-2021_01_07_425675	294	3	research	research	NN
10_1101-2021_01_07_425675	294	4	2020	2020	CD
10_1101-2021_01_07_425675	294	5	,	,	,
10_1101-2021_01_07_425675	294	6	48	48	CD
10_1101-2021_01_07_425675	294	7	(	(	-LRB-
10_1101-2021_01_07_425675	294	8	D1	d1	NN
10_1101-2021_01_07_425675	294	9	)	)	-RRB-
10_1101-2021_01_07_425675	294	10	,	,	,
10_1101-2021_01_07_425675	294	11	462	462	CD
10_1101-2021_01_07_425675	294	12	D261-D264	D261-D264	NNP
10_1101-2021_01_07_425675	294	13	.	.	.
10_1101-2021_01_07_425675	295	1	463	463	CD
10_1101-2021_01_07_425675	295	2	37	37	CD
10_1101-2021_01_07_425675	295	3	.	.	.
10_1101-2021_01_07_425675	296	1	Bondt	Bondt	NNP
10_1101-2021_01_07_425675	296	2	,	,	,
10_1101-2021_01_07_425675	296	3	A.	a.	NN
10_1101-2021_01_07_425675	296	4	;	;	:
10_1101-2021_01_07_425675	296	5	Hoek	Hoek	NNP
10_1101-2021_01_07_425675	296	6	,	,	,
10_1101-2021_01_07_425675	296	7	M.	M.	NNP
10_1101-2021_01_07_425675	296	8	;	;	:
10_1101-2021_01_07_425675	296	9	Tamara	Tamara	NNP
10_1101-2021_01_07_425675	296	10	,	,	,
10_1101-2021_01_07_425675	296	11	S.	S.	NNP
10_1101-2021_01_07_425675	296	12	;	;	:
10_1101-2021_01_07_425675	296	13	de	de	NNP
10_1101-2021_01_07_425675	296	14	Graaf	Graaf	NNP
10_1101-2021_01_07_425675	296	15	,	,	,
10_1101-2021_01_07_425675	296	16	B.	B.	NNP
10_1101-2021_01_07_425675	296	17	;	;	:
10_1101-2021_01_07_425675	296	18	Peng	Peng	NNP
10_1101-2021_01_07_425675	296	19	,	,	,
10_1101-2021_01_07_425675	296	20	W.	W.	NNP
10_1101-2021_01_07_425675	296	21	;	;	:
10_1101-2021_01_07_425675	296	22	Schulte	Schulte	NNP
10_1101-2021_01_07_425675	296	23	,	,	,
10_1101-2021_01_07_425675	296	24	D.	D.	NNP
10_1101-2021_01_07_425675	296	25	;	;	:
10_1101-2021_01_07_425675	296	26	den	den	NNP
10_1101-2021_01_07_425675	296	27	Boer	Boer	NNP
10_1101-2021_01_07_425675	296	28	,	,	,
10_1101-2021_01_07_425675	296	29	M.	M.	NNP
10_1101-2021_01_07_425675	296	30	A.	A.	NNP
10_1101-2021_01_07_425675	296	31	;	;	:
10_1101-2021_01_07_425675	296	32	464	464	CD
10_1101-2021_01_07_425675	296	33	Greisch	Greisch	NNP
10_1101-2021_01_07_425675	296	34	,	,	,
10_1101-2021_01_07_425675	296	35	J.-F.	J.-F.	NNP
10_1101-2021_01_07_425675	296	36	;	;	:
10_1101-2021_01_07_425675	296	37	Varkila	Varkila	NNP
10_1101-2021_01_07_425675	296	38	,	,	,
10_1101-2021_01_07_425675	296	39	M.	M.	NNP
10_1101-2021_01_07_425675	296	40	R.	R.	NNP
10_1101-2021_01_07_425675	296	41	;	;	:
10_1101-2021_01_07_425675	296	42	Snijder	Snijder	NNP
10_1101-2021_01_07_425675	296	43	,	,	,
10_1101-2021_01_07_425675	296	44	J.	J.	NNP
10_1101-2021_01_07_425675	296	45	,	,	,
10_1101-2021_01_07_425675	296	46	Human	Human	NNP
10_1101-2021_01_07_425675	296	47	Plasma	Plasma	NNP
10_1101-2021_01_07_425675	296	48	IgG1	igg1	NN
10_1101-2021_01_07_425675	296	49	Repertoires	repertoire	NNS
10_1101-2021_01_07_425675	296	50	are	be	VBP
10_1101-2021_01_07_425675	296	51	Simple	simple	JJ
10_1101-2021_01_07_425675	296	52	,	,	,
10_1101-2021_01_07_425675	296	53	Unique	Unique	NNP
10_1101-2021_01_07_425675	296	54	,	,	,
10_1101-2021_01_07_425675	296	55	465	465	CD
10_1101-2021_01_07_425675	296	56	and	and	CC
10_1101-2021_01_07_425675	296	57	Dynamic	dynamic	JJ
10_1101-2021_01_07_425675	296	58	.	.	.
10_1101-2021_01_07_425675	297	1	SSRN	SSRN	NNP
10_1101-2021_01_07_425675	297	2	2020	2020	CD
10_1101-2021_01_07_425675	297	3	.	.	.
10_1101-2021_01_07_425675	298	1	466	466	CD
10_1101-2021_01_07_425675	298	2	38	38	CD
10_1101-2021_01_07_425675	298	3	.	.	.
10_1101-2021_01_07_425675	299	1	Ehrenmann	Ehrenmann	NNP
10_1101-2021_01_07_425675	299	2	,	,	,
10_1101-2021_01_07_425675	299	3	F.	F.	NNP
10_1101-2021_01_07_425675	299	4	;	;	:
10_1101-2021_01_07_425675	299	5	Kaas	Kaas	NNP
10_1101-2021_01_07_425675	299	6	,	,	,
10_1101-2021_01_07_425675	299	7	Q.	Q.	NNP
10_1101-2021_01_07_425675	299	8	;	;	:
10_1101-2021_01_07_425675	299	9	Lefranc	Lefranc	NNP
10_1101-2021_01_07_425675	299	10	,	,	,
10_1101-2021_01_07_425675	299	11	M.-P.	M.-P.	NNP
10_1101-2021_01_07_425675	299	12	,	,	,
10_1101-2021_01_07_425675	299	13	IMGT/3Dstructure	IMGT/3Dstructure	NNP
10_1101-2021_01_07_425675	299	14	-	-	HYPH
10_1101-2021_01_07_425675	299	15	DB	DB	NNP
10_1101-2021_01_07_425675	299	16	and	and	CC
10_1101-2021_01_07_425675	299	17	467	467	CD
10_1101-2021_01_07_425675	299	18	IMGT	IMGT	NNS
10_1101-2021_01_07_425675	299	19	/	/	SYM
10_1101-2021_01_07_425675	299	20	DomainGapAlign	domaingapalign	NN
10_1101-2021_01_07_425675	299	21	:	:	:
10_1101-2021_01_07_425675	299	22	a	a	DT
10_1101-2021_01_07_425675	299	23	database	database	NN
10_1101-2021_01_07_425675	299	24	and	and	CC
10_1101-2021_01_07_425675	299	25	a	a	DT
10_1101-2021_01_07_425675	299	26	tool	tool	NN
10_1101-2021_01_07_425675	299	27	for	for	IN
10_1101-2021_01_07_425675	299	28	immunoglobulins	immunoglobulin	NNS
10_1101-2021_01_07_425675	299	29	or	or	CC
10_1101-2021_01_07_425675	299	30	antibodies	antibody	NNS
10_1101-2021_01_07_425675	299	31	,	,	,
10_1101-2021_01_07_425675	299	32	T	T	NNP
10_1101-2021_01_07_425675	299	33	cell	cell	NN
10_1101-2021_01_07_425675	299	34	468	468	CD
10_1101-2021_01_07_425675	299	35	receptors	receptor	NNS
10_1101-2021_01_07_425675	299	36	,	,	,
10_1101-2021_01_07_425675	299	37	MHC	MHC	NNP
10_1101-2021_01_07_425675	299	38	,	,	,
10_1101-2021_01_07_425675	299	39	IgSF	IgSF	NNP
10_1101-2021_01_07_425675	299	40	and	and	CC
10_1101-2021_01_07_425675	299	41	MhcSF	MhcSF	NNP
10_1101-2021_01_07_425675	299	42	.	.	.
10_1101-2021_01_07_425675	300	1	Nucleic	Nucleic	NNP
10_1101-2021_01_07_425675	300	2	acids	acid	NNS
10_1101-2021_01_07_425675	300	3	research	research	NN
10_1101-2021_01_07_425675	300	4	2010	2010	CD
10_1101-2021_01_07_425675	300	5	,	,	,
10_1101-2021_01_07_425675	300	6	38	38	CD
10_1101-2021_01_07_425675	300	7	(	(	-LRB-
10_1101-2021_01_07_425675	300	8	suppl_1	suppl_1	NN
10_1101-2021_01_07_425675	300	9	)	)	-RRB-
10_1101-2021_01_07_425675	300	10	,	,	,
10_1101-2021_01_07_425675	300	11	D301-D307	D301-D307	NNP
10_1101-2021_01_07_425675	300	12	.	.	.
10_1101-2021_01_07_425675	301	1	469	469	CD
10_1101-2021_01_07_425675	301	2	39	39	CD
10_1101-2021_01_07_425675	301	3	.	.	.
10_1101-2021_01_07_425675	302	1	Ehrenmann	Ehrenmann	NNP
10_1101-2021_01_07_425675	302	2	,	,	,
10_1101-2021_01_07_425675	302	3	F.	F.	NNP
10_1101-2021_01_07_425675	302	4	;	;	:
10_1101-2021_01_07_425675	302	5	Lefranc	Lefranc	NNP
10_1101-2021_01_07_425675	302	6	,	,	,
10_1101-2021_01_07_425675	302	7	M.-P.	M.-P.	NNP
10_1101-2021_01_07_425675	302	8	,	,	,
10_1101-2021_01_07_425675	302	9	IMGT	IMGT	NNP
10_1101-2021_01_07_425675	302	10	/	/	SYM
10_1101-2021_01_07_425675	302	11	DomainGapAlign	domaingapalign	NN
10_1101-2021_01_07_425675	302	12	:	:	:
10_1101-2021_01_07_425675	302	13	IMGT	IMGT	NNP
10_1101-2021_01_07_425675	302	14	standardized	standardized	JJ
10_1101-2021_01_07_425675	302	15	analysis	analysis	NN
10_1101-2021_01_07_425675	302	16	of	of	IN
10_1101-2021_01_07_425675	302	17	470	470	CD
10_1101-2021_01_07_425675	302	18	amino	amino	NN
10_1101-2021_01_07_425675	302	19	acid	acid	NN
10_1101-2021_01_07_425675	302	20	sequences	sequence	NNS
10_1101-2021_01_07_425675	302	21	of	of	IN
10_1101-2021_01_07_425675	302	22	variable	variable	JJ
10_1101-2021_01_07_425675	302	23	,	,	,
10_1101-2021_01_07_425675	302	24	constant	constant	JJ
10_1101-2021_01_07_425675	302	25	,	,	,
10_1101-2021_01_07_425675	302	26	and	and	CC
10_1101-2021_01_07_425675	302	27	groove	groove	NN
10_1101-2021_01_07_425675	302	28	domains	domain	NNS
10_1101-2021_01_07_425675	302	29	(	(	-LRB-
10_1101-2021_01_07_425675	302	30	IG	IG	NNP
10_1101-2021_01_07_425675	302	31	,	,	,
10_1101-2021_01_07_425675	302	32	TR	TR	NNP
10_1101-2021_01_07_425675	302	33	,	,	,
10_1101-2021_01_07_425675	302	34	MH	MH	NNP
10_1101-2021_01_07_425675	302	35	,	,	,
10_1101-2021_01_07_425675	302	36	IgSF	IgSF	NNP
10_1101-2021_01_07_425675	302	37	,	,	,
10_1101-2021_01_07_425675	302	38	MhSF	MhSF	NNP
10_1101-2021_01_07_425675	302	39	)	)	-RRB-
10_1101-2021_01_07_425675	302	40	.	.	.
10_1101-2021_01_07_425675	303	1	471	471	CD
10_1101-2021_01_07_425675	303	2	Cold	Cold	NNP
10_1101-2021_01_07_425675	303	3	Spring	Spring	NNP
10_1101-2021_01_07_425675	303	4	Harbor	Harbor	NNP
10_1101-2021_01_07_425675	303	5	Protocols	Protocols	NNP
10_1101-2021_01_07_425675	303	6	2011	2011	CD
10_1101-2021_01_07_425675	303	7	,	,	,
10_1101-2021_01_07_425675	303	8	2011	2011	CD
10_1101-2021_01_07_425675	303	9	(	(	-LRB-
10_1101-2021_01_07_425675	303	10	6	6	CD
10_1101-2021_01_07_425675	303	11	)	)	-RRB-
10_1101-2021_01_07_425675	303	12	,	,	,
10_1101-2021_01_07_425675	303	13	pdb	pdb	NN
10_1101-2021_01_07_425675	303	14	.	.	.
10_1101-2021_01_07_425675	304	1	prot5636	prot5636	LS
10_1101-2021_01_07_425675	304	2	.	.	.
10_1101-2021_01_07_425675	305	1	472	472	CD
10_1101-2021_01_07_425675	305	2	40	40	CD
10_1101-2021_01_07_425675	305	3	.	.	.
10_1101-2021_01_07_425675	306	1	Emsley	Emsley	NNP
10_1101-2021_01_07_425675	306	2	,	,	,
10_1101-2021_01_07_425675	306	3	P.	P.	NNP
10_1101-2021_01_07_425675	306	4	;	;	:
10_1101-2021_01_07_425675	306	5	Cowtan	Cowtan	NNP
10_1101-2021_01_07_425675	306	6	,	,	,
10_1101-2021_01_07_425675	306	7	K.	K.	NNP
10_1101-2021_01_07_425675	306	8	,	,	,
10_1101-2021_01_07_425675	306	9	Coot	Coot	NNP
10_1101-2021_01_07_425675	306	10	:	:	:
10_1101-2021_01_07_425675	306	11	model	model	NN
10_1101-2021_01_07_425675	306	12	-	-	HYPH
10_1101-2021_01_07_425675	306	13	building	building	NN
10_1101-2021_01_07_425675	306	14	tools	tool	NNS
10_1101-2021_01_07_425675	306	15	for	for	IN
10_1101-2021_01_07_425675	306	16	molecular	molecular	JJ
10_1101-2021_01_07_425675	306	17	graphics	graphic	NNS
10_1101-2021_01_07_425675	306	18	.	.	.
10_1101-2021_01_07_425675	307	1	Acta	Acta	NNP
10_1101-2021_01_07_425675	307	2	473	473	CD
10_1101-2021_01_07_425675	307	3	Crystallographica	Crystallographica	NNP
10_1101-2021_01_07_425675	307	4	Section	Section	NNP
10_1101-2021_01_07_425675	307	5	D	D	NNP
10_1101-2021_01_07_425675	307	6	:	:	:
10_1101-2021_01_07_425675	307	7	Biological	biological	JJ
10_1101-2021_01_07_425675	307	8	Crystallography	Crystallography	NNP
10_1101-2021_01_07_425675	307	9	2004	2004	CD
10_1101-2021_01_07_425675	307	10	,	,	,
10_1101-2021_01_07_425675	307	11	60	60	CD
10_1101-2021_01_07_425675	307	12	(	(	-LRB-
10_1101-2021_01_07_425675	307	13	12	12	CD
10_1101-2021_01_07_425675	307	14	)	)	-RRB-
10_1101-2021_01_07_425675	307	15	,	,	,
10_1101-2021_01_07_425675	307	16	2126	2126	CD
10_1101-2021_01_07_425675	307	17	-	-	SYM
10_1101-2021_01_07_425675	307	18	2132	2132	CD
10_1101-2021_01_07_425675	307	19	.	.	.
10_1101-2021_01_07_425675	308	1	474	474	CD
10_1101-2021_01_07_425675	308	2	41	41	CD
10_1101-2021_01_07_425675	308	3	.	.	.
10_1101-2021_01_07_425675	309	1	Afonine	Afonine	NNP
10_1101-2021_01_07_425675	309	2	,	,	,
10_1101-2021_01_07_425675	309	3	P.	P.	NNP
10_1101-2021_01_07_425675	309	4	V.	V.	NNP
10_1101-2021_01_07_425675	309	5	;	;	:
10_1101-2021_01_07_425675	309	6	Grosse	Grosse	NNP
10_1101-2021_01_07_425675	309	7	-	-	HYPH
10_1101-2021_01_07_425675	309	8	Kunstleve	Kunstleve	NNP
10_1101-2021_01_07_425675	309	9	,	,	,
10_1101-2021_01_07_425675	309	10	R.	R.	NNP
10_1101-2021_01_07_425675	309	11	W.	W.	NNP
10_1101-2021_01_07_425675	309	12	;	;	:
10_1101-2021_01_07_425675	309	13	Echols	Echols	NNP
10_1101-2021_01_07_425675	309	14	,	,	,
10_1101-2021_01_07_425675	309	15	N.	N.	NNP
10_1101-2021_01_07_425675	309	16	;	;	:
10_1101-2021_01_07_425675	309	17	Headd	Headd	NNP
10_1101-2021_01_07_425675	309	18	,	,	,
10_1101-2021_01_07_425675	309	19	J.	J.	NNP
10_1101-2021_01_07_425675	309	20	J.	J.	NNP
10_1101-2021_01_07_425675	309	21	;	;	:
10_1101-2021_01_07_425675	309	22	Moriarty	Moriarty	NNP
10_1101-2021_01_07_425675	309	23	,	,	,
10_1101-2021_01_07_425675	309	24	N.	N.	NNP
10_1101-2021_01_07_425675	309	25	W.	W.	NNP
10_1101-2021_01_07_425675	309	26	;	;	:
10_1101-2021_01_07_425675	309	27	475	475	CD
10_1101-2021_01_07_425675	309	28	Mustyakimov	Mustyakimov	NNP
10_1101-2021_01_07_425675	309	29	,	,	,
10_1101-2021_01_07_425675	309	30	M.	M.	NNP
10_1101-2021_01_07_425675	309	31	;	;	:
10_1101-2021_01_07_425675	309	32	Terwilliger	Terwilliger	NNP
10_1101-2021_01_07_425675	309	33	,	,	,
10_1101-2021_01_07_425675	309	34	T.	T.	NNP
10_1101-2021_01_07_425675	309	35	C.	C.	NNP
10_1101-2021_01_07_425675	309	36	;	;	:
10_1101-2021_01_07_425675	309	37	Urzhumtsev	Urzhumtsev	NNP
10_1101-2021_01_07_425675	309	38	,	,	,
10_1101-2021_01_07_425675	309	39	A.	a.	NN
10_1101-2021_01_07_425675	309	40	;	;	:
10_1101-2021_01_07_425675	309	41	Zwart	Zwart	NNP
10_1101-2021_01_07_425675	309	42	,	,	,
10_1101-2021_01_07_425675	309	43	P.	P.	NNP
10_1101-2021_01_07_425675	309	44	H.	H.	NNP
10_1101-2021_01_07_425675	309	45	;	;	:
10_1101-2021_01_07_425675	309	46	Adams	Adams	NNP
10_1101-2021_01_07_425675	309	47	,	,	,
10_1101-2021_01_07_425675	309	48	P.	P.	NNP
10_1101-2021_01_07_425675	309	49	D.	D.	NNP
10_1101-2021_01_07_425675	309	50	,	,	,
10_1101-2021_01_07_425675	309	51	Towards	towards	IN
10_1101-2021_01_07_425675	309	52	476	476	CD
10_1101-2021_01_07_425675	309	53	automated	automate	VBN
10_1101-2021_01_07_425675	309	54	crystallographic	crystallographic	JJ
10_1101-2021_01_07_425675	309	55	structure	structure	NN
10_1101-2021_01_07_425675	309	56	refinement	refinement	NN
10_1101-2021_01_07_425675	309	57	with	with	IN
10_1101-2021_01_07_425675	309	58	phenix	phenix	NNP
10_1101-2021_01_07_425675	309	59	.	.	.
10_1101-2021_01_07_425675	310	1	refine	refine	VB
10_1101-2021_01_07_425675	310	2	.	.	.
10_1101-2021_01_07_425675	311	1	Acta	Acta	NNP
10_1101-2021_01_07_425675	311	2	Crystallographica	Crystallographica	NNP
10_1101-2021_01_07_425675	311	3	477	477	CD
10_1101-2021_01_07_425675	311	4	Section	section	NN
10_1101-2021_01_07_425675	311	5	D	d	NN
10_1101-2021_01_07_425675	311	6	:	:	:
10_1101-2021_01_07_425675	311	7	Biological	Biological	NNP
10_1101-2021_01_07_425675	311	8	Crystallography	Crystallography	NNP
10_1101-2021_01_07_425675	311	9	2012	2012	CD
10_1101-2021_01_07_425675	311	10	,	,	,
10_1101-2021_01_07_425675	311	11	68	68	CD
10_1101-2021_01_07_425675	311	12	(	(	-LRB-
10_1101-2021_01_07_425675	311	13	4	4	CD
10_1101-2021_01_07_425675	311	14	)	)	-RRB-
10_1101-2021_01_07_425675	311	15	,	,	,
10_1101-2021_01_07_425675	311	16	352	352	CD
10_1101-2021_01_07_425675	311	17	-	-	SYM
10_1101-2021_01_07_425675	311	18	367	367	CD
10_1101-2021_01_07_425675	311	19	.	.	.
10_1101-2021_01_07_425675	312	1	478	478	CD
10_1101-2021_01_07_425675	312	2	42	42	CD
10_1101-2021_01_07_425675	312	3	.	.	.
10_1101-2021_01_07_425675	313	1	Chen	Chen	NNP
10_1101-2021_01_07_425675	313	2	,	,	,
10_1101-2021_01_07_425675	313	3	V.	V.	NNP
10_1101-2021_01_07_425675	313	4	B.	B.	NNP
10_1101-2021_01_07_425675	313	5	;	;	:
10_1101-2021_01_07_425675	313	6	Arendall	Arendall	NNP
10_1101-2021_01_07_425675	313	7	,	,	,
10_1101-2021_01_07_425675	313	8	W.	W.	NNP
10_1101-2021_01_07_425675	313	9	B.	B.	NNP
10_1101-2021_01_07_425675	313	10	;	;	:
10_1101-2021_01_07_425675	313	11	Headd	Headd	NNP
10_1101-2021_01_07_425675	313	12	,	,	,
10_1101-2021_01_07_425675	313	13	J.	J.	NNP
10_1101-2021_01_07_425675	313	14	J.	J.	NNP
10_1101-2021_01_07_425675	313	15	;	;	:
10_1101-2021_01_07_425675	313	16	Keedy	Keedy	NNP
10_1101-2021_01_07_425675	313	17	,	,	,
10_1101-2021_01_07_425675	313	18	D.	D.	NNP
10_1101-2021_01_07_425675	313	19	A.	a.	NN
10_1101-2021_01_07_425675	313	20	;	;	:
10_1101-2021_01_07_425675	313	21	Immormino	Immormino	NNP
10_1101-2021_01_07_425675	313	22	,	,	,
10_1101-2021_01_07_425675	313	23	R.	R.	NNP
10_1101-2021_01_07_425675	313	24	M.	M.	NNP
10_1101-2021_01_07_425675	313	25	;	;	:
10_1101-2021_01_07_425675	313	26	Kapral	Kapral	NNP
10_1101-2021_01_07_425675	313	27	,	,	,
10_1101-2021_01_07_425675	313	28	G.	G.	NNP
10_1101-2021_01_07_425675	313	29	479	479	CD
10_1101-2021_01_07_425675	313	30	J.	J.	NNP
10_1101-2021_01_07_425675	313	31	;	;	:
10_1101-2021_01_07_425675	313	32	Murray	Murray	NNP
10_1101-2021_01_07_425675	313	33	,	,	,
10_1101-2021_01_07_425675	313	34	L.	L.	NNP
10_1101-2021_01_07_425675	313	35	W.	W.	NNP
10_1101-2021_01_07_425675	313	36	;	;	:
10_1101-2021_01_07_425675	313	37	Richardson	Richardson	NNP
10_1101-2021_01_07_425675	313	38	,	,	,
10_1101-2021_01_07_425675	313	39	J.	J.	NNP
10_1101-2021_01_07_425675	313	40	S.	S.	NNP
10_1101-2021_01_07_425675	313	41	;	;	:
10_1101-2021_01_07_425675	313	42	Richardson	Richardson	NNP
10_1101-2021_01_07_425675	313	43	,	,	,
10_1101-2021_01_07_425675	313	44	D.	D.	NNP
10_1101-2021_01_07_425675	313	45	C.	C.	NNP
10_1101-2021_01_07_425675	313	46	,	,	,
10_1101-2021_01_07_425675	313	47	MolProbity	MolProbity	NNP
10_1101-2021_01_07_425675	313	48	:	:	:
10_1101-2021_01_07_425675	313	49	all	all	DT
10_1101-2021_01_07_425675	313	50	-	-	HYPH
10_1101-2021_01_07_425675	313	51	atom	atom	NN
10_1101-2021_01_07_425675	313	52	structure	structure	NN
10_1101-2021_01_07_425675	313	53	validation	validation	NN
10_1101-2021_01_07_425675	313	54	480	480	CD
10_1101-2021_01_07_425675	313	55	for	for	IN
10_1101-2021_01_07_425675	313	56	macromolecular	macromolecular	NN
10_1101-2021_01_07_425675	313	57	crystallography	crystallography	NN
10_1101-2021_01_07_425675	313	58	.	.	.
10_1101-2021_01_07_425675	314	1	Acta	Acta	NNP
10_1101-2021_01_07_425675	314	2	Crystallographica	Crystallographica	NNP
10_1101-2021_01_07_425675	314	3	Section	Section	NNP
10_1101-2021_01_07_425675	314	4	D	D	NNP
10_1101-2021_01_07_425675	314	5	:	:	:
10_1101-2021_01_07_425675	314	6	Biological	Biological	NNP
10_1101-2021_01_07_425675	314	7	481	481	CD
10_1101-2021_01_07_425675	314	8	Crystallography	Crystallography	NNP
10_1101-2021_01_07_425675	314	9	2010	2010	CD
10_1101-2021_01_07_425675	314	10	,	,	,
10_1101-2021_01_07_425675	314	11	66	66	CD
10_1101-2021_01_07_425675	314	12	(	(	-LRB-
10_1101-2021_01_07_425675	314	13	1	1	CD
10_1101-2021_01_07_425675	314	14	)	)	-RRB-
10_1101-2021_01_07_425675	314	15	,	,	,
10_1101-2021_01_07_425675	314	16	12	12	CD
10_1101-2021_01_07_425675	314	17	-	-	SYM
10_1101-2021_01_07_425675	314	18	21	21	CD
10_1101-2021_01_07_425675	314	19	.	.	.
10_1101-2021_01_07_425675	315	1	482	482	CD
10_1101-2021_01_07_425675	315	2	43	43	CD
10_1101-2021_01_07_425675	315	3	.	.	.
10_1101-2021_01_07_425675	316	1	Fuglsang	Fuglsang	NNP
10_1101-2021_01_07_425675	316	2	,	,	,
10_1101-2021_01_07_425675	316	3	A.	A.	NNP
10_1101-2021_01_07_425675	316	4	,	,	,
10_1101-2021_01_07_425675	316	5	Codon	Codon	NNP
10_1101-2021_01_07_425675	316	6	optimizer	optimizer	NN
10_1101-2021_01_07_425675	316	7	:	:	:
10_1101-2021_01_07_425675	316	8	a	a	DT
10_1101-2021_01_07_425675	316	9	freeware	freeware	JJ
10_1101-2021_01_07_425675	316	10	tool	tool	NN
10_1101-2021_01_07_425675	316	11	for	for	IN
10_1101-2021_01_07_425675	316	12	codon	codon	NNP
10_1101-2021_01_07_425675	316	13	optimization	optimization	NN
10_1101-2021_01_07_425675	316	14	.	.	.
10_1101-2021_01_07_425675	317	1	Protein	protein	NN
10_1101-2021_01_07_425675	317	2	483	483	CD
10_1101-2021_01_07_425675	317	3	expression	expression	NN
10_1101-2021_01_07_425675	317	4	and	and	CC
10_1101-2021_01_07_425675	317	5	purification	purification	NN
10_1101-2021_01_07_425675	317	6	2003	2003	CD
10_1101-2021_01_07_425675	317	7	,	,	,
10_1101-2021_01_07_425675	317	8	31	31	CD
10_1101-2021_01_07_425675	317	9	(	(	-LRB-
10_1101-2021_01_07_425675	317	10	2	2	CD
10_1101-2021_01_07_425675	317	11	)	)	-RRB-
10_1101-2021_01_07_425675	317	12	,	,	,
10_1101-2021_01_07_425675	317	13	247	247	CD
10_1101-2021_01_07_425675	317	14	-	-	SYM
10_1101-2021_01_07_425675	317	15	249	249	CD
10_1101-2021_01_07_425675	317	16	.	.	.
10_1101-2021_01_07_425675	318	1	484	484	CD
10_1101-2021_01_07_425675	318	2	44	44	CD
10_1101-2021_01_07_425675	318	3	.	.	.
10_1101-2021_01_07_425675	319	1	García	García	NNP
10_1101-2021_01_07_425675	319	2	-	-	HYPH
10_1101-2021_01_07_425675	319	3	Nafría	Nafría	NNP
10_1101-2021_01_07_425675	319	4	,	,	,
10_1101-2021_01_07_425675	319	5	J.	J.	NNP
10_1101-2021_01_07_425675	319	6	;	;	:
10_1101-2021_01_07_425675	319	7	Watson	Watson	NNP
10_1101-2021_01_07_425675	319	8	,	,	,
10_1101-2021_01_07_425675	319	9	J.	J.	NNP
10_1101-2021_01_07_425675	319	10	F.	F.	NNP
10_1101-2021_01_07_425675	319	11	;	;	:
10_1101-2021_01_07_425675	319	12	Greger	Greger	NNP
10_1101-2021_01_07_425675	319	13	,	,	,
10_1101-2021_01_07_425675	319	14	I.	I.	NNP
10_1101-2021_01_07_425675	319	15	H.	H.	NNP
10_1101-2021_01_07_425675	319	16	,	,	,
10_1101-2021_01_07_425675	319	17	IVA	IVA	NNP
10_1101-2021_01_07_425675	319	18	cloning	clone	VBG
10_1101-2021_01_07_425675	319	19	:	:	:
10_1101-2021_01_07_425675	319	20	a	a	DT
10_1101-2021_01_07_425675	319	21	single	single	JJ
10_1101-2021_01_07_425675	319	22	-	-	HYPH
10_1101-2021_01_07_425675	319	23	tube	tube	NN
10_1101-2021_01_07_425675	319	24	universal	universal	NNP
10_1101-2021_01_07_425675	319	25	485	485	CD
10_1101-2021_01_07_425675	319	26	cloning	clone	VBG
10_1101-2021_01_07_425675	319	27	system	system	NN
10_1101-2021_01_07_425675	319	28	exploiting	exploit	VBG
10_1101-2021_01_07_425675	319	29	bacterial	bacterial	JJ
10_1101-2021_01_07_425675	319	30	in	in	IN
10_1101-2021_01_07_425675	319	31	vivo	vivo	NNP
10_1101-2021_01_07_425675	319	32	assembly	assembly	NNP
10_1101-2021_01_07_425675	319	33	.	.	.
10_1101-2021_01_07_425675	320	1	Scientific	scientific	JJ
10_1101-2021_01_07_425675	320	2	reports	report	NNS
10_1101-2021_01_07_425675	320	3	2016	2016	CD
10_1101-2021_01_07_425675	320	4	,	,	,
10_1101-2021_01_07_425675	320	5	6	6	CD
10_1101-2021_01_07_425675	320	6	,	,	,
10_1101-2021_01_07_425675	320	7	27459	27459	CD
10_1101-2021_01_07_425675	320	8	.	.	.
10_1101-2021_01_07_425675	321	1	486	486	CD
10_1101-2021_01_07_425675	321	2	487	487	CD
10_1101-2021_01_07_425675	321	3	488	488	CD
10_1101-2021_01_07_425675	321	4	.CC	.CC	:
10_1101-2021_01_07_425675	321	5	-	-	:
10_1101-2021_01_07_425675	321	6	BY	by	IN
10_1101-2021_01_07_425675	321	7	4.0	4.0	CD
10_1101-2021_01_07_425675	321	8	International	International	NNP
10_1101-2021_01_07_425675	321	9	licenseavailable	licenseavailable	NN
10_1101-2021_01_07_425675	321	10	under	under	IN
10_1101-2021_01_07_425675	321	11	a	a	DT
10_1101-2021_01_07_425675	321	12	(	(	-LRB-
10_1101-2021_01_07_425675	321	13	which	which	WDT
10_1101-2021_01_07_425675	321	14	was	be	VBD
10_1101-2021_01_07_425675	321	15	not	not	RB
10_1101-2021_01_07_425675	321	16	certified	certify	VBN
10_1101-2021_01_07_425675	321	17	by	by	IN
10_1101-2021_01_07_425675	321	18	peer	peer	NN
10_1101-2021_01_07_425675	321	19	review	review	NN
10_1101-2021_01_07_425675	321	20	)	)	-RRB-
10_1101-2021_01_07_425675	321	21	is	be	VBZ
10_1101-2021_01_07_425675	321	22	the	the	DT
10_1101-2021_01_07_425675	321	23	author	author	NN
10_1101-2021_01_07_425675	321	24	/	/	SYM
10_1101-2021_01_07_425675	321	25	funder	funder	NN
10_1101-2021_01_07_425675	321	26	,	,	,
10_1101-2021_01_07_425675	321	27	who	who	WP
10_1101-2021_01_07_425675	321	28	has	have	VBZ
10_1101-2021_01_07_425675	321	29	granted	grant	VBN
10_1101-2021_01_07_425675	321	30	bioRxiv	biorxiv	IN
10_1101-2021_01_07_425675	321	31	a	a	DT
10_1101-2021_01_07_425675	321	32	license	license	NN
10_1101-2021_01_07_425675	321	33	to	to	TO
10_1101-2021_01_07_425675	321	34	display	display	VB
10_1101-2021_01_07_425675	321	35	the	the	DT
10_1101-2021_01_07_425675	321	36	preprint	preprint	NN
10_1101-2021_01_07_425675	321	37	in	in	IN
10_1101-2021_01_07_425675	321	38	perpetuity	perpetuity	NN
10_1101-2021_01_07_425675	321	39	.	.	.
10_1101-2021_01_07_425675	322	1	It	-PRON-	PRP
10_1101-2021_01_07_425675	322	2	is	be	VBZ
10_1101-2021_01_07_425675	322	3	made	make	VBN
10_1101-2021_01_07_425675	322	4	The	the	DT
10_1101-2021_01_07_425675	322	5	copyright	copyright	NN
10_1101-2021_01_07_425675	322	6	holder	holder	NN
10_1101-2021_01_07_425675	322	7	for	for	IN
10_1101-2021_01_07_425675	322	8	this	this	DT
10_1101-2021_01_07_425675	322	9	preprintthis	preprintthis	NN
10_1101-2021_01_07_425675	322	10	version	version	NN
10_1101-2021_01_07_425675	322	11	posted	post	VBD
10_1101-2021_01_07_425675	322	12	January	January	NNP
10_1101-2021_01_07_425675	322	13	8	8	CD
10_1101-2021_01_07_425675	322	14	,	,	,
10_1101-2021_01_07_425675	322	15	2021	2021	CD
10_1101-2021_01_07_425675	322	16	.	.	.
10_1101-2021_01_07_425675	322	17	;	;	:
10_1101-2021_01_07_425675	322	18	https://doi.org/10.1101/2021.01.07.425675doi	https://doi.org/10.1101/2021.01.07.425675doi	NN
10_1101-2021_01_07_425675	322	19	:	:	:
10_1101-2021_01_07_425675	322	20	bioRxiv	biorxiv	VB
10_1101-2021_01_07_425675	322	21	preprint	preprint	NN
10_1101-2021_01_07_425675	322	22	https://doi.org/10.1101/2021.01.07.425675	https://doi.org/10.1101/2021.01.07.425675	NN
10_1101-2021_01_07_425675	322	23	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	ADD